The 26th Annual Dr. George Perez Research Colloquium Abstracts of Presentations by Seton Hall University
Seton Hall University
eRepository @ Seton Hall
Petersheim Academic Exposition Petersheim Academic Exposition
4-24-2015
The 26th Annual Dr. George Perez Research
Colloquium Abstracts of Presentations
Seton Hall University
Follow this and additional works at: https://scholarship.shu.edu/petersheim-exposition
Cover
T H E  2 6 T H  A N N U A L  D R .  G E O R G E  P E R E Z 
R E S E A R C H  C O L L O Q U I U M
ABSTRACTS OF PRESENTATIONS
PRESENTED IN CONJUNCTION WITH THE  
SETON HALL UNIVERSITY PETERSHEIM ACADEMIC EXPOSITION 
2 4  A P R I L  2 0 1 5
EIA for 
GDH Ag 
EIA Toxin 
A/B  
Patients with diarrhea 
and abdominal pain 
N=417 
Toxigenic 
(EIA +)  
C. difficile  
mu taneous y 
Negative  
N=149 
Positive 
N=220 
Positive Negative 
N=0 
Positive EIA 
Toxin A/B 
N=145 
Negative EIA 
Toxin A/B 
PCR for 
toxin B 
gene  
Excluded 
(insufficient data) 
N=48 
EIA (–) 
 C. difficile  
MDAdvantageNow you know…
WE PROVIDE 
VALUE BEYOND INSURANCE.
Want to know more? 
Visit www.MDAdvantageonline.com
100 Franklin Corner Road, Lawrenceville NJ 08648-2104 
888-355-5551
At MDAdvantage®, our mission is to be a
haven of safety, stability and strength for
New Jersey healthcare. We advocate for
physicians and actively support the practice of
medicine in New Jersey. We have earned a
reputation for integrity, responsiveness and
decisive management, and stand prepared
to assist healthcare providers in facing the
challenges associated with today’s changing
healthcare environment.
Exclusive Sponsor of the Perez Research Colloquium
A  H o m e  F o r  t H e  m i n d ,  t H e  H e A r t  A n d  t H e  S p i r i t
School of Health and Medical Sciences
400 South Orange Avenue • South Orange, New Jersey 07079
24 April 2015
 
Dear Colleagues and Students:
It is my distinct pleasure to greet you as you attend the 26th Annual Dr. George Perez Research 
Colloquium of the School of Health and Medical Sciences.
Since 1990, the Research Colloquium has been the vehicle for our faculty, residents, fellows 
and health sciences students to present the results of the scholarly pursuits in which they have 
been engaged. We also enjoy the participation of some of the medical students at the healthcare 
institutions that comprise our graduate medical education consortium. For this year’s Research 
Colloquium, we are also happy to be joined by our colleagues from the Seton Hall College of 
Nursing and Seton Hall’s newest partner in the realm of academic medicine, Hackensack 
University Medical Center.
We welcome, also, our keynote speaker, Danielle Ofri, MD, PhD. Dr. Ofri is an essayist, editor and 
practicing internist at Bellevue Hospital in New York City. Dr. Ofri’s talk will deal with ways and 
means to reinvigorate members of the healthcare team who, all too often, are burdened by the 
many challenges they face on a daily basis.
Once again our program is being sponsored by MDAdvantage Insurance Company of New 
Jersey, a leading provider of medical professional liability insurance in New Jersey. As a company 
committed to investing in the future of New Jersey’s healthcare system, MDAdvantage has been 
an ongoing partner in supporting medical education and encouraging the medical students, 
residents and young physicians of our state to realize their greatest potential.
I would also like to take this opportunity to thank my fellow faculty members who assisted in the 
preparation for today’s event. I would also be remiss if I didn’t recognize the many individuals 
from Seton Hall’s administrative staff for making the Research Colloquium a success. Most of 
all, however, I thank the presenters and their co-authors for sharing the results of their studies 
with us.
Have a wonderful and productive day. 
 
Collegially yours,
Vincent A. DeBari, PhD 
Professor of Medicine and Director of Research 
A  H o m e  F o r  t H e  m i n d ,  t H e  H e A r t  A n d  t H e  S p i r i t
School of Health and Medical Sciences
400 South Orange Avenue • South Orange, New Jersey 07079
24 April 2015 
Dear Colleagues and Students:
Welcome to the School of Health and Medical Sciences’ (SHMS) 26th Annual Dr. George Perez 
Research Colloquium, presented in conjunction with the Seton Hall University Petersheim 
Academic Exposition. I am pleased that you could join us, as it is the collaborative exchange 
of knowledge that makes research and scholarly inquiry exciting. 
Our annual Research Colloquium provides the venue to demonstrate SHMS’ commitment 
to Interprofessional Education (IPE). The Research Colloquium showcases the leading 
research by the medical faculty, residents and fellows from our Division of Medical 
Residencies and Fellowships, as well as faculty and students from our Division of Health 
Sciences. Students and faculty from the University’s Department of Biological Sciences also 
have been regular participants, and I am pleased to welcome the College of Nursing to this 
year’s event.
In recognition of Seton Hall’s recently announced partnership with Hackensack University 
Health Network (HUHN) to create a new school of medicine, I am pleased to welcome our 
colleagues from HUHN to the Research Colloquium. This new partnership, coupled with 
our ongoing legacy partnerships with the other hospitals where our medical residency and 
fellowship programs are based, brings innumerable opportunities for collaboration.
On behalf of all Research Colloquium participants, I extend my sincere thanks to Vincent 
DeBari, PhD, Professor of Medicine and Director of Research, for bringing together the 
nearly 300 platform and poster presentations that we will experience today. I also would 
like to thank the Petersheim Steering Committee, led by Jose Lopez, PhD, and Anthony 
Troha, PhD, co-chairs and assistant professors in the Seton Hall Department of Physics, for 
welcoming our continued participation in the Petersheim Academic Exposition. 
To all of today’s presenters – thank you! Your dedication and scholarship are critical to 
advancing our research mission.
Cordially, 
 
 
 
Brian B. Shulman, PhD, CCC-SLP, ASHA Fellow, BCS-CL, FASAHP 
Dean and Professor of Speech-Language Pathology
P R O G R A M
7:30 a.m. – 8 a.m. .......................................Registration and Continental Breakfast
8 a.m. – 1 p.m. ................................................................................... Poster Session
Basic Medical Sciences (BMS)
Clinical Investigation (CI), except for Oral Presentations, listed on the following page
Clinical Vignettes (CV)
 Health Sciences Research (HSR)
Research in Progress (IP)
NOTE: Posters must be removed at 1:00 p.m.
8:30 a.m. – 10 a.m. .................................................................... Oral Presentations I
10:15 a.m. – 11 a.m. .......................................................................... Invited Speaker
Danielle Ofri, MD, PhD
“Surviving Medicine in the 21st Century”
11 a.m. – 11:30 a.m. ...................................Intermission and Light Refreshments
11:30 a.m. – 1 p.m. ............................................................... Oral Presentations II
NOTE: 	 Throughout this Abstracts of Presentation publication, research denoted with an asterisk (*) indicates that 
 it will be presented orally and not via a poster.
O R A L  P R E S E N T A T I O N S
SESSION I: 8:30 - 10 a.m.
CI 02  Platelet Reactivity Unit in Predicting Risk of Bleeding in Patients Undergoing 
Coronary Artery Bypass Graft Surgery
Altheeb, Z.F.; Isbitan, A.; Shabiah, M.; Hamdan, A.; DeBari, V.; Shamoon, F.
CI 09	 The Characteristics of Rebound Nystagmus in Patients and Normal Subjects
Bhatt, S.H; Patel, K.; Rosenberg, M.L.
CI 18 A Comparison of Transient Elastography (Fibroscan) and The APRI Score, Two 
Non-Invasive Tests for Liver Fibrosis Staging in HIV/HCV Co-Infected Patients
Dazley, J.; Sison, R.; Shukla, P.; Galang, H.; Szabela, E.; Slim, J.; Adebara, A.
CI 33	 Value of Neutrophil to Lymphocyte Ratio as a Predictor of Mortality in Patients 
Undergoing Aortic Valve Replacement
Habib, M.; Thawabi, M.; Habib, H.; Hawatmeh, A.; Elkhalili, W.; Shamoon, F.; Zaher, M.
CI 36 Utility of Brain Natriuretic Peptide Assay in Patients Presenting with Syncope to 
the Emergency Department
Isbitan, A.A.; Altheeb, Z.F.; Patel, K.; Al-Nahar, Y.; Hamdan, A.; Shamoon, F.
INTERMISSION: 11 - 11:30 a.m.
SESSION II: 11:30 a.m. - 1 p.m.
CI 38 The Incident Trends, Epidemiology, Mortality, and Economics Evaluation of 
Vertebral Osteomyelitis in the United States: A Nationwide Inpatient Database 
Study of 283,022 Cases from 1998 to 2010
Issa, K.; Patel, S.; Shafa. E.; Faloon, M.; Sinha, K.; Hwang, K.; Emami, A.
CI 42 Comparison of Thyroid Stimulating Hormone Level and PR Interval in  
Hypothyroid Patients Being Treated with Levothyroxine
Khaddash, I.; Altheeb, Z.; Shahla, L.; Gupta, R.; Sheth, V.; DeBari, V.; Shamoon, F.
CI 67 Laboratory and Clinical Features of EIA Toxin-Positive and EIA Toxin-Negative 
Community-Acquired Clostridium Difficile Infection
Patel, H.; Randhawa, J.; Nanavati, S.; Marton, R.; Baddoura, W.; DeBari, V.
CI 68 Poor Left Atrial Function is associated with Reduced Left Ventricular Ejection 
Fraction in Hospitalized Patients
Patel, H.; Ariyarajah, V.; Haft, J.; Goldfarb, I.; Bikkina, M.; Shamoon, F.
CI 73 ST-Segment Elevation Myocardial Infarction in Octogenarians: 30-day Mortality 
and Peri-Procedural Complications Compared to Younger Adults
Shah, P.; Mechineni, A.; Yamini, S.; Bajaj, S.; Virk, H.; DeBari, V.; Shamoon, F.; Bikkina, M.
AccreditAtion 
Saint Michael’s Medical Center is accredited by the Medical Society of New Jersey to provide continuing medical education for 
physicians.
designAtion	stAtement 
Saint Michael’s designates this educational activity for a maximum of 1 AMA PRA Category I Credit™. Physicians should only 
claim credit commensurate with the extent of their participation in the activity.
disclosure	stAtement 
Saint Michael’s Medical Center is responsible for every aspect of the program it certifies and makes known to the audience 
relevant disclosure information of all those in a position to control content (faculty, planners, moderators, departments heads, 
committee members and others).
I N v I T E d  S P E A k E R
Danielle Ofri, MD, PhD
Dr. Ofri writes regularly for the New York Times about  
medicine and the doctor-patient relationship. Her most recent 
book is What Doctors Feel: How Emotions Affect the Practice 
of Medicine (Beacon Press, 2014). 
Dr. Ofri is an internist at Bellevue Hospital in New York City,  
the oldest public hospital in the country, and an Associate  
Professor of Medicine at New York University School of  
Medicine. She is the Editor-in-Chief of the Bellevue Literary 
Review. Her three other books are Medicine in Translation: 
Journeys with My Patients (Beacon Press, 2011), Incidental 
Findings: Lessons from My Patients in the Art of Medicine 
(Beacon Press, 2006) and Singular Intimacies: Becoming a 
Doctor at Bellevue (Beacon Press, 2009).
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Excerpts from reviews of  
What Doctors Feel  
by Dr. Danielle Ofri:
“Taut, vivid prose … She 
writes for a lay audience 
with a practiced hand.“
— New York Times
“Rich and deeply insightful 
… A fascinating journey into 
the heart and mind of a phy-
sician struggling to do the 
best for her patients while 
navigating an imperfect 
health care system.” 
— Boston Globe
“Surviving Medicine in the 21st Century”
10:15 a.m. 
Richard and Sheila Regan Field House 
Disillusionment in medicine feels like it is reaching epidemic 
proportions. Many medical caregivers say they would never 
choose the field if they had to do it all over again. Medical  
error and burnout seem to be everywhere. 
How do caregivers — and their patients — cope with disillusion-
ment? How do we re-engage ourselves, our colleagues and 
our students? 
It’s probably too soon to close the book on the medical 
profession. Dr. Danielle Ofri discusses how we can survive, 
maybe even thrive, in this new era of medicine. 
BMS01 Syndecan-1 and FGF2 as Stratification Biomarkers for Hodgkin’s Lymphoma
Akl, M.R.; Nagpal, P.; Prabhu, S.; Tai, B.; Gliksman, M.; Hatipoglu, A.; Suh, K.S.
BMS02 The Difference in Time Constant in Patients and Normal Subjects
Bhatt, S.H.; Patel, K.; Shah, Y.; Rosenberg, M.L.
BMS03 Epithelial HIF Plays a Protective Role in Gut Graft Versus Host Disease
Colorado, I.; Dziopa, E.; Dziopa, L.;  Zheng, Y.;  Zilberberg, J.;  Korngold, R.;  Feinman, R.
BMS04 Novel Chromatin Modifying Gene Alterations and Significant Survival 
Association of ATM and TP53 in Mantle Cell Lymphoma 
Goy, A.; Wang, K.; Nahas, M.;  Bhattacharyya, P.;  Miller, V.;  Feldman, T.;  Chow, K.F.
BMS05 A Rare Case of Tortuosity and Lateral Deviation of the Abdominal Aorta
Kirchgessner, A.L.
BMS06 Linguofacial Trunk Arising from a Lateral External Carotid Artery:  
A Rare Anatomic Variant
Kirchgessner, A.L.
BMS07 Alpha-Synuclein Pathology in the Laryngeal Nerves in Parkinson’s Disease 
Mu, L.; Chen, J.; Sobotka, S.
BMS08 Efficacy of Topical Perfluoro(t-butylcyclohexane) (FtBu), Oxygen-Saturated 
Gel in a Model of Delayed Wound Healing: Partial Thickness Burn Wound with 
Pseudomonas Infection in Swine
Ogedegbe, C.; Carlisle, A.; Dave, Parth;  Kaul, S.;  Feldman, J.
BMS09 A Role for MMP-3 in the Modulation of Early T Cell Responses in GVHD
Rosenberg, S.M.; Zilberberg, J.; Korngold, R.
BMS10 Experimental Radiation (2400 MU/min/ 50cGy) In Vitro Achieved Significant  
Increase in Apoptosis on Melanoma Cells with Superior Survival of Normal 
Cells when Compared to 400MU/min
Sarojini, S.; Pecora, A.; Milinovikj, N.; Barbiere, J.; Tuna, M.; Jeong, S.; Jun, J.
BMS11 Modified Nerve-Muscle-Endplate Band Grafting Technique for Muscle 
Reinnervation
Sobotka, S.; Chen, J.; Mu, L.
BMS12 Kallikrein Family Proteases KLK6 and KLK7 are Potential Early Detection 
and Diagnostic Biomarkers for Serous and Papillary Serous Ovarian Cancer 
Subtypes
Tamir, A.; Jag, U.; Sarojini, S.; Blake, P.; Goy, A.;  Pecora, A.; Suh, K.
BMS13 Downregulation of Osteoblastic N-cadherin Decreases Primary Multiple  
Myeloma Cell - Osteoblast Interactions
Zhang, W.; Siegel, D.; Tolias, P.; Lee, W.; Zilberberg, J.
T A b L E  O f  C O N T E N T S
Basic Medical Sciences
CI01 Plasma Volume Contraction Estimated By Hematocrit And Cardiorenal  
Syndrome In Acute Heart Failure
Alattar, F.; Aurshiya, R.; Abualayem, M.; Ford, D.; Shamoon, F.
*CI02 Platelet Reactivity Unit in Predicting Risk of Bleeding in Patients Undergoing 
Coronary Artery Bypass Graft Surgery
Altheeb, Z.F.; Isbitan, A.A.; Shabiah, M.; Hamdan, A.;  DeBari, V.; Shamoon, F.
CI03 Pediatric Appendicitis: Reaching the Finish Line Safely
Avva, U.; Gold, N.; Khan, S.; Reid, K.; Stuart, J.; Themba, N.; Vijayan, R.
CI04 The Use of a Reduced-Intensity Conditioning (RIC) Regimen in Patients Ages 
2-30 Undergoing Allogeneic Transplantation for Sickle Cell Disease
Banugaria, S; Gillio, A.P.; Haugh, J.; Durning, N.; Nycz, M.; Adler-Brecher, B.; Krajewski, J.
CI05 Experience with Norvir 100 mg, Darunavir 800 mg, and Dolutegravir 50 mg  
(r/DRV/DTV) Once A Day In An Inner City Hiv Clinic in Newark, NJ, USA
Barahona, F.; Bhattarai, S.; Slim, J.; Baca, N.; Parker, K.; Al-Saleh, H.; Abd Al Qader, M.
CI06 Are Psychiatric Disorders And Obesity Becoming The Most Prevalent  
Non-Infectious Chronic Comorbid Conditions In Hiv Population?...
Barahona, F.; Bhattarai, S.; Slim, J.; Al-Saleh, H.; Abd Al Qader, M.; Parker, K.; Baca, N.
CI07 The Role of Glutamate and its EAAT Transporters in ADHD and Autism
Bekker, Y.; Allan, H.
CI08 Pharmacokinetic (PK) and Pharmacodynamic (PD) Results of a Novel, First-
in-Class Modulator of Eukaryotic Translation Initiation Factor 5A (eIF5A) in 
Patients (pts) with Relapsed or Refractory B-Cell Malignancies: Data from a 
Phase 1-2 Study
Bexon, B.; Craig, M.; Siegel, D.S.; Bensinger, W.; Novitzky, N.; McDonald, A.; Gutierrez, M.
*CI09 The Charateristics of Rebound Nystagmus in Patients and Normal Subjects
Bhatt, S.H.; Patel, K.; Rosenberg, M.L.
CI10 A Phase IIa, Open-Label, Multicenter Study of Single-Agent MOR00208, an  
Fc-Optimized Anti-CD19 Antibody, in Patients with Relapsed or Refractory  
B-Cell Non-Hodgkin’s Lymphoma
Blum, K.A.; Maddocks, K.; Nagy, Z.; Zinzani, P.L.; Goy, A.;  Provencio, M.; Robak, T.
CI11 TGR-1202, a Novel Once Daily PI3KÎ´ Inhibitor, Demonstrates Clinical Activity 
with a Favorable Safety Profile, Lacking Hepatotoxicity, in Patients with  
Chronic Lymphocytic Leukemia and B-Cell Lymphoma
Burris III, H.A.; Patel, M.R.; Brander, D.; O’Connor, O.A.; Deng, C.; Fenske, T.S.; Gutierrez, M.
CI12 Serious Infections of Hospitalized Patients are Associated with a Higher  
Prevalence of Reported Beta Lactam Antibiotic Allergy
Cai, B.; McGoey, B.A.; Michelis, M.A.
CI13 Compounded Risk Factor for Candida Esophagitis With Concomitant Use of 
Proton Pump Inhibitors and Steroids
Cavanagh, Y.; Shah, N.; DeBari, V.A.; Baddoura, W.
Clinical Investigation
CI14 Selinexor Demonstrates Marked Synergy with Dexamethasone (Sel-Dex) in 
Preclinical Models and in Patients with Heavily Pretreated Refractory Multiple 
Myeloma (MM)
Chen, C.I.; Gutierrez, M.; Siegel, D.S.; Richter, J.R.; Wagner-Johnston, N.; Hofmeister, C.C.; Berdeja, J.G.
CI15 A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-
Treated Systemic Light-Chain (AL) Amyloidosis
Cohen, A.D.; Scott, E.C.; Liedtke, M.; Kaufman, J.L.; Landau, H.; Vesole, D.H.; Gomes, C.L.
CI16 Bendamustine Plus Rituximab (BR) in the Treatment of Relapsed/Refractory 
Mantle Cell Lymphoma of a Phase 2 Study: Multivariate Analysis and Updated 
Final Results By Subgroup
Czuczman, M.; Goy, A.; Lamonica, D.; Graf, D.; Munteanu, M.; Van Der Jagt, R.
CI17 Hepatitis A Vaccine Response in HIV-Infected Patients: The Interchangeability 
of TWINRIX and HAVRIX, a Second Look
Dazley, J.; Jimenez, H.; Szabela, E.; Abdalqadar, M.; Slim, J.
*CI18 A Comparison of Transient Elastography (Fibroscan) and The APRI Score, Two 
Non-Invasive Tests for Liver Fibrosis Staging in HIV/HCV Co-Infected Patients
Dazley, J.; Sison, R.; Shukla, P.; Galang, H.; Szabela, E.; Slim, J.; Adebara, A.
CI19 Haploidentical Allogeneic Transplantation Provides Comparable Outcomes 
to HLA-Matched or Mismatched Unrelated Donor Grafts in Hematological 
Malignancies
Donato, M.; Rowley, S.; Baker, M.; McKiernan, P.; Kim, D.; Vesole, D.; Skarbnik, A.
CI20 Clinical Differences among Hispanics and Non-Hispanic Whites with Colorectal 
Cancer, a Single Institution’s Experience over 20 years.
Duma, N.; Gandhi, A.; Sanchez, L.; Castro, Y.; Jennis, A.; Bamboat, Z.; Gutierrez, M.
CI21 Impact of Thyroid Hormones on Clinical Outcomes in Colorectal Cancer 
Patients
Duma, N.; Streb, G.; Pievsky, D.; Sanchez, L.; Aleksic, S.; Gutierrez, M.
CI22 Amiodarone Protocol Reduces Atrial Fibrillation and Decreases Mortality in 
Cardiac Surgery Patients
Elkhalili, W.; Grinn, M.; Elzomor, W.; Cosenza, R.; Asgarian, K.A; Badami, C.; Connolly, M.
CI23 Brentuximab Vedotin Monotherapy in DLBCL Patients with Undetectable CD30: 
Preliminary Results from a Phase 2 Study
Feldman, T.; Bartlett, N.; Smith, M.; Advani, R.;  Savage, K.; Palanca-Wessels, M.; Siddiqi, T.
CI24 Gray Zone Lymphoma (GZL) with Features Intermediate Between Classical 
Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): Analy-
sis of Tumor Immunophenotype (IP) and Critical Examination of Therapy with 
Associated Impact on Outcome
Feldman, T.; Kritharis, A.; Vose, J.; Gascoyne, R.; Evens, A.; Blum, K.; Mato, A.
CI25 Patient Characteristics and Initial Treatment Patterns in the United States for 
the Most Common Subtypes of Peripheral T-Cell Lymphoma (PTCL)
Feldman, T.F; Pinter-Brown, L.PB; Foss, F.F.; Pro, B.P.; Gisselbrecht, C.G.; Kahl, B.K.; Park, S.P.
CI26 Relapses of Diffuse Large B Cell Lymphoma in Rituximab Era Are Limited to the 
First Two Years After Frontline Therapy
Feldman, T.F; Goy, A.G; Gromko, L.G.; Chow, K.F.C; Bhattacharyya, P.B; Glisch, C.G.; Mato, A.M.
CI27 The Association of Serum Albumin Concentration and Mortality Risk in Acute 
Respiratory Distress Syndrome (ARDS)
Ghazarian, Z.; Mathew, J.J.; Sekhon, R.; Staron, A.; Parikh, N.; Hanna, M.; Khan, M.A.
CI28 Cytogenetic and Molecular Responses in Patients with Chronic-Phase 
Chronic Myeloid Leukemia (CP-CML) in a Prospective Observational Study 
(SIMPLICITY)
Goldberg, S.; Mauro, M.; Gambacorti-Passerini, C.; Cortes, J.; Subar, M.; Mohamed, H.; Zyczynski, T.
CI29 Mature Follow up from a Phase 2 Study of PI3K-Delta Inhibitor Idelalisib in  
Patients with Double (Rituximab and Alkylating Agent)-Refractory Indolent  
B-Cell Non-Hodgkin Lymphoma (iNHL)
Gopal, A.K.; Kahl, B.S.; de Vos, S.; Wagner-Johnston, N.D.;  Schuster, S.J.; Goy, A.H.; Jurczak, W.
CI30 Anti-CD19 CAR T Cells Administered After Low-Dose Chemotherapy Can  
Induce Remissions of Chemotherapy-Refractory Diffuse Large B-Cell 
Lymphoma
Goy, A.G.; Feldman, T.F.; Kochenderfer, J.K.; Rosenberg, S.R.; Klebanoff, C.K.; Sherry, R.S.; Yuan, C.Y.
CI31 Preliminary Results of a Phase I Study of Nivolumab (BMS-936558) in Patients 
with Relapsed or Refractory Lymphoid Malignancies
Gutierrez, M.G.; Lesokhin, A.L; Ansell, S.A.; Timmerman, J.T.
CI32 Nivolumab in Patients with Relapsed or Refractory Hodgkin Lymphoma -  
Preliminary Safety, Efficacy and Biomarker Results of a Phase I Study
Gutierrez, M.G.; Armand, P.A.; Ansell, S.A.; Shipp, M.S.
*CI33 Value of Neutrophil to Lymphocyte Ratio as a Predictor of Mortality in Patients 
Undergoing Aortic Valve Replacement
Habib, M.; Thawabi, M.; Habib, H.; Hawatmeh, A.; ElKhalili, W.; Shamoon, F.; Zaher, M.
CI34 Utility of a Propofol-Based Saline Mixture as a Contrast Agent In Routine  
Transesophageal Echocardiography
Habib, M.; Jmeian, A.; Abualayem, M.; Hawatmeh, A.; Hamdan, A.; Thawabi, M.; Shamoon, F.
CI35 Front-Line, Dose-Escalated Immunochemotherapy is Associated with a  
Significant PFS (but not OS) Advantage in 401 Patients (Pts) with Double-Hit 
Lymphomas (DHL): A Systematic Review and Meta-Analysis
Howlett, C.H.; Mato, A.M; Landsburg, D.L.; Goy, A.G.;  Snedecor, S.S.; Cohen, J.C.; Schuster, S.S.
*CI36 Utility of Brain Natriuretic Peptide Assay in Patients Presenting with Syncope 
to the Emergency Department
Isbitan, A.A.; Altheeb, Z.F.; Patel, K.; Al-Nahar, Y.; Hamdan, A.; Shamoon, F.
CI37 Bariatric Orthopaedics: Total Hip Arthroplasty in the Super-Obese Patients 
(BMI >50 kg/m2), Minimum 5 year Outcomes
Issa, K.; Mcdermott, J.D.; Bartlomiej, C.; Harwin, S.F.; Mont, M.A.; Mcinerney, V.K.; Eifai, A.
*CI38 The Incident Trends, Epidemiology, Mortality, and Economic Evaluation of  
Vertebral Osteomyelitis in the United States: A Nationwide Inpatient Database 
Study of 283,022 Cases from 1998 to 2010
Issa, K.; Patel, S.; Shafa, E.; Faloon, M.; Sinha, K.; Hwang, K.; Emami, A.
CI39 Demographic, Clinical and Treatment Characteristics of the CARRA Registry 
Systemic JIA Cohort
Janow, G.J.; Schanberg, L.E.; Setoguchi, S.; Hasselblad, V.;  Mellins, E.D.; Schneider, R.; Kimura, Y.
CI40 Neurovascular Reconstruction of Ruptured and Non-Ruptured Intracranial 
Blood Blister Aneurysms With the Pipeline Flow Diverter
Karimi, R.J.; Walzman, D.E.; Roth, P.A.
CI41 Indatuximab Ravtansine (BT062) in Combination with Lenalidomide and Low-
Dose Dexamethasone in Patients with Relapsed and/or Refractory Multiple 
Myeloma: Clinical Activity in Patients Already Exposed to Lenalidomide and 
Bortezomib
Kelly David S. Siegel, MD, PhD5, Todd Zimmerman, MD6, Anand Karnad,, K.R.; Chanan-Khan, A.; Heffner, 
L.T.; Somlo, G.; Siegel, D.S.;  Zimmerman, T.; Karnad, A.
*CI42 Comparison of Thyroid Stimulating Hormone Level and PR Interval in  
Hypothyroid Patients Being Treated with Levothyroxine
Khaddash, I.; Altheeb, Z.; Shahla, L.; Gupta, R.; Sheth, V.; DeBari, V.; Shamoon, F.
CI43 Preliminary Results from the Childhood Arthritis and Rheumatology Research 
Alliance Systemic JIA Consensus Treatment Plans Pilot Study
Kimura, Y.; DeWitt, E.M.; Mieszkalski, K.; Schanberg, L.E.
CI44 A Pilot Study to Evaluate the Feasibility of Conducting Juvenile Localized 
Scleroderma Comparative Effectiveness Treatment Studies
Li, S.C.; Torok, K.S.; Becker, M.L.; Dedeoglu, F.D.; Ferguson, P.J.; Fuhlbrigge, R.C.; Higgins, G.C.
CI45 Rituximab (RTX) for the Treatment of Steroid Dependent Nephrotic Syndrome 
(SDNS)
Lieberman, K.V.; Ettinger, L.; Picareli, C.
CI46 Prograf For The Treatment Of Nephrotic Focal Segmental Glomerulosclerosis 
(FSFS) In Children: A Six Year Experience
Lieberman, K.V.; Benchimol, C.; Vergara, M.
CI47 An Emergency Medicine, Education-Based Patient Satisfaction Survey Created 
through Delphi Method Analysis
London, K.S.; Singal, B.; Fowler, J.; Prepejchal, R.; Finefrock, D.C.
CI48 Obesity Paradox In Long Term Survival After Trans-catheter Aortic Valve  
Replacement In Patients With Severe Aortic Stenosis
Mathur, A.P.; Castro-Dominguez, Y.; Vaidya, P.; Cocke, T.; Elmann, E.; Di Luozzo, G.; Parrillo, J.E.
CI49 Prognostic Impact of Improvement in Intra-Operative Pulmonary Artery Sys-
tolic Pressure and Left Ventricular Ejection Fraction in Patients Undergoing 
Trans-Catheter Aortic Valve Replacement
Mathur, A.P.; Castro-Dominguez, Y.; Vaidya, P.; Cocke, T.; Elmann, E.; Di Luozzo, G.; Parrillo, J.E.
CI50 Women Demonstrate Long Term Improvement after Trans-Catheter Aortic 
Valve Replacement in Severe Aortic Stenosis
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BMS01 
Syndecan-1 and FGF2 as Stratification  
Biomarkers for Hodgkin’s Lymphoma 
Akl, M.R.; Nagpal, P.; Prabhu, S.; Tai, B.; Gliksman, M.; 
Hatipoglu, A.; Suh, K.S.; Genomics and Biomarkers Program, 
John Theurer Cancer Center at Hackensack University Medical 
Center, Hackensack, NJ 
introduction: Hodgkin’s lymphoma (HL) is a rare 
lymphoid malignancy with a treatment failure in about 
10% of patients who become refractory to therapy, and 
20-30% of patients who relapse a few years after di-
agnosis. Treatment of poor outcome (PO) HL patients 
remains a challenge as no biomarkers exist to identify 
this patient population. Discovery and validation of 
effective biomarkers for poor outcome HL could save 
substantial medical costs by bringing personalized 
medicine closer and improving treatment outcomes.
metHods: Bioinformatics data mining was used to gen-
erate 151 candidate biomarkers, which were screened 
against a library of 10 HL cell lines. Expression of 
fibroblast growth factor-2 (FGF2) and Syndecan-1 
(SDC1) by CD30+ cells from HL patient samples rep-
resenting good and poor outcomes were analyzed by 
qRT-PCR, immunohistochemical, and immunofluo-
rescence analyses.
results: Boinformatics data mining results identi-
fied 151 possible HL biomarkers. FGF2 and SDC1 were 
overexpressed in all HL cell lines, and the overexpres-
sion was HL specific when compared to non-Hodgkin 
lymphoma (NHL) tissues. Furthermore, FGF2 and 
SDC1 protein expression was significantly elevated in 
peripheral blood leukocytes of chemo-naive HL patient 
samples when compared to NHL sections and normal 
lymph node controls. The expression of FGF2 and SDC1 
genes in the PO HL patients samples was elevated 24 
times for FGF2 and 56 times for SDC1; respectively, 
as compared to the good outcome (GO) group. The 
PO group showed higher expression of CD30, CD68, 
transforming growth factor beta (TGFÎ_) and matrix 
metallopeptidase 9 (MMP9) compared to the GO group.
conclusion: Taken together, bioinformatics data 
analysis identified biomarkers that could be useful in 
identifying poor outcome HL patients. We also iden-
tified subsets of circulating CD30+/CD15+ cells that 
express FGF2 and SDC1 in this patient population. 
Validating the use of SDC1 and FGF2 as a stratification 
biomarker pair could build a vision for the near future 
to improve current therapies and promote personal-
ized medicine for poor outcome HL patients.
BMS13 
The Difference in Time Constant in Patients and 
Normal Subjects
Bhatt, S.H.; Patel, K.; Shah, Y.; Rosenberg, M.L.
introduction: Rebound nystagmus (RN) refers to 
nystagmus noted on return to primary position after 
sustained lateral gaze to one side. RN was once consid-
ered to be a pathological phenomenon found only in 
patients. We have previously presented evidence that 
it is found consistently in normal subjects and that the 
nystagmus fatigues with a reproducible time constant 
(TC). Further investigation was initiated in order to 
discover whether there was a significant difference be-
tween the TC of patients and normal subjects. 
metHods: Data from 59 normal subjects and 89 neuro-
logic patients with different problems was used. All 
first fixated in primary position, then  45Â° to the left, 
back to primary position, then 45Â° to the right, and 
back to primary position, each phase lasting 40 sec-
onds. The TC was obtained by fitting the slow phase 
velocities to an exponential model. Only trials with a 
reliable fit (R2 > 0.2) and at least 3 sequential beats of 
nystagmus were included. 
results: A reliable TC was found in 35/52 (67%) nor-
mal subjects in light conditions and in 29/51 (57%) 
normal subjects under dark conditions. In patients a 
reliable TC was found under light conditions in 42/89 
(47%) and in 29/70 (41%) under dark conditions. The 
average TC in normal subjects in light was 6.28 (std 
2.94) while in patients it was very similar at 6.57, (std 
2.97).  The average TC in normal subjects in the dark 
was 11.66 (std 6.06) and in patients it was 9.02 (std 3.76). 
The average amplitude in normals in the light was 
0.82o (std 0.16) and was 1.20 o (std 0.18) in patients. In 
the dark, normal subjects had an amplitude of 1.53 o 
(std 0.30) and patients had a value of 2.0o (std 0.23). 
Patients were also separated into different groups 
based on pathophysiology but no diagnosis showed 
values of significant difference compared to controls.
conclusion: The significantly greater incidence of RN 
in the light in normal subjects compared to patients 
was surprising and is of unclear etiology. It may re-
flect a better ability of normal subjects to concentrate 
on the task and maintain far eccentric gaze. The great-
er amplitude of RN in patients in the light may explain 
why the rebound seen clinically is always pathologi-
cal. Hopefully future work with additional patients 
will lead to better localization of these findings. 
2BMS03 
Epithelial HIF Plays a Protective Role in Gut 
Graft Versus Host Disease 
Colorado, I.; Dziopa, E.; Dziopa, L.;  Zheng, Y.;  Zilberberg, J.; 
Korngold, R.;  Feinman, R.;  Hackensack University Medical 
Center
introduction: Acute graft-versus-host disease 
(GVHD) is a major cause of nonrelapse morbidity and 
mortality following allogeneic blood and marrow 
transplantation (BMT). Acute gut GVHD affects more 
than 60% of patients and is a leading cause of death. 
The mechanisms for the early, conditioning-related, 
intestinal injuries that are the precipitating event lead-
ing to GVHD or how subsequent gut-specific GVHD 
actually disrupts intestinal homeostasis have not 
been fully explored. Given that inflammatory bowel 
disease (IBD) and GVHD share many pathogenic 
mechanisms and intestinal epithelial hypoxia-induc-
ible factor (HIF) afforded protection in IBD models, 
we hypothesize that the persistent activation of HIF 
will protect the intestinal epithelium from condition-
ing and alloreactive T cell-induced gut damage.
metHods: The effects of epithelial HIF-1 and HIF-2 on 
GVHD-induced crypt damage was tested in a fully 
MHC mismatched B10.BR(H2k)>B6(H2b) BMT model, 
using conditional intestinal epithelial HIF-1Î±Î”IE and 
HIF-2Î±Î”IE knockout mice that lack HIF-1Î± and HIF-
2Î± in the intestinal epithelium. 8 days, post-BMT, the 
histopathologic damage of the jejenum was assessed 
by H&E staining and gene expression of intestinal 
stem cell (ISC) markers and niche factors was quan-
tified by real-time PCR analysis. Crypt proliferation 
and apoptosis was determined by immunohistochem-
istry using Ki67 and TUNEL respectively. Survival 
studies were also performed.
results: Histopathologic assessment of H&E stained 
ileums of HIF-1Î±IE mice showed more severe crypt 
damage, loss of Paneth cells and fewer regenerating 
crypts as compared to wild-type (WT) mice, 8 days 
post-BMT. Loss of epithelial HIF-1 reduced the ex-
pression of two ISC markers, Lgr5 (p<0.01) and Sox9 
mRNA levels (p<0.05) and the expression of ISC 
niche factors, Reg3Î_ (p<0.01) and Notch-dependent 
Hes-1 (p<0.001) in the ileum compared to WT mice, 
post-BMT. Hyperplastic crypts that are character-
istic of regenerating crypts after radiation-induced 
damage were observed in Ki67-stained ileal sections 
of WT mice post-BMT whereas fewer regenerating 
Ki67-labeled crypts were evident in HIF-1Î±IE mice. 
In control WT and HIF-1Î±IE (receiving T cell de-
pleted BM), Ki67+-proliferating cells resided at the 
crypt base. A higher incidence of apoptotic cells was 
found in HIF-1Î±IE mice post-BMT compared to WT. 
Loss of epithelial HIF-2 also caused significant histo-
pathologic crypt damage in the jejenum versus WT 
mice, 8d post-BMT. Finally, loss of epithelial HIF-1 or 
epithelial HIF-2 reduced overall survival time. 
conclusion: Taken together, our findings suggest that 
intestinal epithelial HIF-1 and HIF-2 may protect the 
intestinal stem cell niche from GVHD-induced injury 
and preserve intestinal regeneration in response to 
gut GVHD.
BMS04 
Novel Chromatin Modifying Gene Alterations 
and Significant Survival Association of  ATM and 
TP53 in Mantle Cell Lymphoma 
Goy, A.G.; Wang, K.W; Nahas, M.N;  Bhattacharyya, P.B.;  Miller, 
V.M.;  Feldman, T.F.;  Chow, K.F.C;  John Theurer Cancer Center 
at Hackensack University Medical Center
introduction: The survival of mantle cell lymphoma 
(MCL) has improved due to the use of dose-intensive 
strategies in younger patients achieving a deeper and 
earlier response (including molecular CR) and the ap-
plication of novel therapies in the relapsed/refractory 
setting, where patients are typically chemoresistant. 
A number of prognostic factors have been reported 
in MCL including MIPI, Ki67 and blastoid variants 
among others, the latter being frequently associat-
ed with del 17p or p53 mutations and a particularly 
poor outcome. Recent studies have begun to describe 
the genomic landscape of MCL by whole-genome, 
whole-exome and targeted sequencing. However, 
comprehensive evaluation of genomic alterations re-
mains to be elucidated.
metHods: We studied 33 FFPE or cryopreserved 
blood MCL specimens by performing integrated DNA 
and RNA sequencing or DNA sequencing alone. All 
samples were obtained at diagnosis prior to frontline 
R-HyperCVAD therapy. In this MCL cohort, treated at 
our institution, the median age was 59 y (range 35-75), 
all were stage IV, median Ki-67 was 30 % (range 5-80%), 
MIPI was low risk (27%), intermediate risk (30%), high 
risk (42%), and there were 4 blastoid variants (2 with 
del 17p by FISH or cytogenetics). The FoundationOne 
Heme assay was used Â for comprehensive genomic 
profiling of all genes.Â  Briefly,  genomic DNA and 
total RNA were extracted and captured using cus-
tom bait-sets targeting all exons of 405 cancer-related 
genes by DNA-Seq, and 265 frequently rearranged 
genes by RNA-Seq.
results: In total, we identified 125 genomic altera-
tions with an average of 3.8 per sample, including 45 
base substitutions/indels, 33 truncations, 1 gene am-
plification, 6 gene deletions, and 40 rearrangements. 
ATM and TP53 were among the most frequently al-
3tered genes, found in 45% and 18% (though 3x more 
frequent than by baseline FISH/cytogenetics) of the 
samples, respectively.  The most common genes with 
potential therapeutic implications were ATM (PARP 
inhibitors), CDKN2A and CCND1 (CDK4/6 inhibitors) 
and NOTCH1 (Notch1 inhibitors).  Gene alterations of 
chromatin remodeling pathway were identified in 18 
out of 33 samples, including SMARCB1 (4), SMARCA4 
(2), ARID1A (3), ARID2 (1), PBRM1 (1), CHD2 (1), 
WHSC1 (5), MLL2 (2), SETD2 (1), EZH2 (1), and ASXL1 
(1).  Alterations in SMARCB1 (also known as SNF5 and 
INI1) and ARID1A, members of the SWI/SNF chro-
matin-remodeling complex, have not been reported 
in MCL previously.  Other frequently altered genes 
included NOTCH1/2 (12%), and the cell cycle genes 
CDKN2A/B (9%). 3. Mutations of TP53 and ATM were 
correlated with both the short overall survival (OS) 
and progress free survival (PFS) in our cohort.
conclusion: We identified relevant genomic altera-
tions in MCL patients from baseline peripheral blood 
and/or tissue in all samples tested. We discovered 
novel recurrent mutations in chromatin remodeling 
genes SMARCB1 and ARID1A in MCL, and dem-
onstrated that 55% of tumors carried alterations in 
epigenetic regulation overall. In our frontline cohort 
of MCL pts treated with R-HyperCVAD, we identified 
the significant poor prognostic value of the alteration 
of ATM and TP53 on outcome. These findings high-
light the possibilities for improved prognosis and 
novel therapeutic strategies based on comprehensive 
genomic analysis of these pathways.
BMS05
A Rare Case of Tortuosity and Lateral Deviation 
of the Abdominal Aorta
Kirchgessner, A.L.; School of Health and Medical Sciences, 
Seton Hall University
introduction: A rare case of tortuosity and lateral 
deviation of the abdominal aorta (AA) was observed 
during dissection of an adult male specimen.  The 
AA was deviated to the right side, lying anterior to 
the inferior vena cava (IVC).  A laterally deviated AA 
may be incorrectly mistaken for an aneurysm when 
palpated through the abdominal wall.  A tortuous AA 
may also cause compression of the IVC. Knowledge 
of such cases has important surgical and clinical 
implications.
metHod: During instructional dissection of 30 em-
balmed adult cadavers, an unusual tortuous course 
and lateral deviation of the abdominal aorta (AA) 
was observed in 1 Afro-American male specimen. 
Classically, the AA begins at the aortic hiatus of the 
diaphragm and assumes a straight and axisymmet-
ric course through the abdomen. After giving off its 
major branches, it terminates at the body of L4, by di-
viding into two common iliac arteries.  
results: The presence of deviation of the abdominal 
aorta is rare.  In the present study, the abdominal aor-
ta was deviated to the right inferior to the origin of the 
superior mesenteric aorta, lying anterior to and pos-
sibly compressing the inferior vena cava.  The lateral 
AA included the inferior mesenteric artery and devi-
ated to the left before terminating at its bifurcation.
discussion: Tortuosity of the AA is of clinical signifi-
cance since it may be mistaken for an aortic aneurysm 
when palpated through the abdominal wall as a pul-
satile mass.  Knowledge of such cases has important 
clinical significance in an abdominal operation or in-
vasive arterial procedure.  A tortuous AA may also 
cause compression of the inferior vena cava resulting 
in fibrosis and cirrhosis of the liver.
BMS06
Linguofacial Trunk Arising from a Lateral 
External Carotid Artery: A Rare Anatomic Variant
Kirchgessner, AL; School of Health and Medical Sciences
introduction:	The present study describes a rare case 
encountered during cadaveric dissection, in which 
the right lingual and facial arteries arise together 
from a common linguofacial trunk, from a lateral 
external carotid artery (ECA).  In this conformation, 
the linguofacial trunk coursed medially, crossing and 
partially obscuring the internal carotid artery (ICA), 
potentially limiting access to the ICA during carotid 
endarterectomy.  The transposition of the ECA and 
ICA and presence of a linguofacial trunk could have 
profound surgical implications.
metHods: During cadaveric dissection in this year’s 
class of Functional Human Anatomy, a rare anatomic 
variant was found at the level of the right carotid tri-
angle of an adult male specimen. 
results: On that side, the common carotid artery bi-
furcated between C3 and C4 and the positions of the 
external carotid artery (ECA) and internal carotid 
artery (ICA) beyond the bifurcation was transposed, 
such that the ECA was located lateral to the ICA. In ad-
dition, the right lingual and facial branches of the ECA 
originated from a common linguofacial trunk, which 
coursed medially, crossing and partially obscuring 
the ICA and potentially limiting surgical access to 
the vessel. The hypoglossal nerve passed lateral to the 
ECA before medially crossing the linguofacial trunk 
to lie deep to the digastric. The configuration of the 
contralateral carotid arteries was normal, and the lin-
gual and facial arteries arose separately from the ECA. 
4Angiographic and ultrasound studies have suggested 
the prevalence of a lateral ECA to be ~4-12%, most of-
ten on the right (Teal et al., 1973). The occurrence of a 
unilateral linguofacial trunk arising directly from the 
ECA is ~15% (Yadav et al. 2014).  This is the first report 
describing a right linguofacial trunk originating from 
a lateral ECA, which would limit ICA exposure and 
require care to avoid hypoglossal nerve damage.
discussion: Variations in the position and branch-
ing pattern of the ECA are rare, and have important 
implications in the surgical field. The rotation of the 
ECA and ICA and the presence of a linguofacial trunk, 
hampers access to the ICA, and increase the risk of 
iatrogenic injury to the hypoglossal nerve.
BMS07 
Alpha-Synuclein Pathology in the Laryngeal 
Nerves in Parkinson’s Disease 
Mu, L.; Chen, J.; Sobotka, S.; Department of Research, 
Hackensack University Medical Center
introduction: Voice and speech disorders, dyspha-
gia and aspiration are common in patients with 
Parkinson’s disease (PD). Despite the high incidence of 
these upper airway disorders in PD, a large gap in our 
knowledge is that the underlying pathology is poor-
ly understood. In this study, human larynges were 
obtained from 5 deceased human subjects with clini-
cally diagnosed and neuropathologically confirmed 
PD  and 4 healthy controls. The laryngeal nerves were 
immunostained for phosphorylated Î±-synuclein. The 
results showed the presence of Î±-synuclein-positive 
axons in all the PD subjects and in none of the con-
trols. These findings suggest that the laryngeal related 
disorders in PD may be due to degeneration of the la-
ryngeal nerves caused by Î±-synuclein pathology.
metHods: We studied autopsied human larynges from 
subjects with PD (n=5) and age-matched healthy con-
trols (n=4) (Fig. 1). Three nerve samples were taken 
from cervical vagus nerve (X), recurrent laryngeal 
nerve (RLN), and internal branch of the superior la-
ryngeal nerve (ISLN) (Fig. 2). The tissue samples were 
fixed with 10% formalin, cut longitudinally and im-
munostained. Nerve sections were pretreated with 
1:100 proteinase K for 20 min, incubated overnight in 
anti-Î±-synuclein monoclonal antibody (psyn no. 64; 
diluted 1:1000), incubated with a secondary biotinyl-
ated antibody (anti-mouse IgG diluted 1:1000) for 2 
hours, treated with avidin-biotin complex, with A and 
B components of the Vectastain kit both at 1:1000 di-
lution for 30 min and treated with diaminobenzidine.
results: In the group of subjects with PD, there 
were 4 men and 1 woman, mean age was 78 years 
(range, 73-84), and the mean disease duration of PD 
at time of death was 16 years (range, 11-20). The mean 
Hoehn and Yahr stage was 3.2 (range, 2-4); 1 subject 
was stage 2; 2 subjects were stage 3; and 2 subjects 
were stage 4. The 4 healthy controls included 2 men 
and 2 women without neuromuscular disorders. The 
mean age of the healthy subjects was 75 years (range, 
70-80). PD-induced degeneration of the peripheral 
nerves controlling the larynx was identified. Anti-
Î±-synuclein immunohistochemistry showed axonal 
synucleinopathy lesions in the X, RLN, and ISLN in 
all PD samples and in none of the controls. In PD, the 
Î±-synuclein-immunoreactive axons commonly ap-
peared as threads and dots (Fig. 3). In this series, the X 
and ISLN had a high density of Î±-synuclein-positive 
axons as compared with the RLN (Fig. 3).
conclusion: This is to our knowledge the first 
demonstration of Î±-synuclein pathology in 
the laryngeal nerves in subjects with PD. Our 
preliminary observations suggest that voice and 
speech disorders and aspiration commonly seen in 
PD patients may be due to Î±-synuclein pathology 
in the laryngeal nerves. Sensory nerve lesions could 
diminish laryngeal sensation and cough reflexes, 
while motor nerve pathology results in impaired 
glottic closure, dysphasia, vocal fold atrophy and 
bowing. All of these changes could impair laryngeal 
functions. Further studies in a large sample size are 
needed for a better understanding of the mechanism 
of laryngeal dysfunction in PD and therefore provide 
direction for therapeutic strategies.
BMS08
Efficacy of Topical Perfluoro(t-butylcyclohexane) 
(FtBu), Oxygen-Saturated Gel in a Model of  
Delayed Wound Healing: Partial Thickness Burn 
Wound with Pseudomonas Infection in Swine
Ogedegbe, C.; Carlisle, A.; Dave, Parth;  Kaul, S.;  Feldman, J.; 
Hackensack University Medical Center 
introduction: Annually, there are more than 1 mil-
lion burns, resulting in more than 700 000 emergency 
department visits, 45 000 admissions, and nearly 4500 
deaths in the United States alone. Swine have been 
used to evaluate dermal materials and wound heal-
ing properties of experimental materials, as they 
reliably mimic human skin. Here we evaluate the 
effects of perfluoro(t-butylcyclohexane) (FtBu) oxygen- 
saturated gel on the healing of partial thickness burn 
wounds infected with Pseudomonas Aeruginosa in 
swine compared to control treatments over 22 days.
metHods: 3 swine subjects acquired 16 thermal 
wounds each on their back using a heated 3cm x 
5cm brass template. Day 1 post injury, all wounds 
were infected with 1 x 106 colony forming units of 
5Pseudomonas aeruginosa by injecting the inoculum 
under the eschar and left overnight. Test material 
was FtBu gel on adhesive pad along with 3 different 
controls; N=12 for each. Wound size, healing rate, 
condition of wound dressing/skin, and histological 
evaluations were made.  Histological data was all 
gathered from the hematoxylin and eosin stained 
tissue.
results: The FtBu Gel showed the most advanced re-
epithelialization appearance on post op days 14, 15.  By 
22 days, it appeared that all groups equalize in their 
rates of healing. For comparison of wound area 0.785 
(mm2) with 4 wound dressing treatments for 22-day 
follow-up, a Two-way ANOVA model, with repeated 
measurements on each Day, indicated there was a 
significant dressing effect (P=0.0006) and pairwise 
comparisons were performed using Tukey-Kramer 
adjustment for multiple comparisons. For histology 
parameters for the 4 wound dressing treatments af-
ter 22-day follow-up, all entries were presented as 
frequency (percentages). Categorical variables were 
compared across dressing types using Fisher’s ex-
act test. Comparison between dressing types in skin 
thickness (epidermis + dermis) was performed using 
one-way ANOVA. Kruskal-Wallis test, due to the non-
normality thickness values.
conclusion: Grossly, FtBu gel groups had a slightly 
faster but not significant rate of re-epithelialization 
compared to control groups. A better understanding 
of FtBu oxygen-saturated gel mechanism of action 
at the cellular level, at different concentrations is re-
quired further to better delineate its effects on the 
burn wound healing cascade of events. 
BMS09
A Role for MMP-3 in the Modulation of Early  
T Cell Responses in GVHD
Rosenberg, S.M.; Zilberberg, J.; Korngold, R.; Hackensack 
University Medical Center
introduction: During graft-versus-host disease 
(GVHD), activated alloreactive T cells recirculate from 
the secondary lymphoid organs and extravasate via 
the blood vessels into target tissues, causing pathology 
which if severe enough can ultimately lead to mortal-
ity. We hypothesized that differences at the level of 
the host issue may have an influence on GVHD de-
velopment. In order for alloreactive T cells to infiltrate 
target tissues, they must traverse the extracellular 
matrix (ECM) and the involvement of ECM structural 
and regulatory proteins, specifically matrix metallo-
proteinases (MMP), is much less definedWe therefore 
examined the expression patterns and potential func-
tion of MMP-3 in the development of GVHD.
metHods: Small intestine tissue samples were col-
lected from either lethally irradiated (9 Gy, split dose) 
BALB.B or CXB-2 mice receiving only 2 X 106 anti-Thy 
1 mAb + C’ treated (T cell- depleted) B6 bone mar-
row cells (ATBM) for hematopoietic reconstitution. 
Samples were collected on days 8, 20 and 30 post-
irradiation and homogenized using a mechanical 
dissociator (Miltenyi Biotec).. Expression of MMP-3 
was determined using real time PCR analysis. IFN-
ïÅ§ production by donor T cells was evaluated using 
ELISPOT assays where responder presensitized B6 
enriched T cells were cocultured with either BALB.B 
or MMP-3 KO stimulator splenocytes (exposed to 15 
Gy irradiation).
results: Relative gene expression of MMP-3 using 
GAPDH as an endogenous control was significantly 
lower (39.9% decrease, p<0.05) at day 8 following ir-
radiation of hosts in BALB.B mice when compared to 
CXB2 mice. No significant differences in expression 
levels were observed at later timepoints (20 and 30 
days post-irradiation). GVHD experiments comparing 
MMP-3 knockout (KO) mice on a BALB.B background 
with BALB.B controls, revealed that a lack of MMP-
3 caused a decrease in the median survival time 
(MST) of recipient mice from day 40 to day 31(p=0.06). 
ELISPOT assays studying B6 T cell alloresponses 
against BALB.B or MMP-3 KO splenocytes showed 
an increase  in mean IFNïÅ§+ spots in MMP-3 KO-
stimulated wells from 205.7 to 241.7 (p=0.098) when 
compared to BALB.B controls.
conclusion: Taken together, these data suggest: 1) a 
protective role for MMP-3 in the early stages of GVHD 
development in the B6-> BALB.B model; and  2) a 
potential involvement of both tissue and immune as-
sociated MMP-3 in the development of GVHD. 
BMS10
Experimental Radiation (2400 MU/min/ 50cGy) In 
Vitro Achieved Significant Increase in Apoptosis 
on Melanoma Cells with Superior Survival of 
Normal Cells when Compared to 400MU/min
Sarojini, S.; Pecora, A.; Milinovikj, N.; Barbiere, J.; Tuna, M.; 
Jeong, S.; Jun, J.; Hackensack University Medical Center
introduction: Purpose: Purpose of this study was to 
investigate apoptotic effects of 10MV x-rays at high 
dose rate (2400 MU/min) combined with a low total 
dose (50cGy) in malignant melanoma cells in vitro. 
Concurrently, the preservation of normal melano-
cytes (HEM), keratinocytes (HEK) and stromal cells 
(HEF) and radio-sensitization using mitochondrial 
inhibitors were also studied. 
metHods: The cells were cultured in T25 flasks and 
were radiated using a linear accelerator with 400 or 
62400 MU/min dose rates and total doses from 25-100 
cGy. Cell counting, Colony Assays, Mitotracker fluo-
rescent and bright fileld imaging, and MTT assay were 
used to investigate mitochondrial respiration, cell pro-
liferation/death and radio-resistant cell morphology. 
Genes involved in mitochondrial respiration, apop-
tosis, cell division and signaling were quantitatively 
analyzed by qRT-PCR. Mitochondrial respiration was 
partially blocked by mitochondrial inhibitors.
results: The apoptosis in melanoma cells were 30% 
higher and normal melanocyte survival was pre-
served 80 % with 50cGy delivered at 2400 MU/min 
than 50cGy delivered at a dose rate of 400MU/min 
in vitro setting(p<0.005). qRT-PCR data confirmed 
significant upregulation of apoptosis genes (AIF, FAS, 
FASL, Casp 3, Casp8, Casp9, TP53) in cancer cells 
and DNA repair and cell proliferation genes (MSH2, 
CCND1,CCND2, MDM2, MDM4) in HEM, HEK and 
HEF. Cell counts showed 60% and 68% reduction at 
7 days post-radiation for the aggressive metastatic 
cells (p<.0.001) and for sensitive cells, respectively. 
Colony assays demonstrated 30% more cell killing 
with 2400MU/min than 400 MU/min and preserved 
75% normal primary cells.  Dose rate 2400 MU/min 
caused higher mitochondrial respiration than 400 
MU/min which was directly related to total dose of 
radiation delivered to cells. Respiratory chain genes 
(NDUFS2, UCRC, SDHC, ATPAF2) were down reg-
ulated, suggesting that the increased respiration 
activity after radiation was related to post-translation-
al activation. Mitochondrial inhibition increased cell 
kill to 74% (p<0.005) with inhibitor O and to 83% with 
inhibitor R while HEM maintained 60% survival. 
conclusion: 10 MV x-rays at high dose rate with low 
total dose (2400 MU/min|50cGy) significantly enhanc-
es radio-sensitivity of melanoma cells while reducing 
radio-toxicity on normal cells. Additionally, blocking 
mitochondrial respiration proportionately increases 
melanoma cell kill with this dose rate. Our model im-
plicates potential novel radio therapeutic options and 
opens untested field of radiotherapy research. 
BMS11 
Modified Nerve-Muscle-Endplate Band Grafting 
Technique for Muscle Reinnervation
Sobotka, S.; Chen, J.; Mu, L.;  Department of Research, 
Hackensack University Medical Center
introduction: As the presently used reinnervation 
methods result in poor functional recovery, we devel-
oped a new technique called nerve-muscle-endplate 
band grafting (NMEG) to treat paralyzed muscle. The 
idea is that transferring a NMEG from a donor muscle 
to a neighboring paralyzed muscle could preserve nu-
merous intact motor endplates and nerve terminals 
which provide a rich source of axonal regeneration. 
Our initially designed NMEG, which was implant-
ed into an endplate-free area in the recipient muscle, 
yielded partial functional recovery. We recently re-
fined surgical procedure by transplanting the NMEG 
pedicle into the native motor zone (NMZ) of the target 
muscle. Our experiments showed that the NMEG-
NMZ procedure resulted in successful reinnervation 
and optimal recovery of maximal muscle force.
metHods: In this study 15 adult SD rats were used. The 
right sternomastoid (SM) muscle (recipient) was exper-
imentally denervated and immediately reinnervated 
with a NMEG harvested from the ipsilateral sternohy-
oid (SH) muscle (donor). The NMEG was composed of 
a block of muscle (~6x6x3 mm), an intact donor nerve 
branch with axon terminals, and an endplate band 
with numerous neuromuscular junctions. The NMEG 
was implanted to the native motor zone (NMZ) in the 
recipient muscle (Figs.1 & 2). After a 3-month recovery 
period, the treated muscles were evaluated by the use 
of tetanic force measurement, histological and immu-
nocytochemical analyses. The contralateral SM muscle 
served as a control. The results from the NMEG-NMZ 
technique were also compared with those from our 
initially designed NMEG procedure.
results: The results showed that NMEG-NMZ tech-
nique resulted in better muscle reinnervation and 
functional recovery as compared with our initially 
designed NMEG procedure. There were several major 
findings. First, the weight of the SM muscles reinner-
vated with NMEG-NMZ was greater than that of the 
muscles treated with initially designed NMED proce-
dure (Fig. 3). Second, the NMEG-NMZ reinnervated 
muscles exhibited extensive nerve regeneration, axon-
endplate connections, and full muscle reinnervation 
(Fig. 4). Finally, the NMEG-NMZ technique yielded 
better functional recovery than the NMEG procedure 
(Fig. 5). Optimal outcomes from the NMEG-NMZ 
technique can be attributed to the fact that the re-
generating axons from the implanted NMEG pedicle 
could easily reach and reinnervate the denervated 
motor endplates in the recipient muscle, thereby lead-
ing to optimal functional recovery. 
conclusion: The NMEG-NMZ technique may become 
a valuable tool in the treatment of skeletal muscle de-
nervation in certain clinical situations. 
7BMS12 
Kallikrein Family Proteases KLK6 and KLK7 are 
Potential Early Detection and Diagnostic Bio-
markers for Serous and Papillary Serous Ovarian 
Cancer Subtypes
Tamir, A.; Jag, U.; Sarojini, S.; Blake, P.; Goy, A.;  Pecora, A.; 
Suh, K.; Hackensack University Medical Center
introduction: Ovarian cancer (OVC) has the high-
est mortality rate among gynecologic malignancies. 
Although the 5-year survival rate of OVC is around 
90% when detected in its early stages (I/II), nearly 80% 
of new cases are diagnosed in advanced stages (III/
IV) because of the asymptomatic nature of the disease. 
Early detection of ovarian cancer remains a challenge 
due to widespread metastases and a lack of biomark-
ers. This study aimed to identify relevant biomarkers 
for serum-based early-detection of OVC.
metHods: Bioinformatics analysis and expression 
screening in ovarian cancer cell lines were employed. 
Selected biomarkers were further validated in bio-
specimens of diverse cancer types and ovarian cancer 
subtypes. For non-invasive detection, expression of 
biomarker proteins was evaluated in serum samples 
of ovarian cancer patients in different stages of the 
malignancy.
results: Two kallikrein serine protease family 
members (KLK6 and KLK7) were significantly over-
expressed relative to normal controls in most of the 
OVC cell lines examined. mRNA overexpression was 
specific to OVC, in particular to serous and papillary 
serous subtypes. In situ hybridization and histo-
pathology further confirmed significantly elevated 
levels of KLK6 and KLK7 mRNA and proteins in 
tissue epithelium and a lack of expression in neigh-
boring stroma. Lastly, KLK6 and KLK7 protein levels 
were significantly elevated in serum samples from se-
rous and papillary serous subtypes in the early stages 
of OVC. Their use could potentially decrease the high 
“false negative” rates found in the same patients with 
the common OVC biomarkers human epididymis pro-
tein 4 (HE4) and cancer antigen 125 (CA-125).
conclusion: KLK6 and KLK7 mRNA and protein 
overexpression is directly associated with the ap-
pearance of early-stage ovarian tumors and can be 
measured both in patient tissue and in serum samples. 
Assays based on KLK6 and KLK7 expression may 
provide specific and sensitive information for early 
detection of ovarian cancer and their use can improve 
sensitivity /specificity of biomarkers currently used 
in the clinic.
BMS13 
Downregulation of Osteoblastic N-Cadherin 
Decreases Primary Multiple Myeloma Cell -  
Osteoblast Interactions
Zhang, W.; Siegel, D.; Tolias, P.; Lee, W.; Zilberberg, J.; Stevens 
Institute of Technology and Hackensack University Medical 
Center
introduction: Recent reports have shown that in 
multiple myeloma (MM), direct adhesive interactions 
between MM cells and the bone marrow stroma are 
responsible for the development of drug resistance 
and relapse. This phenomenon termed “cell adhesion-
mediated drug resistance” (CAMDR) is thought to 
be one of the major mechanisms by which multiple 
myeloma cells (MMC) escape the cytotoxic effects of 
therapeutic agents. Using a novel 3D tissue microflu-
idic platform, we found that OSB played a key role 
in the ex vivo maintenance and expansion of MMC. 
In this study, we evaluated the role of osteoblastic 
N-cadherin in regulating MMC-OSB interactions as a 
first step to elucidate the role of this molecule in the 
development of CAMDR in MM. 
metHods: Knockdown of N-cadherin protein ex-
pression in the human OSB cell line hFOB 1.19 was 
achieved using shRNA lentiviral technology. Patient-
derived bone marrow mononuclear cells (BMMC) 
containing malignant MMC were cocultured in the 
microfluidic device with either N-cadherin+OSB or 
with a mixture composed of N-cadherin-OSB and 
N-cadherin+OSB. Monitoring and quantification of 
MMC-OSB interactions was performed using time 
lapsed images and fluorescence microscopy. 
results: Real-time images showed that CD138+ MMC 
were preferentially adhered to N-cadherin+ OSB. The 
retention of CD138+ MMC, based on the scaffold con-
stitution, was determined by flow cytometric analyses 
as the CD138+ MMC/OSB ratio. Notably, after a 2 
day coculture period, only 32.78% Â± 4.15% CD138+ 
MMC was retained in the tissue scaffold containing 
N-cadherin-OSB compared to 70.21% Â± 4.64% reten-
tion in the mock transfected OSB group.
conclusion: For the first time, we demonstrated here 
that osteoblastic N-cadherin is responsible, at least in 
part, for the development of strong interactions be-
tween MMC with stromal elements from the tumor 
microenvironment. Our data suggest a new therapeu-
tic intervention area in the modulation of N-cadherin 
expression by OSB as a way to render MMC more sus-
ceptible to drug treatments and potentially decrease 
CAMDR.
8CI01
Plasma Volume Contraction Estimated by  
Hematocrit and Cardiorenal Syndrome in Acute 
Heart Failure
Alattar, F.; Aurshiya, R.; Abualayem, M.; Ford, D.; Shamoon, F.; 
Saint Michael Medical Center, Seton Hall University
introduction: Cardiorenal syndrome is associated 
with worse outcome in hospitalized patients with 
CHF. Estimated plasma volume contraction using 
hematocrit during diuresis can help avoiding overdi-
uresis and worsening renal function.
metHods: CHF patients who were admitted to Trinitas 
and Saint Michael hospitals were prospectively ob-
served during hospitalization. Daily weight, CBC, 
kidney function, and diuretic doses were recorded 
daily. Change in plasma volume was estimated using 
Strauss formula.
results: A total of 119 pts (56 men) were studied. 
The median age 70 (60-83). Average dose of lasix was 
80 mg IV daily. Cardiorenal syndrome (cr rise >0.3) 
developed in 42%. Patients with plasma volume 
contraction on second day of diuresis were 2.3 more 
likely to develop cardiorenal syndrome (p:0.038). No 
relationship was found between diuretic dose, weight 
change with either plasma volume contraction or car-
diorenal syndrome.
conclusion: Plasma volume contraction after 24 hr of 
diuresis, not weight change, may help predict cardio-
renal syndrome in hospitalized CHF patient.
*CI02
Platelet Reactivity Unit in Predicting Risk of 
Bleeding in Patients Undergoing Coronary  
Artery Bypass Graft Surgery
Altheeb, Z.F.; Isbitan, A.A.; Shabiah, M.; Hamdan, A.;  DeBari, 
V.; Shamoon, F.; Saint Joseph’s Regional Medical Center/ New 
York Medical College
introduction: Bleeding is a common complication of 
cardiac surgery, accounting for a significant propor-
tion of the total transfusions performed in the United 
States and Europe. Response to antiplatelet therapy 
varies from one patient to another. Hence, platelet 
reactivity tests have recently been proven useful in 
predicting long-term outcomes in the setting of acute 
coronary syndromes (ACS). Tailoring antiplatelet 
therapy based on platelet assay results should be con-
sidered in patients undergoing major surgeries like 
coronary artery bypass graft (CABG) surgery.
metHods: Spectively enrolled 238 patients underwent 
CABG in a 700-bed teaching tertiary hospital in 
northern New Jersey. All elements of the Study were 
collected retrospectively. Data collection based on 
obtaining preoperative platelet reactivity unit (PRU) 
values and postoperative outcomes for patients who 
had CABG done. Age, sex, race, Body Mass Index (BMI), 
medications and comorbidities were also considered 
in the study. We used the hospital electronic medical 
records and operative reports in the data collection 
phase.
results: Total number of patients evaluated in this 
study was 238. Postoperative bleeding has been re-
ported in 43 (18%) of the patients, while 195 (82%) 
patients did not experience bleeding after the surgery. 
Consequently, bleeding was further divided into mi-
nor and major depending on PLATO criteria. Out of 
the patients with bleeding, minor and major bleeding 
have occurred in 41 (95%) and 2 (5%) patients respec-
tively. A range of 150-200 PRU suggests the likelihood 
of bleeding after CABG surgery. (OR:3.3; CI:1.5 to 6: 
P<0.01).
conclusion: In conclusion, by using PRU values as a 
method to assess platelet reactivity and antiplatelet 
responsiveness, our findings suggest that it may be 
possible to stratify patients undergoing CABG sur-
gery for the risk of postoperative bleeding particularly 
patients on dual antiplatelet therapy.
CI03
Pediatric Appendicitis: Reaching the Finish Line 
Safely
Avva, U.; Gold, N.; Khan, S.; Reid, K.; Stuart, J.; Themba, N.; 
Vijayan, R.;  Hackensack University Medical Center
introduction: We evaluate patients with abdomi-
nal pain suspected of having acute appendicitis in 
the pediatric emergency room; the process could be 
very challenging. We have to balance between accu-
racy and safety while arriving at the diagnosis.  CT 
is widely being used as the modality of choice dur-
ing the diagnostic process. Recent studies brought 
to awareness the deleterious effects of the radiation 
especially in children.  We want to bring a balance be-
tween these two and still reach the finish line safely.
metHods: It is a retrospectively reviewed charts of 436 
children <22 years of age who were admitted from 
the ED with the diagnosis of acute appendicitis from 
November of 2010- December of 2013.  We gathered 
data on the patients as well as health care profession-
als involved in caring those patients using electronic 
Clinical Investigation
9medical records. We procured time line of events to 
establish a time frame it took to complete the process. 
The patients are divided into 3 groups, which are US 
positive, US inconclusive /US showing secondary 
signs of inflammation and those who only had CT 
scan of the abdomen and pelvis.
results: The preliminary results are as follows. There 
are a total of 437 patients in the analysis, 311 (71%) 
of them underwent ultrasound for appendicitis, of 
which 178 are positive, 133 are inconclusive or showed 
secondary signs of inflammation with out visualiza-
tion of appendix. 119 patients had CT scan without 
US.  About 109 patients had both CT and US.  Of the 
113 patients who were in the Category of non-visual-
ization of the appendix 109 patients underwent CT 
scans. The analysis of the first 3 different groups did 
show statistically significant differences in the patient 
characteristics; like age, BMI duration of the symp-
tomatology.  It did not show much difference in the 
physician characteristics. Rest of the analysis is still 
underway.
conclusion: Preliminary analysis suggests that there 
are differences between the different groups with re-
spect to the patient characteristics including age, BMI, 
duration of the symptoms.  Older age with high BMI; 
CT scan of the abdomen and pelvis is still superior 
to the US of the appendix as the diagnostic modality. 
Where as US still could be the first modality when the 
children are young, thin with shorter duration of the 
symptoms.  The differences among physicians taking 
care of the children are not significant.
CI04
The Use of a Reduced-Intensity Conditioning 
(RIC) Regimen in Patients Ages 2-30 Undergoing  
Allogeneic Transplantation for Sickle Cell Disease
Banugaria, S; Gillio, A.P.; Haugh, J.; Durning, N.; Nycz, M.; 
Adler-Brecher, B.; Krajewski, J.; Hackensack University Medical 
Center; New Jersey Medical School; Rutgers University
introduction: Sickle cell disease affects 72,000 in-
dividuals in the US. Stem cell transplantation is the 
only cure for SCD. Studies show matched sibling 
transplants after myeloablative conditioning have 
acceptable results,but with potential long-term com-
plications. Only 14% of patients will have sibling 
donors,and results have been less promising with 
higher rates of transplant related mortality using al-
ternative donors. Historically,only pediatric patients 
were considered candidates for HSCT,but a study 
demonstrated that young adult SCD patients may be 
able to tolerate a RIC HSCT. In an attempt to minimize 
the risk of TRM while still maximizing the available 
donors,this study examines the use of a RIC regimen 
for either matched sibling or alternative donor HSCT 
in SCD patients ages 2-30.
metHods: Patients were deemed eligible for matched 
sibling HSCT if they had SCD, and for alternative 
donor HSCT if they had SCD with severe features 
with a 9-10/10 unrelated donor or 5-6/6 UCB in the 
donor registry. The conditioning regimen consisted 
of Alemtuzumab, Fludarabine, and Melphalan. Post-
HCST, donor chimerism and hemoglobin S (HbS) 
percentages were followed closely, and there was 
strict monitoring for post-HSCT complications, in-
cluding graft rejection, graft vs. host disease (GVHD), 
infectious complications, and other post-HSCT issues.
results: 11 patients (8 related donors, 3 unrelated do-
nors) with median age of 8.1 years (range: 2.3-23 years) 
were enrolled. For related HSCT, the probabilities of 
primary neutrophil & platelet engraftment, grade II-
IV acute GVHD, chronic GVHD, and graft rejection 
were 100%, 37%, 12.5%, and 0%, respectively. Donor 
chimerisms ranged from 96-100% with HbS% be-
tween 0-43%, with median follow-up of 19 months 
(range: 3-24 months). Probability of 1-yr DFS and OS 
were 100% & 100%. For alternative donor HSCT, the 
probabilities of primary neutrophil & platelet engraft-
ment, grade II-IV GVHD, chronic GVHD, and graft 
rejection were 100%, 33%, 33%, and 33%, respectively. 
Donor chimerisms ranged from 0-100% with HbS% 
between 0-18%, with median follow-up of 8 months 
(range: 2-25 months). Probability of 1-yr DFS and OS 
were 33% & 66%.
conclusion: Our results show that this regimen fol-
lowed by matched sibling HSCT is well tolerated, but 
the results were discouraging for alternative donor 
HSCT. Because of this, we are currently developing a 
protocol using post-transplant cyclophosphamide in 
alternative donor HSCT for SCD.
CI05
Experience with Norvir 100 mg, Darunavir 800 
mg, and Dolutegravir 50 mg (r/DRV/DTV) Once a 
Day In An Inner City HIV Clinic in Newark, NJ
Barahona, F.; Bhattarai, S.; Slim, J.; Baca, N.; Parker, K.; Al-
Saleh, H.; Abd Al Qader, M.; Saint Michael’s Medical Center
introduction: Most randomized controlled studies 
for treatment of HIV include three drugs. Attempts to 
reduce this number to two active agents have yielded 
mixed results. We present a retrospective study of pa-
tients treated with r/DRV/DTV in our inner city HIV 
clinic in Newark, NJ, USA.
metHods: A retrospective chart review of patients who 
were prescribed r/DRV/DTV daily, and had at least 
two follow up visits before January/1/2015 was done. 
We collected epidemiological data, and determined 
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baseline resistance, response to therapy, adverse 
events, comorbidities, non-antiretroviral medications 
(ART) and drug-drug interactions.
results: Out of 1217 patients, 37 were prescribed r/
DRV/DTV daily. Twenty five out of 37 patients had at 
least two follow up visits before January/1/2015. Their 
mean age was 52 years, seventeen were male. Twenty 
were African Americans. Most common risk factor 
for HIV acquisition was heterosexual contact. A re-
sistant virus was found in fifteen patients. The most 
common comorbidities were hypertension, chronic 
kidney disease and chronic pain syndrome. The most 
common prescribed non-ART medications were amlo-
dipine and tramadol, with two recognized drug-drug 
interactions (increased amlodipine and tramadol se-
rum concentrations) however no adverse effects were 
found.
conclusion: This regimen of two potent retroviral 
agents was well tolerated, quiet efficacious and should 
be considered especially in patients with chronic kid-
ney disease and limited ART options. ART/non-ART 
drug interactions were not found to be clinically sig-
nificant. More RCTs comparing r/DRV/DTV to other 
commonly used three drugs combination should be 
undertaken.
CI06
Are Psychiatric Disorders And Obesity Becoming  
The Most Prevalent Non-Infectious Chronic  
Comorbid Conditions In Hiv Population?
Barahona, F.; Bhattarai, S.; Slim, J.; Al-Saleh, H.; Abd Al Qader, 
M.; Parker, K.; Baca, N.; Saint Michael’s Medical Center
introduction: The life expectancy of HIV infected 
patients has improved thanks to the widespread avail-
ability of antiretroviral therapy however the reduction 
in AIDS-related mortality carries an increasing num-
ber of chronic noninfectious comorbid conditions. In 
addition, those with HIV may be at higher risk for 
age-associated comorbid diseases.
metHods: A retrospective chart review of patients who 
had at least two visits in a period between July/1/2013 
and December/31/2014 at an inner city HIV clinic in 
Newark, NJ was done in order to collect their epide-
miological data and to determine their most common 
non-infectious chronic comorbid conditions.
results: The most prevalent non-infectious chronic 
comorbid conditions in 1217 patients who followed in 
our clinic between July/1/2013 and December/31/2014 
were essential hypertension (469 patients), psychiatric 
disorders (390 patients), obesity (295 patients), hyper-
lipidemia (235 patients), chronic pain syndrome (225 
patients). Of the 390 patients with psychiatric disor-
ders 211 patients had major depressive disorder, 106 
had anxiety. The total number of males with depres-
sion and anxiety were 113 and 55 respectively and 
their range of age was 19-69 years-old. The BMI range 
of obese patients was 30-58 kg/m2. 121 patients were 
found to have extreme obesity, 75 of whom were fe-
male. 75% of female patients and 67% of male patients 
within the eight most common non infectious chronic 
comorbidities were African Americans.
conclusion: The three most common non-infectious 
chronic comorbid conditions in an inner city HIV 
clinic of Newark, NJ were hypertension, psychiatric 
disorders, and obesity. Depression, anxiety and ex-
treme obesity are becoming the new health thread in 
HIV patients especially in African Americans. More 
insight into incidence, prevalence and risk factors 
of non-AIDS comorbidity among HIV-infected indi-
viduals is therefore essential to optimize policies for 
prevention and management.
CI07
The Role of Glutamate and its EAAT Transporters  
in ADHD and Autism
Bekker, Y.; Allan, H.; Trinitas Regional Medical Center
introduction: Glutamate excess is found in numerous 
neurodegenerative diseases such as Alzheimer’s, ALS, 
Huntington’s, and Parkinson’s, as well as in acute inju-
ry such as stroke. The same findings have been shown 
in Attention deficit hyperactivity disorder (ADHD) 
and Autism spectrum disorder (ASD). Aberrant gluta-
mate signaling is tied to the pathophysiology behind 
many of these illnesses, leading to the neurobiological 
and behavioral alterations often present. Whether the 
rise of the neurotransmitter is due to a deficiency in or 
malfunction of transporters that act to clear glutamate 
is unclear and needs to be investigated.
metHods: A search of PubMed, UpToDate, and 
PsycINFO (EBSCO) was done to gather information, 
supplemented with articles found through the search 
engine Google Scholar.  Websites that contained rele-
vant information in support of research for this article 
were also found using Google.
results: This literature review examines the rela-
tionship between neurodevelopmental disorders and 
glutamate. Of the 5 subtypes of Na+-dependent high 
affinity glutamate transporter receptors that function 
to clear glutamate, EAAT1 and EAAT2 are found to be 
most abundant in the brain and are mainly expressed 
in astroglial cells. Of specific concern to ADHD and 
Autism are EAAT1 and EAAT2, transporters that clear 
glutamate. If there is defective functioning or a defi-
ciency in the EAAT1/2 transporters, glutamate cannot 
be cleared and builds up, stimulating neurons to their 
demise. In ADHD, the deficiency in dopamine allows 
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for uncontrolled glutamate release, leading to inatten-
tiveness. The repetitive and hyperexcitable behaviors 
seen in ASD can also be attributed to increased stimu-
lation by glutamate.
conclusion: Knowing the role of glutamate and its 
EAAT transporters can aid in the design of medi-
cations targeted to improve the quality of life and 
functional capacity in ADHD and ASD. Whether 
treatments act to upregulate EAAT transporters or 
to normalize their numbers, the overall target of 
medications should be to decrease glutamate accumu-
lation in order to minimize excitotoxicity. Treatments 
that focus on upregulating EAAT transporters show 
promising results.
CI08
Pharmacokinetic (PK) and Pharmacodynamic 
(PD) Results of a Novel, First-in-Class Modulator  
of Eukaryotic Translation Initiation Factor 5A  
(eIF5A) in Patients with Relapsed or Refractory  
B-Cell Malignancies: Data from a Phase 1-2 Study
Bexon, MD1; Craig, M.; Siegel, D.S.; Bensinger, W.; Novitzky, 
N.; McDonald, A.; Gutierrez, M.; John Theurer Cancer Center at 
Hackensack University Medical Center
introduction: eIF5A is the only known protein to be 
modified by hypusination and is highly conserved 
across species.  Hypusinated eIF5A, the predomi-
nant form in normal and cancer cells, is involved in 
cell survival and inflammatory pathway activation. 
siRNAs targeting eIF5A inhibit NF-kB activation 
and reduce pro-inflammatory cytokine production. 
Accumulation of the unhypusinated lysine form of 
eIF5A is associated with apoptosis.
metHods: PK and PD secondary endpoints included 
characterization of PK by measuring pExp5A plasmid 
DNA and eIF5A siRNA in blood and bone marrow 
(BM), assessing potential immunogenicity of SNS01-T 
by measuring serum concentrations of antibodies 
against SNS01-T nanoparticles, and measuring serum 
concentrations of select proinflammatory cytokines 
by enzyme-linked immunosorbent assay in serum 
and plasma samples. Blood PK timepoints were 30 
minutes before the first infusion and at 30 minutes, 
2, 6, and 24 hours after the first infusions on Week 1, 
Week 3, and Week 6 and at the 4, 8, and 12 week visits 
after the last infusion; BM samples were collected 1 
day after the final infusion.
results: Plasmid and siRNA blood levels generally 
peaked 30 minutes post-dosing at weeks 1, 3 and 6 
of dosing. Both plasmid and siRNA exhibited rapid 
clearance from the blood, with levels dropping to near 
pre-dosing levels within 24 hours of administration. 
pExp5A plasmid DNA was detectable in the bone mar-
row of 2 pts at cohort 1, 2 at cohort 2, 1 at cohort 3 and 
1 at cohort 4. eIF5A siRNA was not detectable in bone 
marrow. No antibodies to SNS01-T nanoparticles were 
detected at any timepoint at any dose level. Cytokines 
remained within the expected range of inter-patient 
variability, similar to baseline across all timepoints at 
the first 2 dose levels.
conclusion: PCR analysis demonstrated the pres-
ence of both plasmid DNA and siRNA components of 
SNS01-T in blood at all dose levels, with a dose-depen-
dent increase in plasmid copy number. Plasmid DNA 
was also detected in bone marrow collected 24 hours 
after the final infusion of SNS01-T. Pro-inflammatory 
cytokines did increase within hours of infusion but 
returned to baseline within 24 hours, synchronous 
with clinical infusion reactions (see Abstract 70148). 
No evidence of an anti-SNS01-T antibody response 
was observed in any subject.
*CI09
The Charateristics of Rebound Nystagmus in  
Patients and Normal Subjects
Bhatt, S.H.; Patel, K.; Rosenberg, M.L.; New Jersey Neuro-
science Institute
introduction: Rebound nystagmus (RN) refers to 
nystagmus noted on return to primary position after 
sustained lateral gaze to one side. RN was once consid-
ered to be a pathological phenomenon found only in 
patients. We have previously presented evidence that 
it is found consistently in normal subjects and that the 
nystagmus fatigues with a reproducible time constant 
(TC). Further investigation was initiated in order to 
discover whether there was a significant difference 
between the TC of patients and normal subjects.
metHods: Data from 59 normal subjects and 89 neuro-
logic patients with different problems was used. All 
first fixated in primary position, then  45Â° to the left, 
back to primary position, then 45Â° to the right, and 
back to primary position, each phase lasting 40 sec-
onds. The TC was obtained by fitting the slow phase 
velocities to an exponential model. Only trials with a 
reliable fit (R2 > 0.2) and at least 3 sequential beats of 
nystagmus were included.
results: A reliable TC was found in 35/52 (67%) nor-
mal subjects in light conditions and in 29/51 (57%) 
under dark conditions. In patients, a reliable TC was 
found in 42/89 (47%) under light conditions and in 
29/70 (41%) under dark conditions. The average TC in 
normal subjects in light was 6.28 (std 2.94) while in 
patients it was very similar at 6.57, (std 2.97).  The aver-
age TC in normal subjects in the dark was 11.66 (std 
6.06) and in patients it was 9.02 (std 3.76). The average 
amplitude in normals in the light was 0.82o (std 0.16) 
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and was 1.20 o (std 0.18) in patients. In the dark, nor-
mal subjects had an amplitude of 1.53 o (std 0.30) and 
patients had a value of 2.0o (std 0.23).  There was sta-
tistical significance in the incidence of rebound and 
amplitude in the light condition. Patients were also 
separated into different groups based on pathophysi-
ology but no diagnosis showed values of significant 
difference compared to controls.
conclusion: The significantly greater incidence of RN 
in the light in normal subjects compared to patients 
was surprising and is of unclear etiology. It may re-
flect a better ability of normal subjects to concentrate 
on the task and maintain far eccentric gaze. The great-
er amplitude of RN in patients in the light may explain 
why the rebound seen clinically is always pathologi-
cal. Hopefully future work with additional patients 
will lead to better localization of these findings.
CI10
A Phase IIa, Open-Label, Multicenter Study of 
Single-Agent MOR00208, an Fc-Optimized Anti-
CD19 Antibody, in Patients with Relapsed or 
Refractory B-Cell Non-Hodgkin’s Lymphoma
Blum, K.A.; Maddocks, K.; Nagy, Z.; Zinzani, P.L.; Goy, A.; 
Provencio, M.; Robak, T.; John Theurer Cancer Center at 
Hackensack University Medical Center
introduction: A number of second-generation mono-
clonal antibodies (mAbs) that target the antigens 
CD20 and CD19 have been evaluated across a range of 
non-Hodgkin’s lymphoma (NHL) subtypes combined 
with chemotherapy, as a single agent, or as mainte-
nance therapy. Although these agents are usually well 
tolerated and have demonstrated clinical activity in 
patients (pts) with NHL, there is still a high unmet 
medical need for pts with refractory or relapsed NHL. 
MOR00208 is an Fc-engineered humanized mAb that 
targets the antigen CD19 and possesses significantly 
enhanced antibody-dependent cell-mediated cytotox-
icity, a key mechanism for tumor cell killing.
metHods: Non-randomized, phase IIa, open-label, 
multicenter study (NCT01685008) designed to assess 
efficacy and safety of single-agent MOR00208 in pts 
18 years with relapsed or refractory NHL previously 
treated with rituximab, who were not candidates for 
high-dose therapy with stem cell support. Eligibility: 
pts with DLBCL, FL, MCL, and other indolent NHL 
(iNHL), who had received at least one prior rituximab-
containing therapy; ECOG PS 0-2, measurable disease 
≥1.5 cm, adequate bone marrow function, renal and 
liver function test.
results: Herein we report the efficacy results for the 
51 pts enrolled in stage 1 and the safety for 85 pts en-
rolled to date in stages 1 and 2 of this trial. The median 
age for all 51 stage 1 pts was 70 (35-90) years, 46 had 
stage III-IV disease, and the median number of prior 
therapies was 3 (2-4). Treatment cohorts consisted of 
DLBCL (n=14), FL (n=14), MCL (n=12) and iNHL (n=11). 
The investigator assessed overall response rate in 
stage 1 over all NHL subtypes was 24% (12/51), with 
responses observed in the DLBCL, FL, and iNHL co-
horts (Table). As of February 2014, 62/85 (72.9%) stage 
1 and stage 2 pts had developed treatment emergent 
adverse events (TEAEs). The most frequently reported 
TEAEs of any grade were thrombocytopenia (11.8%), 
anemia and headache (10.6% each), and neutropenia 
(9.4%). Infusion-related toxicities were all grade 1-2 
(except for one case of dyspnea of grade 4). There have 
been no treatment-related deaths. Most of the TEAEs 
occurred in pts with DLBCL (30/36 [83.3%]). In pts 
with DLBCL, the most frequently reported grade 3 
TEAEs were neutropenia (13.9%), thrombocytopenia 
and anemia (8.3% each).
conclusion: The Fc-engineered humanized anti-CD19 
antibody, M0R00208, is well tolerated without signifi-
cant infusional toxicity and demonstrates preliminary 
efficacy in pts with relapsed/refractory DLBCL, FL, 
and iNHL. Accrual to stage 2 for pts with DLBCL and 
FL is ongoing.
CI11
TGR-1202, a Novel Once Daily PI3KÎ´ Inhibitor, 
Demonstrates Clinical Activity with a Favorable 
Safety Profile, Lacking Hepatotoxicity, in  
Patients with Chronic Lymphocytic Leukemia 
and B-Cell Lymphoma
Burris III, H.A.; Patel, M.R.; Brander, D.; O’Connor, O.A.; Deng, 
C.; Fenske, T.S.; Gutierrez, M.; John Theurer Cancer Center at 
Hackensack University Medical Center
introduction: TGR-1202 is a novel oral, next gen-
eration PI3KÎ´ inhibitor which notably lacks the 
hepatotoxicity associated with other PI3KÎ´ inhibitors. 
Preliminary data from an ongoing Ph I study of TGR-
1202 demonstrated clinical activity in patients with 
advanced hematologic malignancies (ASCO 2014). 
Herein we present updated results from this Phase 
I, first in human study of TGR-1202 in patients with 
relapsed and/or refractory CLL and B-cell lymphoma.
metHods: TGR-1202 is administered orally once daily 
following a 3+3 dose escalation design. Previously 
treated patients with an ECOG PS â‰_ 2 and con-
firmed diagnosis of B-cell non-Hodgkin lymphoma 
(NHL), chronic lymphocytic leukemia (CLL), or other 
lymphoproliferative disorders are eligible.  Endpoints 
include safety, PK/PD, and efficacy.
results: 49 patients have been enrolled to date of 
various lymphoma subtypes including CLL, follicular 
13
lymphoma (FL), Hodgkin’s lymphoma (HL), DLBCL, 
mantle cell lymphoma (MCL), and marginal zone 
lymphoma (MZL).  Demographics: 76% male, ECOG 
0/1/2: 17/31/1, median age of 59 yrs (range: 22-85), me-
dian prior treatment regimens: 3 (range: 1-14), and 43% 
were refractory to prior treatment.  35 patients have 
been treated at doses ≥800 mg of a previous formula-
tion where a threshold effect in activity was observed, 
and 6 have been treated with an improved micronized 
formulation (≥200 mg). TGR-1202 was well tolerated 
and no MTD has been reached to date.  The only 
Grade 3 AE occurring in >5% of patients was neutro-
penia (8%).
conclusion: TGR-1202 is well tolerated in patients 
with relapsed and/or refractory hematologic malig-
nancies with no reported hepatotoxicity or events of 
colitis and promising clinical activity.  Enrollment 
continues in expansion cohorts and with the micron-
ized formulation.
CI12
Serious Infections of Hospitalized Patients are 
Associated with a Higher Prevalence of Reported 
Beta Lactam Antibiotic Allergy
Cai, B.; McGoey, B.A.; Michelis, M.A.; The Center for Allergy, 
Asthma & Immune Disorders at Hackensack University Medical 
Center, Hackensack, NJ; Stevens Institute of Technology, 
Hoboken, NJ 
introduction: To determine if having a vancomycin 
resistant enterococcus (VRE), methicillin resistant 
Staphylococcus aureus (MRSA) and Clostridium dif-
ficile (C-diff) infections are associated with a higher 
prevalence of reported beta lactam antibiotic allergy 
in hospitalized patients.
metHods:	A retrospective study of the charts of pa-
tients with documented VRE, MRSA and C-diff 
hospitalized in 2013 at Hackensack University 
Medical Center were evaluated for a reported beta 
lactam antibiotic allergy.  The number of patients 
hospitalized during this time period and the total 
number of patients allergic to a beta lactam antibiotic 
were also determined. Infected patients were evalu-
ated for prevalence of beta lactam antibiotic allergy. 
results: There were 44,733 admissions for 2013 with 
5,299 reporting a beta lactam allergy making a prev-
alence of 11.8%. A total of 798 subjects matched our 
criteria having these serious infections (prevalence 
1.8%), of which 53.9% were male. The study included 
41 patients infected with VRE, 390 with MRSA and 
367 with C-diff. Of the infected patients, 164 (20.5%) 
reported beta lactam allergy. This is 1.75 times the 
prevalence of beta lactam allergy for this hospitalized 
group. The mean age of patients with a beta lactam al-
lergy was 69.7 years and without was 60.6 years. There 
were 138 in-hospital deaths with this group of which 
21 (12.8%) had a history of beta lactam allergy. 
conclusion: Serious infections caused by multi-drug 
resistant organisms in these hospitalized patients 
during 2013 reflected higher prevalence of patients 
with a reported beta lactam allergy. Results were not 
age or sex dependent and all diagnosis’ were included. 
CI13
Compounded Risk Factor for Candida 
Esophagitis With Concomitant Use of Proton 
Pump Inhibitors and Steroids
Cavanagh, Y.; Shah, N.; DeBari, V.A.; Baddoura, W.; St Joseph’s 
Regional Medical Center
introduction: The role of gastric acid suppressors 
as predisposing factors for Candida esophagitis (CE) 
was investigated in a retrospective case-control study 
of AIDS-negative patients from January 2001 to 2012. 
The diagnosis of CE was made endoscopically. Our 
data suggest that CE occurs in patients who have 
previously been treated with antibiotics, steroids or 
gastric acid suppression therapy. These findings are 
consistent with recent reports and support our hy-
pothesis that treatment with proton pump inhibitors 
(PPI) predisposes to the development of CE.
metHods: Eighty-four patients diagnosed with 
Candida Esophagitis were retrospectively identified 
following endoscopy that was conducted between 
January 2001 and January 2012. The study was con-
ducted at two large, urban, academic medical centers 
in northeast USA. These patients were matched with 
336 controls who were matched based on age and gen-
der. The controls also underwent endoscopy but had 
no observed CE. We excluded all known HIV positive 
patients from our study.
results: In this retrospective case control study in-
volving eighty-four non HIV/AIDS patients with 
esophageal candidiasis, we found that the previously 
recognized risk factors such as steroid therapy, diabe-
tes (type I and II), carcinoma, chemotherapy/radiation, 
hypothyroidism, antibiotics, and chronic liver disease, 
did correlate with the development of esophageal can-
didiasis. However, the most prominent finding was 
the strong, statistically significant association of PPI 
use and steroid use with esophageal candidiasis. 
conclusion: Esophageal candidiasis is known to oc-
cur in immuno-compromised patients, but has only 
infrequently been reported in immuno-competent 
hosts. The exact mechanisms are unknown, but a 
number of theories have been postulated. Esophageal 
candidiasis appears to occur when colonization of the 
esophagus is followed by invasion of the epithelial 
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layer. To our knowledge, this is the largest case con-
trol study imply a statistically significant association 
of PPI and steroids with CE.
CI14
Selinexor Demonstrates Marked Synergy with 
Dexamethasone (Sel-Dex) in Preclinical Models 
and in Patients with Heavily Pretreated Refractory  
Multiple Myeloma (MM)
Chen, C.I.; Gutierrez, M.; Siegel, D.S.; Richter, J.R.; Wagner-
Johnston, N.; Hofmeister, C.C.; Berdeja, J.G.; John Theurer 
Cancer Center at Hackensack University Medical Center
introduction: Selinexor (KPT-330) is an oral Selective 
Inhibitor of Nuclear Export (SINE) XPO1 antagonist in 
Phase 1 and 2 clinical studies. Selinexor forces nuclear 
retention and reactivation of tumor suppressor pro-
teins (TSPs) and reduction of many proto-oncogenes, 
including MDM2, MYC and Cyclin D. In addition, se-
linexor potently deactivates NF-ÎºB, through forced 
nuclear retention of IÎºBÎ±. Together these effects in-
duce selective apoptosis in MM cells and inhibition 
of NF-ÎºB dependent osteoclast activation. XPO1 is 
also responsible for nuclear export of glucocorticoid 
receptor.
metHods: In vitro tumor cell viability measurements 
were based on MTT (CellTiter 96Â/¨Promega) and 
combination indices were calculated using CalcuSyn 
software. For xenograft studies, utilized NOD-SCID 
mice with subcutaneous inoculation of MM.1s cells. 
GR nuclear localization was measured with immu-
nofluorescent anti-GR (phosphor-S211) antibody and 
quantitative imaging. To assess GR transcriptional 
activation, GR binding to a GCR consensus sequence 
was measured in nuclear extracts using an ELISA 
method (GR ELISA kit/Affymetrix).
results: In MM.1s cells Sel-Dex showed syn-
ergy for nuclear retention of the DEX activated 
GR (Ser211-phosphorylated) and concomitant GR 
transcriptional activation. Sel-Dex showed highly syn-
ergistic cytotoxicity in MM.1s cells in vitro and in vivo, 
with a corresponding increase in apoptosis. Selinexor 
alone was potently cytotoxic in the DEX resistant MM 
cell lines MM.1R and ANBL6, but addition of DEX 
provided no additional effect. Twenty-eight pts with 
heavily pretreated refractory MM (16 M, 12 F; median 
age 62; ECOG PS 0/1: 7/21; median prior regimens: 6) 
received selinexor at 30 - 60 mg/m2 with either 0, <20, 
or 20 mgs DEX.  All pts have received a proteasome 
inhibitor and an Imid and the majority of pts have re-
ceived pomalidomide (68%) and/or carfilzomib (36%).
conclusion: Sel-Dex combination is markedly syn-
ergistic in preclinical models, which is supported by 
the preliminary clinical data presented. One potential 
mechanism underlying this synergy is amplification 
of GR activity due to combined effects of selinexor-in-
duced nuclear retention of activated GR coupled with 
DEX-mediated GR agonism. These results provide a 
promising basis for continuing study of Sel-Dex for 
treatment of pts with refractory MM.
CI15
A Phase I Dose-Escalation Study of Carfilzomib 
in Patients with Previously-Treated Systemic 
Light-Chain (AL) Amyloidosis
Cohen, A.D.; Scott, E.C.; Liedtke, M.; Kaufman, J.L.; Landau, 
H.; Vesole, D.H.; Gomes, C.L.; John Theurer Cancer Center at 
Hackensack University Medical Center
introduction: The proteasome inhibitor (PI) bortezo-
mib is active in AL amyloidosis.  Carfilzomib (CFZ) is 
a novel irreversible PI approved for relapsed/refrac-
tory multiple myeloma, with less neurologic toxicity 
than bortezomib, but its safety and efficacy in AL am-
yloidosis is not known.  We report the first results of a 
multi-center, Phase I, dose-finding study of CFZ in AL 
(NCT01789242).
metHods: Patients had relapsed AL after â‰¥1 prior 
therapy.  Patients with advanced cardiac involvement 
(Mayo stage III, LVEF<40%, or NYHA Class III/IV) 
were excluded.  A standard 3+3 dose escalation sched-
ule was used, with planned cohorts of 27, 36, 45, and 
56 mg/m2. CFZ was given as a 30-minute infusion on 
days 1, 2, 8, 9, 15, 16 of a 28-day cycle, starting at 20 mg/
m2 on cycle 1, days 1,2, then escalating starting day 8.
results: As of 7/17/14, 12 patients have enrolled. 
Median age was 62 (range 58-81); 50% were male. 
Median time from diagnosis was 2.8 years, with me-
dian of 2 prior regimens (range 1-4). Eleven patients 
(92%) had prior bortezomib (5 were refractory); 50% 
prior IMiDs; 50% prior stem cell transplant.  Median 
# of involved organs was 1 (range 1-2), including 5 
patients with heart, 5 kidney, 1 liver, 2 GI tract, and 
4 peripheral/autonomic nerve.  Median NT-proBNP 
was 854 pg/ml (range 93 - 9702); 3 and 9 patients were 
Mayo cardiac stage I and II, respectively.  Three pa-
tients each were treated at 20/27 and 20/36 mg/m2, 
with no DLTs.
conclusion: Carfilzomib monotherapy is feasible and 
effective in relapsed/refractory AL amyloidosis, with 
MTD identified as 20/36 mg/m2 as a 30-minute infu-
sion.  Cardiac events are common in this population, 
and may be related to drug, underlying disease or 
both, suggesting a role for monitoring with cardiac 
biomarkers and serial echocardiograms.  Preliminary 
hematologic response rates are promising in this bort-
ezomib-exposed population, and organ assessments 
are ongoing.  Further study is warranted.
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CI16
Bendamustine Plus Rituximab (BR) in the 
Treatment of Relapsed/Refractory Mantle Cell 
Lymphoma of a Phase 2 Study: Multivariate 
Analysis and Updated Final Results By Subgroup
Czuczman, M.; Goy, A.; Lamonica, D.; Graf, D.; Munteanu, M.; 
Van Der Jagt, R.; John Theurer Cancer Center at Hackensack 
University Medical Center
introduction: Mantle cell lymphoma (MCL) is an 
aggressive non-Hodgkin lymphoma that usually 
presents as advanced-stage disease. Relapse is com-
mon, and management of relapsed/refractory MCL is 
difficult due to a limited number of approved agents 
and numerous comorbidities seen in this typically 
elderly patient population. We conducted a study of 
bendamustine plus rituximab (BR) in patients with 
relapsed/refractory MCL and presented prelimi-
nary results (Czuczman et al, ASH 2012, Abstract 
3662). Final data are being analyzed in a multivariate 
analysis of baseline demographic and disease factors 
affecting outcomes for this study, and we present be-
low the final data for individual subgroups for best 
overall response, DOR, and progression free survival 
(PFS).
metHods: Relapsed disease was defined as having 
achieved CR with a previous therapy but demon-
strating recurrent disease >6 mo after the last dose. 
Refractory disease was defined as either a lack of CR 
while undergoing previous therapy or the loss of CR 
<6 mo after the last dose. Bendamustine 90 mg/m2 
was administered on days 1 & 2; rituximab 375 mg/
m2 was administered on day 1 of a 28-day cycle. The 
treatment period was 6 cycles, but patients without 
disease progression and without a documented CR 
could receive up to 8 cycles. For the multivariate anal-
ysis, logistical regression will be used to examine the 
predictive value of baseline variables associated with 
response in categorical analyses.
results: 45 pts received â‰¥1 dose of BR. Median 
treatment - 6 cycles. For the entire cohort, the overall 
response rate (ORR) was 82%. Final data among pts w/ 
relapsed (n=21) & refractory (n=24) MCL show ORRs 
of 90% (n=19; CR 16 [76%], PR 3 [14%], 2 not calculable 
[NC]); and 75% (n=18; CR 5 [21%], PR 13 [54%], 1 NC), 
respectively. Median DOR (95% CI) was 19.7 mo  and 
15.3 mo and median PFS was 23.1 mo and 17.1, for re-
lapsed and refractory pts, respectively. ORRs based 
on pts’ response to most recent prior rituximab treat-
ment were CR, 95% (n=18; CR 15, PR 3); PR, 89% (n=8; 
CR 3, PR 5); SD, 56% (n=5; CR 1, PR 4); PD, 71% (n=5; 
CR 1, PR 4); unknown, 100% (n=1; CR 1). DORs based 
on response to prior rituximab: CR, 17.0 mo; PR, 17.9 
mo; SD, 35.3 mo;  PD, 14.3 mo (3.9, NC); unknown was 
NC. PFS results were: CR, 22.1 mo; PR, 18.1 mo; SD, 
17.9 mo; PD, 13.8 mo (5.4, NC); unknown was NC. In 
subgroups based on MIPI category, the ORR of pts in 
categories â‰_3 was 92% (n=22; CR 14, PR 8); in 4-5 
was 92% (n=11; CR 5, PR 6); in >5 was 44% (n=4; CR 2, 
PR 2). DORs based on risk category: â‰_3, 20.6 mo ; 
4-5, 11.1 mo; >5, NC (5.1, NC). PFS results were: â‰_3, 
23.2 mo; 4-5, 12.8 mo ; >5, 7.9 mo (2.0, NC).
conclusion: The multivariate analysis is intended to 
indicate which patient characteristics are most closely 
associated with efficacy endpoints such as durability 
of response to BR. BR showed efficacy across a wide 
range of patient subgroups with relapsed/refractory 
MCL. In the subgroup of patients with relapsed MCL, 
CR was more common than PR, while patients with 
refractory MCL were more likely to achieve PR than 
CR. This information may be used to help guide treat-
ment decisions when considering BR in heavily treated 
MCL patients. The BR regimen is generally well-toler-
ated and may serve as the backbone to which other 
active agents can be added in the study regimens to 
further improve anti-lymphoma activity.
CI17
Hepatitis A Vaccine Response in HIV-Infected 
Patients: The Interchangeability of TWINRIX and 
HAVRIX, a Second Look
Dazley, J.; Jimenez, H.; Szabela, E.; Abdalqadar, M.; Slim, J; 
St. Michael’s Medical Center
introduction: Hepatitis A virus (HAV) is a continuing 
health concern among immunocompromised patients 
such as those with HIV. The rates of seroconversion 
for HAV among vaccinated HIV positive individuals 
are less than the general population. The guidelines 
are non-specific regarding TWINRIX vs. HAVRIX, re-
gardless of immune status.  Our objective to analyze 
the effects of variables including category of vacci-
nation and the immunologic response to hepatitis A 
vaccination in the HIV positive patient who may be on 
highly active antiretroviral therapy.
metHods: We conducted a randomized prospective 
study over the years of 2012-2015 in a clinic with a 
1217 patient load.  Patient were included if they had a 
negative HAV antibody and received either a series of 
a dose of  HAVRIX or TWINRIX given 6 months apart, 
followed by a repeat HAV antibody to determine sero-
conversion.  Variables were then extrapolated in order 
to come up with valuable descriptive data.
results: Conversion rates were 81% in the HAVRIX 
population vs. 100% in the TWINRIX group.  55% of 
the HAVRIX group had a CD4, T cell count of < 350 
cell/mm(3), 36% of the TWINRIX had a T cell count 
< 350 cell/mm(3).  64% of the TWINRIX group is 
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African American, 27% is Caucasian, with the remain-
der being Hispanic.  HAVRIX group has 72% African 
American, 18% is Caucasian and the remainder again 
was Hispanic.  64% of both groups are male.  Half of 
the non-responders did not attain viral suppression.
conclusion: The rates of seroconversion may be defi-
cient after HAV vaccination in HIV positive patients. 
Virologic suppression and the CD4 count at the time 
of vaccination may contribute.  Subjects who re-
ceived TWINRIX seemed to be more sensitive to these 
variables with completion of the series than the alter-
native.  The advantage of TWINRIX vs. HAVRIX as a 
combined product continues to be a concern due to 
the vulnerability that immunocompromised patients 
have to acquiring acute hepatitis A infection.
*CI18
A Comparison of Transient Elastography  
(Fibroscan) and The APRI Score, Two Non-Invasive 
Tests for Liver Fibrosis Staging in HIV/HCV  
Co-Infected Patients
Dazley, J.; Sison, R.; Shukla, P.; Galang, H.; Szabela, E.; Slim, 
J.; Adebara, A.; St. Michael’s Medical Center
introduction: Transient elasticity is a non-invasive 
alternative to liver biopsy for detecting hepatic fi-
brosis. Many studies have compared elas-tography 
to percutaneous biopsy. Our objective  is to perform 
a retrospective chart review comparing fibroscan to 
APRI scoring for hepatic fibrosis using percutaneous 
biopsy as the gold standard for the staging of liver fi-
brosis due to causes such as infection with hepatitis 
C virus. A selection of studies was based on reported 
accuracy of fibroscan and APRI score compared with 
liver biopsy.
metHods: The charts of 623 subjects who received 
elasticity scans were reviewed.  Eighty four are HIV 
and hepatitis C positive and had a percutaneous bi-
opsy and were included. Gross liver appearance was 
assessed and biopsy specimens were blindly evalu-
ated by a pathologist. Elastography (FibroScan) was 
used to measure liver stiffness. A ROC curve analysis 
comparison of the two diagnostic tests was used, and 
a P-value of â‰_0.05 was regarded as significant.
results: The mean age is 58.2 ± 6.3 years. 49 (58.3%) 
were male. 61 (72.6%) were black and 78 (92.9%) had 
Hepatitis C genotype 1.  ROC curves for significant 
fibrosis and severe fibrosis were determined to com-
pare the Fibroscan and APRI score.
conclusion: Fibroscan and APRI score, although not 
useful in early stages of cirrhosis, continue to appear 
to be clinically useful tools for detecting cirrhosis. 
FibroScan may be more useful for detecting advanced 
stages of fibrosis when compared with the APRI score 
using a percutaneous biopsy as the gold standard. 
Our hope is that this study may be a springboard for 
larger prospective, multi-centered studied performed 
with more diversity of subjects to add clarity to this 
important objective.
CI19
Haploidentical Allogeneic Transplantation  
Provides Comparable Outcomes to HLA-
Matched or Mismatched Unrelated Donor Grafts 
in Hematological Malignancies
Donato, M.D.; Rowley, S.R.; Baker, M.B.; McKiernan, P.M.; Kim, 
D.K.; Vesole, D.V.; Skarbnik, A.S.; John Theurer Cancer Center 
at Hackensack University Medical Center
introduction: Haploidentical (HAPLO) and unrelated 
donors (URD) are established cell sources for patients 
(pts) who lack HLA-matched siblings. Limited data 
are available comparing transplant (TP) outcomes us-
ing cells from HAPLO vs URD donors.  We performed 
a retrospective analysis of sequential pts (n=54) un-
dergoing HAPLO transplants with post-transplant 
cyclophosphamide (Cy)
metHods: A control group of HLA 7/8 or 8/8 matched 
URD recipients (n=59) matched by diagnosis, trans-
plant date, and cell source (PBSC or marrow) was 
identified. Bone marrow staging and CD34+ cell 
chimerism were assessed at day +84.  GvHD was 
staged per standard guidelines. Analysis of categori-
cal variables was performed using the Fisher’s exact 
test. Non-parametric analysis of median values was 
used for continuous variables. Survival was assessed 
using the log-rank test. Informed consent for analysis 
of transplant outcome data was obtained before trans-
plantation for all patients and donors.
results: ANC and PLT recoveries were faster for 
URD PB compared to BM recipients.  However, en-
graftment kinetics did not differ for HAPLO PB or 
BM recipients. HAPLO donor CD3 engraftment was 
robust, with 44 of 48 (92%) HAPLO compared to 37 of 
52 (71%) URD recipients achieving >95% CD3+ chime-
rism at day +28 (p=0.01). Engraftment failure defined 
by failure to achieve ANC recovery and day +28 donor 
CD3 chimerism >5% was reported in 4 (7.4%) HAPLO 
and 2 (3%) URD recipients (p=0.42). The cumulative 
incidences of cGVHD in the HAPLO vs URD cohorts 
were comparable (39% vs 36%, p=0.84) and the inci-
dence of moderate or severe cGVHD was 15% and 22%, 
respectively (p=0.34). At time of analysis, relapse oc-
curred for 37% HAPLO pts (n=20) compared to 33% 
(n=20) in the URD group (p=0.84). 23 pts died (43%) in 
the HAPLO group: 12 from relapse, 5 from infection, 
6 from other causes. In the URD group, 23 (39%) died: 
13 from relapse, 3 from infection, 7 from other causes. 
The one-yr survival probabilities were 56% HAPLO 
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and 66% URD, with median OS probabilities 18 mo 
and 22 mo (p=0.85). OS was lower for recipients of 7/8 
vs 8/8 matched URD grafts, but the difference was not 
significant (not shown).
conclusion: These results show similar outcomes 
after HAPLO and URD transplant for engraftment, 
GvHD, relapse and OS.  Almost all HAPLO pts 
achieved full donor CD3+ chimerism by day +28. In 
conclusion, HAPLO transplant with post transplant 
Cy is an option for pts lacking HLA matched sib-
lings; prospective studies are needed to validate these 
findings.
CI20
Clinical Differences among Hispanics and Non-
Hispanic Whites with Colorectal Cancer, a Single 
Institution’s Experience over 20 years
Duma, N.; Gandhi, A.; Sanchez, L.; Castro, Y.; Jennis, A.; 
Bamboat, Z.; Gutierrez, M.; Rutgers-New Jersey Medical 
School/Hackensack University Medical Center
introduction: Clinical Differences among Hispanics 
and non-Hispanic Whites with Colorectal Cancer, a 
Single Institution’s Experience over 20 years.
metHods: We reviewed the records of all patients (pts) 
diagnosed with CRC at our institution from 1993 to 
2013. A total of 2146 pts were studied. Demographics, 
tumor characteristics, and survival were analyzed. 
Kaplan-Meier and Cox regression were used for sur-
vival and multivariate analysis.
results:	There were 318 H and 1828 NHW. Median age 
at diagnosis was 63 years in H and 70 years in NHW. 
At diagnosis, 30% of H had stage IV disease compared 
with 18% of NHW (p < 0.0001). H were more likely to 
have left sided and poorly differentiated tumors com-
pared to NHW (71% vs. 63%, p < 0.008; 24% vs 10%, p 
< 0.0001, respectively). H had a higher recurrence rate 
than NHW (13% vs 4%, p < 0.0001). There was a signifi-
cant difference on median overall survival (all stages) 
between the two groups, being 76 mo for H (95% CI: 
69-83) and 180 mo for NHW (95%CI: 112-251), p < 0.0001. 
Hispanic ethnicity (OR: 1.64, p < 0.009), histologic 
grade (OR: 1.21, p < 0.003) and negative margins after 
resection (OR: 0.41, p < 0.0001) were independent pre-
dictors of survival by multivariate analysis.
conclusion: In our cohort, Hispanic pts were diag-
nosed with CRC at a younger age, were more likely 
to have left sided and poorly differentiated tumors, 
to present with advanced disease at diagnosis, and 
had shorter overall survival when compared to 
NHW. Further research should aim to elucidate the 
basis of these differences, as this could potentially 
impact screening and management in the Hispanic 
population.
CI21
Impact of Thyroid Hormones on Clinical  
Outcomes in Colorectal Cancer Patients
Duma, N.; Streb, G.; Pievsky, D.; Sanchez, L.; Aleksic, 
S.; Gutierrez, M.; Rutgers-New Jersey Medical School/
Hackensack University Medical Center
introduction: Thyroid hormones (THs) may play 
a role in diseases other than hyper- and hypothy-
roidism. Several lines of evidence have attributed 
tumor-promoting effects of TH and TH receptors. It 
has been suggested that increased circulating hor-
mones contribute to the growth of different cancers, 
by promoting tumor angiogenesis.  We plan to in-
vestigate the role of thyroid hormones in colorectal 
cancer (CRC) patients.
metHods: We conducted a retrospective review of 
all patients diagnosed with CRC at the John Theurer 
Cancer Center in Hackensack, New Jersey from 2011 
to 2013. Demographics, tumor characteristics, TSH/
T4 levels, survival and recurrence were studied. 
Kaplan Meier method and Cox regression were used 
for survival and multivariate analysis.
results: 376 patients with diagnosis of CRC were 
selected. Median age at diagnosis was 65 years. We 
found an overall prevalence of 4.2% (16) of hypothy-
roidism and <1% of hyperthyroidism. Patients were 
staged as I (24%), II (22%), III (38%) or IV (16%)  The 
median serum TSH was 3.3 (range: 0.01-66.5) and 
median total T4 was 6.6 (0.83-18). There was no sub-
stantial difference in median TSH and total T4 levels 
between lower and higher stages of disease. Patients 
with TSH levels lower than 3.3 were associated with 
a better histologic grade (OR: 0.78, p<0.05). Overall 
median survival was 25.7 months (95%CI: 23.3-28.0). 
TSH and T4 levels were not predictors of survival by 
univariate or multivariate analysis.
conclusion: Our cohort had similar prevalence of 
hypothyroidism and hyperthyroidism when com-
pared with the general population. While absolute 
thyroid hormone levels were similar throughout the 
CRC stages, an important relationship between histo-
logic grade and TSH levels was observed, this could 
support the theory that higher TSH levels are associ-
ated with greater cell proliferation.  Further research 
with a larger sample is required in order to evaluate 
whether thyroid hormones have a direct effect in the 
pathophysiology and natural history of CRC.
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CI22
Amiodarone Protocol Reduces Atrial Fibrillation 
and Decreases Mortality in Cardiac Surgery 
Patients
Elkhalili, W.; Grinn, M.; Elzomor, W.; Cosenza, R.; Asgarian, 
K.A; Badami, C.; Connolly, M.; St. Joseph’s Regional Medical 
Center. New York Medical College
introduction: Following cardiac surgery, the most 
common occurring arrhythmia is atrial fibrillation. 
Nationwide, the percentage of postoperative atrial 
fibrillation (POAF) can be as high as 50%.  At our in-
stitution, beginning in January 2011, an amiodarone 
protocol was instituted for all patients undergoing 
coronary artery bypass grafting (CABG) surgery.  This 
analysis will assess the efficacy of our amiodarone 
protocol to reduce post-operative atrial fibrillation in 
our cardiac surgery patient population.
metHods: This is a retrospective cohort study of a 
prospectively maintained cardiac surgery database 
consisting of 1,439 patients from January 2009 until 
December 2012.  After including only patients under-
going coronary artery bypass graft (CABG) surgery, 
and excluding those who had prior cardiac surgery 
and with pre-existing atrial fibrillation, a total of 727 
patients were analyzed. The incidence of POAF and its’ 
complications were then compared prior to (2009-10), 
and after (2011-12), the institution of the amiodarone 
protocol in 2011.
results: Prior to the establishment of the amiodarone 
protocol at our institution, the incidence of POAF was 
19.73%. During the following 2 years after protocol es-
tablishment, the average incidence of POAF dropped 
to 10.73%.  This was associated with a relative risk re-
duction of 0.455 (CI: 0.220-0.620). The final year of the 
study resulted in a POAF average decrease to 7.91%, 
the lowest value during this investigation.
conclusion:	The incidence of POAF can be reduced 
by a strict adherence to an amiodarone protocol. A 
multicenter trial should be conducted to establish its 
efficacy.
CI23
Brentuximab Vedotin Monotherapy in DLBCL 
Patients with Undetectable CD30:  Preliminary 
Results from a Phase 2 Study
Feldman, T.; Bartlett, N.; Smith, M.; Advani, R.;  Savage, K.; 
Palanca-Wessels, M.; Siddiqi, T.; John Theurer Cancer Center 
at Hackensack University Medical Center
introduction: Patients  with relapsed/refractory 
DLBCL have a poor outcome. For pts ineligible for 
transplant, no standard of care exists and median 
overall survival for pts not responding to 2nd-line 
therapy is only 4 months (Elstrom 2010). A phase 2, 
open-label study was initiated to assess antitumor 
activity of brentuximab vedotin (ADCETRISÂ®) in 
relapsed/refractory CD30+ NHL, including DLBCL. 
Significant antitumor activity was observed in DLBCL 
over a wide range of CD30 expression, including very 
low levels (<1-10%). 41% of DLBCL pts achieved an 
objective response (16% CR), regardless of CD30 ex-
pression (Bartlett, ASH 2013).  The trial was amended 
to investigate the antitumor activity of brentuximab 
vedotin in ~50 DLBCL pts with undetectable CD30 ex-
pression using standard IHC.
metHods: Eligible pts must have DLBCL with unde-
tectable CD30 expression on tumor cells by visual 
assessment using routine IHC (anti-CD30 BerH2 an-
tibody) per local lab.  Pts must also have had 1-3 prior 
therapies and an ECOG performance status â‰_2. 
Brentuximab vedotin 1.8 mg/kg is administered ev-
ery 3 weeks until disease progression or unacceptable 
toxicity for pts who achieve stable disease or better. 
The primary endpoint is objective response rate per 
Revised Response Criteria for Malignant Lymphoma 
(Cheson 2007).  Key secondary endpoints include safe-
ty and duration of response.
results: 27 DLBCL pts with undetectable CD30 ex-
pression per local lab have been enrolled and treated. 
All patients had elevated soluble CD30 at baseline 
with a median of 166 ng/mL and range of 55-1,696 ng/
mL (normal, â‰_29 ng/mL).  Most pts had advanced 
stage disease at baseline (78%); median age was 65 
years (range, 42-91); and 81% had an ECOG perfor-
mance status of 1-2.  The median number of prior 
therapies was 2, and 8 pts had 3 prior therapies.  Six 
(22%) pts had received prior autologous SCT.  Of 14 pts 
(52%) with refractory disease at study entry, 11 were 
also refractory to their frontline treatment.  To date, 
pts have received a median of 2 cycles of brentux-
imab vedotin (range, 1-10), and 12 (44%) pts remain on 
treatment.  13 pts discontinued treatment due to PD, 1 
withdrew consent, and 1 pt died due to an unrelated 
SAE of cardiac arrest. At the time of this analysis, 6 
(27%) of 22 pts who have had restaging assessments 
achieved an objective response, including 1 CR and 5 
PRs.  The CR began at Cycle 6 and is ongoing after 9 
weeks.  It is too early to assess median response dura-
tion.  For the 6 pts who achieved an objective response, 
undetectable CD30 was confirmed by central review.
conclusion: In this interim analysis of DLBCL pts 
with undetectable CD30, objective responses have 
been observed in 6 of 22 pts (27%) who have under-
gone restaging assessments.  Safety data are consistent 
with historic results and pts continue to enroll on 
study.  Activity of brentuximab vedotin in pts with 
undetectable CD30 by IHC may be explained wholly 
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or in part by one of several factors, including tumor 
heterogeneity, levels of CD30 on tumor below the 
level of IHC sensitivity, uptake by cells in the tumor 
microenvironment that can release the cytotoxic pay-
load, or deletion of repressive cells within the tumor 
microenvironment.  Correlative work to better under-
stand this activity is ongoing.
CI24
Gray Zone Lymphoma (GZL) with Features Inter-
mediate Between Classical Hodgkin Lymphoma 
(cHL) and Diffuse Large B-Cell Lymphoma  
(DLBCL): Analysis of Tumor Immunophenotype 
(IP) and Critical Examination of Therapy with  
Associated Impact on Outcome
Feldman, T.F.; Kritharis, A.K.; Vose, J.V.; Gascoyne, R.G.; Evens, 
A.E.; Blum, K.B.; Mato, A.M.; John Theurer Cancer Center at 
Hackensack University Medical Center
introduction: The WHO recognizes a category of 
B-cell lymphoma unclassifiable with features interme-
diate between DLBCL and cHL, also known as GZL. 
This is a challenging disease entity to treat due to dis-
ease heterogeneity and lack of pathologic or clinical 
prognostic indicators as well as absence of standard 
management guidelines for untreated or relapsed/re-
fractory patients (pts).
metHods: We performed a multicenter retrospective 
analysis of newly diagnosed GZL pts treated from 
2001-2012 across 19 North American academic cen-
ters. Diagnosis was established by institutional expert 
pathology review. This work is an expansion and 
update of prior reported data (Evens AM et al, ASH 
2013, #847) with 16 cases added to the original report. 
Additionally, new data were examined including his-
topathologic and IP analysis and detailed frontline 
and salvage therapy. Prognostic factors associated 
with survival on univariate and multivariate Cox re-
gression analyses were examined.
results: Characteristics of 112 GZL pts included: me-
dian age 39 years (19-86); M:F 1.8:1; ECOG PS 0-1 87%; 
B symptoms 40%; anemia 59%; hypoalbuminemia 
30%; bulky disease (â‰¥10cm) 24%; non-mediastinal 
presentation 57%; bone marrow pos 11%; Stage III/IV 
52%; IPI 0-2 77%; and IPS 0-2 in 81%. The most preva-
lent tumor IPs were: 93% CD20+ (100/108), 91% CD30+ 
(98/108), 78% CD79+ (43/55), 97% Pax5+ (67/69), 97% 
Oct2+ (27/28), and 94% MUM1+ (32/32). CD15 (44%, 
45/101) and CD45 (69%, 48/70) were variable. Only 
13% and 24% of pts were CD10+ (4/30) and EBV+ 
(13/55), respectively. Notably, IP did not differ based 
on clinical presentation (ie, mediastinal vs non-medi-
astinal). The most common frontline treatments were 
R-CHOP n=52, ABVD +/- R n=34, and R-EPOCH n=11. 
71% of CD20+ pts were treated with rituximab as part 
of frontline therapy. At 31-month median follow-up, 
2-year PFS and OS for all pts were 40% and 88%, re-
spectively. The only pathologic factor correlating with 
outcome was CD20 positivity (PFS: HR 0.34, 95% CI 
0.16-0.73, P=0.006).
conclusion: To the best of our knowledge, this rep-
resents the largest series of GZL reported to date. 
Presence of CD20 appeared to be an independent 
prognostic factor and treatment with a rituximab-
based DLBCL-specific regimen for frontline therapy 
was associated with the most optimal PFS. In addition, 
pts who underwent SCT at relapse appeared to have 
superior OS, however caution should be given to this 
finding given likely selection bias. Continued exami-
nation of this unique lymphoma is warranted.
CI25
Patient Characteristics and Initial Treatment 
Patterns in the United States for the Most  
Common Subtypes of Peripheral T-Cell Lymphoma 
(PTCL)
Feldman, T.F; Pinter-Brown, L.PB; Foss, F.F.; Pro, B.P.; 
Gisselbrecht, C.G.; Kahl, B.K.; Park, S.P.; John Theurer Cancer 
Center at Hackensack University Medical Center
introduction: Comprehensive Oncology Measures for 
Peripheral T-Cell Lymphoma Treatment (COMPLETE) 
is the largest registry of prospectively treated PTCL 
patients in the United States.  Patients are enrolled at 
the initial diagnosis of PTCL and within 30 days of 
starting treatment.  Data on demographics, clinical 
characteristics, diagnosis, therapy delivered as induc-
tion or salvage, and outcomes are collected.
metHods: For this report, we examined baseline 
characteristics and induction treatment patterns for 
patients with the 3 most common subtypes of PTCL: 
PTCL not otherwise specified (NOS), anaplastic 
large cell lymphoma (ALCL) and angioimmunoblas-
tic T-cell lymphoma (AITL). Only data from locked 
records are reported.  Locked records are those that 
have been reviewed and digitally signed by the treat-
ing investigator.
results: Five hundred patients were enrolled from 
February 2010 until January 2014. As of July 2014, 
there were 257 locked baseline records and 188 locked 
treatment records for patients with a diagnosis of 
PTCL-NOS, ALCL or AITL. The mean age of these pa-
tients was 60 (range: 51-70).  Most were male (66%) and 
white (78%).  At study entry, 234 (91%) had an ECOG 
performance status of 0-1, 190 (74%) had Ann Arbor 
stage of III/IV, and 120 (47%) had one or more B symp-
toms. Half of the patients had extranodal disease. 
Mean international prognostic index (IPI) score was 2 
(range 0-5). For staging, a PET/CT was the most com-
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mon radiographic method used (58% of patients), and 
for pathologic diagnosis, on average, 10 phenotypic 
and ~1 genetic markers were assessed. For baseline 
characteristics reported here, patients treated at aca-
demic centers had more extranodal disease, a higher 
IPI score and tended to have more advanced disease 
compared to patients treated in the community. The 
primary intent of initial therapy was a cure for 89% 
of patients and 60% received an anthracycline or an-
thracycline plus etoposide-containing regimen. A 
minority of patients (21%) participated in a clinical 
trial for PTCL.
conclusion: Early results from the first prospec-
tive US-based registry of newly diagnosed patients 
with PTCL-NOS, ALCL and AITL show that beyond 
CHOP-based therapy, there is little consensus on 
initial management of these patients.  These data 
strongly support the need to develop evidence-based 
approaches for this rare and heterogeneous group of 
patients.
CI26
Relapses of Diffuse Large B Cell Lymphoma in 
Rituximab Era Are Limited to the First Two Years 
after Frontline Therapy
Feldman, T.F; Goy, A.G; Gromko, L.G.; Chow, K.F.C; 
Bhattacharyya, P.B; Glisch, C.G.; Mato, A.M.; John Theurer 
Cancer Center at Hackensack University Medical Center
introduction: Rituximab has increased the CR rate, 
improved both PFS and OS and changed the pattern 
of relapse of DLBCL pts treated with R-CHOP (lead-
ing to a > 50% cure).  In contrast to the pre rituximab 
era, the majority of failures occur early (80% of fail-
ures occur in the 1st 18 months). The observation 
made that few relapses (7-8%) occur after 24 months 
of pts enrolled in clinical trials needs validation in the 
community setting. We report here  a large cohort of 
pts treated at our institution over a period of 7 years 
with rituximab-containing chemotherapy regimens.
metHods: We performed a retrospective cohort anal-
ysis to describe the survival experiences of adult 
patients with de novo DLBCL treated at our institu-
tion between 2007 and 2013. Patients were identified 
using Hematopathology and John Theurer Cancer 
Center outcomes databases. Patients who didn’t re-
ceive rituximab as part of their initial combination 
chemotherapy were excluded, as well as transformed 
DLBCL, primary CNS DLBCL, HIV-related DLBCL 
pts, those lacking follow up data.
results: A total of 245 patients with DLBCL treated 
at our institution were identified. Baseline character-
istics were as follows: median age was 63(20-92), 53% 
males, 75%  stage III-IV and 24% stage I-II; IPI score 
was high in 25% of pts, high-int in 22%, low-int in 45% 
and low in 7%. Most patients received R-CHOP (66%), 
while 34% were treated with dose intense regimens 
based on high risk features such as high IPI, Ki-67 
over 80% (R-HyperCVAD, DA-R-EPOCH, R-Magrath), 
only two patients had frontline planned stem cell 
transplant. 91% of the patients achieved a CR, 7% were 
primary refractory (progressed during therapy), 2% 
PR/SD ). With a median follow up time of 32.5 months, 
the median OS and PFS have not been reached (75% 
of patients are alive at 55.9 months). In contrast, the 
median OS of relapsed patients was only 14.4 months 
No gender-specific differences in survival were ob-
served. No differences in PFS and OS were observed 
based on frontline chemotherapy regimen. Achieving 
CR significantly determines survival (p.<05, LR test). 
Relapses occurred within first 24 months in 54 out 
of total of 60 patients who relapsed after frontline 
therapy.
conclusion: Our series confirm outside  clinical trial 
setting that in contrast to the pre-rituximab era, late 
relapses are rarely observed in patients treated with 
rituximabâ€“containing induction therapy. The ma-
jority of relapses occur within the first two years of 
the initial therapy. Our findings validate the data 
from the Mayo clinic experience (Maurer et al, JCO 
2014). This observation not only provides reassur-
ance to patients but also support the current imaging 
guidelines with no longer a need for routine imaging 
surveillance for relapse in DLBCL beyond 2 years af-
ter frontline therapy.
CI27
The Association of Serum Albumin Concentration 
and Mortality Risk in Acute Respiratory Distress 
Syndrome (ARDS)
Ghazarian, Z.; Mathew, J.J.; Sekhon, R.; Staron, A.; Parikh, N.; 
Hanna, M.; Khan, M.A.; St. Joseph’s Regional Medical Center / 
Seton Hall University
introduction: Acute Respiratory Distress Syndrome 
(ARDS) is a potentially fatal disease process. There is 
a need for markers that may help with earlier diagno-
sis and prediction of clinical outcomes. Low protein 
states cause disruption of oncotic pressure, which 
results in extravasation of fluid into the alveoli. The 
purpose of this study is to evaluate the association of 
hypoalbuminemia with in-hospital mortality risk in 
ARDS.
metHods: We conducted a retrospective study within a 
cohort of patients admitted to the ICU, from 2006-2013, 
diagnosed with ARDS based on The Berlin Definition. 
88 patients (42 females and 46 males) met the diagnos-
tic criteria; 36 of whom presented with septic shock. 
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Serum albumin levels were collected and APACHE2 
scores were calculated at the time of admission, and 
subsequently evaluated against in-hospital mortality. 
Lastly, we evaluated the impact of sepsis and septic 
shock on prognosis.
results: In comparing albumin’s association with 
mortality, there was statistically significant findings 
(p=0.0017); median value of albumin 3.5 mg/dl in the 
group that survived versus 2.9 mg/dl in the group that 
did not survive. Comparing the impact of septic shock 
in the cohort that survived as well as those who did 
not survive, yielded non-significant results (p=0.1467 
and p=0.4802 respectively). APACHE2 scores were 
also calculated for each patient at the time of admis-
sion. This was analyzed to see whether APACHE2 
scores could hold predictive results on the mortality 
of this study group. Median value of the APACHE2 
calculation of those who survived was 12.00 (CI 
11.44-13.86), whereas those who did not survive had a 
median value of 18.00 (CI 17.13-20.87).
conclusion: Our results indicate a statistically signifi-
cant association between albumin level and prognosis 
in patients with ARDS.  In addition, the significance of 
the association of APACHE2 score versus that of albu-
min levels was compared. APACHE2 scores did have 
a higher statistical significance than albumin levels on 
the day of admission, but both met criteria for signifi-
cance (p< 0.05). As such, it would be easier to look at 
albumin values on the day of admission rather than 
calculating the APACHE2 score.
CI28
Cytogenetic and Molecular Responses 
in Patients with Chronic-Phase Chronic 
Myeloid Leukemia (CP-CML) in a Prospective 
Observational Study (SIMPLICITY)
Goldberg, S.; Mauro, M.; Gambacorti-Passerini, C.; Cortes, J.; 
Subar, M.; Mohamed, H.; Zyczynski, T.; John Theurer Cancer 
Center at Hackensack University Medical center
introduction: Data on clinical response and predic-
tors of response outside clinical trials are limited. 
Previous SIMPLICITY data include cytogenic response 
(CyR) and molecular response (MR) monitoring pat-
terns in patients (pts) with CP-CML differing from 
NCCN/ELN guideline recommendations, as well as 
the clinical predictors of these patterns.
metHods: SIMPLICITY (NCT01244750) is an ongoing 
observational study of CP-CML pts in routine clinical 
practice receiving first-line (1L) imatinib (IM), dasat-
inib (DAS) or nilotinib (NIL) in the US and Europe 
(Eu). Clinical response following start of 1L tyrosine 
kinase inhibitor (TKI) therapy was assessed by CyR 
(karyotype or FISH) and MR (PCR on the interna-
tional scale). Descriptive statistics are presented and 
p values were calculated using a chi-square test. A 
proportional odds model was used to reveal factors 
associated with a better category of clinical response 
among those evaluated for “optimal”, “warning” or 
“failure” response, as defined by ELN 2013 guidelines.
results: The proportion of pts achieving CCyR 
differed according to 1L TKI: of those tested by 6 
mths, 50%, 58% and 65% of pts on 1L IM, DAS and 
NIL achieved CCyR; this proportion increased by 12 
mths (IM: 63%, DAS: 79%, NIL: 81%). Mean (Â± SD) 
time from start of 1L TKI to best response was 3.5 
(Â± 1.4) and 5.4 (Â± 2.8) mths for the 0â€“6 mths and 
0â€“12 mths cohorts. In each timeframe, there was no 
meaningful difference in mean time to best response 
between TKI cohorts. By  6 & 12 mths from start of 
1L TKI, 46% and 64% of pts were tested for MR; of 
these, 34% and 57% achieved major MR (MMR) and 
12% and 27% achieved MR4.5 by 6 and 12 mths. By 6 
mths, MMR was achieved by 28%, 31% and 46% for IM, 
DAS and NIL cohorts, and 6%, 14% and 18% achieved 
MR4.5. By 12 mths from start of 1L TKI, 51%, 59% and 
65% of IM, DAS and NIL cohorts achieved MMR, and 
20%, 33% and 30% achieved MR4.5. Mean (Â± SD) time 
from start of 1L TKI to best MR was 4.0 (Â± 1.3) & 7.3 
(Â± 3.0) mths for the 0-6 mths a & 0-12 mth cohorts. In 
each timeframe, there was no meaningful difference 
in mean time to best response between TKI cohorts. 
The proportion of pts w/ “optimal”, “warning” and 
“failure” responses varied over time & by 1L TKI.
conclusion: In SIMPLICITY, the proportions of CCyR 
and MR increased over time. Compared with DAS- 
and NIL-treated pts, a lower proportion of IM-treated 
pts achieved CCyR and MR (MR4/5 and MMR), and 
a higher proportion experienced ELN 2013-defined 
“failure” by 12 mths. Factors associated with a better 
category of clinical response included female gender 
second-generation TKI as 1L therapy.
CI29
Mature Follow up from a Phase 2 Study of PI3K-
Delta Inhibitor Idelalisib in Patients with Double 
(Rituximab and Alkylating agent)-Refractory  
Indolent B-Cell Non-Hodgkin Lymphoma (iNHL)
Gopal, A.K.; Kahl, B.S.; de Vos, S.; Wagner-Johnston, N.D.; 
Schuster, S.J.; Goy, A.H.; Jurczak, W.; John Theurer Cancer 
Center at Hackensack University Medical Center
introduction: Rituximab-alkylator combinations 
are the standard therapies for patients (pts) with 
iNHL, however, refractory disease nearly uniformly 
develops. Once iNHL becomes “double-refractory” 
to both rituximab + alkylating agents, there are lim-
ited options to induce durable remissions. PI3K-delta 
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signaling is critical for activation, proliferation and 
survival of B cells, and is hyperactive in many B-cell 
malignancies. Idelalisib, a selective oral inhibitor of 
PI3KïÅ_, demonstrated considerable clinical activ-
ity in double-refractory iNHL (Gopal NEJM 2014). 
FDA granted accelerated approval for Idelalisib 
(ZydeligÂ®) in patients who have received at least two 
prior systemic therapies with relapsed FL or SLL.
metHods: Eligible iNHL pts included those with mea-
surable disease refractory to both rituximab and an 
alkylating agent.  Refractory was defined as lack of 
response to, or progression of lymphoma within 6 
months of completion of index therapy, confirmed by 
imaging.  Idelalisib 150 mg PO BID was administered 
continuously until disease progression or intolerance. 
Responses were evaluated by an independent review 
committee, using standard criteria (Cheson, 2007, and 
Owen 2013). The new data cutoff date for this analysis 
was June 2014, 20 months after the last patient enrolled.
results: Enrolled pts (N=125) had a median age 
of 64 years and included follicular lymphoma (FL) 
n=72 (58%), small lymphocytic lymphoma (SLL) 
n=28 (22%), marginal zone lymphoma (MZL) n=15 
(12%) and lymphoplasmacytic lymphoma (LPL)/
Waldenstrom’s macroglobulinemia (WM) n=10 (8%). 
The median number of prior therapies was 4 [range 
2-12], including bendamustine/rituximab (BR) (n=60) 
and rituximab, cyclophosphamide, doxorubicin, vin-
cristine, prednisone (R-CHOP) (n=56) and autologous 
transplant (n=14). 81 pts (65%) had prior bendamus-
tine, of which 61/81 (75%) were refractory. 112 pts 
(90%) were refractory to their last regimen, and 99 pts 
(79%) were refractory to â‰¥2 regimens. 38 pts (30%) 
had elevated LDH, and 33 pts (26%) had bulky disease 
>7 cm. The median time to progression from last prior 
therapy was 3.9 months. With median exposure of 
11.1 months (range 0.7 to 35.4), overall response rate 
(ORR) is 56% (95% CI = 46.8-64.9) with 70 responders, 
comprising 12 CRs (9.6%), 58 PRs (46.4%). The median 
time to response was 1.9 months (time of first evalu-
ation) and time to CR was 4.5 months. There were 43 
pts with stable disease (SD) (34.4%). 90% of pts experi-
enced some decrease in tumor burden.
conclusion: The prolonged administration of idelalis-
ib was well tolerated, had an acceptable safety profile, 
and was highly effective in inducing and maintain-
ing remissions in double-refractory iNHL population 
with an ORR of 56%, PFS of 11 months, and DOR of 
13.9 months.  The response rate and long term dura-
tion of responses in the small number of subjects with 
LPL/WM is very promising, and will be evaluated 
in larger trials of this disease. The observed disease 
control compared to prior regimens suggests the 
potential for prolonged clinical benefit in this chal-
lenging patient population with unmet medical need”
CI30
Anti-CD19 CAR T Cells Administered after Low-
Dose Chemotherapy Can Induce Remissions of 
Chemotherapy-Refractory Diffuse Large B-Cell 
Lymphoma
Goy, A.; Feldman, T.; Kochenderfer, J.; Rosenberg, S.; 
Klebanoff, C.; Sherry, R.; Yuan, C.; John Theurer Cancer Center 
at Hackensack University Medical Center
introduction: We have treated a total of 30 patients 
with autologous T cells genetically modified to ex-
press a chimeric antigen receptor (CAR) targeting 
the B-cell antigen CD19; 22 of 27 evaluable patients 
obtained either complete remissions (CR) or partial 
remissions (PR).  Ten patients remain in ongoing CRs 
of 1 to 37 months duration.  The CAR was encoded by 
a gammaretroviral vector and included the variable 
regions of an anti-CD19 antibody along with CD28 
and CD3-zeta moieties.  The first 21 patients treated 
on this protocol have been reported (Kochenderfer 
et al. Blood 2010, Blood 2012, and Journal of Clinical 
Oncology 2014).
metHods: To enhance the activity of the transferred 
CAR T cells, T-cell infusions in the previously reported 
pts were preceded by a chemo regimen of high-dose 
cyclophosphamide (60-120 mg/kg) plus fludarabine. 
In an attempt to reduce the overall toxicity of our 
anti-CD19 CAR treatment protocol, we substantially 
reduced the doses of chemotherapy administered 
before CAR T-cell infusions. This abstract communi-
cates results from 9 patients with B-cell lymphoma 
who received a single infusion of 1x106 anti-CD19-
CAR-expressing T cells/kg bodyweight preceded by a 
low-dose chemotherapy regimen consisting of cyclo-
phosphamide 300 mg/m2 and fludarabine 30 mg/m2 
(Table).  Each chemotherapy agent was administered 
daily for 3 days.
results: 8 of 9 treated patients had DLBCL that was 
chemo-refractory or that had relapsed less than 1 yr 
after ASCT.  Despite the very poor prognoses of our 
patients, one patient with DLBCL obtained a CR and 
4 DLBCL patients obtained PRs.  In some patients, 
PRs included resolution of large lymphoma masses. 
Compared to our previous experience with anti-CD19 
CAR T cells preceded by high-dose chemotherapy, 
toxicity was reduced when CAR T cells were infused 
after low-dose chemotherapy.  None of the 9 patients 
treated with low-dose chemotherapy and CAR T cells 
required vasopressor drugs or mechanical ventilation, 
although some patients did have short-term neuro-
logical toxicity.  Cytopenias were mild with a mean 
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of only 1.4 days of blood neutrophils<500/microliter. 
Blood anti-CD19 CAR T-cell levels were assessed in 
6 patients with a quantitative PCR assay; we detected 
CAR+ cells in the blood of all 6 patients.  The mean 
peak absolute number of blood CAR+ T cells was 73 
cells/microliter.  6 months after infusion, persisting 
CAR+ T cells were detected in a lymphoma-involved 
lymph node by flow cytometry.
conclusion: These results demonstrate that anti-CD19 
CAR T cells administered after low-dose chemother-
apy have significant activity against chemo-refractory 
DLBCL and could potentially become a standard treat-
ment for aggressive lymphoma.
CI31
Preliminary Results of a Phase I Study of 
Nivolumab (BMS-936558) in Patients with  
Relapsed or Refractory Lymphoid Malignancies
Gutierrez, M.; Lesokhin, A.; Ansell, S.; Timmerman, J.; John 
Theurer Cancer Center at Hackensack University Medical 
Center
introduction: Programmed cell death-1 (PD-1) is an 
immune checkpoint receptor that inhibits T cell ac-
tivation upon interaction with its ligands PD-L1 or 
PD-L2. Increased PD-L1 expression has been reported 
in various lymphoid malignancies, and may allow 
these tumors to circumvent host anti-tumor immuni-
ty. Nivolumab, a fully human IgG4 monoclonal PD-1 
receptor blocking antibody, potentiates T cell activity, 
and has clinical efficacy in various solid tumors. We 
hypothesized that nivolumab might also have clini-
cally important anti-tumor activity in patients with 
lymphoid malignancies.
metHods: This open-label study enrolled patients 
with relapsed or refractory lymphoid malignancies 
including B-cell non-Hodgkin lymphoma (B-NHL), 
T-cell NHL (T-NHL), multiple myeloma (MM), and 
classical Hodgkin lymphoma (cHL). Patients were 
treated using a dose escalation design (1 mg/kg and 3 
mg/kg) of nivolumab administered every two weeks 
for up to two years. Responses were assessed using 
standard criteria. The primary endpoint was safety; 
key secondary endpoints included anti-tumor activ-
ity and expression of immunomodulatory proteins in 
tumor biopsies. The preliminary results for the cHL 
patients will be reported separately.
results: 29 pts with B-NHL; 27 patients with MM; 
and 1 with CML were enrolled. Pts were heavily pre-
treated having received ≥3 prior treatment regimens. 
Previous ASCT was reported for 56% of MM, 14% of 
B-NHL, and 9% of T-NHL patients. Prior brentuximab 
treatment was reported in 7% of B-NHL and 26% of 
T-NHL patients. When this pre-planned interim anal-
ysis was performed, 6 pts had been treated at the 1 
mg/kg dose with 2 dose-limiting toxicities (DLTs) oc-
curring in the same patient: grade 3 pneumonia and 
pneumonitis. At the 3mg/kg dose, 7 pts were treated 
with one patient experiencing two DLTs: grade 3 eo-
sinophilia and diplopia. Additional pts were enrolled 
in the cohort expansion at 3 mg/kg. The overall re-
sponse rate (ORR) and complete response (CR) rate in 
pts with B-NHL were 28% and 7%, respectively, in-
cluding an ORR of 36% in patients with DLBCL, and 
40% in patients with follicular lymphoma (FL). In pa-
tients with T-NHL, ORR was 17% (no CR), including 
an ORR of 40% in the 5 patients with peripheral T cell 
lymphoma. No objective responses were observed in 
MM. Analysis of PD-L1 expression and correlation 
to clinical outcome is being performed and will be 
presented.
conclusion: Nivolumab administered at a dose of 3 
mg/kg every two weeks was tolerable and the safety 
profile was similar to that of the agent in solid tumors. 
Objective responses were observed in DLBCL, FL, 
mycosis fungoides (MF), and peripheral T cell lym-
phoma (PTCL). Durable stable disease was observed 
in relapsed MM. The results of this phase 1 study have 
led to phase 2 studies in DLBCL and FL, which are 
ongoing.
CI32
Nivolumab in Patients with Relapsed or  
Refractory Hodgkin Lymphoma - Preliminary 
Safety, Efficacy and Biomarker Results of a 
Phase I Study
Gutierrez, M.; Armand, P.; Ansell, S.; Shipp, M.; John Theurer 
Cancer Center at Hackensack University Medical Center
introduction: Recent studies suggest that Hodgkin 
Reed Sternberg cells have developed mechanisms 
that exploit the programmed cell death-1 (PD-1) path-
way to evade immune detection. In cHL, chromosome 
9p24.1 gain is a frequent structural alteration that in-
creases the gene dosage of the PD-1 ligands, PD-L1 
and PD-L2, and their induction via JAK/STAT signal-
ing. Epstein-Barr Virus (EBV) infection also increases 
the expression of the PD-1 ligands in EBV-positive 
cHL. Ligand binding to PD-1 receptor-positive acti-
vated T cells induces “T cell exhaustion,” a reversible 
inhibition of T cell activation and proliferation. We 
hypothesized that nivolumab may augment anti-
tumor activity in patients with relapsed or refractory 
(R/R) cHL and evaluated the PD-1 blocking antibody.
metHods: Patients with R/R cHL were included as an 
independent cohort in a dose escalation and cohort 
expansion phase I study of nivolumab in lymphoma 
and multiple myeloma (MM). Results for patients with 
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non-Hodgkin lymphoma and MM are reported sepa-
rately. Patients with cHL received nivolumab 3 mg/
kg every 2 weeks until confirmed tumor progression 
or excessive toxicity. Responses were evaluated using 
standard criteria. The primary endpoint was safety; 
key secondary endpoints included anti-tumor activ-
ity and expression of immunomodulatory proteins in 
tumor biopsies.
results: 23 patients were enrolled with R/R cHL. 
Drug-related adverse events (AEs) of any grade oc-
curred in 78% of patients, the most common of which 
were rash (22%), decreased platelet count (17%), diar-
rhea, nausea, pruritus, fatigue, and pyrexia (each at 
13%). Drug-related grade 3/4 AEs occurred in 22% of 
patients. 3 pts experienced 1 SAE each (gr 3 myelo-
dysplastic syndrome [MDS], gr 3 pancreatitis, and gr 
2 lymph node pain). The objective response rate (ORR) 
was 87% (20/23), with 4 patients (17%) achieving a CR 
and 16 (70%) obtaining a PR. The remaining 3 patients 
(13%) had SD. All 23 patients had a reduction in tumor 
burden. Among the 18 patients who had previously 
failed BV, the ORR was 89% (16/18), with 6% (1/18) 
achieving CR and 83% (15/18) PR. Progression-free 
survival (PFS) rate at 24 weeks was 86% (95% CI, 62-
95%). The median overall survival (OS) has not been 
reached (range, 21+ to 75+ weeks). In all tumors, RS 
cells had copy gains of PD-L1 and PD-L2, as a result 
of either polysomy or amplification; these tumors also 
exhibited increased protein expression of PD-L1. RS 
cells were also largely positive for pSTAT3, indicative 
of active JAK/STAT signaling.
conclusion: In patients with R/R cHL, nivolumab-
mediated PD-1 blockade is safe and tolerable with 
a safety profile similar to that in solid tumors. The 
frequent and long-lasting responses in heavily pre-
treated, R/R patients, including those who have failed 
BV, highlight the importance of the PD-1 pathway in 
cHL, and the genetically defined sensitivity to PD-1 
blockade in this disease. Based on these results, the 
FDA granted nivolumab breakthrough status in re-
lapsed cHL and a large, multinational, phase II trial of 
this therapy is underway.
*CI33
Value of Neutrophil to Lymphocyte Ratio As a 
Predictor of Mortality in Patients Undergoing 
Aortic Valve Replacement
Habib, M.; Thawabi, M.; Habib, H.; Hawatmeh, A.; ElKhalili, W.; 
Shamoon, F.; Zaher, M.; Saint Michael’s Medical Center
introduction: Neurtrophil to Lymphocyte Ratio 
(NLR) has been established as a measure of inflam-
mation and as a prognosticating factor in various 
medical conditions including neoplastic, inflamma-
tory and cardiovascular. The prognostic role of NLR 
in predicting mortality in patients with aortic stenosis 
undergoing aortic valve replacement (AVR) has not 
been studied. Our primary aim in this study is to ex-
plore the utility of NLR as a predictor of both, short 
and long-term mortality, in patients undergoing AVR 
surgery.
metHods: Consecutive patients with aortic stenosis 
admitted for aortic valve replacement to our institu-
tion were evaluated for study inclusion. Of the 335 
patients admitted from January 2007 to September 
2011, 234 met study inclusion criteria. Patients were 
divided into two groups depending on their initial 
preoperative NLR level, NLR greater than or equal 
to 3, or NLR less than 3. Three-year vital status was 
accessed with electronic medical records and Social 
Security Death Index. Survival analysis, stratified by 
NLR, was used to evaluate the predictive value of pre-
operative NLR levels.
results: Patients with NLR greater than or equal to 3, 
when compared to those with NLR less than 3, had a 
significantly higher short-term (9.40% vs. 0, p= 0.0006), 
6-month (19.54% vs. 0.95%, p< 0.0001), and 3-year mor-
tality (27.35% vs 3.78%, p< 0.0001). After adjustment for 
baseline characteristics, co-morbidities, symptomatol-
ogy, echocardiographic findings, and blood tests, NLR 
level remained a significant independent predictor of 
short-term, 6-month, and 3-year mortality. Hazard ra-
tios increased by a factor of 1.22 (1.04-1.42, p= 0.0129), 
1.31 (1.18-1.47, p< 0.0001), and 1.29 (1.17-1.43, p <0.0001), 
respectively.
conclusion: NLR is an independent predictor of short-
term and long-term mortality in patients with aortic 
stenosis undergoing AVR surgery, especially those 
with NLR greater than or equal to 3. We strongly sug-
gest the use of NLR as a tool to risk stratify patients 
with aortic stenosis undergoing aortic valve replace-
ment surgery.
CI34
Utility of a Propofol-Based Saline Mixture as 
a Contrast Agent In Routine Transesophageal 
Echocardiography
Habib, M.; Jmeian, A.; Abualayem, M.; Hawatmeh, A.; Hamdan, 
A.; Thawabi, M.; Shamoon, F.; Saint Joseph’s Regional Medical 
Center- Seton Hall University
introduction: Contrast agents are generally used in 
routine transesophageal echocardiography (TEE) to 
improve detection of patent foramen ovale and atrial 
septal defects, and better measure pulmonary artery 
systolic pressure on spectral doppler. Agitated saline 
is commonly used given its convenience, and ease of 
performance. Air-blood-saline mixture has been stud-
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ied as an alternative agent, and found to be superior. 
Propofol is widely used as an induction agent in an-
esthesia during routine TEE. Our primary aim in this 
study is to examine and analyze the use of an air-pro-
pofol-saline solution as a contrast agent in comparison 
to an air-blood-saline mixture and air-saline mixture, 
for right heart chamber contrast opacification.
metHods: In this prospective study, consecutive pa-
tients scheduled for routine TEE to our center were 
evaluated for study inclusion. Of the 68 patients 
screened, 49 qualified for inclusion. Each patient re-
ceived three agitated contrast agents in random order. 
The first contrast solution consisted of 9 mL normal 
saline and 1 mL air; the second consisted of 8 mL nor-
mal saline, 1 mL propofol, and 1 mL air; and the last 
consisted of 8 mL normal saline, 1 mL patient’s blood, 
and 1 mL of free air. The recordings were reviewed by 
three independent cardiologists in a blinded fashion. 
Each reviewer used a point-scale system to grade the 
extent of opacification of the right heart chambers.
results: Agitated propofol-saline and blood-saline 
mixtures were found to be superior to agitated saline 
alone in obtaining images with greater echogenecity 
and full chamber opacification; however, no statisti-
cally significant difference was found between the 
agitated propofol-saline and blood-saline mixtures 
(X2 = 5.53, p = 0.005).
conclusion: Agitated propofol-saline mixture 
produced superior chamber opacification when com-
pared to agitated saline, and comparable to agitated 
blood-saline mixture. Propofol-saline mixture is easy 
to prepare and to administer in practical use, and 
avoids handling of patients’ blood. We suggest the 
use of agitated propofol-saline as a contrast agent to 
increase the sensitivity of evaluating cardiac anatomy 
and intracardiac shunts.
CI35
Front-Line, Dose-Escalated Immunochemother-
apy is Associated with a Significant PFS (but not 
OS) Advantage in 401 Patients (Pts) with Double-
Hit Lymphomas (DHL): A Systematic Review and 
Meta-Analysis
Howlett, C.; Mato, A.; Landsburg, D.; Goy, A.; Snedecor, 
S.; Cohen, J.; Schuster, S.; John Theurer Cancer Center at 
Hackensack University Medical Center
introduction: “Double-hit lymphoma” (DHL), char-
acterized by the presence of both c-Myc and BCL-2 
rearrangements, is an aggressive B-cell non-Hodgkin’s 
lymphoma (NHL) that is clearly associated with an 
inferior prognosis compared to standard risk DLBCL. 
DHL pts do poorly when treated with R-CHOP and 
typically cannot be salvaged once relapsed. We 
generated pooled, meta-analytic estimates of the ef-
fectiveness of dose-escalated approaches vs. standard 
dose immunochemotherapy in prolonging overall 
survival (OS) and progression-free survival (PFS) in 
newly diagnosed DHL pts.
metHods: DHL was defined by the presence of c-Myc 
rearrangement (FISH) in combination with BCL2 rear-
rangement (FISH) in pts with DLBCL or transformed 
follicular lymphoma. Treatment regimens included 
dose intensive (DI; R-Hyper-CVAD, R-CODOX-M/
IVAC), intermediate dose [Dose adjusted (DA)-R-
EPOCH], or standard dose (R-CHOP). Data were 
collected from study authors or extracted from publi-
cations as the proportions of pts surviving at specific 
follow-up times or individual event times. Data were 
synthesized to estimate the hazard ratios of higher-
dose treatments relative to R-CHOP using a Weibull 
proportional hazards model within a Bayesian meta-
analysis framework.
results: After independent review by three investi-
gators, 11 studies examining 401 pts were included 
in the analysis. Pts were treated with either R-CHOP 
(n=180), DA-R-EPOCH (n=91), or DI regimen (n=130) 
in the front-line setting. There were no significant 
differences in baseline characteristics of pts between 
included studies or across treatment regimens (me-
dian age at diagnosis 60 years, median Ki-67 88%, 
53% IPI ≥3). The estimated median (and 95% credible 
intervals [CrIs; the Bayesian analog to confidence in-
tervals]) OS and PFS for the entire cohort were 27.8 
(15.1-48.5) and 20.5 (10.9-36.0) months. No significant 
differences in OS (n=374) were observed among any 
of the treatments (estimated med OS: R-CHOP, DA-
R-EPOCH and DI were 24.2, 37.5, and 29.5 months, 
respectively. Estimated hazard ratios (HR) of OS were 
0.77 (95% CrI: 0.50-1.11) for DA-R-EPOCH and 0.90 
(95% CrI: 0.62-1.25) for DI relative to R-CHOP.  The PFS 
(n=357) among pts receiving DA-R-EPOCH (HR 0.64, 
95% CrI: 0.42-0.92) or DI (HR 0.75, 95% CrI: 0.51-1.05) 
was similar and DA-R-EPOCH demonstrated signifi-
cant improvement over R-CHOP (estimated med PFS: 
R-CHOP, DA-R-EPOCH and DI of 13.9, 27.8, and 21.9, 
respectively.
conclusion: We have demonstrated that dose-esca-
lated chemotherapy was associated with a significant 
increase in PFS (particularly DA-R-EPOCH) which 
did not translate into an OS advantage. This suggests 
DHL is a disease of chemotherapy resistance. These 
results highlight (1) outcomes remain poor for DHL 
pts regardless of the intensity of R-chemotherapy in-
duction (2) the need for routine screening for MYC 
and BCL2 by FISH in DLBCL pts with high-risk fea-
tures and (3) the need for prospective induction and 
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consolidation strategies that incorporate our growing 
understanding of the biological basis of DHL such as 
combinations of novel targeted therapies and/or up-
front consolidation with CAR-T-cells.
*CI36
Utility of Brain Natriuretic Peptide Assay in  
Patients Presenting with Syncope to the  
Emergency Department
Isbitan, A.A.; Altheeb, Z.F.; Patel, K.; Al-Nahar, Y.; Hamdan, 
A.; Shamoon, F.; Saint Michael’s Medical Center, Seton Hall 
University
introduction: Unfortunately, current admissions 
practices for syncope result in a marginal diagnostic 
and therapeutic benefit and consume health care 
resources. However to accomplish such a medical 
change in the care strategy, an essential step is to 
provide the E.D and urgent care physicians with 
well considered “risk stratification” guidelines. 
Moreover, the potential rule of biochemical markers 
in risk stratification has not been assessed. Brain 
natriuretic peptide (BNP) represents a promising 
and important independent biomarker that has been 
under investigated in the context of syncope.
metHods: Between August 2010 and June 2011,we 
prospectively enrolled 115 patients presented to 
Emergency departments in two medical centers. All 
elements of the ROSE rule were collected prospective-
ly. BNP levels were not made available to the treating 
clinician, so treatment decisions will not affected by 
them. Patients were admitted, referred for outpatient 
investigation or discharged according to current ED 
protocols. After the data collection, patients condition 
was followed whether in hospital or as out-patients to 
identify 30-day serious outcomes.
results: 115 syncope-patients were included in 
the study (51% females) ,mean age was 60 . 50 pa-
tients(43%) were considered high risk by ROSE rule 
compared to 59 patients (51%) identified as high risk 
by San Francisco rule . There is significant associa-
tion between Rose rule’s high risk patients and poor 
outcomes compared to Sanfrancisco rule which didn’t 
show significant association (OR: 2.82; CI:1.29 to 6.18: 
P<0.01), (OR:1.24; CI:0.58 to 2.66: P<0.69), respectively 
.Also in the study we found that BNP can be as inde-
pendent factor to predict high risk syncope patients 
with MI and arrhythmia (OR for MI: 14.8; CI: 1.57 to 
139:p<0.011).
conclusion: Of the ROSE criteria, only the BNP assay 
represents a major addition to the standard evaluation 
of syncope in the emergency department. This study 
showed that measuring BNP and adding ROSE rule 
to the standard evaluation would sufficiently change 
clinician decision making, and help prevent unneces-
sary admissions without increasing adverse outcomes.
CI37
Bariatric Orthopaedics: Total Hip Arthroplasty 
in the Super-Obese Patients (BMI >50 kg/m2), 
Minimum 5 year Outcomes
Issa, K.; Mcdermott, J.D.; Bartlomiej, C.; Harwin, S.F.; Mont, 
M.A.; Mcinerney, V.K.; Eifai, A.; Saint Joseph’s Regional 
Medical Center, John’s Hopkins, Down State University
introduction: The purpose of this study was to assess 
the clinical and patient-reported outcomes of pri-
mary THA in super-obese patients (BMI ≥50kg/m2) 
compared to a matched cohort of patients who had a 
normal body mass index (BMI<25 kg/m2). A second-
ary objective was to assess patients’ experiences in 
finding a treating surgeon.
metHods: Forty-eight hips in forty-five patients who 
had a minimum BMI of 50kg/m2 who underwent a 
primary THA at one of the four high-volume institu-
tions between 2001-2010 were reviewed. This included 
twenty-six women and eighteen men who had a mean 
age of 54 years (range, 36 to 71 years) and who were 
followed for a mean of six years (range, four to twelve 
years).  These patients were compared to a non-obese 
matched cohort of 132 patients (1:3 ratio) who had un-
dergone a THA during the same time period by the 
same surgeons. Outcomes evaluated included implant 
survivorship, complication rates, Harris hip scores, 36-
item Short-Form (SF-36) questionnaires, University of 
California Los Angeles (UCLA) activity scores, as well 
as patients’ experience in finding a treating surgeon.
results: The super-obese cohort had a 5.5 times sig-
nificantly higher odds ratio of undergoing a revision 
compared to the matching group (89.6 vs. 97.5% over-
all implant survivorship) and significantly higher 
odds ratio of complications.  They also had achieved 
a significantly lower mean Harris hip score (82 vs. 91 
points), SF 36 physical (39 and 47 points) and mental 
(49 and 59 points), and activity scores (3.9 vs. 6.2 points) 
compared to the matching group.  Also, super-obese 
were evaluated by a higher number of orthopaedic 
surgeons prior to undergoing THA compared to the 
matching group.
conclusion: The clinical and patient-reported out-
comes of primary total hip arthroplasty were lower 
in the super obese patients and these patients faced 
challenges in finding surgeons who would perform 
their procedure. The authors believe that super-obese 
patients may benefit from counseling with their treat-
ing surgeon to set realistic expectations regarding the 
outcomes of their procedure.
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*CI38
The Incident Trends, Epidemiology, Mortality, 
and Economic Evaluation of Vertebral Osteo-
myelitis in the United States: A Nationwide 
Inpatient Database Study of 283,022 Cases from 
1998 to 2010
Issa, K; Patel, S; Shafa, E; Faloon, M; Sinha, K; Hwang, K; 
Emami, A; Saint Joseph’s Regional Medical Center
introduction: Vertebral osteomyelitis (VO) represents 
3 to 5% of all cases of osteomyelitis. There is a paucity 
of reports on the demographics, patient characteris-
tics, and mortality of vertebral osteomyelitis (VO) in 
the USA.  However, with increasing use of illicit drugs, 
the incidence of this condition may be increasing and 
evaluating potential contributing factor to mortality 
may be a topic of clinical importance. The purpose of 
this work was an attempt to assess the incidence & 
epidemiology of VO in the USA over a 13 year period.
metHods: The Nationwide Inpatient Sample (NIS) 
database was carefully evaluated to identify all pa-
tients who were admitted for a diagnosis of vertebral 
osteomyelitis in the United States from 1998 to 2010 
using related ICD-9 codes (730.28, 730.08, 730.2, 730.00, 
722.90, 722.91, 722.92, 722.93).  National trends in in-
cidence, patient demographics, mortality during the 
hospital stay, length-of-stay (LOS), and total admis-
sion costs were further evaluated.  The United States 
Census data was used to assess the annual US popu-
lation.  The impacts of various contributing factors to 
these outcomes were further evaluated using adjusted 
multivariable linear and logistic regression analyses.
results: The study population consisted of 283,022 
admissions for vertebral osteomyelitis, however, the 
incidence of this condition increased from approxi-
mately 15,400 cases (6.5 per 100,000 US population) 
in 1998 to 27,710 (9 per 100,000 US population) in 2010. 
Our model estimated the incidence of this disease to 
reach 32,500 in 2015 (RÂ_ =0.91).  Overall, 55% of pa-
tients were younger than 60 years of age, 54% were 
male, 28% were non-white, and 43% had Medicare 
insurance.  The overall mortality during the hospital 
stay had reduced from 2.1% in 1998 to 1.4% in 2010. 
Mortality rate was significantly higher with older age 
(p<0.01), male gender (p=0.02), higher Deyo comor-
bidity score (p<0.01), and urban teaching hospitals 
(p<0.01), however, race had not affected the mortality. 
In various adjusted multivariable regression models, 
comorbidity-specific mortality risk was increased 
with previous myocardial infarct (p=0.03), conges-
tive heart failure (p<0.01), peripheral vascular disease 
(p=0.03), cerebrovascular disease (p<0.01). The overall 
mean LOS had significantly increased from approxi-
mately 9.5 to 11 days during the study period (p<0.01).
conclusion: The incidence of vertebral osteomyelitis 
has been increasing in the United States, and various 
factors were identified to affect the inpatient mortal-
ity rate, length-of-stay, and admission costs.  Patients 
may benefit from counseling with their orthopaedic 
surgeons to set realistic expectations.  The findings of 
this study can be used for all future related compara-
tive studies.
CI39
Demographic, Clinical and Treatment Charac-
teristics of the CARRA Registry Systemic JIA 
Cohort
Janow, G.J.; Schanberg, L.E.; Setoguchi, S.; Hasselblad, V.; 
Mellins, E.D.; Schneider, R.; Kimura, Y.; Hackensack University 
Medical Center, Duke University, Stanford University, University 
of Toronto
introduction: The treatment of systemic Juvenile 
Idiopathic Arthritis (sJIA) has changed dramati-
cally in the last 10 years.  The Childhood Arthritis 
and Rheumatology Research Alliance (CARRA) 
Registry is a rich resource of information about pedi-
atric rheumatic diseases. We aimed to: (1) describe the 
characteristics of the CARRA Registry sJIA cohort; (2) 
identify medication usage trends; and (3) identify sub-
groups at increased risk for poor outcomes.
metHods: 54 US and Canadian sites enrolled 528 sJIA 
pts from 2010-2013. Pts were enrolled as a cross-sec-
tional convenience sample. Only pts with complete 
datasets were included. We tested for subgroup differ-
ences among binary and continuous variables across 
groups using a chi-square test or ANOVA.
results: 435 pts were included (median age 11yrs). 
Disease activity was low: 14.9% had rash, 6.7% fever, 
median joint count 0, and median physician global as-
sessment 1. Significant changes in medication usage 
occurred: DMARD and TNF inhibitor use decreased 
while IL-6 inhibitor (IL-6i) use increased.  There were 
significant differences among racial groups with 
African Americans (AA) having higher mean CHAQ 
scores, worse quality of life scores and poorer ACR 
functional class (p 0.0004). Current/prior biologic use 
increased with longer disease duration. Pts diagnosed 
at a younger age (< 2 yrs) had more frequent biologic 
use and lower overall well being scores. Joint damage 
on imaging was increased with younger age at diag-
nosis (p 0.0003).
conclusion: This study describes characteristics and 
medication use of the largest sJIA cohort reported to 
date. Significant changes occurred in medication us-
age, but corticosteroids are still frequently used. AA 
children have more severe disease, as do children 
diagnosed at a younger age. A significant propor-
28
tion have persistent arthritis despite new treatments. 
We need to identify predictors of persistent arthritis 
in order to improve treatment and outcomes in this 
subgroup.
CI40
Neurovascular Reconstruction of Ruptured and 
Non-Ruptured Intracranial Blood Blister Aneu-
rysms With the Pipeline Flow Diverter
Karimi, R.J.; Walzman, D.E.; Roth, P.A.; Department of 
Neurosurgery, Hackensack University Medical Center
introduction: Intracranial “blood blister” aneurysms 
are notoriously challenging neurosurgical lesions as-
sociated with a high morbidity and mortality with 
conventional treatment. This subtype of intracra-
nial aneurysm is exquisitely fragile, thin-walled and 
arises from a friable and circumferentially diseased 
parent artery. Conventional treatments including 
microsurgical clipping and endovascular coiling are 
often associated with intraoperative rupture of the 
aneurysm or avulsion of the parent artery, with cor-
respondingly high complication rates of major stroke 
and significant intraoperative bleeding. The Pipeline 
Embolization Device, a “flow diverting” stent with a 
30%-35% metal wall density, alters the hemodynamic 
flow of aneurysms, leading to gradual intra-aneurys-
mal thrombosis and ultimately reconstruction of the 
parent artery. We describe its use in the treatment of 
both ruptured and nonruptured blister aneurysms of 
the intracranial circulation. 
metHods: All consecutive patients who underwent 
endovascular treatment of blood blister aneurysms 
with the Pipeline flow diverter over a 2 year 
period were included in the study. Patients with 
prior subarachnoid hemorrhage were pre-treated 
with intravenous antiplatelet therapy (Integrilin 
infusion) prior to Pipeline deployment. Patients 
with non-ruptured aneurysms were pre-treated 
with dual antiplatelet therapy (Aspirin and Plavix) 
for 7 days prior to the procedure. All patients were 
maintained on antiplatelet therapy for a minimum 
of 12 months. The Pipeline device was deployed 
using a transfemoral artery approach with a tri-axial 
catheter system under biplane digital fluoroscopic 
guidance in all cases. Follow up angiography was 
obtained at 3 months in all patients, at 6 months 
and 12 months in 4 patients. The patients’ clinical 
characteristics, intraoperative and postoperative 
course were tabulated from the medical record. 
results: A total of 5 consecutive patients with 8 
intracranial blood blister aneurysms (2 ruptured 
aneurysms, 6 nonruptured aneurysms) who were 
treated with the Pipeline embolization device 
were included in the study. Seven aneurysms were 
located in the supraclinoid internal carotid artery, 1 
aneurysm was located in the middle cerebral artery. 
A single Pipeline device was deployed in 3 patients, 3 
Pipelines were deployed in 2 patients. Supplementary 
microcoil embolization was not performed. The mean 
follow-up period was 10.2 months (range 3-12 months). 
There were no intraoperative aneurysm ruptures or 
perioperative strokes. No patient suffered recurrent 
or de novo subarachnoid hemorrhage indicative 
of aneurysm rupture during the follow up period. 
Complete aneurysm regression and parent artery 
reconstruction was noted on angiography at 6 months 
(2 patients) and 12 months (2 patients). One patient 
demonstrated persistent aneurysm filling at 3 months 
(latest available follow-up). There were no instances of 
in-stent thrombosis or stenosis. No patient developed 
new neurological deficits during the perioperative 
or follow up period. Glasgow outcome scales were 
5 (functionally independent) in 4 patients and 4 
(moderate disability) in one patient. 
conclusion: Intracranial blood blister aneurysms are 
notoriously challenging neurosurgical lesions that 
can safely and effectively be treated with endovascu-
lar flow diverting stents which alter the hemodynamic 
inflow and outflow of the aneurysm. Aneurysm 
thrombosis, involution and parent artery reconstruc-
tion can take up to 12 months to occur. Despite this 
delay in achieving angiographically complete aneu-
rysm occlusion, recurrent or de-novo subarachnoid 
hemorrhage did not occur in this cohort. Compared 
with traditional treatment modalities, perioperative 
complications including life-threatening intracranial 
hemorrhage and major stroke may be significantly 
lower with the use of the Pipeline flow diverter as 
compared to open microsurgical aneurysm clipping 
or endovascular aneurysm embolization. 
CI41
Indatuximab Ravtansine (BT062) in Combination 
with Lenalidomide and Low-Dose Dexa-
methasone in Patients with Relapsed and/or 
Refractory Multiple Myeloma: Clinical Activity in 
Patients Already Exposed to Lenalidomide and 
Bortezomib
Kelly, D.; Siegel, D., Zimmerman, T.; Chanan-Khan, A.; Heffner, 
L.T.; Somlo, G.; Karnad, A.; John Theurer Cancer Center at 
Hackensack University Medical Center
introduction: To determine the dose-limiting toxici-
ties (DLTs), the maximum tolerated dose (MTD), the 
recommended phase II dose (RPTD), pharmacokinet-
ics (PK), and anti-MM activity of increasing doses of 
BT062 (days 1, 8, and 15, every 4 weeks) used in com-
bination with Len (25 mg, daily on days 1-21) and low 
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dose Dex (40 mg on days 1, 8, 15, and 22) in patients 
with relapsed and/or refractory MM.
metHods: This is a prospective, open label, multicenter 
Phase I/IIa study. The Phase I part includes dose esca-
lation, and the Phase IIa the expansion of the RPTD 
cohort. Patients aged â‰¥18 years with relapsed and/
or refractory MM who have failed at least one prior 
therapy were eligible to participate. Prior treatment 
with Len and/or Dex was allowed. Patients with clini-
cal response (or no evidence of progressive disease) 
and without unacceptable toxicities were eligible for 
additional treatment cycles. Patients were enrolled 
in cohorts of at least 3 at each dose level; DLT in the 
first cycle triggered cohort expansion. Toxicities were 
assessed by CTCAE v4 and clinical response was as-
sessed according to International Myeloma Working 
Group criteria.
results: The maximum administered dose (MAD) 
was 120 mg/mÂ. Two of six patients treated at this 
dose had a DLT: mucosal inflammation (CTC grade 
3) and anemia (CTC grade 3). The MTD was defined 
as 100 mg/mÂ_ and selected as RPTD. Additional 
patients are being treated at this RPTD to further 
evaluate safety and efficacy. Enrollment into the study 
is ongoing. As of July 2014, a total of 45 patients had 
received BT062 at dose levels of 80 mg/mÂ_ (N=3), 
100 mg/mÂ_ (N=36) or 120 mg/mÂ_ (N=6). Fifteen 
patients discontinued study treatment: 5 for disease 
progression, 7 for adverse events, 1 died (not treat-
ment related) and 2 for withdrawal of consent. The 
other 30 patients remain on treatment.
conclusion: Preliminary data from this ongoing 
study indicate that BT062 is well tolerated in combina-
tion with Len/Dex at dose levels that induce responses 
in patients with relapsed and/or refractory multiple 
myeloma, including patients with prior exposure to 
both Len and bortezomib and patients refractory to 
prior treatment with Len. Updated results on safety 
and efficacy will be presented.
*CI42
Comparison of Thyroid Stimulating Hormone 
Level and PR Interval in Hypothyroid Patients 
Being Treated with Levothyroxine
Khaddash, I.; Altheeb, Z.; Shahla, L.; Gupta, R.; Sheth, V.; 
DeBari, V.; Shamoon, F.; Saint Joseph’s Regional Medical 
Center/New York Medical College and Seton Hall University
introduction: Thyroid disease is quite common, and 
since thyroid hormone has both inotropic and chro-
notropic effects on the heart, variations in thyroid 
hormone among the general public has demonstrated 
EKG changes. Hypothyroidism has been shown to 
be associated with AV blocks, QTc interval prolonga-
tion, and heart rate variability as well. The goal of this 
study is to observe PR interval changes on EKG and 
investigate their correlation with TSH in hypothyroid 
patients being treated with levothyroxine.
metHods: This is a retrospective study looked at 
504 admissions of hypothyroid patients who had an 
EKG and a TSH within three months of each other. 
Exclusion criteria were patients with atrial fibrilla-
tion, atrial flutter, and patients not on levothyroxine, 
which left the study with 455 admissions. Each ad-
mission was stratified based on TSH with low TSH 
(<0.4) had 85 admissions, normal TSH (0.5-5.0) had 269 
admissions, and high TSH (>5.0) had 101 admissions. 
The mean PR intervals were 152.2,163.0, and 158.8 
for the low TSH, normal TSH, and high TSH groups, 
respectively.
results: Our data demonstrated that the low TSH 
group compared to normal TSH group had a lower 
mean of PR intervals (P value <0.05); however this 
analysis is not practical, as risks of over treating hy-
pothyroid patients in order to treat or prevent 1st 
degree AV block would likely outweigh the benefits, 
while comparing the low TSH group with the high 
TSH group and normal TSH group compared to high 
TSH group did not show statistical significance (P 
value >0.05). This potentially shows that as long as 
a patient is getting thyroid hormone replacement in 
these subgroups, they will not have a higher chance 
of increasing PR intervals and subsequent blocks re-
gardless of their TSH level.
conclusion: In conclusion, as long as patients with 
normal or high TSH level are getting thyroid hormone 
replacement, they will not have a higher chance of in-
creasing PR intervals and subsequent atrioventricular 
blocks, giving that benefits of over treating hypothy-
roid patients in order to treat or prevent first degree 
AV block would likely outweigh the risks of develop-
ing thyrotoxicosis.
CI43
Preliminary Results from the Childhood Arthritis 
and Rheumatology Research Alliance Systemic 
JIA Consensus Treatment Plans Pilot Study
Kimura, Y.; DeWitt, E.M.; Mieszkalski, K.; Schanberg, L.E.; 
Hackensack University Medical Center, Cincinnati Children’s 
Hospital and Medical Center, Duke University
introduction: Treatment options for systemic JIA 
(sJIA) have recently expanded to include IL1 and IL6 
inhibitors in addition to traditional treatments such 
as glucocorticoids (GC) and methotrexate (MTX).  The 
Childhood Arthritis and Rheumatology Research 
Alliance (CARRA) developed standardized consen-
sus treatment plans (CTPs) for new onset sJIA to study 
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comparative effectiveness of these treatments using 
an observational registry. A pilot study was conduct-
ed to assess the feasibility of using the CTPs for this 
purpose.
metHods: New onset sJIA pts in the CARRA Registry 
are treated according to the CTP selected by the treat-
ing physician (GC alone; MTX + GC; IL1 inhibitor 
(IL1i) + GC; IL6 inhibitor (IL6i) + GC). Data is col-
lected at standard intervals for 9 mos from baseline. 
Physicians could deviate from the chosen CTP for in-
adequate response. If GC is started, the CTPs suggest 
an aggressive taper (<50% of the starting dose by 3 
mos). Biospecimens are being collected for future use.
results: 13 CARRA study sites enrolled at least 1 pt 
(total 30, range 1-6 pts/site). The GC-only CTP was 
used in only 2 pts (7%) and a biologic was used as ini-
tial therapy in 22 (73%).  The chosen CTP varied by 
site, especially with regard to use of biologics vs non-
biologics. Most common reasons cited for choosing 
non-biologic CTPs were: usual treatment at site (63%), 
perceived safer treatment (63%), and pt preference 
(38%); most common reasons for choosing biologic 
CTPs: will likely work best (77%), better tolerated (59%), 
and perceived safer (45%).  As of 6/2014, 13 pts (43%) 
had changed or deviated from the starting CTP. 67% 
of patients did not consent for specimen collection.
conclusion: The CARRA sJIA CTP pilot study suc-
cessfully reached its target enrollment. Despite the 
absence of randomization, CTP choice is reasonably 
balanced aside from the GC CTP and appears to be 
based on physician/center preference. Most provid-
ers found the CTPs acceptable to use, and enrollment 
of additional patients at more CARRA sites to study 
comparative effectiveness of the CTPs appears fea-
sible. Exploring barriers and improving processes for 
biospecimen collection consent may increase partici-
pation in future studies.
CI44
A Pilot Study to Evaluate the Feasibility of 
Conducting Juvenile Localized Scleroderma 
Comparative Effectiveness Treatment Studies
Li, S.C.; Torok, K.S.; Becker, M.L.; Dedeoglu, F.D.; Ferguson, 
P.J.; Fuhlbrigge, R.C.; Higgins, G.C.; Joseph M. Sanzari 
Children’s Hospital, Hackensack University Medical Center; 
Children’s Hospital of Pittsburgh; Children’s Mercy Hospital; 
Children’s Hospital of Boston; University of Iowa; Nationwide 
Children’s Hospital; Hospital for Sick Children Toronto; Texas 
Scottish Rite Hospital; Mayo Clinic; Duke University
introduction: Juvenile localized scleroderma (jLS) of-
ten causes severe morbidity in the developing child, 
including growth defects and disfigurement. Optimal 
therapy is not known. The LS Children’s Arthritis and 
Rheumatology Research Alliance (CARRA) subgroup 
has developed standardized treatment regimens 
based upon best available evidence and consensus 
methodology, and clinical tools to use in compara-
tive effectiveness treatment studies. We are currently 
conducting a pilot study to evaluate the performance 
characteristics of developed tool and feasibility of 
conducting jLS comparative effectiveness treatment 
studies.
metHods: Fifteen physicians from 10 CARRA centers 
have been conducting a prospective observational 
cohort study of jLS subjects initiating systemic immu-
nosuppressive treatment. Inclusion criteria include 
diagnosis of jLS by pediatric rheumatologist or der-
matologist, and presence of active disease according 
to delineated activity criteria generated by the group. 
Exclusion criteria include treatment with methotrex-
ate (MTX) within prior 3 months or corticosteroids 
(CS) within prior 2 weeks. Subjects were treated with 
one of three MTX-based regimens (MTX alone, MTX 
with intravenous CS (IV CS), or MTX with oral CS), 
determined by treating physician, and evaluated at 6 
visits over 1 year. At the start of the study, a workshop 
meeting was held to standardize evaluation.
results: The target enrollment (50 subjects) was 
reached. All sites enrolled subjects, with enrollment 
taking approximately 23 months to complete following 
study initiation at the first site. Subjects were enrolled 
at all sites, with about 60% of screened subjects were 
enrolled. Subjects were enrolled in all 3 regimens, 
with half enrolled in the  MTX + IV CS regimen. 
Sites showed distinct preferences in their choice of 
regimens; only one site used all three regimens, half 
the sites used only one regimen. Between 28-38% of 
subjects deviated from their initial regimen, with 
inadequate response the most common reason.  Over 
80% of subjects agreed to participate in the optional 
sample collection and banking sub study.
conclusion: This is the first study to explore the 
feasibility of conducting comparative effectiveness 
treatment studies in jLS. We achieved our target en-
rollment of 50 subjects, with subjects enrolled in all 3 
standardized treatment regimens. Biological samples 
have been collected from the majority of subjects, 
which will enable future translational studies. This 
study will enable us to evaluate and refine clinical 
tools needed for treatment studies based upon study 
data, and identify issues related to conducting jLS 
treatment studies. Further analyses of these data once 
completed will also include clinical effectiveness and 
tolerability of the 3 different treatment regimens in LS 
subjects.
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CI45
Rituximab (RTX) for the Treatment of Steroid  
Dependent Nephrotic Syndrome (SDNS).
Lieberman, K.V.; Ettinger, L.; Picareli, C.; Hackensack University 
Medical Center
introduction: Although most children with idiopath-
ic NS are steroid responsive, the steroid dependent 
subset is at higher risk for complications of NS and 
toxicities of medication. Many of these patients re-
ceive antiproliferative and calcineurin inhibitor 
immunosuppressive agents in addition to alternate 
day steroids chronically. T and B lymphocyte prod-
ucts have been hypothesized to be the causitive agents 
of NS. RTX, a monoclonal anti-CD20 (pan B cell) anti-
body, has been previously identified”
metHods: In remission, 3 patients (mean age of 8 years) 
with SDNS who had been maintained on mycophenal-
ate mofeteil (MMF), tacrolimus (Tac) and alternate day 
prednisone for at least 2 years received a single dose 
of RTX, 375 mg/m2 BSA. After RTX infusion the MMF 
and Tac were abruptly discontinued and the steroid 
was tapered off over 1 month. Lymphocyte subset de-
termination was performed at between 2 and 4 weeks.
results: Adverse reactions seen during RTX infusion 
included: fever, vomiting, and cough. All patients 
achieved absolute CD19 counts of < 20/Î_L. At last 
follow-up, one patient has required a second infusion 
to remain in remission.
conclusion: After receiving a single infusion of RTX, 
some patients with previously multidrug requiring 
SDNS can remain in remission (at least in the short 
term). Longer follow-up with larger numbers of pa-
tients will be required to fully assess the efficacy of 
this new treatment.
CI46
Prograf For The Treatment Of Nephrotic Focal 
Segmental Glomerulosclerosis (FSFS) In Children:  
A Six Year Experience
Lieberman, K.V.; Benchimol, C.; Vergara, M.; Hackensack 
University Medical Center
introduction: FSGS is the most frequent biopsy find-
ing in children with steroid resistant nephrosis. The 
majority of these pts eventually have progressive 
chronic renal failure. FSGS is the most common ac-
quired cause of ESRD in children (NAPRTCS, 1997). 
The goal of this study was to establish the efficacy and 
safety of Prograf in inducing long term remission of 
the nephrosis and stabilization of renal function.
metHods: Fifteen pts (age: 2 - 19 yrs) with steroid resis-
tant nephrosis and FSGS received Prograf montherapy 
(no steroids, ACEIs, ARBs, or NSAIDs). The majority of 
the children were black or Hispanic. The starting dose 
was 0.15 mg/kg/d and the dose was escalated weekly 
until clinical response or limiting toxicity. There were 
attempts to wean the pts off Prograf, but the drug was 
restarted if the pt relapsed.
results: The mean Prograf response dose was 
0.2Â±0.1 mg/kg/d. The mean response time was 
3.9Â±2.7 wks. The mean response trough Prograf 
level was 11.7Â±4.2 ng/ml. The mean followup was 
2.8Â±1.8 yrs. Serum albumins increased from a mean 
of 2.1Â±0.4 to 3.7Â±0.6 gm/dl (p<0.05). Serum creati-
nines did not change, mean of 0.7Â±0.4 to 0.8Â±0.2 
mg/dl (p NS). Spot urine protein to creatinine ra-
tios decreased from a mean of 11.1Â±5.0 to 1.8Â±2.2 
(p<0.05). A complete remission was experienced by 
10/15 pts; 5/10 had a partial response. Only one child 
was able to sustain these benefits after discontinuing 
the drug. During the followup period 13/15 pts had 
stable, normal serum creatinines; 1/15 developed CRI; 
1/15 developed ESRD. Actuarial renal survival was 
90% at 5 years, as compared to 10% based on historical 
controls.
conclusion: Prograf was highly effective as mono-
therapy in safely inducing prolonged remissions of 
the nephrotic syndrome in steroid resistant children 
with FSGS. The majority of the children experienced 
long term normal, stable renal function.
CI47
An Emergency Medicine, Education-Based  
Patient Satisfaction Survey Created through  
Delphi Method Analysis
London, K.S.; Singal, B.; Fowler, J.; Prepejchal, R.; Finefrock, 
D.C.; University of Michigan, Ann Arbor, MI; St. Joseph Mercy 
Hospital, Ann Arbor, MI; Hackensack University Medical Center
introduction: Feedback on patient satisfaction (PS) 
as a means to monitor and improve performance in 
patient communication is lacking in resident training; 
once in practice, promotion, compensation and job 
satisfaction may be impacted by PS scores. Many com-
munication and satisfaction surveys exist but none 
focus solely on emergency medicine (EM) settings for 
educational purposes.
metHods: The goal of this project was to create an EM 
based educational PS survey with strong evidence 
for content validity. Methods: The Delphi Method 
(DM) created by the RAND Corporation was used to 
obtain expert opinion via an iterative process of sev-
eral rounds of surveys, each one followed by feedback, 
until a pre-specified level of consensus was achieved. 
Experts were sought from PS education leadership 
(via the Council of Residency Directors of EM PS 
Taskforce), emergency physician PS researchers and 
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residents with career interest in PS. Questions were 
mined from four popular PS surveys as well as or-
ganically from group suggestion.  The DM analysis 
determined the ultimate structure, content and ap-
propriate use of the tool.
results: Twelve experts from around the country 
were recruited. The group used four point Likert-
type scales and Lynn’s criteria for content validity to 
determine relevant questions from the stated goals. 
These were then honed to the preferred number of 
survey items.  A total of seven surveys were required 
to achieve consensus. 100% response rates for all sur-
veys were maintained. A ten question, single page 
survey was selected. An additional page with quali-
tative questions and demographics was also agreed 
upon. Thirty one items were judged to be relevant 
from an original sixty seven question list. Of these, 
the top ten were chosen.
conclusion: The DM produced a consensus survey 
with content validity evidence. Further work will be 
needed to obtain evidence for response process, face 
and construct validity.
CI48
Obesity Paradox In Long Term Survival After 
Trans-catheter Aortic Valve Replacement In  
Patients With Severe Aortic Stenosis
Mathur, A.P.; Castro-Dominguez, Y.; Vaidya, P.; Cocke, T.; 
Elmann, E.; Di Luozzo, G.; Parrillo, J.E.; Hackensack University 
Medical Center
introduction: This study sought to examine effect 
of body mass index (BMI) on 1 year outcomes after 
trans-catheter aortic valve replacement (TAVR) in 
symptomatic patients with severe aortic stenosis (AS). 
An obesity paradox has previously been reported in 
a range of cardiovascular and non-cardiovascular 
conditions, with improved clinical outcomes in obese 
when compared to normal weight patients. However, 
prevalence of this paradox in patients undergoing 
TAVR is not well defined.
metHods: We retrospectively evaluated 100 consecu-
tive patients undergoing TAVR at our institution 
between 2012 and 2013. We categorized the patients 
into 4 categories based on their BMI: normal weight 
(18.5-25 kg/m2, n=35), overweight (25-30 kg/m2, 
n=40), obese (30-40 kg/m2, n=18), and morbidly obese 
(40 kg/m2, n=7). Baseline characteristics, 30 day ma-
jor adverse cardiovascular events (MACE), defined as 
composite of stroke, myocardial infarction, cardiovas-
cular death or re-hospitalization, and 1 year mortality 
were compared across the groups.
results: Obese patients were younger, had higher 
prevalence of diabetes, a lower Society of Thoracic 
Surgeons (STS) score, shorter length of stay in in-
tensive care unit (ICU) and shorter length of stay in 
hospital than normal weight patients. Despite higher 
mean (Â±SD) baseline serum creatinine (mg/dl) levels 
(1.6 Â± 1.7 vs. 1.3 Â± 1.0), the incidence of postopera-
tive renal failure (> 0.3 mg/dl increase from baseline) 
was similar between obese and non-obese patients 
(21% vs 20%, p = 1.0). At 30 days, there was a trend 
towards higher MACE rate in normal weight patients 
(47%) when compared to overweight (35%), obese 
(22%) and morbidly obese (0%) patients (p = 0.06). At 1 
year, a similar difference was seen in all-cause mortal-
ity rates (22% vs. 12.5%, 11.1% and 0% respectively, p 
= 0.05).
conclusion: In this retrospective analysis, obese pa-
tients undergoing TAVR had lower MACE rate at 30 
days and lower mortality rate at 1 year when com-
pared to normal weight individuals. This “obesity 
paradox” has been seen with a number of medical di-
agnoses, critically ill patients, and is now evident in 
patients undergoing TAVR. More large scale studies 
are needed to further evaluate this paradox.
CI49
Prognostic Impact of Improvement in Intra- 
Operative Pulmonary Artery Systolic Pressure 
and Left Ventricular Ejection Fraction in Patients 
Undergoing Trans-Catheter Aortic Valve  
Replacement
Mathur, A.P.; Castro-Dominguez, Y.; Vaidya, P.; Cocke, T.; 
Elmann, E.; Di Luozzo, G.; Parrillo, J.E.; Hackensack University 
Medical Center
introduction: Previous studies have demonstrated 
reduced survival in high risk patients with symp-
tomatic AS undergoing TAVR who had elevated 
pulmonary artery systolic pressure (PASP) at baseline. 
However, effects of elevated intra-operative PASP on 
long term outcomes in these patients are not clearly 
defined.
metHods: We retrospectively evaluated 100 consecu-
tive patients undergoing TAVR at our institution 
between 2012 and 2013. Baseline characteristics, 30 
day major adverse cardiovascular events (MACE), 
defined as composite end point of stroke, myocardial 
infarction, cardiovascular death or re-hospitalization, 
and 1 year all-cause mortality stratified by intra-oper-
ative PASP were analyzed.
results: On Cox regression survival analysis in 
patients undergoing TAVR, being in the highest tertile 
of intra-operative PASP was an independent predictor 
of a higher 30 day MACE event rate (HR: 4.1, 95% 
CI: 1.8 to 9.2, p = 0.001) and long term mortality at 12 
month (hazard ratio (HR): 6.6, 95% confidence interval 
(CI): 3.8 to 11.4, p < 0.001). Following TAVR, patients 
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with greater than 10mmHg reduction in their intra-
operative PASP, had improved long term survival at 
12 months (HR: 0.14, 95% CI: 0.04 to 0.46, p = 0.001). 
In addition, an increase of greater than 5% in left 
ventricular (LV) ejection fraction (EF) after TAVR was 
also associated with improved long-term survival at 
12 months (HR: 0.23, 95% CI: 0.07 to 0.78, p = 0.02).
conclusion: In high risk patients with severe aortic 
stenosis, elevated pulmonary artery systolic pressures 
during trans-catheter aortic valve replacement was 
associated with reduced survival at 1 year. Reduction 
in PASP after TAVR was one of the strongest predictor 
of survival in our patient population. More large scale 
randomized studies are needed to further evaluate 
these results.
CI50
Women Demonstrate Long Term Improvement 
after Trans-Catheter Aortic Valve Replacement 
in Severe Aortic Stenosis
Mathur, A.P.; Castro-Dominguez, Y.; Vaidya, P.; Cocke, T.; 
Elmann, E.; Di Luozzo, G.; Parrillo, J.E.; Hackensack University 
Medical Center
introduction: Previous studies have demonstrated 
improved short term survival in high risk patients 
with symptomatic aortic stenosis (AS) undergoing 
trans-catheter aortic valve replacement (TAVR) when 
compared to surgical aortic valve replacement (SAVR). 
However, gender specific outcomes in these patients 
are not clearly defined. This study sought to examine 
these outcomes after SAVR or TAVR.
metHods: We retrospectively evaluated 200 consecu-
tive patients undergoing aortic valve replacement 
at our institution between 2002 and 2012. In all, 100 
patients undergoing TAVR were matched on their 
propensity scores with 100 patients undergoing SAVR. 
Baseline characteristics, 30 day major adverse cardio-
vascular events (MACE), defined as composite end 
point of stroke, myocardial infarction, cardiovascular 
death or re-hospitalization, and 1 year all-cause mor-
tality were compared among males and females.
results: All patients undergoing TAVR had sig-
nificantly lower mortality rate at 12 month when 
compared to those undergoing SAVR (15% vs. 29%, 
HR 0.47, 95% confidence interval (CI): 0.26 to 0.84, p 
= 0.01). When compared to male patients, the female 
patients were predominantly older (82Â±6 vs 79Â±8 
years), had lower prevalence of prior coronary ar-
tery bypass surgery (11% vs. 42%), peripheral artery 
disease (19% vs. 31%) and lower pre-operative creati-
nine levels (1.2 vs. 1.5 mg/dl). STS score was similar 
between both genders (10.7 and 10.8). Among women, 
the 30-day MACE events and 1 year all-cause mortal-
ity was significantly lower in the TAVR group (30% vs 
67%, p < 0.001 and 12% vs. 31%, p = 0.002, respectively). 
Among men, although the 30 day MACE event was 
significantly lower in TAVR group (12% vs. 31%, p = 
0.01), there was no significant survival benefit at 1 year 
(18% vs. 26%, p = 0.19).
conclusion: Although the female patients who un-
derwent transcatheter aortic valve replacement had 
a higher risk profile compared to those treated surgi-
cally, they had significantly improved short and long 
term outcomes. Our data suggest that in high risk 
female patients, TAVR may therefore be a better alter-
native than surgery. Large scale randomized control 
trials are needed to further evaluate this gender ef-
fect on long term outcomes in high risk patients with 
severe aortic stenosis undergoing valve replacement.
CI51
A Phase II Study of the Combination of FCR-Lite 
and Lenalidomide Followed By Lenalidomide 
Maintenance in Front-Line CLL: The FCR2 
Regimen
Mato, A.; Goy, A.; Feldam, T.; Morin, M.; Schuster, S.; Porter, 
D.; Chow, K.F.; John Theurer Cancer Center at Hackensack 
University Medical Center
introduction: (FCR) remains the standard of care for 
the treatment of newly diagnosed, fit CLL pts requir-
ing therapy. Strategies aimed at minimizing toxicity 
without compromising efficacy have been reported 
including modifications of the optimal dosing and 
duration of FCR using a dose-reduced approach (Foon 
et al, “FCR lite”) or reduction in number of FCR cy-
cles based on MRD status (Strati et al). In the era of 
biological agents, both preclinical and clinical data 
have shown the efficacy of lenalidomide (Len) in CLL. 
n CLL, Len presents a clinical opportunity both in 
combination with chemotherapy and as maintenance 
strategy. This was the rationale for our trial using Len 
in combination with FCR and as maintenance to im-
prove outcomes and shorten therapy.
metHods: Eligible pts were treated with 4-6 cycles of 
FCR2 (D1-3 fludarabine 20 mg/m2, D1-3 cyclophos-
phamide 150 mg/m2, D1&15 rituximab 500 mg/m2 
every 28 days). Len was administered on D 8-28 of 
each cycle (starting dose of 5 mg increasing to 10 mg 
and 15 mg in cycle ≥2 based on toxicity algorithm). Pts 
who were MRD (-) in PB and BM (multicolor flow cy-
tometry) initiated Len maintenance after cycle 4 FCR2 
(otherwise proceeded to 6 cycles). Daily Len mainte-
nance started two months after FCR2 completion in 
responding pts for a total of 12 months (5-15 mg based 
on toxicity algorithm). The primary study endpoint 
was the proportion of CR pts after cycle 4 of FCR2 
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with ≥8/19 (≥40%) CR+CRi considered a positive re-
sult and worthy of further study (Î± 0.05, Î_ 90%).
results: 25 pts met inclusion criteria for enrollment of 
which 22 pts enrolled and 19 were evaluable.  30% pts 
had Rai stage III-IV, 53% unmutated-CLL, 5% del17p 
and 30% del11q. After 4 cycles of FCR2 (n=19) response 
rates were as follows CR 47%, CRi 5%, PR 42%, SD 5% 
(pts were MRD neg in 29% BM and 56% PB samples, 
3 pts (16%) were MRD neg in both PB and BM). After 
6 cycles of FCR2 (n=16), response rates improved and 
were as follows: 63% CR, 13% CRi, 19% PR, 5% PD 
(pts were MRD neg in 50% BM and 72% PB samples). 
During induction, 12 pts required a treatment inter-
ruption or dose reduction of Len per protocol (median 
dose of len was 10 mg). The most common grade 3-4 
toxicities were as follows (% events): neutropenia (51%), 
leukopenia (20%), hyperglycemia (5%), NTP fever (5%). 
Grade 3-4 TLS and tumor flare were not noted. The 
med follow up for the entire cohort is 13.1 months (7.3-
22.5 months). One progression has occurred in a pt 
who withdrew from study after 2 cycle of FCR2. One 
death has occurred in a pt with del17p who died on 
D+255 following allogeneic SCT in CR from the com-
plications of cGVHD. 10 pts have gone on to initiate 
Len maintenance.
conclusion: CR-lite in combination with Len is fea-
sible and demonstrates encouraging clinical activity 
in a high-risk, CLL pt population with an acceptable 
toxicity profile. A significant proportion of pts are 
MRD neg in PB and/or BM following FCR2. Addition 
of Len to FCR may minimize chemotherapy exposure 
without compromising outcome.
CI52
MM-008: A Phase 1 Trial Evaluating Pharma-
cokinetics and Tolerability of Pomalidomide + 
Low-Dose Dexamethasone in Patients with  
Relapsed or Refractory and Refractory Multiple 
Myeloma and Renal Impairment
Matous, J.; Siegel, D.; Lonial, S.; Harvey, R.D.; Kasserra, C.; 
Li, Y.; Chen, M.; John Theurer Cancer Center at Hackensack 
University Medical Center
introduction: POM in combination with low-dose 
dexamethasone (LoDEX) has shown efficacy in pts 
with RRMM and moderate RI (creatinine clearance 
[CrCl] < 30-44 mL/min), but pts with severe RI (CrCl < 
30 mL/min; serum creatinine> 3 mg/dL) were exclud-
ed from most trials (Siegel, et al., Blood. 2012; Weisel, et 
al., J Clin Oncol, 2013). MM-008 is a multicenter, open-
label, phase 1 study assessing the pharmacokinetics 
(PK) and safety of POM + LoDEX in pts with RRMM 
and normal or severely impaired renal function.
metHods:	Pts with RRMM (≥1 prior Tx) and normal 
kidney function or mild RI (creatinine clearance 
[CrCl] ≥60 mL/min; Cohort Aâ€”control arm), severe 
RI (CrCl < 30 mL/min) not requiring dialysis (Cohort 
B), and severe RI requiring dialysis (Cohort C) were 
eligible. Cohort A received POM 4 mg, and Cohort B 
received POM 2 or 4 mg on days 1-21 of a 28-day cycle, 
following a 3 + 3 dose-escalation design. Cohort B re-
sults informed the 4 mg dosing of Cohort C.
results: As of July 17, 2014, updated data for 16 treat-
ed pts were available (8 in Cohort A; 3 in Cohort B 
at 2 mg; 4 in Cohort B at 4 mg; and 1 in Cohort C). 
Median age was 67 yrs (range, 46-76 yrs), 56% were 
male, all had Eastern Cooperative Oncology Group 
performance status 0 or 1, and a median time from 
diagnosis of 3.8 yrs (range, 0.6-12.5). No DLTs in cycle 
1 were reported for any cohort. The most common Gr 
≥3 adverse events (AEs) were neutropenia, anemia, 
infection, and fatigue (Table). Median relative dose 
intensity was consistent across cohorts: 90% (Cohort 
A), 90% (Cohort B; 2 mg), 100% (Cohort B; 4 mg) and 
100% (Cohort C).
conclusion: MM-008 is an ongoing trial prospec-
tively evaluating the PK and safety of POM + LoDEX 
in pts with RRMM and severe RI. Preliminary PK 
data support mean dose-normalized exposure in pts 
with RRMM being similar between those with severe 
RI and those with no or mild RI at the clinical dose 
of 4 mg; early tolerability data (after one cycle) are 
encouraging.
CI53
Deep Molecular Response in Patients with 
Newly Diagnosed Chronic Myeloid Leukemia in 
Chronic Phase (CML-CP) Treated with Nilotinib: 
ENESTNext Update
Mauro, M.J.; Dakhil, S.; Cortes, J.; Rizzieri, D.A.; Keir, C.H.; Yi, 
S.; Goldberg, S.L.; John Theurer Cancer Center at Hackensack 
University Medical Center
introduction: The BCR-ABL tyrosine kinase in-
hibitor nilotinib elicits faster and deeper molecular 
responses (MRs) vs imatinib in patients with CML-CP. 
Achievement of sustained deep MR is associated with 
improved long-term outcomes and is a key criterion 
for entry into treatment-free remission (TFR) studies. 
Given the importance of accurately measuring deep 
MR in patients with CML, increasingly sensitive tech-
niques are needed for monitoring minimal residual 
disease.
metHods: In this single-arm, open-label, multicenter 
study (NCT01227577), adults with CML-CP diagnosed 
within 6 months of enrollment were treated with nilo-
tinib 300 mg twice daily (BID) for up to 2 years. Dose 
escalation to nilotinib 400 mg BID for patients with 
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suboptimal response or treatment failure (per modi-
fied European LeukemiaNet 2009 recommendations) 
was permitted per physician discretion.
results: A total of 128 patients were enrolled (medi-
an age, 56.5 years [range, 21.0-89.0 years]); 64 patients 
(50.0%) were male and 103 (80.5%) were Caucasian. As 
of the data cutoff, 45 patients (35.2%) had completed 
the study, 49 (38.3%) remained on treatment, and 34 
(26.6%) had discontinued early. With a median treat-
ment duration of 12.7 months, 88 (68.8%), 94 (73.4%), 
and 32 (25.0%) patients achieved CCyR, MMR, and 
MR4.5, respectively, at any time (Table). Of 32 patients 
who achieved MR4.5, 14 achieved MR4.5 by 6 months. 
A total of 169 samples from 32 patients with confirmed 
MR4.5 by conventional RQ-PCR were analyzed by 
digital PCR.
conclusion: Frontline treatment with nilotinib 300 
mg BID in patients with newly diagnosed CML-CP 
led to rapid achievement of MR4.5 as assessed with 
conventional RQ-PCR. As > 40% of samples with at 
least MR4.5according to standard RQ-PCR were posi-
tive using the digital PCR assay, this tool may have 
potential in evaluating MR to determine eligibility for 
TFR studies.
CI54
All Anxiety Is Not The Same: The Relationship 
Between Autonomic Function and Anxiety in 
Parkinson’s vs Other Patients
Murthy, M; Cristini, J; Hanna, P.A.; Rosenberg, M.L.; JFK 
Medical Center- NJ Neuroscience Institute
introduction: Anxiety is common in the general 
population and has been shown to be even more 
common in Parkinson’s disease (PD). Although this 
increase may be secondary to situational difficulties 
related to their PD, we hypothesized that anxiety in 
PD may have a different pathophysiologic mechanism 
than anxiety not associated with PD. Specifically we 
suspected that this might be related to the autonomic 
dysfunction that is inherent to the disease itself. This 
study was done to test the above hypothesis.
metHods: We reviewed the records of 59 subjects 
diagnosed with PD, and 588 subjects with other or 
unknown diagnoses (non-PD) who had completed 
autonomic testing and a questionnaire asking them 
to judge their anxiety on a scale of 0-4. Testing was 
done at baseline, during deep breathing, Valsalva and 
stand with repeat baseline after each stimulus. We 
used this data to look for correlations between anxiety 
and autonomic measurements to see if they differed 
between the two groups.
results: 40/59 (67.79%) PD subjects and 446/588 (75. 
8%) non-PD subjects reported anxiety. Both groups 
had a number of individual variables that were sta-
tistically correlated with anxiety. In patients without 
PD, there were a number of variables with statistically 
significant correlations between ANS stimulation 
and anxiety but none of the variables gave a statisti-
cally significant predictive value. In contrast, for PD 
patients using a regression analysis, the change after 
deep breathing in sdNN (a measure of heart rate vari-
ability) and HFnu (a measure of parasympathetic tone 
showed a highly significant relationship to anxiety 
(R2 = 19.4, p = 0. 04).
conclusion: Although not conclusive because of the 
relatively low number of patients with more marked 
anxiety, this study strongly suggests an underlying 
ANS abnormality in patients with PD. The fact that 
these variables were not significant in the non-PD pa-
tients suggests that this is not an epiphenomena from 
the anxiety itself but rather a direct effect of the ANS 
changes in PD. We hope that further study will con-
firm these findings.
CI55
Cognitive Recovery and Neuropsychological 
Evaluation: A Prospective Study in ED Patients 
After Mild Traumatic Brain Injury
Ogedegbe, C.; Azmi, H.; Voelbel, G.; Wylie, G.R.; Dobryakova, 
E.; Dave, P.; Feldman, J.; Hackensack University Medical 
Center
introduction: Mild traumatic brain injury (mTBI) 
is the most prevalent acquired brain injury, yet the 
neuropsychological mechanisms underlying cogni-
tive recovery from mTBI remain poorly understood. 
During the acute and post acute period in mTBI 
multiple cognitive processes are negatively affected. 
Studies have demonstrated cognitive recovery, with 
subjective and objective assessments, that within 
days to weeks these cognitive abilities are recovered. 
We compared 12 adults presenting to the emergency 
department  (ED) that met the criteria for mTBI to a 
healthy control group of 13 adults.
metHods: The neuropsychological and neurocog-
nitive evaluation for the mTBI group as well as the 
healthy controls was performed within 10 days of 
the injury and 4 months following the injury.  Tests 
done include: Neurobehavioral Symptom Inventory, 
Symbol Digit Coding, Shifting Attention, Continuous 
Performance, Verbal Memory, Visual Memory, PTSD 
Checklist-Civilian, The Stroop, The Non-Verbal 
Reasoning, Test of Memory Malingering, Impact of 
Events Scale-Revised, Memory of event question-
naire, Wechsler Test of Adult Reading, Drug Abuse 
Screening Test, Beck Depression Inventory, and Beck 
Anxiety Inventory, among other tests.
36
results: The results demonstrate the mTBI group has 
significant deficits in processing speed, attention and 
concentration, as well as verbal and visual memory 
compared to the control group at baseline. The mTBI 
group showed cognitive recovery in most cognitive 
areas at the four month follow- up. Processing speed 
and visual memory were still significantly below 
the performance of the control group at the 4-month 
post-assessment.
conclusion: The results support prior studies that pro-
cessing speed and memory may be the most sensitive 
cognitive domains affected by a mTBI. Furthermore, 
this study reveals individuals that experience a mTBI 
may still experience impairment in these cognitive 
domains 4-months post injury.
CI56
BMI and Abdominal Ultrasound Image Quality: A 
Pilot Survey of Ultrasound Trained Technologists.
Ogedegbe, C.; Brahee, D.; Nyirenda, T.; Hazelwood, V.; 
Morchel, H.; Patel, R.; Feldman, J.; Hackensack University 
Medical Center
introduction: Ultrasound (US) is increasingly being 
used as a non-invasive, inexpensive imaging modal-
ity. Point-of-care US is being used by non-radiologists 
of various specialties. However, the body habitus of 
patients and the limitations of abdominal US imaging 
has not been well defined.  Other imaging modalities 
have been extensively researched in this regard. There 
is a dearth of research in US image quality and pa-
tient body habitus. We aim to determine opinions of 
US trained technologists on the relationship of body 
habitus and abdominal US image quality.
metHods: Study design was cross sectional, via paper 
survey, fielded across participants at a 775-bed com-
munity teaching hospital, in Northern New Jersey. 
Fourteen US technologists completed a 12-item ques-
tionnaire to evaluate their experience with abdominal 
US imaging considering the patient’s image quality in 
correlation to body adipose tissue. Survey sheet were 
fielded by 2 medical students who covered partici-
pants in all work shifts, and on all days of the week. 
Written consent was obtained, and participant data 
sheets were identity-coded.
results: 85.7% of responders agreed that there is an 
association between the amount of adipose tissue on 
a patient’s abdomen and the quality of US images ob-
tained. 85.7% agreed that a normal BMI of 18.5-24.9 
provides the best US image quality. However, only 
28.6% agreed that normal amounts of adipose tissue 
produce poor image quality. This was surprising as 
intuitively it may be thought that absence of adipose 
tissue would provide the highest quality image. The 
descriptions of moderate amounts of adipose tis-
sue and “a little more than minimal body fat” (BMI 
25.0-29.9) may not have been considered equal in the 
opinions of the surveyed. The lack of agreement be-
tween questions proves the participants understood 
the questions that were proposed in the survey.
conclusion: Results indicated consensus on amount 
of adipose tissue and quality of image. There appears 
to be agreement that BMI is a factor in obtaining good 
quality abdominal US images. General consensus was, 
normal BMI was best while BMI 30.0-34.9 and to a 
lesser extent BMI 25.0-29.9 were detrimental in obtain-
ing good quality abdominal US images.
CI57
Relationship between Rate of Intubation and 
CPAP Use in the Prehospital Setting.
Ogedegbe, C.; Knox, N.; Nyirenda, T.; Feldman, J.; Ashtyani, H.; 
Hackensack University Medical Center
introduction: Continuous Positive Airway Pressure 
(CPAP) therapy for sleep apnea was initiated in the 
1980s.  CPAP has been used in acute respiratory dis-
orders in the ED. However, there has been less focus 
on the expansion of CPAP into the prehospital set-
ting.  Early application of CPAP may be important 
in patients with acute respiratory disorders.  Here 
we determine if pre-hospital use of CPAP treatment 
is associated with endotracheal intubation, among 
patients brought to the Emergency Department (ED) 
with acute respiratory distress.
metHods: Study design was a retrospective cohort. We 
compared the rate of intubation in patients with acute 
respiratory distress, in the years  (2004) preceding the 
availability of CPAP with the years after initiation 
of CPAP use (2010-2011). Categorical variables were 
compared between groups using Fisher’s exact test or 
Chi-square test. Continuous variables were summa-
rized as median (intequartile range) and comparison 
between groups was performed using Wilcoxon rank 
sum test. Association between the use CPAP and 
rate of endotracheal intubation was examined us-
ing multivariable logistic regression analysis. The 
adequacy of the model was calibrated using Hosmer 
and Lemeshow’s goodness-of-fit test. P<0.05 was con-
sidered statistically significant. Data analysis was 
conducted using SAS version 9.2.
results: Records of 775 patients (median age 78 years, 
59% women) were reviewed. Of the 215 patients treat-
ed with CPAP in the MICU, 13% were intubated after 
admission. In contrast, of the 570 patients who did 
not receive CPAP, 28% were intubated after admis-
sion to the ED. Unadjusted logistic regression showed 
that patients who received CPAP were less likely to 
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be intubated compared to patients without CPAP use 
[OR=0.37, 95% CI, 0.24 to 0.57, p<0.0001]. Adjusted (for 
age, sex and diagnosis) multivariate logistic regres-
sion showed that CPAP treatment was associated with 
a 66% reduced need for intubation [OR=0.34, 95% CI, 
0.19 to 0.59, p=0.0001]. 
conclusion: Among patients with acute respiratory 
distress, use of CPAP in pre-hospital setting was asso-
ciated with less need for intubation upon Emergency 
Department (ED) admission. Findings from this study 
support the rejection of limiting the use of CPAP only 
as a chronic therapy device, and reinforce the poten-
tial of its use as an acute therapeutic device, in the 
prehospital setting.
CI58
The Prevalence of Alcohol Use and Abuse 
among Geriatric Trauma Patients  Presenting to 
the Emergency Department
Ogedegbe, C.; Mammen, G.; Tariq, M.; Maresca, M.; Locurto, 
J.; Feldman, J.; Hackensack University Medical Center
introduction: The significant drinking pattern 
among older adults is an invisible public health epi-
demic often overlooked within hospital Emergency 
Departments (EDs).  Alcohol continues to be the most 
commonly abused substance, in this population. As a 
result, the consequence of alcohol abuse among older 
adults is an emerging problem.  The objective of this 
research study is to evaluate alcohol use and abuse 
in the geriatric trauma population as well as raising 
awareness of this overlooked public health issue.
metHods: A relevant, review of the literature was 
conducted, accessing the PubMed and Science Direct 
databases. Fifty-five articles reviewed, and thirty 
articles, from the last five years, were selected. A ret-
rospective chart review looked at medical records 
from April 2009 through April 2014 of trauma patients, 
65 years and older.  Rate of alcohol (EtOH) screening 
in the ED among the geriatric trauma patients was de-
termined and the breakdown of that screening data 
was characterized.
results: A median of 406 elderly patients was admit-
ted for trauma related causes, of which a median of 
66 had alcohol levels drawn. Also at least 10 patients 
per year had an alcohol level above the legal limit. 
Furthermore, an average of 18 (0.26%) patients out of 
an average of 67 screened for EtOH had levels above 
the legal limit of 80 dL. Review of the current litera-
ture showed evidence that alcohol misuse or abuse 
arises from reasons ranging from declining health to 
loss of loved ones.  Other findings were that the ef-
fects of EtOH on elderly adults can be detrimental and 
even lead to increased risk to both their health and 
psyche due to slowed metabolism, comorbid condi-
tions, as well as use of prescribed medication.
conclusion: These findings suggest the need for pos-
sible revision of the EtOH screening criteria currently 
in place for this population, implementing appropri-
ate interventions based on a new screening tool, and 
promoting educational awareness among healthcare 
providers.
CI59
Making Rapid Triage Decisions in National  
Mass Casualty Disasters
Ogedegbe, C.; Morchel, H.; Hazelwood, V.; Chaplin, B.; Hassler, 
C.; Feldman, J.; Hackensack University Medical Center
introduction: Through the use of the novel 
Telesonography system, cellular and satellite trans-
mission of medical ultrasound examinations can 
potentially enhance patient throughput in disaster 
situations.
metHods: Six pre-determined e-FAST (Extended 
Focused Assessment with Sonography in Trauma) ul-
trasound images of different regions of the body (left 
and right chest, hepatorenal, splenorenal, suprapu-
bic, cardiac parasternal long axis or subxiphoid) were 
obtained, and transmitted real time via the TS to the 
hospital (in New Jersey) for live view by doctors in the 
trauma room. 
results: We report descriptive statistics as means 
with standard deviations for items and QUIS scale 
scores. In addition, we used paired samples t-tests to 
test if the ratings differed between the baseline and 
transmitted conditions. Finally we computed dif-
ference scores measuring signal degradation which 
occurs in the transmission of ultrasound images. 
These difference scores were then compared between 
transmission methods using a paired samples t-test. 
Paired sample tests were used because the same rat-
ers were used in all conditions, making the ratings 
dependent.
conclusion: The Telesonography System success-
fully transmitted real-time, secure ultrasound images 
across multiple cellular and satellite networks from 
an austere environment. The successful integration of 
the BGAN satellites provided image transmission and 
voice communication in a simulated national disaster 
model.
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CI60
A Novel Portable Telesonography System  
for Prehospital Trauma Care from an Austere,  
International Location
Ogedegbe, C.; Morchel, H.; Hazelwood, V.; Hassler, C.; 
Feldman, J.; Hackensack University Medical Center
introduction: The goal of this study was to describe 
the performance characteristics of the TS system in 
transmitting real time medical ultrasound images 
images via cellular network compared to satellite 
network transmission from an international location 
(Medical Clinic Dominican Republic)  to our medical 
institution in the US (New Jersey).
metHods: A Sonosite M- Turbo portable ultrasound 
system by (Sonosite Inc.) was equipped with a C 15/4-
2 m Hz transducer for extended Focused Assessment 
with Sonography in Trauma (e-FAST) abdominal 
exams and interfaced with a portable transmission 
device, LU-60 (LiveU).  These technologies formed the 
Telesonography System (TS) which is capable of trans-
mitting real-time, audio and video simultaneously 
over multiple cellular networks.  The system was en-
hanced with the addition of two broad ground area 
network (BGAN) satellite terminals (Hughes 9201) to 
allow for transmission of data in areas where other 
networks are unavailable.
results: The data shows the evaluator rating of base 
images for subjects were similar for both the cellular 
and satellite transmission. The base location images 
were generally rated slightly better in quality, resolu-
tion, and detail by evaluators. In addition, the images 
transmitted by satellite were rated better when com-
pared to those by cellular network transmission. 
Internal consistencies of our QUIS questionnaire 
subscales by the evaluators were high and therefore 
reliable.
conclusion: Abdominal trauma ultrasound images 
obtained via the TS system from an international loca-
tion, were rated to be high quality and also rated to be 
good enough to make a diagnosis by “expert” at the 
second location, such as the hospital in New jersey, for 
interpretation. In addition to e-FAST images, the TS 
system has the capability of sending other real-time, 
quality ultrasound images such as cardiac, OB, renal, 
gallbladder, etc from austere locations to an ”expert” 
at a base location for interpretation. Performing ultra-
sounds in a pre hospital setting may make a significant 
difference in patient care by potentially reducing the 
door to scalpel time.
CI61
Prospective Analysis of Laparoscopic Chole-
cystectomies Based on Post-Graduate Resident 
Level
Parikh, S.; Castillo, R.; Szczech, E.; Moskowitz, R.; Sori, A.; 
Zuberi, J.; Elsawy, O.; St. Joseph’s Regional Medical Center
introduction: Complications in laparoscopic chole-
cystectomies have been thoroughly studied. Many of 
these studies have attempted to ascertain the safety 
and efficacy of surgical resident participation in lapa-
roscopic surgical cases; however, few have looked at 
these endpoints based on specific resident post-grad-
uate year, and their experience. We hypothesize that 
there is no difference in complications based on resi-
dent year in laparoscopic cholecystectomies.
metHods: 200 laparoscopic cholecystectomies were 
prospectively reviewed over one year. Patient de-
mographics, operative time, ambulatory status, 
intraoperative complications, and the residents in-
volved in the case were recorded. Residents were 
classified as surgeon chief, surgeon junior, or teaching 
assistant. Post-operatively patients received telephone 
calls, clinic visits, or emergency department visits. 
Variables analyzed included operative resident post-
graduate year, operative time, elective vs. emergent 
status of each operation, and intraoperative as well as 
postoperative complications.  Primary outcomes ana-
lyzed: Surgical complications based on resident level. 
Secondary outcomes: Operative time based on resi-
dent level, operative time based on ambulatory status.
results: 167 patients had data completed for the study. 
33 patients were excluded due primarily to a lack of 
follow up. 73 patients were operated on by a surgeon 
chief (46% elective), 62 operated on by a surgeon junior 
(39% elective), and 32 operated by a teaching assistant 
and surgeon junior (55% elective). The average oper-
ating time was 65.17 minutes 95% CI [59.51,70.84] for 
surgeon chief, 69.38 minutes 95%CI [63.93,74.83] for 
surgeon junior, and 63.91 minutes 95%CI [57.98,69.84] 
for teaching assistant/surgeon junior. Average op-
erative time in the elective group was 62min vs. the 
emergent group, 70.67min, was statistically significant 
(p=0.037).  There were a total of 13 (7.8%) major surgi-
cal complications across all 3 resident level groups. 5 
major complications occurred in the SJ group, 2 ma-
jor complications occurred in the SJ/TA group, and 6 
major complications occurred in the SC group. These 
were not significant in comparison (p=0.937).  Major 
complications occurred in 9/97 emergent cases had, 
and 4/70 elective cases. Pearson Chi-Squared test of 
major surgical complications in emergent and elec-
tive cases showed no correlation between both factors 
(p=0.396).
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conclusion: Operative time was longest in the resi-
dent level of least experience; however, operative time, 
and complication rate was not statistically significant 
across any resident level. We did find operative time 
to be significantly longer with regards to ambulatory 
status.
CI62
Does Low Risk Chest Pain, Utilizing the HEART 
Score for Early Discharge in the ED, Have a  
Decreased 30 Day Readmission Rate?
Patel, C.; Charles, P.; Finefrock, D.; Bhuvanagiri, S.; Ogedegbe, 
C.; Hackensack University Medical Center
introduction: To identify the low risk chest pain pop-
ulation who may benefit from an early ED discharge, 
without having to undergo long observation period 
and thus reducing costs and hospital length of stay by 
using the HEART Score, for the risk stratification and 
consists of five elements: History, Electrocardiogram 
(ECG), Age, Risk factors, and Troponin.The prima-
ry end point of this study is a composite of Acute 
Myocardial infarction, percutaneous coronary inter-
vention, coronary artery bypass graft surgery and 
death, together called the Major Adverse Cardiac 
Event (MACE) and the secondary end point being 30-
day readmission rate.
metHods: This is a retrospective, case-control study, 
taking place in a tertiary care community teaching 
hospital, enrolling patients who came in between 
01/01/2013 to 12/31/2013 to the adult Emergency 
Department There is no treatment plan in this study 
as it is a retrospective case control study, which in-
volves looking at patient History, ECG, Age, Risk 
factors and Troponin. There is no use of placebo/ran-
domization/drugs/hospitalization. The patient chart 
is reviewed for 30 day- readmission once the patient 
was discharged from the ED.
results: During the study period, a total of 160 pa-
tients with chest pain were admitted to the ED. The 
main reason for admission was chest pain which in-
cluded cardiac as well as non-cardiac cause.  Amongst 
the excluded cases were twenty four (15%) cases who 
were admitted for non-cardiac reasons, twenty four 
(15%) cases had STEMI, known CAD, CHF, previous 
MI/stent placement and six (3.8%) were patients who 
were pregnant, deceased, transferred to other hospi-
tal, left AMA and had missing ECG/Troponin on their 
chart.  Low risk group had sixty three patients, out 
of which, two (3.2%) had non-cardiac related readmis-
sion and one (1.6%) had a cardiac related readmission.
conclusion: The HEART Score may help us making 
accurate decisions in the ED without the use of radia-
tion or invasive procedures. Low HEART Scores go 
with low likelihood of an ACS and decreased 30 day 
readmission where as high HEART Score predict high 
numbers of MACE.  It can be used as a quick, easy and 
useful tool as a reliable predictor of outcome in chest 
pain patients and therefore may be used in the ED.
CI63
Arthroscopic Surgery of the Ankle: Analysis and 
Follow-up Study of 108 Patients
Patel, Y.; Patel, D.V.; McInerney, V.K.; St. Joseph’s Regional 
Medical Center, Paterson, New Jersey and Seton Hall University
introduction: In the past three decades, ankle ar-
throscopy has gained increasing popularity due to 
advances in surgical technique and endoscopic in-
strumentation. In this paper, we report our experience 
with operative ankle arthroscopy. The basic ankle ar-
throscopy setup and operative technique is described. 
The indications for surgery, follow-up results, and 
complications of arthroscopic surgery are reported.
metHods: One hundred and eight patients (112 ankles) 
underwent operative ankle arthroscopies. Indications 
for surgery included pain, recurrent swelling, me-
chanical catching, locking, and instability that failed 
to respond to a prolonged course of non-operative 
management. Preoperative diagnoses were synovitis 
(42 ankles), osteochondral defects of the talar dome 
(54 ankles), anterior tibiotalar impingement (6 ankles), 
degenerative joint disease with osteophytes and/or 
loose bodies (8 ankles), and septic arthritis (2 ankles).
results: The mean age of the patients at the time of 
surgery was 29 years (range, 17 to 64 years). The av-
erage postoperative follow up was 6.8 years (range, 
1.5 to 10.3 years). The mean preoperative American 
Orthopaedic Foot & Ankle Society (AOFAS) ankle-
hindfoot score was 44 points (range, 18 to 58 points). 
The mean postoperative AOFAS ankle-hindfoot score 
was 81 points (range, 26 to 100 points). Overall, 90 
patients (83%) were improved, 16 (15%) remained un-
changed, and 2 (2%) became worse after undergoing 
ankle arthroscopic surgery. The best clinical results 
were seen in patients who had ankle synovitis and in 
those who had small or medium-sized, stable osteo-
chondral lesions of the talus. The outcome was better 
in patients who had anterolateral talar dome lesions 
as compared to those with posteromedial lesions. 
Patients with degenerative joint disease had an unsat-
isfactory outcome. Overall, 12 of the 108 patients (11%) 
had complications.
conclusion: Operative ankle arthroscopy is a safe, ef-
fective and useful procedure. Careful patient selection 
is critical. There is a steep learning curve. A thorough 
knowledge of foot and ankle surgical anatomy is es-
sential to avoid complications. At times, the surgical 
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technique is demanding and challenging, even in 
the hands of experienced surgeons. Predictable and 
satisfactory clinical results are obtained in most pa-
tients with synovitis or osteochondral lesions of the 
talar dome. The results are less predictable and un-
satisfactory in patients who have mild-to-moderate 
degenerative joint disease.
CI64
Revision Anterior Cruciate Ligament Recon-
struction Using the Autogenous Bone-Patellar 
Tendon-Bone Graft: A Five- to Seven-Year  
Follow-up Study
Patel, Y.; Patel, D.V.; McInerney, V.K.; St. Joseph’s Hospital and 
Regional Medical Center, Paterson, New Jersey and Seton Hall 
University
introduction: Revision anterior cruciate ligament 
(ACL) reconstructions are challenging and techni-
cally demanding surgical procedures. Less favorable 
results have been reported after revision ACL recon-
struction as compared to those following primary 
ACL reconstruction. The purpose of our study was 
to report the clinical, functional, and radiographic 
results of revision ACL reconstructions using autog-
enous bone-patellar tendon-bone graft.
metHods: Thirty-eight revision ACL reconstructions 
were performed. Previously unharvested, ipsilateral, 
autogenous bone-patellar tendon-bone graft was used 
for all cases. Concurrent operative procedures were 
performed in 22 of the 38 knees (58%). These proce-
dures included repair of a meniscal tear in 13 knees 
(34%), and reconstruction of deficient posterolateral or 
medial ligamentous structures in 9 knees (24%). Seven 
of the 38 knees (18%) had a high tibial osteotomy to 
correct varus malalignment before undertaking revi-
sion ACL reconstruction.
results: The average age of the patient at the time 
of revision ACL surgery was 29.3 years (range, 21 to 
44 years). The mean postoperative follow-up was 
78 months (range, 60 to 87 months). At latest follow 
up, 24 knees (63%) had negative Lachman tests, 11 
knees (29%) had positive Lachman tests with a hard 
end-point, and 3 knees (8%) had positive tests with a 
soft or no end-point. The pivot shift test was grade 0 
(absent subluxation) in 23 knees (61%); grade I (slight 
subluxation) in 8 knees (21%); grade II (definite sub-
luxation) in 5 knees (13%); and grade III (subluxation 
and momentary locking) in 2 knees (5%). At latest fol-
low up, the mean Lysholm knee score was 83.7, the 
average Tegner activity level was 5.8, and the mean 
subjective IKDC score was 84.1. Based on the objective 
IKDC scores, 18 patients (47%) had a Grade A (normal) 
result; 14 patients (37%) had a grade B (nearly normal) 
result; and 6 patients (16%) had a grade C (abnormal) 
result. None of the patients had a grade D (severely 
abnormal) result.
conclusion: Meticulous preoperative planning is vi-
tal before undertaking revision ACL reconstruction. 
The causes of primary ACL reconstruction failure 
should be carefully analyzed before undertaking re-
vision ACL reconstruction. In general, the results of 
revision ACL reconstructions are less satisfactory as 
compared with those of primary ACL reconstructions. 
The outcome of revision ACL surgery may be affected 
by factors such as previous meniscectomy, articular 
cartilage damage, concomitant ligamentous injury 
with loss of secondary restraints, or varus malalign-
ment. We conclude that revision ACL reconstruction 
provides reasonable pain relief, restores knee stability, 
improves knee function, and provides good clinical 
and functional outcome in most cases.
CI65
The Predictive Role of Thrombocytosis in  
Identifying Lung Carcinoma patients in an Urban 
Medical Center
Patel, A.S.; Abdeen, Y; Katpally, R; Shaaban, H; Saint Michael’s 
Medical Center
introduction: According to recent World Health 
Organization reports, lung cancer is the most com-
mon type of malignancy and the leading cause of 
death from cancer; approximately 19.4% of cancer 
deaths per annum. Therefore, factors such as progno-
sis and mortality play a crucial role with lung cancer 
diagnosis. Over the past century, many studies have 
implicated the significance of thrombocytosis in vari-
ous types of malignancy, with a reported incidence of 
10% to 57%. Currently, the most important prognostic 
factor for both SCLC and NSCLC is tumor stage, with 
advanced stage disease being associated with worse 
outcomes. In our study, we will evaluate the implica-
tion of thrombocytosis as a poor prognostic indicator 
for lung cancer.
metHods: This is a retrospective cohort study of an 
electronic medical records review of 180 patients di-
agnosed with lung cancer at Saint Michael’s Medical 
Center between 2009 and 2013. As per pathology re-
ports and TMN staging, the histology subtype and 
staging of lung cancer was recorded as well as plate-
let count at the time of diagnosis. Excluded from the 
study were patients with known disorders that may 
cause abnormal platelet counts or prior carcinomas. 
Total exclusions were 74 cases. The patients who met 
inclusion criteria were categorized into 2 subgroups: 
small cell lung cancer and non-small cell lung cancer. 
The stages of the lung cancer and the platelet level was 
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compared using T test. Subgroup  analysis was con-
ducted using ANOVA test, all using SPSS software.
results: There were 106 cases with pathology reports 
indicating type and stage of lung cancer. Of the to-
tal, there were 94 (84.9%) cases of non small cell lung 
cancer and 12 (11.3%) cases of small cell lung cancer. 
Further categorization revealed 39 (36.8%) cases of 
limited stage (including NSLC Stage I, Stage II, Stage 
IIIa) and 67(63.2%) cases of advanced stage (includ-
ing NSLC Stage IIIb and Stage IV).  The mean platelet 
count was 286.29, with the minimum count of 47 and 
maximum count of 837. The mean platelet count for the 
group with limited staging lung cancer was 259.64 (SD 
107.697); whereas the mean platelet count for the group 
with advanced staging of lung cancer was 301.81(SD 
122.81).  Comparing advanced and limited staging, 
there was a statistical difference achieved with p value 
of 0.078 and 95% CI of 4.774 to 89.103. On a subgroup 
analysis including only the NSCLC the mean platelet 
count in limited stage and advanced stage were 255.32 
and 307.75 respectively; with no statistically significant 
p value of 0.018 and CI of 9.104 to 95.756.
conclusion: Given the importance of platelets, 
thrombocytosis serves as a pathological clue to diag-
nosis. Our study examined the correlation between 
neoplasm and reactive thrombocytosis.  Upon case 
review, thrombocytosis is prevalent in a wide range 
of malignancies. Our final review of 106 lung cancer 
patients included a statistical significance of thrombo-
cytosis in NSCLC and advanced staging. The average 
platelet count at the time of diagnosis was higher in 
advanced staging than in limited staging. Therefore 
the presence of thrombocytosis at the time of diagno-
sis may assist in determining prognosis of lung cancer.
CI66
Can a Simple Test Like Serum Albumin Predict  
a Complicated Condition Like Cardiorenal  
Syndrome Type-1?
Patel, H.; Rodriguez, A.; Abboud, J.; Bikkina, M.; Haft, J.; 
Shamoon, F.; Saint Michael’s Medical Center-Newark; The 
Brooklyn Hospital Center-NY
introduction: Cardiorenal syndrome type1 (CRS1) 
is characterized by the development of acute kidney 
injury (AKI) in a patient with Acute Decompensated 
Heart Failure (ADHF). CRS1 occurs in approximately 
25-40%of patients admitted with ADHF and presents 
a myriad of challenges in diagnosis and management. 
Hypoalbuminemia is detected in up to 28% of ADHF 
patients and is a proven independent mortality pre-
dictor in patients with ADHF. Hypoalbuminemia 
is a significant independent predictor for AKI and 
increased mortality following AKI in patients of sur-
gery, intensive care unit and other hospital settings. 
Although hypoalbuminemia is independently associ-
ated with ADHF and AKI, its role in predicting CRS1 
has not been published.
metHods: With IRB approval we performed a single 
center retrospective cohort study from records of 
adult patients (n=201) discharged with diagnosis 
of ADHF in 2011. Patients were excluded if they had 
creatinine (Cr) >2.5mg/dl or end stage renal disease, 
active malignancy or no record of serum albumin 
(S.Alb) levels. CRS1 was defined as an increase in se-
rum Cr of â‰¥0.3mg/dl from the baseline serum Cr 
on admission.
results: From our sample of 201 patients (mean 
age_68.1, SD_15.8), 48% were male and majority were 
African American. The mean S.Alb level on admis-
sion was 3.4g/dl with SD_0.4 and the mean admission 
Cr clearance (MDRD) was 57.3ml/min with SD_31.5. 
Despite the standard dose of furosemide about 45% 
patients developed CRS-1. S.Alb cut-off level of 3.4g/
dl was determined from ROC curve; patients with 
S.Alb <3.4g/dl (group1, n=90) were compared with 
patients with higher S.Alb (group2, n=111). Group 1 
had more elder patients and worse renal function on 
admission (P=0.02 and P=0.012 respectively). Group 1 
was found to be at a higher risk of developing CRS1 
during hospitalization (OR=4.48; 95% CI 2.46 to 8.14; 
P=<0.0001; adjusted OR for age=2.7; 95% CI 1.2 to 6.9; 
P=0.03; adjusted OR for <30ml/min creatinine clear-
ance on admission=1.7; 95% CI 1.1 to 4.0; P=0.04) and 
also had significantly longer hospital stay (13.3Â±17.5 
versus 7.2Â±5.3; P=0.003). Patients with CSR1 had 
worse clinical outcomes with higher in hospital mor-
tality (10%, n=7 versus 2%, n=2; P=0.04) and a trend 
towards higher 6-months mortality (n=13 versus n=8; 
P=0.09).
conclusion: Hypoalbuminemia (S.Alb <3.4g/dl) pre-
dicts CRS1 in patients admitted with ADHF and can 
aid in their early risk stratification. It also portends a 
complicated hospital course in patients with ADHF 
and can have an important impact on aggressive man-
agement and better resource utilization (like ultra 
filtration) in care of these patients.
*CI67
Laboratory and Clinical Features of EIA Toxin- 
Positive and EIA Toxin-Negative Community- 
Acquired Clostridium Difficile Infection
Patel, H.; Randhawa, J.; Nanavati, S.; Marton, R.; Baddoura, 
W.; DeBari, V.; St. Joseph’s Regional Medical Center, School of 
Health and Medical Sciences, Seton Hall University
introduction: Studies have described the clinical 
course of patients with Clostridium difficile infection 
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(CDI) with positive enzyme immunoassay (EIA) for 
toxins A and B. Limited information is available for 
the patients with negative EIA but positive for the 
toxin B gene (TcdB) by the PCR. The aim of our study 
is to determine if there are any differences that exist 
among the clinical and laboratory parameters in the 
patients tested to be positive by EIA for toxin and 
those who were negative.
metHods: This is a retrospective cohort study con-
ducted in a 700-bed teaching hospital. We reviewed 
charts of the patients with presumptive CDI between 
January 2006 and July 2013. We divided these patients 
into two groups, EIA-positive and EIA-negative based 
on result of EIA for toxins A and B and the require-
ment for a positive PCR analysis of the TcdB gene.
results: The EIA-positive group had significantly 
higher white blood cell counts (p < 0.001), with a sig-
nificantly greater percentage of bands (p < 0.0001). 
Albumin and total protein both exhibit significantly 
(p < 0.0001, both comparisons) lower values in the 
EIA-positive group.  Among clinical findings, the 
EIA-positive group had significantly longer length of 
hospital stay (p = 0.010).
conclusion: These data suggest that an infection with 
an EIA-negative strain of C. difficile presents labora-
tory markers closer to those of healthy subjects and 
clinical features suggesting considerably less severe 
than infection with EIA-positive C. difficile.
*CI68
Poor Left Atrial Function is associated with 
Reduced Left Ventricular Ejection Fraction in 
Hospitalized Patients
Patel, H.; Ariyarajah, V.; Haft, J.; Goldfarb, I.; Bikkina, M.; 
Shamoon, F.; Saint Michael’s Medical Center-Newark; The 
Brooklyn Hospital Center-NY
introduction: The left atrial (LA) has been recognized 
as a morphophysiologic barometer of left ventricular 
(LV) diastolic dysfunction. Because in the myocardial 
ischemia cascade where LV diastolic dysfunction of-
ten precedes LV systolic dysfunction, the LA which 
fashions as an early marker of diastolic anomaly, 
could equally reflect a declining LV function and/or 
be a good predictor of potential sequelae. We assessed 
this association of LA function with reduced LV sys-
tolic function among hospitalized patients.
metHods: LA volumes were echocardiographically de-
termined using the biplane area-length method in the 
apical 4-chamber view. LA function was calculated: 1) 
LA passive emptying fraction (LAPEF) = (VOLmax - 
VOLac) x 100% / VOLmax; 2) LA active emptying 
fraction = (VOLac - VOLmin) x 100% / VOLac, and 
Left Atrial kinetic energy (LAKE) = LA kinetic energy 
(LAKE) = Â= x 1.06 x (density of blood in g/cm-cubed) 
x LA stroke volume x A-wave velocity-squared.
results: Our sample comprised of 294 patients (18-95 
years of age; mean +/- SD 62 +/- 17.4; 58.8% female) 
who met criteria. LV ejection fraction (LVEF), be it on 
2D Echo or M-mode, was strongly associated with 
LA Passive emptying fraction (LAPEF) (p <0.0001). 
Among patients with reduced LVEF, measurements 
with 2D Echo showed that LAPEF was lower (0.149 
+/-0.10 vs. 0.197 +/-0.13, p = 0.023 in PLAX view and 
0.172 +/-0.12 vs. 0.232 +/-0.14, p = 0.013 in A4C view), 
whereas LAKE was higher (4.69 +/-4.2 vs. 4.17 +/-3.2, 
p = 0.362 in PLAX view and 6.48 +/-6.3 vs. 4.57 +/-3.5, 
p = 0.005 in A4C view). This was similarly reflected 
with M-Mode measurement among those with re-
duced LVEF, where LAPEF was lower (0.142 +/-0.09 
vs. 0.197 +/-0.13, p = 0.010 in PLAX view and 0.159 +/-
0.11 vs. 0.233 +/-0.14, p = 0.002 in A4C view), whereas 
LAKE was higher (4.59 +/-4.3 vs. 4.19 +/-3.2, p = 0.504 
in PLAX view and 6.81 +/-6.4 vs. 4.54 +/-3.5, p = 0.001 
in A4C view).
conclusion: Echocardiographic assessment of LA 
function appears correlated with LVEF and could be 
important when risk stratifying hospitalized patients. 
Further studies are needed to look into the clinical im-
plications of our study findings. Also, LA remodeling 
is more severe in patients with reduced LVEF as com-
pared to preserved LVEF. This may be of significant 
clinical relevance regarding the morbidity and mor-
tality of these two conditions.
CI69
Does Antibiotic-Loaded Bone Graft Used in  
Scoliosis Surgery Lead to Superbugs?
Patel, S.; Stadler, C.; Pourtaheri, S.; Shah, S.; Miller, F.; St. 
Joseph’s Medical Center, Seton Hall University
introduction: Antibiotic-loaded bone graft has de-
creased surgical site infections (SSIs) in pediatric 
scoliosis surgery; however, are decreased infection 
rates obtained at the expense of creating antibiotic 
resistance in the community? We reviewed cultured 
pathogens from SSI cases with and without antibi-
otic-loaded allograft and determined if there were 
antibiotic resistant pathogens seen in the antibiotic-
loaded group.
metHods: 851 consecutive pediatric scoliosis surger-
ies from 2006-2010 with antibiotics in bone graft (ABX) 
were compared to 620 cases from 1998-2004 without 
antibiotics in bone graft (Non-ABX).  In 2006, we ini-
tiated a protocol of placing antibiotics in bone graft. 
All patients received intra-operative IV antibiotics. 
Control cohorts included non-infected cases in the an-
tibiotic-loaded group (Control-ABX) and non-infected 
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cases without antibiotics in bone graft group (Control-
Non-ABX). Analysis completed using chi-squared 
statistic, Fisher’s exact, and single sample t-tests.
results: 24 ABX cases were compared to 30 Non-ABX 
cases.  The infection rate was significantly less in the 
ABX cohort (2.8% vs. 4.8%).  Patient demographics 
were similar in AIS (57% in Control-ABX vs. 54% in 
Control-Non-ABX) and cerebral palsy (25% in Control-
ABX vs. 27% in Control-Non-ABX).  The proportion of 
gram positive and negative infections was similar be-
tween the infected groups [gram positive: 58% (ABX) 
vs. 54% (Non-ABX); gram negative: 42% (ABX) vs. 46% 
(Non-ABX)].  MRSA infections were greater in the 
ABX group.  38% of the S. aureus infections in the ABX 
cohort were MRSA; however, none of S. aureus infec-
tions in Non-ABX were MRSA.
conclusion: Antibiotic-loaded bone graft was ef-
fective prophylaxis for infection in scoliosis surgery. 
However, increased occurrence of MRSA was seen 
with antibiotic-loaded bone graft.  The rise of MRSA 
infections could be attributable to the antibiotics used; 
or, it could be a result of the rise of MRSA in the com-
munity, since the earlier cases predate our protocol for 
placing antibiotics in the bone graft.
CI70
Safety Results from the United States Cohort of 
the Ibrutinib Early Access Treatment Protocol 
(EAP: MCL4001) in Patients with Relapsed or  
Refractory Mantle Cell Lymphoma
Peter, P.; Goy, A.; Ramchandren, R.; Ferrante, L.; Reddy, V.; 
Londhe, A.; Wildgust, M.; John Theurer Cancer Center at 
Hackensack University Medical Center
introduction: Ibrutinib is a first-in-class, once daily, 
oral covalent inhibitor of BTK approved in the US 
(November 2013) based on an international multi-
center Phase 2 study in patients with relapsed or 
refractory MCL, with an ORR of 68% (CR 21% and 
PR 47%) and median progression free survival of 
13.9 months (Wang et al. NEJM 2013). EAP conducted 
in a similar patient population to provide access to 
ibrutinib prior to market authorization and to collect 
additional safety data.
metHods: Open-label EAP in patients with relapsed or 
refractory MCL who resided in areas where ibrutinib 
unavailable and were ineligible for ongoing ibrutinib 
trials. Key entry criteria: age ≥18 years, relapsed or re-
fractory MCL, and no prior ibrutinib therapy. Patients 
received ibrutinib 560mg orally once daily in 28 day 
cycles until progressive disease, unacceptable toxicity, 
no further benefit or end of study (US approval). AE 
(Grade ≥ 3), SAE, and adverse events of interest (major 
hemorrhage, intracranial hemorrhage) were collected.
results: 149 patients participated in the EAP. Median 
age 68 years (range: 39-90 years) and 89% were white. 
Median treatment exposure 3.65 months (range: 0.0-7.7 
months) with approximately 26% of patients receiv-
ing treatment for more than 6 months. Of 149 patients, 
58.5% had refractory disease and 66.7% had received 
â‰¥3 prior lines of therapy. AE  grade â‰¥3 reported 
in 59 patients (39.6%) with most common neutropenia 
(6.7%), dyspnea (4%), anemia (3.4%) and thrombocyto-
penia (3.4%). SAE reported in 46 patients (30.9%). AE of 
interest reported in two patients (1.3%): 1 major hem-
orrhage (0.7%) and 1 intracranial hemorrhage (0.7%). 
10 patients (6.7%) discontinued treatment due to AE 
with primary reason of progressive disease in 20 pa-
tients (13.4%) and death in 12 patients (8.1%).
conclusion: The safety profile observed in this 
US cohort of the EAP was consistent with that ob-
served during the registration trial for MCL. No new 
safety signals were observed in this predominantly 
refractory population of patients. Moreover, this EAP 
provided an important mechanism for patients to re-
ceive ibrutinib prior to US approval.
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Revisiting Abdominal Aortic Aneurysms (AAA): 
Factors that Correlate with the Risks and Forma-
tion as well as Novel Treatment Techniques
Rhoden, B.; Caceres, A.; Hackensack University Medical 
Center
introduction: Annually, Abdominal Aortic 
Aneurysms (AAA) account for about 9000 deaths in 
the U.S. Unfortunately, this is due largely in part to 
the fact that early detection of an enlarged aorta is not 
common and therefore, a significant number of the 
cases generally seen in emergency departments (EDs) 
are fatal.  The objective of this research study includes 
thoroughly reviewing the literature regarding what is 
already known about AAA: from its development to 
its risks.
metHods: The researchers intend to systematically 
review between 50 and 100 peer-reviewed journal 
articles from the PubMed, Medline and EbscoHost 
Databases, highlighting treatment techniques and 
risk factors proven to assist in the treatment of AAA 
as well as present any novel techniques found to be 
efficient with the last 3-5 years.
results: The literature suggests that those patients 
diagnosed with atherosclerosis, those having mur-
murs in the femoral artery as well as those with a 
history of smoking and high cholesterol, experienced 
enlargement or rupture of the aorta. Also, having a 
first degree, or immediate, family member diagnosed 
with AAA also contributes as a risk. Genetic risk fac-
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tors include inherited connective tissue conditions. 
Fatalities and aortic ruptures were significantly less 
likely to be seen in diabetic patients. Past preventative 
methods included a diet rich in fruits and vitamin D. 
Advances in endovascular techniques enable most pa-
tients with abdominal aortic aneurysms to be treated 
with minimally invasive stent grafts. Novel treat-
ment methods include the use of doxycycline, which 
causes the inhibition of proteins that contribute to col-
lagen and elastin degradation within the aortic wall. 
Studies found that there is therapeutic potential in the 
use of prolyl hydroxylase domain (PHD) inhibitors to 
prevent the development of AAA. Maintaining low 
levels of superoxidative stress can be effective as the 
enzyme superoxidase dismutase plays a significant 
role in the pathogenesis of AAA.
conclusion: Our data suggests that those diagnosed 
with atherosclerosis, high cholesterol, femoral mur-
murs, and inherited conditions such as being closely 
related to someone diagnosed with AAA or being di-
agnosed with certain genetic syndromes are at greater 
risk for aortic enlargement and rupture.   The untime-
ly death of patients and diagnosis of AAA can be 
prevented with a diet rich in fruits and vitamin D, as 
well as maintaining low levels of superoxidase stress.
CI72
Does Bilevel Positive Airway Pressure  
Ventilation In Acute Asthma Exacerbation  
Prevent Mechanical Ventilation?
Sekhon, R.; Mathew, J.J.; Ghazarian, Z.; Khan, M.A.; 
St. Joseph’s Regional Medical Center / Seton Hall University
introduction: Non-invasive positive pressure venti-
lation (i.e. bilevel) has been used to treat respiratory 
conditions in patients presenting to the emergency 
department. Studies have demonstrated the use of 
bilevel pressure ventilation in treating obstructive 
respiratory diseases, in particular asthma. Bilevel has 
been shown to reduce the work of breathing and po-
tentially prevent the need for invasive ventilation.
As such, we reviewed the incidence of patients admit-
ted with acute asthma exacerbation who were placed 
on bilevel, but subsequently required invasive me-
chanical ventilation.
metHods: A retrospective study was conducted on 
patients admitted from 2008-2013 to St. Joseph’s 
Health Care System in New Jersey, with a diagnosis of 
asthma exacerbation. Charts of eligible patients were 
identified through billing codes, and further subdi-
vided based on mechanical ventilation.  All patients, 
irrespective of outcome, were at least given standard 
therapy of inhaled bronchodilators and systemic ste-
roids.  Patients’ initial vital signs upon presentation 
to the emergency department were noted, as well as 
initial arterial blood gas measurement.
results: In our study, 53 patients were identified as 
having asthma exacerbations and being placed on 
NIPPV (i.e. BPAP).  Of these patients, 6 (11.3%) pa-
tients subsequently required invasive mechanical 
ventilation.  In comparing the data, patients requiring 
subsequent intubation had a lower average pH (7.31 vs 
7.36, p=0.063, CI -0.01243 to 0.1039) and a higher aver-
age pCO2 (55 vs 44, p=0.0714, CI -17.933 to 2.663).
conclusion: The results of our study evidence the po-
tential utility of NIPPV, specifically bilevel, in asthma 
exacerbation.  From our experience, initiation of phar-
macotherapy is paramount in treating these patients. 
If therapy is not initiated in a timely fashion, NIPPV 
may provide a false sense of clinical improvement. 
Specifically, by decreasing the work of breathing, but 
not immediately addressing the underlying pathology, 
there is an increased chance of treatment failure and 
complications.  As such, placing patients on NIPPV re-
quires close monitoring.
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ST-Segment Elevation Myocardial Infarction in 
Octogenarians: 30-day Mortality and Peri- 
Procedural Complications Compared to Younger 
Adults
Shah, P; Mechineni, A; Yamini, S; Bajaj, S; Virk, H; DeBari, V.; 
Shamoon, F; Bikkina, M; St. Joseph’s Regional Medical Center; 
Seton Hall University
introduction: Few studies have compared outcomes 
of ST-segment elevation myocardial infarction (STEMI) 
in octogenarians versus younger adults undergoing 
primary percutaneous coronary intervention(PCI). 
The primary aim of our study was to determine dif-
ferences in 30-day mortality and door toballoon (D2B) 
times in these two groups in a tertiary care setting. 
Secondary aim was todetermine differences in length 
of stay (LOS) and peri-procedural complications 
among the two groups.
metHods: We studied a total of 658 STEMI patients 
who underwent PCI at our hospital between 2007-2013. 
Fifty-three patients were > or = 80 years old (group 1) 
and 605 were <80 years old (group2). Data were evalu-
ated for fit-to-normality. As all continuous data were 
not normally distributed, we used nonparametric 
methods throughout. Data were expressed as medi-
ans and interquartile ranges (IQR).
results: Thirty day mortality was significantly high-
er in group 1 as compared to group 2 (24.4% vs. 8.8%, p 
<0.01). D2B times < 90 minutes were achieved in both 
groups, however median D2B was slightly higher in 
group 1, 67 minutes (IQR of 46-98 minutes) vs. 57 min-
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utes (IQR of 41-72 minutes) in group 2, p=0.01. The 
total complication rate was higher in group 1, 26.4% 
vs. 6.8% in group 2 (p<0.0001), majority of them due 
to higher arrhythmias (5.6% in group 1 vs. 0.6% in 
group 2, p<0.01) and peri-procedural bleeding (5.6% 
in group 1 vs. 1.3% in group 2, p=0.049). We did not 
find a significant difference in the LOS between the 
two groups.
conclusion: Thirty-day mortality was higher in oc-
togenarians. Although D2B times < 90 minutes was 
achieved in octogenarians, it was slightly higher than 
younger adults. The peri-procedural complications, 
mainly arrhythmias and bleeding were significantly 
higher in octogenarians.
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Mature Results of a Phase 1-2 Open-Label, 
Dose-Escalation Study of Intravenous SNS01-T 
in Patients (pts) with Relapsed or Refractory  
B-Cell Malignancies
Siegel, D.S.; McDonald, A.; Novitzky, N.; Bensinger, W.; Craig, 
M.;  van Rhee, F.; Gutierrez, M.; John Theurer Cancer Center at 
Hackensack University Medical Center
introduction: Eukaryotic translation initiation factor 
5A (eIF5A) has been implicated in regulation of cell 
proliferation, apoptosis, and inflammation.  SNS01-T 
is a novel therapeutic with a dual mechanism of eIF5A 
modulation: inducing cell death via siRNA-mediated 
inhibition of hypusinated eIF5A while simultaneously 
causing over-expression of pro-apoptotic eIF5AK50R 
via a DNA plasmid with a B-cell promoter to induce 
tumor cell death, using a PEI vector. SNS01-T signifi-
cantly inhibits tumor growth and increases survival 
in mouse models of myeloma (MM), mantle cell and 
DLBCL.
metHods: This is an open label, phase 1-2 dose es-
calation study in pts with refractory B-cell cancers, 
comprising 4 SNS01-T dose cohorts: 0.0125, 0.05, 0.2 
and 0.375 mg/kg twice weekly IV for 6 weeks.  Key 
inclusion criteria are: MM per IMWG criteria or 
lymphomas or plasma cell leukemia with histologic 
confirmation; measurable disease, relapsed or re-
fractory after â‰¥2 prior regimens; not eligible for 
standard therapy known to extend life expectancy. 
Primary endpoints are safety and tolerability of 
SNS01-T.
results: All cohorts will have completed enroll-
ment in August 2014 and dosing in cohort 4 will be 
complete by September. A total of 21 pts have been 
treated, of whom 18 currently have data available. 
Demographics are provided in Table 1.
conclusion: SNS01-T administration was feasible in 
all 4 dose cohorts with prophylaxis for infusion reac-
tions. Early signs of potential efficacy are encouraging. 
Expansion of efficacy testing to more patients and 
combination studies are planned.
CI75
Updated Results from a Phase 2 Extension 
Study of Patients with Multiple Myeloma or 
Solid Tumors Previously Enrolled in Carfilzomib 
Company-Sponsored Phase 1 and 2 Clinical 
Trials (PX-171-010)
Siegel, D.S.; Berdeja, J.G.; Infante, J.R.; Kaufman, J.L.; Wang, 
M.L.; Martin III, T.G.; Niesvizky, R.; John Theurer Cancer Center 
at Hackensack University Medical Center
introduction: PX-171-010 (010; NCT00884312) is an ex-
tension study of patients who completed a phase 1 or 
2 carfilzomib study that aims to provide insights into 
the long-term tolerability, safety, and clinical benefit 
of carfilzomib.
metHods: Patients who completed a carfilzomib study 
were eligible to enroll and continue receiving carfilzo-
mib at the same dosing level, with dose adjustments 
permitted per protocol. Addition of other approved 
anticancer agents at the time of progression was al-
lowed. The primary end point was safety; efficacy was 
also evaluated.
results: Between 2009 and 2012, patients with mul-
tiple myeloma (MM; n=91) or solid tumors (ST; n=9) 
were enrolled in this extension study. Patients were 
enrolled from the PX-171-002, PX-171-003-A0, PX-171-
003-A1, PX-171-004, PX-171-005, PX-171-006, PX-171-007, 
and PX-171-008 studies (Table 1). Among patients 
with MM, 57.1% had prior bortezomib exposure and 
95.6% had prior immunomodulatory agent (IMiD) 
exposure; 37.4% were refractory to bortezomib, 61.5% 
were refractory to an IMiD, and 31.9% were refrac-
tory to both bortezomib and an IMiD. In the initial 
studies, patients received 15-70 mg/m2 carfilzomib. 
In 010, patients received a median dose of 27 mg/m2 
carfilzomib (range, 13-52 mg/m2). Median duration 
of carfilzomib treatment (initial study+010) was 88.9 
weeks (range, 4.4-273.4 weeks).
conclusion: The types and rates of AEs in 010 were 
similar to those previously reported with single-agent 
carfilzomib. Patients were able to receive carfilzomib 
for an average of 89 weeks (up to 273 weeks; medi-
an of 22.5 treatment cycles) and continued receiving 
clinical benefit, with no new significant safety signals 
noted from additional cumulative exposure.
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Updated Results from a Multicenter, Open-Label, 
Dose-Escalation Phase 1b/2 Study of Single-
Agent Oprozomib in Patients with Waldenstrom’s 
Macroglobulinemia (WM)
Siegel, D.S.; Kaufman, J.L.; Raje, N.S.; Mikhael, J.R.; Kapoor, 
P; Treno, S.P.; Castillo, J.J.; John Theurer Cancer Center at 
Hackensack University Medical Center
introduction: Oprozomib (OPZ) is an oral epoxyk-
etone proteasome inhibitor that has shown promising 
antitumor activity in patients (pts) with hematologic 
malignancies (HM), including WM (Kaufman, EHA 
2013, P223; Ghobrial, ASH 2013, 3184). Updated safety 
and efficacy results from the subset of pts with WM 
enrolled in this ongoing phase 1b/2 study in pts with 
HM are presented.
metHods: This open-label, multicenter, phase 1b/2 
study (NCT01416428) is enrolling adult pts with HM 
who have relapsed after receiving â‰¥1 line of ther-
apy. The primary objectives of the phase 1b portion 
of the study are to determine the maximum tolerated 
dose (MTD) and the safety and tolerability profile of 
OPZ. The primary objective of the phase 2 portion of 
the study is to determine the best overall response 
rate (ORR; â‰¥minimal response [MR]).
results: As of July 21, 2014, 106 pts with HM (includ-
ing 36 pts with WM) were enrolled and treated with 
the OPZ tablet. Enrollment and baseline demographic 
information for pts with WM are presented in Table 
1. For WM patients in the phase 1b portion, median 
treatment duration was 17.1 weeks (range, 3.1-51.4; 2/7 
schedule) and 51.7 weeks (range, 3.9-74.9; 5/14 sched-
ule); preliminary median treatment duration in the 
ongoing phase 2 portion was 8.1 weeks (range, 0.7-22.0). 
In all pts with HM, the MTD for the 2/7 schedule was 
300 mg/d and 240 mg/d for the 5/14 schedule. None of 
3 dose-limiting toxicities (DLTs) on the 2/7 schedule 
occurred in patients with WM.
conclusion: The MTD of OPZ was 300 mg/d in the 
2/7 schedule and 240 mg/d in the 5/14 schedule; these 
MTDs were determined from all pts with HM. In pts 
with WM who received single-agent OPZ, the most 
common grade 3 AEs were neutropenia and diarrhea; 
grade 4 AEs were infrequent. Additional measures 
will be taken to improve gastrointestinal tolerability. 
Single-agent OPZ continues to have promising antitu-
mor activity in pts with WM.
CI77
Subcutaneous (SQ) Bortezomib (BTZ) in Patients 
(Pts) with Relapsed Mantle Cell Lymphoma 
(MCL): Retrospective, Observational Study of 
Treatment Patterns and Outcomes in US  
Community Oncology Practices
Skarbnik, A.; Ma, E.; Goy, A.; Lafeuille, M.; Duh, M.; Bonthapally, 
V.; Dow, E.; John Theurer Cancer Center at Hackensack 
University Medical Center
introduction: The outcome of MCL has improved 
thanks to the use of dose-intensive strategies Â± 
ASCT and novel therapies in the relapsed/refrac-
tory setting. IV BTZ was the first agent approved by 
the FDA in relapsed/refractory MCL, in 2006, based 
on the phase 2 PINNACLE study (Fisher et al, J Clin 
Oncol 2006); overall response rate (ORR) was 32%, PFS 
was 6.5 mos, and OS was 23.5 mos. SQ BTZ was FDA 
approved in January 2012 based on the phase 3 MMY-
3021 trial, which showed non-inferior efficacy (ORR 
after 4 cycles) & an improved systemic safety profile 
with SQ vs IV BTZ in relapsed multiple myeloma 
(Moreau et al, Lancet Oncol 2011). In this retrospective, 
observational study we evaluated treatment patterns 
& outcomes with SQ BTZ in relapsed MCL pts in US 
community oncology practices.
metHods: Data on pts diagnosed with MCL aged 
â‰¥18 yrs who had received at least 1 prior line of 
therapy and who subsequently received 1 SQ BTZ 
dose between April 2006 and April 2014, either as a 
single agent or in combination, were extracted from 
the Altos Onco EMR oncology-specific electronic med-
ical records database and medical charts. Treatment 
patterns, including treatment regimens and exposure, 
and outcomes, including ORR, TTP, PFS, TTNT, OS, 
and AEs, were descriptively analyzed.
results: 53 relapsed MCL pts with 1 SQ BTZ dose. 
Among these 53 pts, median treatment duration was 
2.4 mos (median 4 21-day-equivalent cycles); 28 re-
ceived SQ BTZ as a single agent, and 25 received it 
in combination. Median time from MCL diagnosis 
was 2.1 yrs; pts had received a median of 2 lines of 
prior therapy (1 for pts receiving single-agent BTZ, 2 
for those receiving SQ BTZ in combination), includ-
ing 9% with prior transplant and 17% with prior IV 
BTZ treatment as induction; 40% of pts were refrac-
tory to their last prior therapy. ORR (CR+PR) was 22%, 
including 17% CR (1 CR in 7 evaluable pts with prior 
IV BTZ). Median observation period was 5.3 mos; at 
data cut-off, 45% of pts had progressed, 38% had start-
ed a new line of therapy, and 42% had died. Median 
PFS was 4.7 mos (IQR: 1.9-11.3); median OS was 11.3 
mos (IQR: 5.1-not reached [NR]). The most common 
AEs included 42% fatigue, 36% anemia, 25% nausea, 
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25% neutropenia, 21% thrombocytopenia, and 21% 
neuropathy; 9%/8%/4% reported local redness/rash/
tenderness. Grade 3 AEs included 1 pt (2%) each with 
CHF (pt with baseline arrhythmia), diarrhea, fatigue, 
neuropathy, rash, and vomiting.
conclusion:	 These findings indicate that SQ BTZ, 
alone or in combination, was active and generally well 
tolerated in relapsed MCL. In the context of findings 
from PINNACLE, these data appear consistent with 
the non-inferior efficacy and improved safety profile 
of SQ BTZ in MM, notably the low rate of neuropa-
thy (21%; 2% grade â‰¥3). As data mature, additional 
analyses will further evaluate treatment outcomes.
CI78
Carfilzomib, Lenalidomide, and Dexamethasone 
vs Lenalidomide and Dexamethasone in Patients 
(Pts) with Relapsed Multiple Myeloma: Interim 
Results from ASPIRE, a Randomized,  
Open-Label, Multicenter Phase 3 Study
Stewart, A.K.; Rajkumar, S.V.; Dimopoulos, M.A.; Masszi, T.; 
Spicka, I; Oriol, A; Siegel, D.S.; John Theurer Cancer Center at 
Hackensack University Medical Center
introduction: Lenalidomide with dexamethasone 
(Rd) is a standard of care used for pts with relapsed 
multiple myeloma (RMM). The randomized, open-la-
bel, multicenter, phase 3 study ASPIRE (NCT01080391) 
is comparing carfilzomib, lenalidomide, and dexa-
methasone (KRd) to Rd in pts with RMM. The primary 
end point is progression-free survival (PFS; assessed 
by an independent review committee). Secondary end 
points include overall survival (OS), overall response 
rate (ORR), duration of response (DOR), health-related 
quality of life (EORTC QLQ-C30 Global Health Status/
QoL), and safety.
metHods: Adults with RMM who received 1-3 prior 
regimens were eligible. Pts were randomized (1:1) 
to receive KRd or Rd and were stratified by Î_2-
microglobulin levels (<2.5 vs â‰¥2.5 mg/L), prior 
bortezomib (no vs yes), and prior R (no vs yes). All 
pts received lenalidomide (25 mg) on days 1-21 and 
dexamethasone (40 mg) on days 1, 8, 15, and 22 of a 
28-day cycle.
results: Data are presented for KRd followed by 
Rd throughout the abstract. Between July 2010 and 
March 2012, 792 pts from 20 countries were random-
ized. Baseline characteristics were balanced between 
the 2 groups. Median age was 64.0 years (range: 
31.0â€’91.0). Pts received a median of 2 prior regimens 
in each group. In both the KRd and Rd groups, 66% of 
pts received prior bortezomib; 20% of pts in each arm 
received prior R. Median treatment exposure was 22 
cycles (KRd) and 14 cycles (Rd).
conclusion: The addition of carfilzomib to lenalido-
mide and dexamethasone in pts with RMM resulted 
in a statistically significant and clinically meaningful 
improvement in PFS. KRd had an acceptable safety 
and tolerability profile and represents a potential new 
standard of care.
CI79
Smartphones and Sleep-Time Related 
Information and Communication Technology 
(STRICT): Impact on Sleep Patterns, Insomnia 
and Daytime Functioning in American 
Adolescents
Upadhyay, H.; Polos, P.; Bhat, S.; Gupta, D.; Chokroverty, S.; 
DeBari, V.; O’Melly, R.; JFK Hospital Medical Center and Edison 
Public School
introduction: Unrestricted usage of information and 
communication technology (ICT) and smartphone 
usage around bedtime has proven effect on sleep pat-
terns and daytime functioning and overall well-being. 
Several large European and Asian studies have con-
firmed the adverse impact of unrestricted Sleep-Time 
Related ICT (STRICT) use on sleep quality and quan-
tity, daytime sleepiness, insomnia and chronotype. 
However, to our knowledge, there have been no stud-
ies concentrating on STRICT conducted on a similar 
scale in the United States. We therefore performed 
this cross-sectional study in Edison Public School 
to evaluate the impact of smartphone-based STRICT 
use on sleep-related parameters and academic perfor-
mance among the general population of students in a 
New Jersey.
metHods: Data was collected via a confidential online 
survey. We analyzed 3139 completed questionnaires 
(2123 middle school and 1016 high school students, 
mean age 13.3 years, 49.3% female). Insomnia was 
evaluated by the Minimal Insomnia Severity Scale 
(MISS), daytime sleepiness by the Pediatric Daytime 
Sleepiness Scale (PDSS) and chronotype by the 
Children’s Morningness-Eveningness Preferences 
Scale (CMEPS).  Information about sleep habits, aca-
demic performance, and amount of STRICT use were 
obtained.  For statistical analysis of correlations, we 
used the Pearson product moment correlation (r) 
method when data were continuous and Spearman’s 
rank-correlation method when either variable was 
ordinal.
results: STRICT use was highly prevalent, with 
55.3% of respondents spending more than an hour 
on STRICT each night just before bedtime and 32.1% 
indulging in STRICT use after bedtime. Texts, tweets 
and instant messages were sent and received nightly 
in bed by 56.7% of adolescents, causing awakenings 
from sleep in 20.8%. Mean scores for MISS, PDSS and 
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CEMP were 4.4 (SD 2.4), 16.0 (SD 6.1) and 24.8 (SD 5.5) 
respectively. STRICT use (both before and after bed-
time) correlated positively with age (r=0.277, p<0.0001), 
MISS score (r=0.252, p<0.0001) and PDSS score (r=0.34, 
p<0.0001), and negatively with CMEPS score (signi-
fying eveningness, r=-0.372, p<0.0001), self-reported 
academic grades (rs =-0.297, p<0.0001) and hours of 
sleep on school nights (rs=-0.322, p p<0.0001).
conclusion: STRICT use increases with age, and 
is significantly associated with insomnia, daytime 
sleepiness, eveningness, decreased hours of sleep and 
poor academic performance in American adolescents. 
It is important for parents, educators, clinicians and 
students to be aware of the adverse effects of unregu-
lated STRICT use and to monitor its usage.
CI80
Management of Safety Following Lenalidomide 
in Patients With Relapsed/Refractory Mantle 
Cell Lymphoma
Valentinetti, M.; Kdiry, S.; Rice, C.K.; Yannotti, K.M.L.; John 
Theurer Cancer Center at Hackensack University Medical 
Center
introduction: Experience with the phase II MCL-001 
study of 134 patients with relapsed/refractory MCL 
who received lenalidomide following multiple prior 
treatments including bortezomib.
metHods: Mantle cell lymphoma (MCL) accounts for 
<10% of all non-Hodgkin lymphomas, with an aggres-
sive disease course consisting of multiple relapses 
after initial therapy. In the relapsed/refractory set-
ting, patients often encounter progressively shorter 
durations of response and become chemoresistant. 
Lenalidomide is an oral immunomodulatory agent 
showing durable activity and a consistent safety pro-
file in multiple phase II studies in relapsed/refractory 
MCL. A majority of adverse events (AEs) experienced 
with lenalidomide are related to myelosuppression, 
therefore it is important to clearly understand how 
best to monitor and manage expected myelosuppres-
sion, as well as less frequent, lower-grade AEs.
results: Patients receiving lenalidomide showed an 
overall response rate of 28% and median duration of 
response of 16.6 months. Most grade 3/4 toxicity con-
sisted of myelosuppression, whereas it was essential 
to also manage lower-grade AEs such as fatigue, di-
arrhea, nausea, cough, pyrexia, and rash. An integral 
part of nursing is developing an open relationship 
with patients so they feel comfortable sharing symp-
toms. To establish this relationship it is important 
to clearly explain possible side effects while giving 
examples of how manageable most side effects are 
with early discovery, and assuring patients they may 
continue therapy even if AEs occur. While MCL-001 
provided experience with single-agent lenalidomide, 
combination therapies are also being employed in 
relapsed/refractory MCL, which require additional 
clinic visits to allow the team to assess toxicities, drug 
compliance and symptom management.
conclusion: It is essential to establish open lines of 
communication and educate patients so that symp-
toms may be effectively managed while minimizing 
under-reporting of potentially dangerous side effects. 
Through our safety and risk management strategies, 
we have found that we are able to effectively treat 
patients while simultaneously building trusting re-
lationships and ensuring comprehensive care.  We 
educate patients that it is better to over-report symp-
toms than under-report in order to intervene early if 
possible - this leads to effective symptom manage-
ment, better treatment outcomes, and improved 
quality of life.
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Clinical Profile of Single-Agent Oprozomib in  
Patients (Pts) with Multiple Myeloma (MM):  
Updated Results from a Multicenter, Open-Label, 
Dose Escalation Phase 1b/2 Study
Vij, R.; Savona, M.; Siegel, D.S.; Kaufman, J.L.; Badros, 
A.; Ghobrial, I.; Paner, A.; John Theurer Cancer Center at 
Hackensack University Medical Center
introduction: Oprozomib (OPZ) is an oral epoxyk-
etone proteasome inhibitor that selectively and 
irreversibly binds to its target. Preliminary findings of 
OPZ in pts with hematologic malignancies (HM) have 
been reported previously (Savona, ASH 2012, 203; 
Kaufman, EHA 2013, P223; Ghobrial, ASH 2013, 3184). 
Updated safety and efficacy results from the subset 
of pts with MM enrolled in this ongoing phase 1b/2 
study in pts with HM are presented.
metHods: Open-label, phase 1b/2 study (NCT01416428) 
enrolling adult patients with HM who have relapsed 
after receiving â‰¥1 line of therapy. Phase 1b: OPZ 
administered once daily on days 1, 2, 8, and 9 of 14-
day cycle (2/7 schedule) or on days 1-5 of 14-day cycle 
(5/14 schedule). Starting dose was 150 mg/day (mg/d); 
doses escalated in 30-mg increments up to 330 mg/d. 
Phase 2 patients receive OPZ (240 mg/d) on 5/14 
schedule (initial phase 2 schedule opened to enroll-
ment). For this report, all enrolled patients with HM 
are included in description of MTD while only the 
subset of patients with WM is included in safety and 
efficacy results.
results: As of July 21, 2014, 106 pts with HM (includ-
ing 68 pts with MM) were enrolled and treated with 
the OPZ tablet. Enrollment and baseline demographic 
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information for pts with MM are presented in Table 1. 
Median treatment duration (phase 1b) was 21.3 weeks 
(range, 0.3-62.1; 2/7 schedule) and 10.1 weeks (range, 
0.3-81.1; 5/14 schedule); preliminary median treat-
ment duration in the ongoing phase 2 portion was 5.4 
weeks (range, 0.7-26.7). In all pts with HM, the MTD 
for the 2/7 schedule was 300 mg/d and 240 mg/d for 
the 5/14 schedule.
conclusion: MTD of OPZ was 300 mg/d in the 2/7 
schedule and 240 mg/d in the 5/14 schedule; these 
MTDs were determined from all patients with HM. 
Most common grade 3 AEs were diarrhea, nausea, 
and vomiting; grade 4 AEs were infrequent. Single-
agent OPZ continues to have promising antitumor 
activity. Enrollment of pts with MM is continuing in 
phase 2 in both treatment schedules. Extended-release 
OPZ tablets will be introduced and assessed for safety, 
activity, and pharmacokinetics.
CI82
Ibrutinib, Single Agent or in Combination with 
Dexamethasone, in Patients with Relapsed or 
Relapsed/Refractory Multiple Myeloma (MM): 
Preliminary Phase 2 Results
Vij, R.; Huff, C.; Bensinger, W.; Siegel, D.S.; Jagannath, S.; 
Berdeja, J.; Lendvai, N.; John Theurer Cancer Center at 
Hackensack University Medical Center
introduction: Ibrutinib is a first-in-class, once-daily, 
oral, covalent inhibitor of BTK, an essential enzyme in 
the B-cell receptor signaling pathway. Expression of 
BTK in malignant plasma cells is increased 4-fold and 
comparable to BTK expression levels in CLL and MCL. 
Pre-clinical models show that BTK inhibition with 
ibrutinib led to direct inhibition of both osteoclast 
bone resorption and the release of osteoclast-derived 
tumor growth factors (Tai et al, Blood 2012).
metHods: Open label phase 2 dose escalation study 
designed for patients in 4 cohorts to evaluate effica-
cy (â‰¥MR) and secondary endpoints of safety, PK, 
ORR and DOR. Patients must have documented non-
responsive/progressive disease at time of study entry 
following at least 2 prior lines of therapy including 
at least one immunomodulatory agent.  Efficacy and 
safety assessed at 4 weeks intervals using IMWG re-
sponse criteria for efficacy assessments (Rajkumar et 
al, Blood 2011) while safety was assessed according to 
CTCAE v4.0 criteria.
results: Anti-tumor activity noted across all cohorts. 
Highest activity with CBR of 25% including 1 PR, 4 
MR and 5 sustained (>4 cycles) SD observed in Cohort 
4. Cohorts 1 and 3: 14 patients had dex added follow-
ing PD, resulting in 1 PR and 9 SD. 57% experienced 
Grade 3 or higher AE.  Non-hematologic toxicities: 
diarrhea (51%), fatigue (41%), nausea (35%), dizziness 
(25%), muscle spasms (23%).  Majority Grade 1 and 2. 
Myelosuppression reported overall incidence of any 
grade anemia (29%), thrombocytopenia (23%), and 
neutropenia (7%) with 16%, 9% and 4% being Grade 
3, respectively.  No clinically meaningful differences 
among dose levels. 23 patients experienced a SAE for 
a total of 47 reported events with 16 assessed as pos-
sibly/definitely related to ibrutinib.
conclusion: In this heavily pre-treated patient popu-
lation ibrutinib, as a single agent and in combination 
with dex, demonstrated evidence of anti-tumor ac-
tivity.  Trend toward improved efficacy (â‰¥MR) in 
Cohort 4. Treatment was well tolerated with man-
ageable toxicities.  Correlative studies are ongoing 
to determine changes in cytokines, chemokines and 
indices of bone metabolism and the effect of dex, a 
known CYP3A4/5 inducer, on pharmacokinetic 
profile of ibrutinib. Ibrutinib is currently being evalu-
ated in combination with carfilzomib in an ongoing 
Phase1/2b study. (NCT01962792)”
CI83
Efficacy and Safety of Single-Agent Ibrutinib  
in Patients with Mantle Cell Lymphoma Who  
Progressed after Bortezomib Therapy
Wang, M.; Goy, A.; Martin, P.; Ramchandren, R.; Alexeeva, J.; 
Popat, R.; Avivi, I.; John Theurer Cancer Center at Hackensack 
University Medical Center
introduction: Ibrutinib, a first-in-class, once-daily, 
oral covalent inhibitor of BTK, demonstrated durable 
single-agent efficacy in previous phase 2 study of pa-
tients with MCL who received 1 to 5 prior therapies 
(Wang M, et al. N Engl J Med. 2013;369:507-516). In that 
study, investigator-assessed overall response rate was 
68% (complete response rate, 21%). This study reports 
on efficacy and safety of single-agent ibrutinib in pa-
tients with MCL who received a rituximab-containing 
regimen and progressed after at least 2 cycles of bort-
ezomib therapy.
metHods: In this phase 2, multicenter, single-arm 
study, patients received 560 mg/day oral ibrutinib 
continuously until progressive disease or unaccept-
able toxicity. The primary end point was the overall 
response rate (ORR) in response evaluable patients, as 
assessed by an Independent Review Committee (IRC). 
Secondary end points, also assessed by IRC, included 
duration of response (DoR), progression-free survival 
(PFS), overall survival (OS), and safety.
results: At the time of clinical cut-off for the primary 
analysis (29 April, 2014), median follow-up was 14.9 
months with median treatment duration of 8 months 
(range: 0.5-20.9 months). Main reasons for treatment 
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discontinuation: disease progression in 53 patients 
(44.2%) and an AE in 8 patients (6.7%). The ORR for re-
sponse evaluable patients was 62.7% (95% confidence 
interval [CI]: 53.7%-71.8%) with a complete response 
rate of 20.9%. Subgroup analysis suggested that the 
ORR was independent of age, gender, geographic 
region, number of prior lines of therapies, baseline ex-
tranodal disease, simplified MIPI score, bulky disease, 
and stage of MCL.
conclusion: Single agent ibrutinib is highly effica-
cious and well tolerated, with an acceptable toxicity 
profile in patients with MCL who progressed after 
rituximab-containing chemotherapy and bortezomib 
therapy. These results are consistent with previous 
ibrutinib studies, with no new safety signals.
CI84
Single-Agent Ibrutinib Demonstrates Safety and 
Durability of Response at 2 Years Follow-up in 
Patients with Relapsed or Refractory Mantle Cell 
Lymphoma: Updated Results of an International, 
Multicenter, Open-Label Phase 2 Study
Wang, M.; Rule, S.; Martin, P.; Goy, A.; Auer, R.; Kahl, B.S.; 
Jurczak, W.; John Theurer Cancer Center at Hackensack 
University Medical Center
introduction: Bruton’s tyrosine kinase (BTK) is a crit-
ical signaling molecule in the B-cell receptor signaling 
pathway essential for B-cell development, survival, 
and function. Ibrutinib is a first-in-class, once-daily, 
oral covalent inhibitor of BTK approved for the treat-
ment of patients with MCL who have received at least 
1 prior therapy. Previous results of the international, 
multicenter, open-label phase 2 trial demonstrated the 
durability of responses and favorable safety profile 
of daily oral ibrutinib in relapsed or refractory MCL 
(Wang et al, NEJM 2013). Here, we present the updat-
ed safety and efficacy results of this phase 2 trial with 
a median follow-up of approximately 27 months.
metHods: 115 relapsed or refractory MCL patients 
were enrolled, and 111 patients were treated. All pa-
tients provided informed consent. Patients received 
oral ibrutinib 560 mg once daily until disease progres-
sion or unacceptable toxicity. Patients were eligible to 
continue therapy into a long-term extension study if 
they had stable disease or better. Tumor response was 
assessed by investigators using the 2007 revised IWG 
criteria. Adverse events (AEs) were characterized by 
preferred terms using MedDRA version 16.1 and were 
evaluated over 6-month time intervals (1-6, 7-12, 13-18, 
19-24, >24 months). Prevalence was based on the num-
ber of patients with an AE occurring during a given 
interval (either a new episode or an ongoing episode 
from the prior 6-month period continuing into the 
current interval).
results: Most common treatment-emergent AEs (re-
ported in >30% patients) included infection (78% all 
grade, 28% grade â‰¥3), diarrhea (54% all grade, 5% 
grade â‰¥3), bleeding (50.5% all grade, 6% grade 
â‰¥3), fatigue (49.5% all grade, 4.5% grade â‰¥3), 
nausea (33% all grade, 1% grade â‰¥3), and dyspnea 
(32% all grade, 4.5% grade â‰¥3). In total, grade 
â‰¥3 AEs occurred in 81% of patients and serious 
AEs (SAEs) of any grade in 63%. Treatment discon-
tinuation due to AEs was reported in 11% of patients. 
prevalence rates for infection, diarrhea, and bleeding 
events were highest for the first 6 months and gradu-
ally declined thereafter.
conclusion: Results with a median 27-month fol-
low-up demonstrate the durability of responses and 
sustained single-agent activity of continuous ibru-
tinib in relapsed or refractory MCL. Approximately 
one-third of patients remain progression free at 24 
months. Ibrutinib continues to show a favorable 
risk-benefit profile over time, with a safety profile con-
sistent with that reported previously; these data with 
additional follow-up time did not reveal an increase 
in unforeseen AEs.
CI85
Symptom and Treatment Characteristics of 
Juvenile Primary Fibromyalgia Syndrome: Are 
Males and Females Created Equal?
Weiss, J.W.; Schikler, K.N.; Boneparth, A.; Hoffart, C.; Connelly, 
M.A.; Hackensack University Medical Center, UMDNJ
introduction: Children and adolescents with 
persistent widespread musculoskeletal pain fre-
quently present to pediatric rheumatologists for 
evaluation.  Limited data are available on the char-
acteristics and treatments used for these patients, 
particularly for males.  Using the Childhood Arthritis 
and Rheumatology Research Alliance (CARRA) reg-
istry, we sought to evaluate the overall demographic, 
symptom, and treatment characteristics of patients 
diagnosed with juvenile primary fibromyalgia syn-
drome (JPFS) and to compare these characteristics as 
a function of gender.
metHods: Deidentified data on demographics, 
symptoms, functional measures and treatment char-
acteristics were extracted from the baseline visits of 
JPFS patients in the CARRA registry between May 
2010 and May 2014.
results: There were 172 patients (27 males), ages 8-21 
years (M = 15.4 +/- 2.3) included. Patients reported ex-
periencing symptoms for a mean of 1.7 +/- 2.2 years 
prior to their first visit to a pediatric rheumatologist, 
with no significant difference between males and 
females (M = 2.2 versus 1.6 respectively, t(169)=1.18, 
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p=.24). The most commonly reported symptoms 
included widespread pain (89%), fatigue (83%), dis-
ordered sleep (77%), headaches (61%), and extremity 
numbness/tingling (32%). Females were more likely 
to report numbness and tingling (35% versus 13% 
respectively, Ï‡2 = 4.41, p = 0.04).  Table 1 lists treat-
ments used and recommended as a function of gender. 
Males were significantly more likely to have used ga-
bapentin (26% versus 8%, Ï‡2 = 7.58, p <0.01).  Of the 
63 patients reporting non-pharmacologic treatment 
for chronic pain, the most commonly used treatment 
was physical therapy (60%), with females significantly 
more likely to have used massage and yoga (Table 1). 
Less then 10% of patients tried opioids, serotonin nor-
epinephrine reuptake inhibitors, craniosacral therapy, 
hypnosis, and biofeedback.
conclusion:	Based on data from the largest known 
cohort of JPFS patients, there appear to be few sig-
nificant gender differences in disease characteristics 
and treatment.  However, higher levels of disability 
are reported by male patients despite no comparable 
differences observed on physician severity measures, 
suggesting the need to consider gender on evaluation 
and treatment of JPFS.
CI86
Incidence Of Early Left Ventricular Thrombus 
Formation After ST-Segment Elevation  
Myocardial Infarction In Primary Percutaneous  
Coronary Intervention Era: A Single-Center 
Experience
Yamini, S.; Mechineni, A.; Shah, P.; Bajaj, S.; Virk, H.; Shamoon, 
F.; Bikkina, M.; St Joseph`s Regional Medical Center
introduction: Although the incidence of LVT has 
decreased in patients undergoing primary PCI when 
compared to thrombolytic era, its incidence still re-
mains 2.5 - 15% of STEMI and 23.5% in AWMI. Hence 
we aim to primarily estimate the incidence of LVT in 
STEMI patients undergoing primary PCI in a tertiary 
care setting and secondarily to detect differences in 
left ventricular ejection fraction (LVEF) and symptom 
onset to balloon times in patients who had LVT versus 
those who did not.
metHods: We studied 543 STEMI patients undergoing 
primary PCI from 2007-2013 at a tertiary care hospi-
tal. Presence of LVT was determined by transthoracic 
echocardiogram (TTE), which was done prior to dis-
charge in all the patients. LVEF was also estimated by 
TTE. Since the data were not normally distributed, we 
used non parametric methods for analyses.
results: Out of 543 patients, 391 (72.01%) were males 
and 152 (27.99%) females. The mean age was 60.1 years. 
211 out of 543 (38.8%) had AWMI. 6 patients (all with 
AWMI) out of total (1.1%) had LVT on TTE. Incidence 
of LVT in AWMI was 2.84%. Median LVEF was signifi-
cantly lower in patients with LVT [37.5% (interquartile 
range (IQR), 22.5-46.25%] vs those without LVT [50% 
(IQR, 40-57.5%)], p =0.034. The median symptom on-
set to balloon time was not significantly different 
in patients with LVT [347 minutes, IQR (102.5-15180 
minutes)] vs those without LVT [155 minutes, IQR 
(106-8705 minutes)], p =0.245. LVT developed with-
in 24 hours in 5 patients (83.3%). 1 of 6 LVT patients 
(16.7%) had embolic stroke and died.
conclusion: The incidence of LVT has significantly 
decreased in STEMI patients undergoing primary 
PCI. Our study showed lower incidence of LVT com-
pared to other studies in PCI era. In our study, all 
the LVT patients had AWMI. Median LVEF was sig-
nificantly lower in patients with LVT vs those without 
it.  Although higher in patients with LVT, median 
symptom onset to balloon time was not significantly 
different in patients with or without LVT. Mortality 
from embolic complications is high in LVT patients.
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CV01
Subcutaneous Emphysema and Hypercarbia  
Following Laparascopic Hysterectomy
Aboeed, A.; Mathew, J.J.; Ghazarian, Z.; Sekhon, R.; Khan, 
M.A.; St. Joseph’s Regional Medical Center
introduction: Laparoscopic surgery is being 
performed increasingly to treat intraperitoneal ab-
normalities. To perform laparoscopic intra-abdominal 
procedures, gas must be insufflated under pressure 
into the peritoneal cavity to establish a pneumoperi-
toneum to allow for visualization of intra-abdominal 
contents. Carbon dioxide (CO2) is the most widely 
used gas for insufflation.
cAse	rePort: 48 year old Hispanic female with medi-
cal history significant for large subserosal fibroid, 
and anemia and past surgical history of laparoscopic 
cholecystectomy. She was evaluated as outpatient for 
chronic pelvic pain and dysfunctional uterine bleed-
ing then electively admitted for total laparoscopic 
hysterectomy. After induction for general anesthe-
sia a 5 mm incision was made. A blunt-tipped trocar 
was inserted into the peritoneal cavity under direct 
visualization and without difficulty. The abdomen 
was insufflated with CO2 to a maximum pressure of 
10mm Hg. Then the end-tidal CO2 (ETCO2) acutely 
increased from 39mm Hg to a peak of 90mm Hg over 
20 min. The total hysterectomy and bilateral salpin-
gectomy were performed by exploratory laparotomy 
after deflation. At the end of the procedure the ETCO2 
returned to normal with Arterial blood gas analyses 
demonstrated the following: pH, 7.39; Pao2, 178mm 
Hg; Paco2, 44 mm Hg; HCO3, 26 mEq/L; and oxygen 
saturation, 99%. Postoperatively marked subcutane-
ous emphysema was apparent on examination and 
chest radiograph. The patient was in hemodynami-
cally stable condition but was kept on mechanical 
ventilation support in the surgical intensive care unit. 
There was no pneumothorax present, and peak air-
way pressure remained low. Over the next 8 hours, 
the subcutaneous emphysema disappeared and the 
patient was weaned off the ventilator appropriately.
discussion: Laparoscopic techniques are not free of 
complications. Hypercarbia has been observed during 
laparoscopy with CO2 insufflation. The systemic ab-
sorption of CO2 from the peritoneal cavity can cause 
hemodynamic decompensation and cardiovascular 
compromise from hypercarbia and resulting acido-
sis.  Continuous ETCO2 monitoring can help prevent 
subcutaneous emphysema and hypercapnia during 
laparoscopic procedures.
CV02
Hydroxychloroquine Induced Torsades  
Precipitates a Unique Combination of Myocardial 
Infarction and Takotsubo
Abualayem, M.; Alattar, F.; Khalili, W.; Alkhateeb, A.; Saint 
Michael’s Medical Center; Seton Hall University
introduction: Hydoxychloroquine is a known 
antimalarial agent that is used in treatment of rheu-
matologic diseases. It has a long half-life of about one 
month to a month and half. For Rheumatic diseases it 
May require 4-6 weeks to respond. It is Rapidly and 
completely absorbed from the gut, Binds to protein 
55%. About 30% metabolized by the liver and about 
half of the dose is excreted unchanged in the urine. It 
is a medication that is well known of causing cardiac 
toxicity from QT prolongation to cardiomyopathy, tor-
sade arrhythmia and cardiac arrest.
cAse	rePort: We are reporting a case of 60 year-old 
woman with end stage renal disease on hemodialysis, 
who was on chronic treatment with hydroxychlo-
roquine for about 2 years for SLE. The patient was 
pulseless at the nursing home for about 5 minutes 
of CPR. Then she came back with full conscious-
ness. Was brought to the ER and found to have a QT 
interval of 650ms but without any ischemic changes 
or positive cardiac biomarkers. She had an old EKG 
that was done 2 years before and showed normal QT 
at that time. The patient was admitted to the CCU and 
after 6 hours she developed Torsades and arrested 
she was coded for about 5 minutes again and shocked 
once. She was intubated at that time. Her blood work 
showed hypermagnesemia, and normal K and Na. 
The patient was taken to the Catheterization lab this 
time to rule out ischemic causes of the ventricular 
arrhythmia. In the Cardiac Cath Report a There was 
a thrombus in the mid RCA causing 99% stenosis 
thrombectomy was done with successful stent with 
DES and 0% residual stenosis in the RCA. The LAD 
had mild disease of about 60%. The LV systolic EF was 
30% and the blood pressure was around 90mmhg sys-
tolic so balloon pump was placed. The patient Blood 
pressure dropped at night and started on vasopres-
sors, she was also on Lidocaine drip and she did not 
go again into torsade but she continued to have the 
QT prolongation and developed second-degree heart 
block.  The echocardiography showed that there was 
ballooning of the LV consistent with Takotsubo and 
an LV ejection fraction of 30%.  The patient stayed 
in the CCU the balloon pump was removed on day 
Clinical Vignettes
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7, and the patient did well of vasopressors and un-
derwent several weaning attempts. Meanwhile we 
repeated the echocardiography one week after the 
first one and it showed that the LV ventricular bal-
looning disappeared and the left ventricular ejection 
fraction is back to normal of 60-65% consistent with 
the Takotsubo reversibility. She continued to fail the 
weaning attempts, and continued to have the pro-
longed QT, which dropped to 500ms. On day fifteen of 
admission the patient coded again with PEA for half 
an hour and unfortunately passed away.
discussion: In this we presented a case of refractory 
torsades secondary to severely prolonged QT result-
ing from chronic accumulation of HCQ in a patient 
with normal base line QT who has been on HCQ for 2 
years. She has ESRD with resulted in impaired excre-
tion of the HCQ and increased toxicity. she developed 
cardiac arrest resulting in a clot in the RCA. she also 
had a takotusbo that completely revesed on one week 
follow up.
CV03
Duodenal Perforation and Biliary Peritonitis  
Secondary To Biliary Stent Migration
Adib, S.; Delatorre, A.; Grossman, M.A; Saint Joseph’s Regional 
Medical Center
introduction: Biliary stents can be placed to estab-
lish patency of an obstructed bile or pancreatic duct, 
treat biliary/pancreatic leaks. Alimentary track per-
foration is a serious but infrequent complication of 
biliary stent migration with no reported incidence 
rate in the literature. 
cAse	rePort: A 73 year old asymptomatic female un-
derwent routine labs with evidence of elevated liver 
function tests. She underwent Magnetic resonance 
imaging MRI of the abdomen that showed common 
bile duct CBD dilation to 19 mm, a rounded filling de-
fect in the distal CBD measuring 12 mm, representing 
a stone versus a mass. An endoscopic ultrasound EUS 
followed by ERCP were performed.  The endoscopic 
studies revealed a fungating mass at the ampulla 
suspicious for an adenoma or adenocarcinoma of the 
ampulla of vater. Cholangiogram did not demonstrate 
intraductal filling defects. Bile flow was not present 
in the duodenal lumen. As histology would be nec-
essary to determine the course of treatment, a biopsy 
was obtained, two plastic stents were then placed in 
the CBD, a 10fr X 7cm plastic stent followed by a 7fr 
X 9cm plastic stent. The patient was discharged post 
procedure without pain or abdominal tenderness on 
post-procedure physical examination. After 4 days the 
patient came back to the emergency department with 
diffuse abdominal pain, and the abdomen was found 
to be rigid with diffuse tenderness. Rebound tender-
ness and guarding were present. A CT scan revealed 
that the inferior margin of one of the stents appeared 
to be extra luminal suggesting perforation of the sec-
ond or third portion of the duodenum. A laparotomy 
was performed and showed an anterior perforation 
of the third part of the duodenum caused by the 7fr 
stent that was draining bile into the peritoneal cavity, 
the stents were removed. Closure of the perforation 
was performed. Histology results from the endoscopy 
four days prior were now available. The ampullary 
lesion was a tubulovillous adenoma TVA without 
dysplasia. The lesion was found to involve the distal 
CBD and Pancreatic duct PD. Therefore a deeper re-
section was performed necessitating reconstruction 
of the CBD and PD with primary anastomosis over a 
newly placed CBD and PD stents to prevent strictures. 
Following this surgery, the patient recovered well and 
was discharged home after 6 days. Surgical pathology 
revealed a tubullovillous adenoma without dysplasia, 
after 4 weeks an ERCP was performed and the stents 
were removed the CBD and the PD were non-dilated 
nor were strictures present.
discussion: This case illustrates that the smaller di-
ameter 7fr stent migrated distally from the CBD into 
the duodenal lumen. The larger diameter stent 10fr 
remained in the bile duct, suggesting that the smaller 
diameter stents may be more prone for migration. In 
theory smaller diameter stents will apply pressure 
on a smaller surface area of the intestinal wall, fa-
cilitating erosion and perforation. Therefore this case 
advocates for placement of larger diameter stents to 
prevent migration and perforation.
CV04
A Case of Painless Leg with Moving Toes 
Syndrome
Ahmad, M.; Imayama, I.; Upadhyay, H.; Bhat, S.; Gupta, D.; 
Hanna, P.; Chokoverty., S.; Sleep Medicine, JFK Medical Center
introduction: Painless legs and moving toes syn-
drome is a variant of painful legs and moving toes. 
It is extremely rare and its pathophysiology is yet to 
be identified. Studies have hypothesized that both 
peripheral and central nervous system are involved 
in development of this syndrome. A review of 76 
cases of painful leg and moving toes syndrome has 
discussed that pain and movement of this disorder 
are not necessarily correlated and that high preva-
lence of autoimmune disorder among patients with 
this syndrome could indicate possible autoimmune 
processes in this disorder. Given the low incidence of 
this condition, more information is needed to increase 
our understanding of this disease. We report a case of 
painless legs and moving toes syndrome.
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cAse	 rePort: A 61 year-old woman with a past 
medical history of hypothyroidism, hyperlipidemia, 
history of aneurysm at left posterior inferior cer-
ebellar artery (PICA) status post clipping, and left 
femur fracture  presented to clinic with complaints 
of involuntary toe movements. About 4 years ago, 
she noticed vertigo and was diagnosed with an 11.7 
mm aneurysm at the origin of PICA. She underwent 
surgical clipping which was complicated with an in-
traoperative rupture of the aneurysm and ischemic 
stroke. Later she had intermittent jerky movements 
to her left leg during rest and sitting that spontane-
ously subsided. Three years after stoke, she fell and 
broke her left femur. After 4 months of the fracture, 
she developed involuntary, wiggling toe movements 
on her left foot. The movement consisted of ankle 
inversion and eversion, and internal and external ro-
tation of the left leg. The wiggling movement of toes 
gradually spread to her right toes. She was seen at 
sleep medicine clinic for evaluation of her movement 
disorder. She was alert and oriented x3, appropri-
ate thought content, follows simple and complex 
commands, appropriate mood. Cranial nerve (CN) 
exam showed right CN VI palsy, decreased sensa-
tion to pin-prick on the left face, decreased corneal 
reflex on the left, absent gag reflex, left palatal weak-
ness and tongue deviation to the left. There was a 
mild left eye ptosis. Mild dysarthria but able to re-
peat complicated phrases, but is dysarthric when 
attempting to repeat tongue-twisters and isolated 
sounds of speech. Motor exam revealed decreased 
motor strength on right upper and lower extremities. 
Tone was increased in left leg and arm. Pin-prick and 
temperature sensations were decreased on left face 
and right side of her body. Decreased proprioception 
and vibe sense in both toes, worse on the left. She 
had bilateral ataxia, dysmetria on left arm, and inter-
mittent truncal ataxia. Proprioception and vibratory 
sensation was decreased in both toes, worse on the 
left. She was unable to stand without assistance. 
Polysomnography with multiple muscle montage 
recorded continuous choreoathetoid toe movements 
in bilateral feet only when awake. Electromyogram 
channels revealed activities of bilateral feet with in-
dependent cycles of 2.5 cycles/second and 1.5 cycles/
second in the right and left foot, respectively. She 
was diagnosed with painless legs and moving toes 
syndrome.
discussion: We report a case of painless leg and 
moving toes syndrome that developed after left fe-
mur fracture. The patient developed abnormal toe 
movements after 4 months of fracture suggesting 
that abnormal reconstruction of the peripheral ner-
vous system could explain etiology of this disorder. 
It is also possible that autoimmune process could be 
involved in development of this condition given her 
history of dystonia and hypothyroidisism.
CV05
Clinical and Epidemiologic Significance of 
Gender Difference in AIDS-Associated Kaposi 
Sarcoma
Ahmad, R.; Basnet, A.; Viswanathan, L.;  Sartawi, T.; Sonia, 
F.; Salamera, J.; Trinitas Regional Medical Center, Seton Hall 
University School of Health and Medical Sciences
introduction: Kaposi Sarcoma (KS) is a low grade 
angioproliferative cancer of endothelial origin asso-
ciated with human herpes virus 8 (HHV-8).  KS can 
affect any organ with mucocutaneous involvement 
being the most common. Pulmonary involvement 
occurs in approximately 30% of KS patients, more 
commonly in homosexual males, and very rarely in 
women. KS behaves more aggressively in HIV infect-
ed women than men.  The diagnosis of pulmonary KS 
can be challenging because of the nonspecific features 
and wide differential diagnosis.
cAse	rePort: A 43-year-old African American female 
smoker, with HIV (viral load 216,606 copies, and CD4 
count of 5) and Hepatitis C virus co-infection, noto-
riously non-compliant to highly active antiretroviral 
therapy (HAART), presented with shortness of breath 
and nonproductive cough of two weeks duration, as-
sociated with weight loss, but no fever, chills, or night 
sweats. On examination, she manifested with tachy-
pnea, purplish lesions on the hard palate, along with 
a diffuse darkly pigmented macular skin rash, hy-
poxia, and diffuse bronchial breathing with rhonchi. 
Tuberculin skin test was negative, with indeterminate 
Quantiferon TB Gold assay.  Initial diagnostic work 
up showed relative leukopenia, elevated lactate dehy-
drogenase, right middle lobe consolidation, bilateral 
patchy nodular opacities, with focal thickening of the 
proximal left main stem bronchus.  Fiberoptic bron-
choscopy disclosed masses involving the trachea, and 
left main stem bronchus.  Cultures as well as special 
stains for bacteria, AFB, fungi, and Pneumocystis 
were non-diagnostic. A spindle cell neoplasm was 
noted with vascular differentiation, interstitial 
hemorrhage, fibrosis and atypical mitoses on histopa-
thology, with positive immunohistochemical staining 
for HHV-8, consistent with pulmonary KS. Tenofovir/
emtricitabine with ritonavir-boosted atazanavir 
was re-initiated. A CT of the abdomen and pelvis 
did not show any metastatic spread. After oncologic 
evaluation, systemic chemotherapy using liposomal 
doxorubicin was administered, with some clinical 
and radiographic improvement.
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discussion: KS incidence in the United States has var-
ied over time. Racial, genetic, and hormonal factors 
all have been reported to influence the development 
of KS. The observations that human chorionic go-
nadotropin inhibited KS growth in vitro suggested 
a possible biologic basis for the lower KS incidence 
among women.
CV06
Mycoplasma Pneumonia Triggering  
Thyrotoxicosis Which Exposes Non-Compaction 
Cardiomyopathy
Ahmed, S; Kadri, M; Latif, N; Slim, J; Habib, H; Saint Michael’s 
Medical Center
introduction: Mycoplasma pneumonia is an 
”atypical” bacterium, a common cause of community-
acquired pneumonia . However, It also causes various 
extra-pulmonary manifestations (cardiac, thyroid, he-
molytic anemia, etc.). We present a case of Mycoplasma 
pneumonia infection which triggers thyrotoxicosis in 
a young female that exposes a severe underlying car-
diac disease.
cAse	 rePort: Case: 26 year old African American 
female with no significant past medical history, pre-
sented to the ER with dyspnea, palpitations, and fever. 
One week prior to presentation, patient was having 
a sore throat, ear aches, fever, and productive cough. 
Patient treated herself with over the counter remedies 
and improves. But 3 days prior to presentation, pa-
tient started to have dyspnea and severe palpitations 
which prompted the patient to come to the ER. Patient 
was found to have a temp of 101, BP 111/55, HR 139, RR 
24, POX 100 on 2L. On physical exam, patient had JVD, 
B/L diffuse rales, S3 gallop, and 3+ pitting edema. CXR 
showed B/L pulmonary edema and sinus tachycardia 
on ECG. On labs, patient had a BNP 1255, TSH <0.01, 
elevated T3/T4. Diagnosis of thyrotoxicosis was made 
and patient was started on propranolol, diuretics, pro-
pylthiouracil. A 2D echo cardiogram was done which 
showed an EF of 25-30% and non-compaction of the 
left ventricle. Patient was found to have Mycoplasma 
pneumonia IgM >2000 and Doxycycline was started 
(due to prolong QT). After a week of medical therapy, 
patient clinically improved but due to heavy burden 
of PVCs and low EF, patient was at high risk of sud-
den death. Patient was sent home on a life vest. A few 
months later, the patient’s EF did not improve with 
maximal medical therapy and subsequently had an 
AICD placement.
discussion: Our patient had Mycoplasma infection 
which produced auto-antibodies that triggered thy-
rotoxicosis (family hx of Graves disease) that put the 
patient in a high output cardiac failure thus expos-
ing the patients underlying heart disease which was 
severe enough that she needed an AICD to prevent 
sudden cardiac death. Thus, what seemed liked a 
simple upper respiratory infection from a common 
organism, transpired events that showed us the true 
capability of seemingly benign organism.
CV07
A Case of Atypical Hemolytic Uremic Syndrome 
with Massive Proteinuria
Akhtar, R.; Triolo, D.; St. Joseph’s Regional Medical Center
introduction: Atypical Hemolytic Uremic syndrome 
is most commonly due to dysregulation of the alter-
native complement pathway.  It is characterized by 
the classic triad of hemolytic anemia, thrombocyto-
penia, and acute kidney injury.  Treatment includes 
supportive care including hemodialysis along with 
steroids, plasmapheresis, and eculizumab.  We report 
a case of a 22 year old female diagnosed with atypical 
HUS who was also noted to have massive protein-
uria.  Proteinuria is observed in cases of atypical HUS 
because of the glomerular leakage of protein due to 
severe endothelial and epithelial injury.  There is little 
data addressing the degree of proteinuria in these 
patients.  This leads us to ask whether the degree of 
proteinuria has any prognostic significance on dis-
ease progression and recovery.
cAse	rePort: A 22 year old female with a history of 
dysmenorrhea presented to her PMD’s office with 
epigastric abdominal pain for two days.  The pa-
tient also reported dark urine and upper respiratory 
tract symptoms.  At her PMD’s office she was noted 
to have scleral icterus so was instructed to come to 
our emergency department for further evaluation. 
Initial laboratory tests revealed hemoglobin of 10.9 g/
dL; severe thrombocytopenia with platelets of 16,000/
mm3; BUN, 61 mg/dL; Creatinine, 2.58 mg/dL; bi-
carb, 21 mEq/L; total bilirubin, 3.0 mg/dL; LDH, 1935 
U/L.  C3 and C4 levels were within normal limits. 
Direct Coomb’s test was negative.  Peripheral smear 
revealed schistocytes and very few platelets.  On uri-
nalysis, she had moderate bilirubin, specific gravity 
>1.030, large blood, > 300 mg/dl of protein, positive 
nitrite, small leukocyte esterase, 0-4 RBC’s, 5-9 WBC’s, 
moderate bacteria.  Her antinuclear antibody and 
HIV antibody were both negative.  Our patient was 
admitted to the medical ICU with a suspected diag-
nosis of TTP/HUS.  Nephrology and Hematology 
consultations were obtained.  She was initially started 
on steroids, plasmapharesis as well as hemodialy-
sis.  After failing to respond to plasmapharesis and 
with normal ADAMTS13 levels, she was started on 
eculizumab therapy.  She had an initial 24-hour urine 
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collection which showed nearly 24 grams of protein. 
She underwent a kidney biopsy which showed diffuse, 
thrombotic microangiopathy involving all glomeruli, 
arterioles, and focal small arteries of a severe nature; 
global collapsing glomerulopathy; and diffuse acute 
tubular injury.  She also developed hypertension 
during her hospital stay and was started on multiple 
antihypertensive medications.  She eventually im-
proved and was discharged with plans to continue 
on hemodialysis and eculizumab infusions as an out-
patient.  Upon discharge, her hemoglobin was 9.1 g/
dL, platelets of 50,000/mm3, Creatinine of 4.47 mg/dL, 
LDH of 629, and on urinalysis she still had > 300 mg/
dL proteinuria.  Over the next several months, her re-
nal function improved and was eventually able to be 
taken off dialysis.  During the most recent follow-up 
visit, her creatinine was 1.15 mg/dL and more remark-
ably a protein:creatinine ratio of 385 mg.  She is still 
following with Hematology for continued biweekly 
infusions of eculizumab and Nephrology for monitor-
ing of renal function.
discussion: Proteinuria is observed in cases of 
atypical HUS because of the glomerular leakage of 
protein due to severe endothelial and epithelial injury. 
However, there is little data directly addressing the 
degree of proteinuria observed in these patients.  This 
leads us to ask whether the degree of proteinuria has 
any prognostic significance or impact on disease pro-
gression and recovery.
CV08
Severe Hypertriglyceridemia Presenting As 
Acute Pancreatitis in an Undiagnosed Patient 
with Type 2 Diabetes Mellitus
Al-Dallal, R.; Kollu, V.; Basnet, A.; Osman, N.; Eckman, A.; 
Trinitas Regional Medical Center, Seton Hall University
introduction: Hypertriglyceridemia (HTG) is the 
third most common cause of acute pancreatitis (AP) 
after alcohol and gallstones comprising 1 to 4 % of 
all cases. HTG may be as prevalent as 50% in type 2 
diabetes. Pancreatitis secondary to uncontrolled dia-
betes usually presents in a patient with an underlying 
genetic abnormality of lipoprotein metabolism. The 
risk of acute pancreatitis in patients with serum tri-
glycerides >1000 and >2000 mg/dL is 5% and 10% to 
20%, respectively.
cAse	rePort: We are presenting a 29 year old Hispanic 
male with past medical history significant only for 
asthma, who presented with complaints of epigastric 
and left upper quadrant abdominal pain for one day. 
Pain was described as sharp in nature, radiating to the 
back, 10/10, aggravated by deep breathing, alleviated 
by fetal position. It was associated with nausea and 
vomiting. He denied change in bowel habits, malena, 
hematochezia, hematemesis, cough, chest pain, fever 
or chills and recent travel. He denied alcohol abuse or 
any history of gallstones or pancreatitis in the past. The 
initial laboratory work up showed leukocytosis with 
lipase of 185 in a very lipemic serum with metabolic 
acidosis without ketonemia. The initial impression was 
acute pancreatitis secondary to hypertriglyceridemia 
with metabolic acidosis secondary to accumulation 
of fatty acids. Triglycerides (Tg’s) were elevated at 
6266 mg/dL. Insulin drip was initiated along with 
gemfibrozil, omega- 3 fatty acids and aggressive 
intravenous fluid hydration. His hemoglobin A1C was 
13.5%. His Tg’s came down to 550 mg/dL. Insulin drip 
was switched to long acting insulin. Symptomatic 
management was done for pancreatitis and Tg’s came 
down to 131 mg/dL during the hospitalization. He 
was later discharged home on gemfibrozil, omega-3 
fatty acids, metformin and metoprolol.  
discussion:	 Our case is interesting in the context 
that uncontrolled and undiagnosed diabetes lead 
to secondary hypertriglyceridemia which lead to 
acute pancreatitis. It responded very well to insulin 
therapy.It is the breakdown of Tg’s into toxic free fatty 
acids by pancreatic lipases that causes lipotoxicity 
during AP. The course of acute hypertriglyceridemic 
pancreatitis seems to be worse and more recurrent 
than other causes of acute pancreatitis. Insulin 
infusions in diabetic patients with HTG can rapidly 
lower Tg levels.
CV09
Unusual Presentation of Bladder Cancer with 
Cardiac Metastasis
Al-Khateeb, A.J.; Hawatmeh, A.; Massarweh, F.; Abo, S.; Saint 
Michael’s Medical Center
introduction: Metastasis from bladder cancer usu-
ally follows a predictable pattern, with involvement of 
the pelvic lymph nodes, liver, lung, bone and adrenal 
glands. Cardiac metastasis was reported in the litera-
ture as a feature of end stage disease, up until now 
there are few cases of bladder cancer with cardiac me-
tastasis. If present, cardiac metastasis is almost always 
a grave sign indicating near death. Keywords: Bladder 
cancer, heart, cardiac metastasis”
cAse	rePort: We present an 83 year old female, with 
past medical history of hypertension, dyslipidemia, 
and bladder cancer diagnosed 1 month prior to this 
presentation, for which she underwent cystoscopy 
that showed invasive multifocal tumor, pathology 
demonstrated nonspecific findings of atypical spindle 
cells and squamous epithelium with atypia and exten-
sive necrosis. She presented with shortness of breath 
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on exertion, fatigue and gross painless hematuria. 
Physical examination was notable for hypotension 
and a firm large suprapubic mass with bloody urine 
in foley’s catheter. An ECG showed sinus rhythm 
with premature atrial complexes. 2D echocardio-
gram showed moderate pericardial effusion without 
physiologic findings of pericardial tamponade, along 
with a 1 mm pericardial thick material suggestive 
of metastasis, and a cystic structure near apex of 
RV on pericardial space. Chest/abdomen/pelvic CT 
scan showed 11 cm heterogeneous mass with air and 
calcification in bladder, an ill-defined 1.5 cm right he-
patic lesion, in addition to a single lung mass 2.9 cm 
possibly representing synchronous primary lung neo-
plasm with a pathologic paratracheal lymph node and 
bilateral large pleural effusions that were transudate 
with negative cytology. At this point, oncology team 
discussed with patient palliative chemotherapy and 
supportive care. Patient decided to withhold further 
therapy. She died 1 week later
discussion: Pericardial metastasis is not uncommon, 
as what was shown on several studies of postmortem 
analysis. Although lung, breast, and hematologic 
malignancies represent the most common source, 
mesothelioma and melanoma have the highest 
proclivity for cardiac metastasis. While bladder cancer 
has been reported to metastasize to heart especially 
with high disease burden, it is still rather rare.
CV10
When Sgarbossa Criteria Do Not Predict 
MI:Dynamic and Concordant ST Elevation and 
LBBB as Presentation of Myocarditis
Alattar, F.; Jmeian, A.; Saad, M.; Goldfarb, I.; Shamoon, F.; Saint 
Michael’s Medical Center, Seton Hall University
introduction: The presence of Concordant ST eleva-
tion in the set up of LBBB changes in EKG in a patient 
with chest pain is considered very specific of acute 
myordial infarction. We report this finding in acute 
myocarditis confirmed by MRI.
cAse	 rePort: 52 year old male presented with 
retrosternal chest pain and positive troponin (tro-
ponin 19) to the ER. EKG during admission showed 
evolution of ST elevation in the lateral leads followed 
by overlapping new onset LBBB. Cardiac catheteriza-
tion showed 60% lesion in the LCX which deemed not 
culprit for patient presentation as LBBB suggest proxi-
mal LAD lesion. MRI was done and  revealed patchy 
subepicardial infiltrates in the septal and lateral wall. 
The subendocardial region was intact which ruled out 
ischemia as a cause for the inflitrates. Eventually the 
diagnosis of myocarditis was reached and the patient 
was discharged home in 2 days.
discussion: Concordant ST elevation and new onset 
LBBB is very suggestive but not diagnostic of acute 
MI.Myocarditis is another differential diagnosis, es-
pecially if the patient is hemodynamically stable.
CV11
Myocardial Bridging Detected by iFR and IVUS 
as a Cause of Chest Pain
Alattar, F.; Shah, P.; Abualayem, M.; Shamoon, F.; Saint 
Michael’s Medical Center, Seton Hall University
introduction: Myocardial bridging is a known but 
infrequent cause of recurrent chest pain. In this en-
tity, intramyocradial part of the coronary artery 
undergoes constriction during systole which leads to 
decrease in  blood flow. This entity has characteristic 
angiographic appearance. In this case, abnormal iFR 
despite subtle coronary disease lead to iVUS imaging 
which revealed the presence of bridging
cAse	 rePort: 69 year old male presented with 
recurrent chest pain after recent myocardial infarction. 
Repeated coronary angiography revealed 50% LAD 
lesion. The interventionalist elected to do iFR which 
showed signficant lesion; IVUS revealed myocardial 
bridging, and the lesion was stented.
discussion: iFR assesses the coronary flow in dias-
tole which may be compromised in severe myocardial 
bridging. IVUS may delineate the lesion and stening 
is a valid treatment modality.
CV12
Medical versus Early Surgical Intervention:  
A Case of Toxic Megacolon in IBD
Ambreen, B.; Moncayo, J.L.; Chowdhury, B.; Wallach, S.; 
Pantelick, J.; St. Francis Medical Center
introduction: Toxic megacolon(TM) is a rare and seri-
ous complication of ulcerative colitis. TM affects male 
and female patients of all ages. It can also occur in 
severe infectious, ischemic and metabolic diseases of 
colon. TM is characterized by total or segmental non-
obstructive colonic distension of at least 6 cm, with 
systemic toxicity. We present a case of a young male 
diagnosed with toxic megacolon secondary to ulcer-
ative colitis. The patient was managed medically but 
later underwent colonic resection.
cAse	rePort: A 29 year-old caucasian male with past 
medical history of asthma was transferred from pris-
on for a two-month history of bloody diarrhea, crampy, 
diffuse abdominal pain, nausea, non-bloody vomiting, 
and a 13-pound weight loss.  The patient had a history 
of tobacco abuse, but quit one year prior, and reported 
no recent fever or night sweats.  Alcohol and illicit drug 
use history was also negative. On examination heart 
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rate was 107, blood pressure 127/76 mm Hg, tempera-
ture 37.1 C, respiratory rate 16, and oxygen saturation 
100% on room air. The remainder of examination was 
significant for hypoactive bowel sounds and mild 
tenderness in right lower quadrant of abdomen.  Skin 
exam showed a few apthous ulcers but no rash or 
lymphadenopathy.  There were no masses or tender-
ness on rectal exam. Initial workup showed WBC of 
16000, platelet count of 617000, positive hemeoccult 
stool test, and an erythrocyte sedimentation rate of 68. 
CAT scan of the abdomen revealed diffuse colitis and 
a dilated cecum measuring approximately 9 cm, con-
sistent with toxic megacolon. Colonoscopy and biopsy 
confirmed diagnosis of ulcerative colitis. The patient 
was started on mesalamine and intravenous meth-
ylprednisone along with metronidazole. After seven 
days of treatment abdominal pain resolved, leukocy-
tosis improved and the patient started tolerating an 
oral diet. The patient was discharged on day eleven. 
Two weeks after discharge the patient returned with 
worsening abdominal pain.  Imaging showed perfora-
tion of the descending colon. A total colectomy and 
ileostomy were successfully performed.
discussion: Due to high morbidity and mortality, 
early recognition and management of TM is of para-
mount importance. The initial treatment of TM should 
be medical, including intravenous corticosteroids and 
broad-spectrum antibiotics. Subtotal colectomy is 
recommended when distension persists or if improve-
ment is not observed on maximal medical therapy 
after 24-72 hours.
CV13
Cerebral Malaria Caused By Non-Falciparum 
Malaria
Amireh, S.; Aurshiya, R.; Szabela, M.; Shaaban, H.; Boghossian, 
J.; Slim, J.; Saint Michael’s Medical Center, Seton Hall University 
School of Health and Medical Sciences
introduction: Malaria causes more than one million 
deaths worldwide each year, and over 90% of them 
occur in Africa. Cerebral malaria is one of the most 
severe neurological complication.The World Health 
Organization defines it as a clinical syndrome 
characterized by coma at least 1 hour after termination 
of a seizure or correction of hypoglycemia, asexual 
forms of Plasmodium falciparum parasites on peripheral 
blood smears and no other cause to explain the coma. 
Usually, it is caused by P. falciparum. We present a case 
of cerebral malaria caused by non falciparum malaria.
cAse	 rePort: A 23 year old Nigerian male with no 
significant past medical history, presented to our ER 
with fever, chills, and confusion. The patient had re-
cently travelled to USA from Nigeria (where he stayed 
for three weeks). While on the flight, the patient expe-
rienced subjective fever and chills which persisted for 
5 days. Patient was brought to the hospital by his fam-
ily the next day, as he became progressively lethargic 
and confused. Patient’s vitals on admission were tem-
perature 102.5, blood pressure 119/70, heart rate 119, 
respiratory rate 20 and saturating 98% on room air. On 
physical examination patient was lethargic, minimal-
ly verbal, confused, oriented only to person and had 
scleral icterus. Rest of the physical examination was 
unremarkable. Pertinent laboratory studies showed 
total bilirubin 5.5, direct bilirubin 3.6, AST 59, ALT 33, 
Alkaline Phophatase 106, LDH 633, Haptoglobin<8, 
Hb 15.8, platelet 19,000. Thick and thin blood smears 
showed Non-Falciparum Plasmodium parasit-
emia. The diagnosis of Cerebral Malaria was made. 
Quinidine and Doxycycline were initiated, but due 
to QTC prolongation on serial ECGs, Quinidine was 
discontinued and Malarone(Atovaquone/proguanil) 
was initiated. The patient developed hemolytic ane-
mia with lowest hemoglobin being 6.9, for which he 
subsequently received blood transfusions.  Patient 
also developed acute renal failure during the hospi-
tal course requiring hemodialysis, which prompted 
stopping the Malarone. The CDC was contacted for 
parenteral Artesunate. The patient clinically im-
proved with artesunate, his renal failure resolved and 
he was discharged home. Patient was advised to take 
malaria prophylaxis before his travel to any malaria 
endemic areas.
discussion: Cerebral malaria and severe acute anemia 
are often peculiar to falciparum infection while organ, 
respiratory and metabolic dysfunction are common 
with severe knowlesi, vivax and other forms of severe 
falciparum infection.The CDC recommended treat-
ment for cerebral malaria is quinidine. Artesunate 
is available as an investigational new drug through 
CDC in patients with adverse effects to quinidine, or 
with parasitemia >10% of baseline at 48 hours after 
quinidine.
CV14
A Case of Parapharyngeal Abscess in a  
Young Male
Amodu, A.; Buhkari, S.; Miriyala, V ; Zijoo, R.; Colella, R.; Smith, 
J.M.; St. Francis Medical Center
introduction: Parapharyngeal abscess is one of the 
deep neck infections. It is usually polymicrobial and 
can involve both aerobic and anaerobic organisms. 
Tonsillitis, odontogenic infections, dental infections 
and surgical procedures have all been implicated as 
causes of deep neck infections. Symptoms usually 
include neck pain, dysphagia, odynophagia and fe-
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ver. Parapharyngeal abscess should be recognized 
and treated promptly to prevent significant morbidity 
and mortality that can occur because of the potential 
for airway compromise and spread to contiguous 
structures.
cAse	 rePort: 47 years old Hispanic male with past 
medical history of low back pain s/p local steroid in-
jections presented to our SFMC emergency room with 
odynophagia of 2 days. There was associated high-
grade fever, chills, diaphoresis, generalized weakness, 
body aches and loss of appetite. He does not recall any 
preceding upper respiratory tract infection, no dental 
or surgical procedures. There was no history of trauma 
to the neck. Patient had not had any sick contacts or 
recent travel. Social history: smokes tobacco with 40-
pack year. Drinks alcohol socially but does not use 
illicit drugs.
discussion: The potential for airway compromise 
makes early recognition important and airway is 
the first priority for treatment in parapharyngeal ab-
scess. Broad-spectrum coverage with antibiotics for 
gram-positive, gram-negative organisms and anaer-
obes should be used before culture results become 
available. Surgical drainage of abscess may also be 
necessary.
CV15
Cauda Equina Syndrome: A Bewildering  
Diagnosis in a Young Hispanic Male
Amodu, A.; Zijoo, R.; Moncayo, J.L.; Wallach, S.; Smith, J.M.; 
St. Francis Medical Center
introduction: Cauda Equina Syndrome, a rare clini-
cal finding, results from compression of lumbosacral 
nerve roots below the conus medullaris. Common 
causes are: disc herniation, spinal trauma, neoplasm 
and abscess. No set risk factors have been recognized, 
but males, African American and Middle age seems 
to play a little role. The clinical presentation is key 
for further timely approach and better described as 
a lower motor neuron lesion that includes: neuromus-
cular and urogenital symptoms. Here a case of acute 
medullar compression.
cAse	rePort:	A 32 year old Hispanic male with past 
medical history of non-Hodgkin’s lymphoma pre-
senting with low back pain for one week, described 
as pounding, radiated to both lower extremities, no 
known increasing factors, to alleviate tried ibuprofen 
without relief. Associated with left lower extremity 
weakness, loss of sensation around the buttocks and 
urinary retention. He denied fever, recent trauma 
or fall. He has history of two similar episodes with 
spontaneous resolution. He recently received his last 
radiotherapy session four weeks ago and denied any 
symptoms post therapy. He denied family history of 
malignancy, He denied alcohol, illegal drug abuse or 
tobacco. Previously used to work as a cook, currently 
unemployed, but denied history of recent heavy lift-
ing. On physical examination, vital signs were blood 
pressure: 126/80, heart rate: 97 temperature: 37.2. 
Cardiopulmonary not contributory, musculoskeletal 
showed local tenderness over lumbar spine, neurolog-
ic exam noted: bilateral lower extremities weakness 
4/5, left more than right. Deep tendon reflexes absent 
in ankle and patellar bilaterally, saddle anesthesia 
around the anus and perineal, rectal tone decreased 
without masses or tenderness. Bilateral lower extremi-
ties had palpable pulses, no hair loss, and no edema. 
On lab work: only normocytic anemia of Hb: 13.7. On 
imaging MRI of lumbar spine denoted large epidural 
tumor extending from L3-L5 causing compression of 
the conus medullaris and large paraspinal masses, 
left greater than right. Instantaneously, started on 
IV Dexamethasone and intense physical therapy. As 
recommended by Oncology team followed by man-
agement for his non-Hodgkin’s lymphoma with 
proper radiotherapy.
discussion: Cauda Equina Syndrome is a clinical 
diagnosis, a high index of suspicion to recognize it 
is a must, because a delay in treatment may worsen 
prognosis and outcomes. Its recommended manage-
ment varies from corticosteroids through urgent 
surgical decompression. Rehabilitation with physical 
and occupational therapy plays an important role for 
recovery.
CV16
A Case of Malaria with Mixed Parasitemia
Amodu, A.; Iyer, P.; Tahir, M.; Lopez, J.;  Mathai, S.; Christmas, 
D.; Pantelick, J.; Saint Francis Medical Center
introduction: Malaria is predominantly a disease of 
the tropics caused by the Plasmodium species that are 
transmitted by female anopheles mosquito. Most cas-
es identified in U.S are seen amongst immigrants or 
recent travelers to endemic regions. Symptoms could 
be nonspecific: fever, chills, headache and arthralgias. 
The use of precautions and host immunity determine 
the risk and intensity of the infection. The severity of 
infection varies from uncomplicated malaria to severe 
infection with end organ damage (cerebral malaria) 
and permanent neurological sequel.
cAse	 rePort: A 62 year old Indian male with past 
medical history of non-ischemic cardiomyopathy, 
hypothyroidism, hyperlipidemia, hypertension, ob-
structive sleep apnea, gout and anxiety disorder 
presented to our SFMC emergency room with fever, 
headaches, chills and sweating of 6 days duration. 
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Fever was intermittent, high-grade and occurred in 
the evenings and was  associated with non-bloody 
diarrhea. Social History: Patient is an IT consultant 
and had travelled to India 6 weeks back without tak-
ing any anti-malaria prophylaxis before travel. He 
recalled no mosquito bites. No other family members 
were ill. There were no pets at home. Physical exam: 
Patient was febrile to 101 deg F, tachycardia with 
HR 106bpm and had chills. Skin and mucosa were 
dry, patient was anicteric, with no rashes or palpable 
lymph nodes. Abdominal exam was negative for pain 
or hepatosplenomegaly and bowel sounds were nor-
mal. Neurological examination did not reveal any 
abnormality. Laboratory studies were positive for 
normocytic anemia with hemoglobin of 12.8, plate-
lets of 104.  White blood cell count was within normal 
limits. Liver function tests revealed: high indirect 
bilirubin, but was otherwise normal. Coagulation 
profile was also normal. Electrolytes revealed: hy-
ponatremia and acute kidney injury. Pertinent 
peripheral blood smear showed mixed plasmodium 
species including Plasmodium vivax, Plasmodium 
malariae and Plasmodium ovale with 0.4% parasit-
emia. Immunology was also positive for Dengue fever 
IgM antibody. Accordingly primaquine/chloroquine 
combination was started and repeated smear after 3 
days of treatment showed <0.1% parasitemia. After 
clinical improvement, our patient was discharged on 
Primaquine for a total of 14 days with completed reso-
lution of symptoms at the time of outpatient follow-up.
discussion: Malaria is a life-threatening infection by 
Plasmodium falciparum, the most prevalent species 
in lethal cases. Interestingly a co-infection with dif-
ferent species can occur, as with our patient. Clinical 
suspicion and careful history including recent travel 
to endemic areas of the world is essential for prompt 
diagnosis and treatment of malaria.
CV17
Myopericarditis Secondary to a Recent Tdap 
Vaccination
Arolli, T.; Shamoon, F.; Patel, K.; St. Michael’s Medical Center
introduction: Myocarditis is an inflammatory dis-
ease of myocardium. It can be produced by a variety 
of different causes. The viral infection is the most 
common cause in developed countries. The clini-
cal manifestations are highly variable, ranging from 
subclinical disease to fatigue, chest pain, cardiogenic 
shock, and sudden death. It is important to recognize 
myocarditis so the appropriate treatment is promptly 
initiated. Our patient presented with chest pain with 
diffuse ST elevations and history of fever after a re-
cent Tdap vaccination.
cAse	rePort: A 37-year-old Brazilian male with past 
medical history of pineal gland cyst removal pre-
sented to emergency room for evaluation of left-sided 
chest pain for a few hours. The pain started in the epi-
gastric area and travelled to the left side of the chest. It 
was pressure-like, non-radiating, relieved somewhat 
by movement, no exacerbating factors, no previous oc-
currences. The patient admitted to fever for 72 hours 
(started after receiving a Tdap vaccination). He denied 
diaphoresis, palpitations, cough, diarrhea, dysuria. 
No family history of cardiovascular problems. Patient 
is an ex-smoker, and admitted to history of cocaine 
and marijuana use (few years ago). In the emergency 
room, patient was found to have had diffuse ST eleva-
tions. Code STEMI was called, and patient was taken 
emergently for cardiac catheterization (normal coro-
naries, ejection fraction around 60%). The patient’s 
troponin came back elevated (30), decreased to 0.19 on 
discharge. The main differential was myopericarditis 
given the recent history of fever and immunization. 
The blood work was done to rule out viral causes 
(came back negative). Cardiac MRI was done (indi-
cated possible myocarditis). Patient was subsequently 
cleared for discharge home with outpatient follow up 
with cardiology. Nuclear stress test was done as an 
outpatient four months after discharge and indicated 
low risk for cardiac events.
discussion:	 It is important to determine the etiol-
ogy of myocarditis as the treatment may differ. All 
patients need to be asked about recent vaccination his-
tory. The infectious causes need to be excluded as the 
most common cause of myocarditis. While smallpox 
vaccine is the one that is most commonly associated 
with vaccination-induced myocarditis, the clinicians 
need to be aware of other causes.
CV18
Recurrent Stroke Secondary to Large Atrial 
Myxoma
Aung, M.; Iyer, P.; Ursani, M.; Siddiqui, W.; Kososky, C.; Wallach, 
S.; Barn, K.; Saint Francis Medical Trenton
introduction: Primary cardiac tumors are extremely 
rare.  Their incidence is estimated to be 0.1% of total 
cases on autopsy. Cardiac tumors can present with 
different manifestations including embolization, 
heart failure, heart blocks, arrhythmias, pericardial 
effusion. Additionally, embolization of the tumor can 
manifest as thrombi in the systemic circulation lead-
ing to neurological sequelae.  We present a case of a 46 
y/o Hispanic healthy male who was presented with 
CVA and had a left atrial myxoma on imaging studies.
cAse	rePort: A 46 year-old Hispanic male with no past 
medical history presented with complaints of slurred 
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speech, change in mentation, blurry vision, right 
upper and lower extremity weakness.  The patient’s 
symptoms began one day prior to presentation. On 
admission, weakness and blurry vision improved but 
speech and mentation progressively worsened. Patient 
also reported a history of intermittent palpitations 
and dyspnea on exertion that prevented him from car-
rying out his daily activities. The patient denied any 
family history of a hypercoagulable state, coronary 
disease or cardiac tumors.  On exam, the patient had 
a 4/6 systolic murmur, loudest at the 5th intercostal 
space. Neurological exam demonstrated expressive 
aphasia and dysarthria.  Furthermore, right upper 
and lower extremity weakness was noted with appro-
priate tone.  The rest of the exam was benign.  Patient 
underwent a computerized tomography of head 
which displayed bifrontal hypodense brain lesions 
indicative of ischemia.  Magnetic Resonance Imaging 
of the brain displayed acute left frontal infarction well 
as old right frontal, left pontine and left cerebellar 
infarctions.  As patient presented after window pe-
riod he couldn’t receive tissue plasminogen activator, 
so he was given high dose aspirin. Transesophageal 
Echocardiogram displayed a large highly mobile left 
atrial mass attached to lower atrium and mitral annu-
lus area.  The mass transversed the mitral valve and 
encroached on left ventricle, leading to severe mitral 
regurgitation.  The patient underwent an emergent ex-
cision of the mass and mitral valve annuloplasty. No 
post-operative complications were noted. Coumadin 
was started and he was recommended to follow up 
with cardiothoracic surgery and cardiology.
discussion: In evaluation of multiple cerebral infarcts 
in a young individual who has a long standing history 
of non-specific cardiac symptoms, left atrial myxoma 
should be considered in the differential diagnosis. 
There needs to be increased awareness on early recog-
nition of secondary causes of ischemic CVA; outside 
the realm of hypercoagulability.
CV19
Pontine Infarction -A Case of Millard-Gubler 
Syndrome
Awan, M.U; Barenbaum, S.; Miriyala, V.; Tabowada, J.; Kososky, 
C.; Wallach, S.; Seton Hall University at St. Francis Medical 
Center
introduction: Millard-Gubler Syndrome, first de-
scribed in 1858, is caused by a lesion of the ventral 
pons and manifests as unilateral facial and/or abdu-
cens palsy with contralateral weakness of the arm and 
leg (1, 2). This description was based on postmortem 
examinations, which discovered that hemorrhage, 
tumor, or infarction were the common causes. We 
describe a patient with Millard-Gubler Syndrome 
caused by an ischemic stroke in the left pons. Precise 
anatomic confirmation was obtained by computed to-
mography (CT) and magnetic resonance (MR).
cAse	 rePort: A 69-year-old male with past medical 
history significant for diabetes mellitus and hyper-
tension presented to the emergency department (ED) 
with complaints of two-days of progressive weak-
ness of the right upper and lower extremities, slurred 
speech, and double vision. His home medications 
included metformin, Januvia and lisinopril. On ad-
mission his vitals were: blood pressure: 160/90, pulse 
rate: 98, respiratory rate: 18, O2 saturation: 98% on 
room air. His NIH stroke scale was 8 but the patient 
was out of the window for intravenous tissue plas-
minogen activator. On neurological examination the 
patient was alert, awake, and oriented to time, place 
and person. Speech was slowed but articulation was 
intact. Abduction of the left eye was impaired (left 6th 
cranial nerve), the mouth was deviated to the right, 
and the nasolabial fold was lost on the left (5th cranial 
nerve). Additional findings on the right side included: 
flaccid hemiparesis, brisk deep tendon reflexes, and 
extended plantar reflexes. The remainder of the exam 
was normal. CT revealed hypodensity in the left pons, 
and MRI revealed restricted diffusion in the left pons, 
both consistent with acute left pontine infarct. MRA 
showed limited flow related enhancement in the 
basilar artery suggestive of thrombosis/high grade 
stenosis. The patient was admitted to the hospital, his 
medications were optimized, and physical therapy 
was initiated. The patient began to regain strength in 
both the right upper and lower extremities and was 
discharged to a rehabilitation facility with secondary 
stroke prevention.
discussion: We describe a case of Millard-Gubler 
Syndrome with lesion located in lateral and medial 
inferior pons involving facial and corticospinal tracts. 
Due to the myriad of other tracts and nuclei located 
proximally, it is often associated with one and half 
syndrome, abducens palsy, contralateral cerebellar 
ataxia and contralateral sensory deficits.
CV20
A Rare Case of Primary Hodgkin Lymphoma of 
the Rectum
Awan, M. U.; Ambreen, B.; Karabulut, N.; Kish, K.; Conaway, H.; 
Seton Hall University at St. Francis Medical Center
introduction: Hodgkin Lymphoma (HL) is a B-Cell 
neoplasm characterized by Reed-Sternberg cells (or 
one of the variants), typically presents with lymph 
node enlargement in the neck and mediastinum and 
B symptoms (fever, drenching sweats and weight loss). 
Extranodal disease seen only in 15 % of patients, is 
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either a manifestation of advanced disease or associat-
ed with immunodeficiency disease. We present a rare 
case of primary Hodgkin Lymphoma of the rectum in 
a 31 year old male with HIV and EBV infection.
cAse	rePort: A 30 year old Hispanic male with past 
medical history of newly diagnosed HIV presented 
to the clinic with complaints of rectal bleeding for 3 
months. Examination under anesthesia and colonosco-
py revealed rectal mass in anterior and lateral margin 
starting from anal verge with active bleeding. Biopsy 
of mass revealed CMV colitis with scattered lymphoid 
infiltrate. Patient was treated for CMV infection with 
ganciclovir. Treatment of HIV was also initiated. Four 
months after 1st encounter patient came to hospital 
complaining of bright red bleeding per rectum, fecal 
incontinence and malaise. He also reported weight 
loss of 10 lbs over the last few months without fever, 
abdominal pain, night sweats, diarrhea or constipa-
tion. Examination showed temperature 38.3 Co, pulse 
88 beats/min, BP 107/63, oxygen saturation 100% on 
room air. The remainder of the examination revealed 
an ulcerated, tender, fungating mass in rectum in-
volving anus. No lymphadenopathy was noted. Initial 
workup revealed hemoglobin of 8.9 g/dl with low 
MCV fL and platelet count of 507,000 thou/ml. Patient 
underwent examination under anesthesia and biopsy 
of the mass. Histopathological examination showed 
fragments of lymphoid connective tissue with lym-
phoid infiltrate, composed predominantly of small 
mature lymphocytes with scattered large atypical 
and mono and bi-nucleated cells with abundant eo-
sinophilic cytoplasm consistent with Reed Sternberg 
and Hodgkin cells. Latent membrane protein 1 im-
munostain for Epstein Barr Virus was positive. Taken 
together, these findings were consistent with classical 
Hodgkin lymphoma of rectum.
discussion: Hodgkin Lymphoma manifests extranod-
ally in only 15% of cases. Primary gastrointestinal HL 
is frequently associated with HIV and IBD. Stomach, 
small bowel and esophagus are the most commonly 
involved sites. We present a rare case of classical HL 
of the rectum in patient with HIV and EBV infection.
CV21
Spontanous Retroperitoneal Hemhorrage:  
A Case Report
Badin, K.M.; Shahla, L.; Michael, P.; St. Joseph’s Regional 
Medical Center
introduction: Spontaneous retroperitoneal hemor-
rhage is a rare clinical entity that has various causes 
including aortic aneurysm rupture, renal cell car-
cinoma, angiomyoplipoma, or other intrabdominal 
malignancies. We present a case of a patient that was 
found to have a retroperitoneal hemorrhage with no 
apparent etiology that was venous in nature with 
concurrent iliac vein aneurysm and acute venous 
thrombosis found on CT scan.
cAse	rePort: A 72-year-old Caucasian female present-
ed to the Emergency Department with generalized 
weakness and light-headedness upon standing for the 
past 2 days. Patient denies any vomiting, abdominal 
pain, diarrhea, weight loss, bleeding or trauma. Patient 
has past medical history significant for right lower ex-
tremity DVT and IVC filter placed over 10 years ago, 
IDDM type II, COPD, and obesity. Home medications 
included low dose ASA . On physical exam orthostatic 
hypotension and tachycardia were observed and pa-
tient was found to have mild right lower quadrant 
abdominal tenderness. On preliminary labs patient 
was found to have a UTI and admitted to the hospital. 
PT was 14.6, INR 1.1, Aptt 26.9, Hgb 13.8, Hct 41.2%. 
The following day patient reported vague abdominal 
pain on the left side and some discomfort in her left 
lower extremity. Her Hgb dropped to 11.2, Hct 33.8%. 
Patient proceeded to have a CT scan of her abdomen, 
which revealed a retroperitoneal hemorrhage on the 
left with an adjacent expansion of the left common 
iliac vein that may have ruptured as well as a hyper-
density below the IVC filter in the iliac vein suspicious 
for a diffuse thrombosis.  CT with IV contrast showed 
the retroperitoneal hemorrhage with no active extrav-
asation to suggest an active arterial bleed. During the 
hospital course no intervention was necessary and the 
patient was monitored closely for hemodynamic sta-
bility. Hemoglobin remained stable and patient was 
discharged to rehabilitation with follow up for a hy-
percoaguable work up once out of the acute phase.
discussion: Spontaneous retroperitoneal hemorrhage 
is rare entity. The interesting aspect in this case is that 
trauma and iatrogenic bleed caused by anticoagulants 
are ruled out. This suggests the patient may have un-
derlying malignancy or a hypercoagulopathy that 
will be further investigated once the patient is no lon-
ger in the acute phase of bleeding and thrombosing.
CV22
Adenosine-Induced Ventricular Tachycardia  
Complicating Fractional Flow Reserve 
Measurement
Bajaj, S.; Shah, P.; Virk, H.; Shamoon, F.; Bikkina, M.; Bajaj, 
S.; Dept of Cardiology, St. Joseph’s Regional Medical Center, 
Seton Hall University
introduction: Even though coronary angiography 
represents the gold standard in the diagnosis of CAD, 
it has the major limitation that it cannot provide cer-
tainty on the hemodynamic relevance of the observed 
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stenosis. The measurement of fractional flow reserve 
(FFR) is a standardized and well-established method 
frequently used to evaluate the hemodynamic sig-
nificance of epicardial coronary stenoses. Although 
intravenous infusion of adenosine is frequent, its use 
in the catheterization lab may have some drawbacks 
compared with intracoronary adenosine, such as the 
need for large amount of drug, higher costs and high-
er occurrence of systemic adverse effects. No major 
adverse events related to the intracoronary drug ad-
ministration have been reported from multiple trials 
measuring FFR.
cAse	rePort: An 82-year-old female with history of hy-
pertension, dyslipidemia with complaints of dyspnea 
on exertion and abnormal nuclear stress test present-
ed for cardiac cath. The right coronary artery had a 
discrete 70% stenosis. The decision was made to check 
if the lesion was physiologically significant using FFR. 
After the intracoronary adenosine was administered, 
the patient went into polymorphic ventricular tachy-
cardia. The patient spontaneously converted back to 
sinus rhythm. It was taken that this may be suggestive 
of ischemia, though the actual gradient could not be 
measured due to drop in pressure during the tachy-
cardia. Therefore, an intervention was performed and 
a stent was deployed. Final cineangiography revealed 
no significant residual stenosis, and no evidence of 
dissection or thrombus. The patient was discharged 
home the following day and has been doing well on 
subsequent office visits with no evidence of any fur-
ther arrhythmias.  A 76-year-old female with diabetes, 
hypertension and dyslipidemia was admitted to the 
hospital for gastroenteritis. During the hospital stay 
she developed chest pain and troponin of 0.12.  The 
patient had a recent stress nuclear scan done, which 
showed anterolateral reversible ischemia.  The patient 
also had a cardiac catheterization done few months 
ago and at that time was noted to have a prox-mid 
60% long LAD lesion that was managed with medical 
therapy. Since, the patient kept having recurrent chest 
pain, the cardiac cath was repeated and showed the 
LAD lesion was unchanged. 
discussion:	 We described two patients here who 
went into ventricular tachycardia after intracoronary 
adenosine injection. In both instances no actual FFR 
reading was recorded and the ventricular tachycar-
dia was taken as a sign of ischemia. Although, based 
on this assumption both patients underwent stent 
placement, they had very different outcomes. To our 
knowledge there is only one such case reported in the 
literature. Proposed mechanism is QT prolongation 
with adenosine injection leading to torsades.
CV23
A Rare Presentation of Polymicrobial Bacteremia
Barahona, F.; Slim, J.; Boghossian, J.; Sison, R.; Saint Michael’s 
Medical Center
introduction: This is a 56-yo M with a past medical 
history of uncontrolled diabetes type II, hypertension, 
hyperlipidemia who presented with SIRS criteria 8 
days after falling in snow. Patient was found to have 
sepsis secondary to polymicrobial bacteremia with 
streptococcus agalactiae and methicillin sensitive 
staphylococcus aureus in the setting of a 7.7 cm 
pleural space abscess which likely developed from a 
hematoma in the setting of patient’s fall.
cAse	 rePort: 56M with a past medical history of 
uncontrolled diabetes type II, hypertension, hyper-
lipidemia who presented with tachycardia, tachypnea 
and fever 8 days after falling in snow hitting the an-
terior and lateral part of his right shoulder. Physical 
was remarkable for shotty supraclavicular and right 
axillary lymphadenopathy, and tenderness in right 
axillary area. His work up revealed a leukocytosis 
of 19.6, with a left shift of 91%, and bandemia of 13. 
Patient was found to have sepsis secondary to poly-
microbial bacteremia with streptococcus agalactiae 
and methicillin sensitive staphylococcus aureus in 
the setting of a 7.7 cm pleural space abscess which 
likely developed from a hematoma in the setting of 
patient’s fall. A chest x ray showed an opacity in the 
right upper lobe field. Patient was started empirically 
on zosyn and daptomycin. A chest CT showed a 7.7 
cm pleural space air and debris containing mass an-
terior to the right upper lobe which extends through 
the first intercostal space and abuts the undersurface 
of the right pectoralis muscle. A doppler ultrasound 
was compatible with deep venous thrombosis of right 
subclavian and axillary veins. Blood cultures came 
positive for streptococcus agalactiae and methicillin 
sensitive staphylococcus aureus. Patient underwent 
for drainage and a percutaneous pig tail catheter 
placement. Initial drainage produced 60cc of purulent 
fluid. Cultures of this purulent fluid produced same 
organisms identified in blood cultures. A transesoph-
ageal echocardiogram was negative for endocarditis. 
Patient was discharged on ceftriaxone and recovered 
uneventfully.
discussion: Polymicrobial bacteremia involving 
group B streptococcus was found in 13-20% according 
to case series. Staphylococcus aureus was associated 
with group B streptococcus polymicrobial bacteremia 
in most studies. In our patient, the trauma sustained 
during the fall in snow likely produced a hematoma 
which became infected and acted as the source of 
bacteremia.
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CV24
Clostridium Perfringens Septic Arthritis in a  
Natural Joint
Barahona, F.R.; Slim, J.; Boghossian, J.; Sison, R.; Saint 
Michael’s Medical Center
introduction: An 87 year-old African American male, 
nursing home resident with past medical history of 
hypertension, Alzheimer dementia, chronic consti-
pation, diverticulosis, osteoarthritis, left total knee 
replacement, presented with encephalopathy in the 
setting of sepsis secondary to septic arthritis of his 
native right knee joint. Synovial fluid cultures pro-
duced Clostridium perfringens. Patient was found to 
have colitis which likely was the source of the C. per-
fringens septic arthritis through bloodstream distant 
seeding. No other similar case has been found in the 
literature.
cAse	rePort: An 87 year-old African American male, 
nursing home resident with past medical history of 
hypertension, Alzheimer dementia, chronic consti-
pation, diverticulosis, osteoarthritis, left total knee 
replacement, who was sent to the hospital because 
of three days history of anorexia, weakness and 
altered mental status. As per nursing home staff pa-
tient had 3 episodes of non-bloody diarrhea 3 days 
prior to admission which self-resolved the same day 
however patient became progressively anorexic, and 
with mental status deterioration. The morning prior 
admission patient was difficult to arouse. Reviewing 
nursing home records patient had received two doses 
of oral metronidazole when diarrhea started. Physical 
was remarkable for tachycardia of 97/minute, fever of 
38Â°C. Patient was somnolent, arousable upon painful 
stimuli. Patient’s abdomen had present bowel sounds, 
it was not distended but patient grimaced upon pal-
pation of left side of colon. The extremities showed 
changes consisting with degenerative joint disease, 
left knee with an old surgical scar, with no warmness, 
and no edema. Right knee was edematous, warm 
upon palpation, with decreased range of motion (pa-
tient grimaced), and with crepitus. Work up revealed 
elevated CRP (15.1) and ESR (150). Sinovial fluid had a 
leukocyte count of 2100 with 70% neutrophils. X-ray 
of right knee was compatible with severe lateral joint 
space narrowing, subchondral sclerosis with a mod-
erate effusion. CT of abdomen showed colitis. Joint 
fluid cultures came positive for Clostridium perfrin-
gens. Blood cultures were negative. Patient recovered 
uneventfully and was discharge on levofloxacin and 
metronidazole.
discussion: Septic arthritis due to Clostridium spe-
cies is an unusual clinical occurrence. Previously 
reported cases of C. perfringens septic arthritis have 
prosthetic joints, rheumatoid arthritis and puncture 
wounds as predisposing factor. To the knowledge of 
the author this is the first case of C. perfringens septic 
arthritis in a native joint.
CV25
Xanthogranulomatous Cholecystitis in a Patient 
with Acalculous Cholecystitis and an Innocuous 
Appearing Gallbladder
Basnet, A.; Jofre, S.; Aman, I.; Fish, H.; Butler, J.; Trinitas 
Regional Medical Center, Seton Hall University School of 
Health and Medical Sciences
introduction: Xanthogranulomatous cholecystitis 
(XGC) is an idiopathic inflammatory disease of the 
gallbladder characterized by an intramural destruc-
tive process with marked proliferative fibrosis and 
infiltration of lipid-laden histiocytes. XGC accounts 
for 0.7-10% of all inflammatory diseases of the gall-
bladder. The mean age of presentation is between 44 to 
63 years, with female predominance. Although XGC is 
seen primarily with chronic calculous cholecystitis or 
polyps, our patient presented with acalculous chole-
cystitis yet was found to have Xanthogranulomatous 
Cholecystitis on histopathologic examination.
cAse	rePort: This 49 year-old Hispanic female with 
past medical history of hypertension presented to our 
medical clinic with complaints of intermittent right 
upper quadrant pain of 3-4 years duration. Her dis-
comfort was associated with nausea and dyspepsia 
but she denied anorexia, weight loss, jaundice, me-
lena, hematemesis and association of pain with food. 
She denied personal history of cholecystitis or family 
history of hepatobiliary carcinoma. Physical exami-
nation was normal and did not reveal Murphy’s sign. 
The gallbladder ultrasound demonstrated a non-echo-
genic focus in the posterior wall of the gallbladder 
commented upon as possible sludge or polyp but no 
gallstones were visualized. She was referred for sur-
gery and underwent an uncomplicated laparoscopic 
cholecystectomy. The intraoperative report described 
a mobile gallbladder with a smooth serosal surface 
and velvety, bile-stained mucosa without adhesions 
or fibrous tissue; no polyps or stones were seen in the 
gallbladder. Histopathological examination revealed 
findings consistent with XGC. Our case is unique 
in that the gallbladder had normal gross pathologic 
features as contrary to the morphology mentioned in 
other published case reports and that this occurred in 
the absence of cholelithiasis or polyps.
discussion: XGC is due to extravasation of bile into 
the gallbladder wall via breaks in the sinuses of 
Rokitanski-Aschoff, or mucosal ulceration, which 
can create fistulas, hepatic abscesses, perforations 
and strictures. XGC is clinically important because 
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it can be masked by chronic cholecystitis and con-
fused, clinically and radiologically, with gallbladder 
carcinoma.
CV26
Malignant Triton Tumors in Sisters with Clinical 
Neurofibromatosis Type-1
Basnet, A.; Jofre, S.; Capo, G.;  1,3- Trinitas Regional Medical 
Center, Elizabeth, NJ. 2- Touro College of Osteopathic 
Medicine- New York
introduction: Malignant triton tumors (MTTs) are 
uncommon sarcomas, a subgroup of malignant pe-
ripheral nerve sheath tumors (MPNSTs). MPNSTs 
arise from Schwann cells or in existing neurofibromas. 
MPNSTs with elements of rhabdomyoblastic differen-
tiation are termed MTTs. MTTs are associated with a 
high incidence of local recurrence and distant metas-
tases. The treatment consensus yet does not exist. We 
report two sisters, both of whom were diagnosed with 
MTTs. MTTs account for <10% of MPNSTs.
cAse	 rePort: Firstly, a 36 yr. old female presented 
with left sided chest wall swelling.  On examination, 
she was found to have examination findings con-
sistent with clinical NF-1. On imaging, a soft tissue 
mass in the left lower anterolateral chest wall was 
seen. Histopathological examination (HPE) showed 
high grade MPNSTs with skeletal muscle differen-
tiation (Triton Tumor). The patient was treated with 
Ifosfamide and Adriamycin along with radiation.  She 
still has no evidence of disease recurrence 4 years 
later. Her sister subsequently presented to us at age 
42 yr. with left sided lateral chest wall pain. Imaging 
showed a multi-compartmental retroperitoneal cystic 
mass. HPE of which showed MTT. The plan for her is 
to start on chemotherapy and radiation. Around 50% 
of MPNSTs cases arise in patients with neurofibroma-
tosis type 1 (NF1).
discussion: The 5-year survival rate is 5-15% for MTTs. 
Radical surgical excision is the only curative interven-
tion known so far. With this case reports we hope to 
emphasize further the association of NF-1 with this 
rare MTTs and that the first sibling is disease free four 
years after diagnosis.
CV27
Non-Healing Ulcer
Bataineh, A.; Jumean, K.; Rajasingam, J.; Hanafy, K.; Seton 
Hall University
introduction: Patient with Rheumatoid Arthritis pre-
sented to the clinic with Right leg Ulcer
cAse	rePort: A 51 year old female patient which start 
complaining of painful bilateral hand join swelling 
that started 4 months ago, which has been treated with 
NSAID without improvement start noticing painful 
papule on her posterior aspect of the leg, she went to 
an emergency room and she was given Doxycycline 
for possible skin infection and to follow up with pri-
mary clinic, the papule then turned into ulcer and 
getting worsened with time, when she presented to 
our clinic the Diagnosis of Rheumatoid arthritis was 
made and pyoderma gangrenosum was the most like-
ly cause of the ulcer, Methotrexate 7.5 mg weekly was 
started and marked improvement was noticed over a 
period of three weeks.
discussion: Pyoderma Gangrenosum is uncommon 
type of ulcer, that usually presented in association 
with systemic disease, usually Inflammatory bowel 
disease and polyarthritis, therapy usually consists of 
Biological agents and antibiotics, mostly it shows im-
provement over the course of treatment.
CV28
Crazy Paving Appearance: A Case Of Chronic 
Dyspnea
Bhatti, H.; Iyer, P.; Zia, S.; Ejidike, M.; Siddiqui, W.; Seelagy, M.; 
Wallach, S.; Saint Francis Medical Center
introduction: Pulmonary alveolar proteinosis (PAP) 
is a rare disorder characterized by abnormal ac-
cumulation of alveolar surfactant. Its prevalence is 
approximately 3.7 to 6.2 cases per million. Diagnosis 
of PAP could be delayed as it is a rare disorder requir-
ing invasive diagnostic procedures (e.g. open lung 
biopsy or bronchoscopy). We report a case of 41 year 
old Haitian female, who was diagnosed with acquired 
PAP by transbronchial biopsy and transferred to ter-
tiary facility for whole lung lavage.
cAse	rePort: A 41 year old Haitian female who works 
as a nurse’s aide presented with several months’ histo-
ry of exceptional dyspnea and dry cough. She denied 
any history of COPD, asthma, fever, chills, weight loss, 
edema, night sweats, PND, orthopnea or smoking. She 
had no past history of Tuberculosis or exposure to TB, 
HIV, bird/pigeon exposure or cardiovascular disease. 
On examination she was afebrile, hypoxic requiring 
oxygen and had bilateral basal crackles. There was 
no clubbing or cyanosis. Initial x-ray showed bilateral 
alveolar, interstitial and questionable nodular appear-
ing infiltrate consistent with bilateral airspace disease. 
Patient was empirically started on antibiotics for 
atypical pneumonia. Workups for tuberculosis, HIV, 
Blood and sputum cultures were negative. Serum 
Angiotensin Converting Enzyme level was elevated 
which led to consideration of sarcoidosis. CT scan of 
chest with contrast revealed bilateral diffuse crazy 
paving appearance of the lungs with thickening of 
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the interlobular and intralobular septa; no lymph-
adenopathy. Patient was offered lung biopsy but she 
refused as she was symptomatically mildly improved 
with antibiotics. She was readmitted after 8 weeks 
with worsening complaints and persistent bilateral 
infiltrates and crazy paving pattern on radiologic im-
aging. Patient was started on steroids to treat possible 
interstitial lung disease or sarcoidosis. Bronchoscopy 
guided biopsy was performed and was positive for 
PAS positive staining consistent with a diagnosis of 
pulmonary alveolar proteinosis. Patient was then 
transferred to a tertiary care center for further man-
agement including whole lung lavage.
discussion: Imaging and currently available routine 
blood tests are non-specific for the diagnosis of PAP. 
Furthermore, increased susceptibility to infections 
among individuals with PAP may further complicate 
diagnosing this condition. Our case suggests the need 
for a more readily accessible non-invasive laboratory 
testing method than what is currently available.
CV29
Acute Wilson’s Disease Managed by Hemodialysis 
and Chelating Agent
Botros, Y.; Asslo, F.; Volfson, A.; St. Joseph’s Regional Medical 
Center
introduction: Wilson’s disease was first described by 
Alexander Wilson, a neurologist who described path-
ological changes of the liver and brain. The disease 
is caused by copper deposition in different tissues, 
commonly presents with liver dysfunction and neu-
ropsychiatric disorders. There is wide spectrum of 
liver affection in Wilson’s disease including acute 
liver cell failure. We present a case report of a patient 
with medical history of depression and kidney stones 
who developed acute liver cell failure due to Wilson’s 
disease. The patient survived with hemodialysis and 
copper chelating agents with significant improvement 
of his clinical condition.
cAse	rePort: A 38 years Caucasian male with medical 
history of depression and hypertension was initially 
admitted to hospital for lower extremities edema and 
cellulitis. On the second day, he was transferred to in-
tensive care unit (ICU) for hypoxic respiratory failure 
secondary to pulmonary edema. Later on, the patient 
developed multi-lobar pneumonia and sepsis.  While 
in ICU, patient developed jaundice with increasing 
Total bilirubin from 1.3 mg/dl on admission to 28.1 
mg/dL, mostly direct bilirubin 22.3mg/dL, with mild 
elevation of ALT 108IU/L, AST 248IU/L. Of note, alka-
line phosphatase level was 31IU/L.  As the patient had 
cholestatic pattern with low alkaline phosphatase and 
the ratio of ALP: Total bilirubin was less than 2, acute 
liver failure due to Wilson’s disease was suspected. 
Indeed, the serum ceruloplasmin was low (10.6 mg/
dl), serum copper level was found to be elevated (216 
UG/Dl) and Kayser-Fleischner rings were detected 
with slit lamp examination. Ultrasound guided percu-
taneous liver biopsy was done and showed liver tissue 
with mild to moderate fatty change, inflammatory ac-
tivity grade I and fibrosis grade I on trichrome stain 
using Scheuer classification for grading and staging. 
Quantitative copper measurement in the liver was 11 
mcg/g As the Patient was still in ICU being treated 
for severe pneumonia with multiple organ failure in-
cluding renal and liver failure on hemodialysis and 
mechanical ventilator support, was deemed medical-
ly unstable for liver transplantation and the decision 
was to start medical treatment for Wilson disease on 
day 16.The patient was started on trientine 500mg Q8 
hours via NG tube. 
discussion: Wilson’s disease is autosomal reces-
sive disease leading to decreased copper excretion. 
Acute WD is a rare cause for acute liver cell failure. 
Treatment of acute Wilson’s disease is liver transplan-
tation which is life-saving. Other measures including 
plasma exchange, molecular adsorbent recirculating 
system and hemodialysis have been studied as alter-
native to lower the serum copper [3-4].  In our case 
report, the patient survived with hemodialysis and 
copper chelating agents.
CV30
Babesiosis in an Immunocompetent Patient
Bulos, S.; Imayama, I.; Blanco Jr., R.; Moser, R.; Chowdhury, B.; 
Smith, J. M.; Saint Francis Medical Center, Seton Hall University
introduction: Babesiosis is a tick-borne illness with 
an overall mortality of 5%. Although high parasitemia 
is an indication for red blood cell exchange, its associ-
ation with severity of babesiosis is conflicting. Studies 
show that alkaline phosphatase (ALP)>125 U/L, white 
blood cell count (WBC) >5x103/Î_L, splenectomy and 
high parasitemia (>4%) are associated with severe ba-
besiosis. We report a case of babesiosis in an elderly 
patient who did not develop any complications de-
spite high parasitemia.
cAse	rePort: A 68 year old Caucasian female with a 
past medical history of chronic lower back pain pre-
sented to the emergency department with complaints 
of lower back pain radiating to the abdominal right 
lower quadrant.  She had associated symptoms of gen-
eralized body aches, subjective fever, and malaise. She 
stated that she lived in a rural area, saw deer frequent-
ly in her neighborhood and recalled sitting on grass 
about 4 weeks ago. She denied any recent travel, skin 
lesions including insect bites, or blood transfusions in 
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the past. The physical examination showed no obvious 
abnormalities except jaundice. No skin lesions were 
observed. Laboratory results revealed hyponatremia 
126, elevated alkaline phosphatase 366 IU/L, total bili-
rubin 5.3 mg/dL, aspartate aminotransferase 115 IU/L, 
and alanine aminotransferase 61 IU/L. The patient had 
an elevated white blood cell count of 11.9 and a normo-
cyctic anemia (hemoglobin 9.3) and platelets of 121. A 
urinalysis showed amber color, containing moderate 
bilirubin, large blood, total protein >300, nitrite posi-
tive, RBCs 5-10, many crystals, finely granular casts 
with proteinuria of 1.8 g/day. A computed tomography 
of the abdomen showed mild hepatomegaly, intrahe-
patic edema, gallbladder mural thickening, no biliary 
duct dilation, renal calcification without obstructive 
uropathy, but no splenic abnormality. On the day af-
ter admission, the patient developed a fever of 38.3C 
with a drop in hemoglobin. A peripheral blood smear 
revealed ring-shaped parasites with no sideroblasts or 
helmet cells, which was later confirmed as babesiosis. 
A Babesia polymerase chain reaction showed an ele-
vated Babesia microti IgG antibody titer of 1:256, but a 
normal IgM antibody titer of <1:20. All immunological 
testing was negative for any underlying disease in-
cluding asplenemia, human immunodeficiency virus 
(HIV), Ehrlichiosis and Lyme disease. The patient 
was started on ceftriaxone, doxycycline, mepron and 
azithromycin. Due to the progressive hemolysis after 
initiation of antibiotics, along with the high parasit-
emia of > 50%, red cell exchange transfusion was 
initiated. A total of 3 sessions with 20 units of PRBCs 
was performed. The hemolytic anemia improved after 
the exchange transfusion and she was maintained on 
doxycycline, azithromycin, and atovaquone.
discussion: Cellular immunity plays a pivotal role 
in the resolution of babesiosis. Our case did not have 
any risk factors for compromised immunity except for 
older age, which could explain no complications de-
spite the high parasitemia. Further investigations are 
warranted in understanding the role of parasitemia in 
babesiosis.
CV31
Endoscopic Ultrasound Guided Drainage of  
Peri-Rectal Abscess
Cavanagh, Y.; Shah, N.; Hosein, K.; Shaikh, S.; St Joseph’s 
Regional Medical Center
introduction: Abdominal and pelvic abscesses can 
occur as a consequence of surgery and are associated 
with significant morbidity and mortality. It is well 
accepted that the preferred treatment is antibiotic 
therapy and drainage. Surgery is reserved for patients 
presenting with perforation or those who do not re-
spond to conservative measures. Previously available 
options for drainage included percutaneous and CT 
guided drainage. Recently, endoscopic ultrasound 
(EUS) guided drainage of abscesses has come to light 
as a viable and safe alternative.
cAse	 rePort: The patient is a 41 y/o male who un-
derwent appendectomy 18 days prior to presenting 
with a two-day history of pulsating, 10/10 abdomi-
nal pain; exacerbated by passing stool, and alleviated 
by Gavisconnon. He reported accompanying bloody 
vomitus, diarrhea, fever, chills and dizziness. On 
physical examination, suprapubic tenderness was ap-
preciated however there were no rebound tenderness, 
ascites or organomegaly.  An abdominal CT scan with 
contrast demonstrated a fluid collection with fat ne-
crosis measuring 3.3cm in the right lower quadrant, a 
pelvic abscess below the rectum measuring 5.6cm, and 
a seminal vesicle abscess above the urinary bladder 
measuring 4cm. The patient underwent exploratory 
laparoscopy, which demonstrated extensive adhe-
sions involving the omentum, anterior abdominal 
wall, small bowel and sigmoid colon. The laparoscopy 
was aborted due to dense adhesions and CT guided 
drainage was attempted but also unsuccessful. A 
subsequent colonoscopy identified an abscess cavity 
<2cm from the colonic lumen, by utilizing endoscopic 
ultrasound (EUS) guidance. The dimensions of the 
abscess cavity were further delineated fluoroscopi-
cally. Implementing a 19-gauge needle, a guide wire 
was passed through the FNA needle and coiled in the 
abscess cavity. A hurricaine balloon was used to dilate 
the track (10mm x 4cm), after which a copious amount 
of purulent material was evacuated into the gastroin-
testinal lumen. A 10 French x 3cm double pigtail stent 
was inserted to facilitate drainage of residual materi-
als. Repeat imaging verified complete resolution of 
the stented abscess cavity, at which time the stent was 
removed.
discussion: EUS-guided drainage and stenting pro-
vides an accurate, efficient and safe management 
option. It allows access to areas that are technically 
challenging to access with a CT-guided or surgical ap-
proach. This novel approach is a valuable, innovative 
tool in the management of intra-abdominal collec-
tions such as abscesses.
CV32
Multiple Intussusceptions in an Anabolic Steroid 
Abuser
Cavanagh, Y.; Shah, N.; Thomas, A.B.; Gupta, A.; St. Joseph’s 
Regional Medical Center
introduction: Androgens are hormones whose 
abuse has been steadily increasing over the past four 
decades. It has expanded beyond the scope of profes-
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sional athletes to include high school students (1-5%), 
individuals focused on physique (13.5%) and certain 
occupations.  Intussusception is a complication of an-
abolic steroid abuse that has not overtly been reported 
in the literature. However, it is well established that 
aanabolic steroids contribute to polycythemia and in-
travascular hyperviscosity. This induces sludging that 
may subsequently cause ischemic injury. It is also well 
documented that ischemic bowel may serve as foci for 
telescoping, leading to intussusceptions.
cAse	 rePort: We present the case of a 34 y/o male 
with a history of hypertension, dyslipidemia, anxiety, 
reflux, hiatal hernia and IBS who presented with com-
plaints of severe cramping abdominal pain associated 
with nausea, vomiting, bright red blood per rectum 
and constipation. He is a recreational body builder; 
weighing 265 pounds, with a BMI of 40.3. The pa-
tient denied having similar symptoms in the past and 
was most recently taking 1,500mg of Testosterone/
Nadrolone, via unspecified injection, per week for 
three months. Three weeks prior to admission, when 
he decreased the dose to 500mg per week.  On presen-
tation he was found to be diaphoretic, tachcyardic and 
in mild distress. He had tenderness in the suprapubic 
region with no guarding, rebound tenderness or pal-
pable masses. Laboratory studies revealed WBC: 15.0, 
HGB: 17.9 and HCT: 51.2%. An abdominal CT scan 
demonstrated mild, diffuse, nonspecific colonic thick-
ening, with two separate short segment small bowel 
intussusceptions without evidence of obstruction. A 
colonoscopy was completed the day after admission 
and demonstrated edema and erythema in the distal 
ileum and colon, most dense in the distal transverse 
colon and increasing within the rectum. Biopsies in-
dicated acute and chronic colitis from the descending 
colon forward and changes suggesting ischemic coli-
tis in the rectum. The patient was medically managed 
and follow-up CT scan on the third day of admission, 
demonstrated resolution of intussusceptions.
discussion: Consistent with previous reports, our 
patient’s anabolic steroid abuse led to the develop-
ment of polycythemia that resulted in hyperviscosity 
and subsequently led to intravascular sludging and 
mesenteric ischemia with associated bowel wall thick-
ening. These bowel segments, consequently served 
as lead points in the formation of two simultaneous 
small bowel intussusceptions.
CV33
Urinary Tract Infection and Staghorn Calculus 
Associated with Raoultella Planticola
Cavanagh, Y.; Alford, J.; Rabbat, M.; St. Joseph’s Regional 
Medical Center
introduction: Raoultella planticola is a gram-negative 
bacillus, formerly known as Klebsiella planticola 
and Klebsiella trevisanii. It is a member of the 
Enterobacteriaceae family, and although it is primarily 
an environmental commensal, there has recently been 
a surge in pathogenic cases.
cAse	 rePort: Our patient is a 75-year-old male 
with a history of diverticulosis, enlarged prostate, 
nephrolithiasis, and hypertension, who presented 
with encephalopathy three weeks after resection of a 
thoracic intradural meningioma. Physical exam was 
significant for lower abdominal pain and urinary 
retention. On laboratory evaluation acute kidney injury, 
uremia, and hyperkalemia were observed. Abdominal 
ultrasound revealed a large, non-obstructive staghorn 
calculus in the left kidney. Urine culture was positive 
for ampicillin-resistant R. planticola.  
Historically R. planticola has not presented a pathogenic 
threat to humans. As recently as 2000, the incidence 
of K. planticola was reported to be less than 0.5%. 
However, some authors including Podschun et al 
postulated that K. planticola was increasingly becoming 
more prevalent as a human pathogen. Since the first 
reported pathogenic case in 1984 R. planticola has been 
implicated in cases of conjunctivitis, acute prostatitis, 
cystitis, cholecystitis, necrotizing fasciitis, cholangitis, 
soft tissue infections, and pancreatitis. Among these 
cases only that of prostatitis and cholangitis occurred 
in immunocompromised patients. The incidence of 
both pathogenic and drug resistant cases of R. planticola 
infection is increasingly being reported in the literature. 
Recent epidemiologic studies have also described 
pathogenic cases of drug resistant R. planticola. The 
first case of R. planticola carrying the blaIMP-8 gene 
that codes for imipenem resistance was published in 
early 2014. Additionally, pathogenic strains isolated in 
New Jersey and Ohio carried blaKPC gene, conferring 
hesitance to beta-lactams. In our case, susceptibility 
testing indicated ampicillin resistance. This reinforces 
recent speculation regarding the emergence of 
pathogenicity and drug resistance among R. planticola. 
To the best of the authors’ knowledge, this is the second 
reported case of urinary tract infection associated with 
R. planticola and the first associated with a staghorn 
calculus. Staghorn calculi are typically associated with 
urease producing bacteria such as Proteus and Klebsiella; 
neither of which our patient had a prior history of. He 
was successfully treated with ciprofloxacin.
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discussion: Among the exceedingly rare cases of 
pathogenic infection associated with R. planticola, we 
present the second documented case of UTI caused by 
R. planticola and the first case to be associated with a 
staghorn calculus. Our case highlights the emergence 
of R. planticola as a drug resistant pathogen that must 
now be considered in the differential for a variety of 
infections, particularly UTI.
CV34
Sotalol Induced Torsades de Pointes Ventricular 
Tachycardia
D’ Souza, RD; Kollu, VK; Pullatt, RP; Trinitas Regional Medical 
Center, Elizabeth, NJ. Seton Hall University School of Health 
and Medical Sciences
introduction: Torsade de pointes(TDP) is an uncom-
mon and distinctive form of polymorphic ventricular 
tachycardia  characterized by a gradual change in the 
amplitude and twisting of the QRS complexes around 
the isoelectric line. Early afterdepolarization (EAD), 
triggers torsades. Sotalol has been associated with 
life-threatening pro-arrhythmias, including torsade 
de pointes, although the incidence of this adverse ef-
fect is low. One of the key factors to consider is that 
sotalol is excreted unchanged renally.
cAse	 rePort: 42 year old female with PMH of pe-
ripartum cardiomyopathy s/p AICD for primary 
prevention in 2012, HTN, DM Type 2 presented to the 
ED after several syncopal episodes. She felt short of 
breath and lightheaded, following by which she lost 
consciousness. Patient regained consciousness with-
in a few seconds, the event happened about five times. 
When the EMS arrived she was noted to be in ven-
tricular tachycardia. Her AICD also fired three times. 
The patient denied any chest pain, palpitations, nau-
sea, vomiting or diaphoresis during the events. The 
patient also had CPR performed for thirty minutes. 
Cardiac monitor strips available from the ambulance 
records as well as from the ER suggestive of multiple 
runs of ventricular tachycardia, and also the12-lead 
EKG showed  normal sinus rhythm at 68 beats per 
minute, prolonged QTc at 733 milliseconds  but there 
is no significant ST or T wave changes. The patient 
was initially started on amiodarone and lidocaine 
drip in the ER. On reviewing patient’s medications it 
was noted that patient was on Sotalol 160 mg po twice 
a day. Had elevated creatinine of 1.2 at presentation 
with creatinine clearance of 60.On reviewing the 
Telemonitor, it was noted that patient was in Torsades 
with heart rate of 133. Patient was admitted to the 
ICU, 8 mg intravenous magnesium sulfate infusion 
was intiated, which normalized the QTc. Amiodarone 
and lidocaine was discontinued. Echocardiogram 
showed EF of 50-55%. Patient remained asymptom-
atic throughout hospital stay.
discussion: TDP is hemodynamically unstable and 
can cause dizziness and syncope. Depending on their 
cause, most individual episodes of torsades de pointes 
revert to normal sinus rhythm within a few seconds, 
but may also persist and degenerate into ventricular 
fibrillation, leading to sudden death in the absence of 
prompt medical intervention.
CV35
Anti-N-Methyl-D-Aspartate Receptor (NMDAR) 
Encephalitis Associated with Ovarian Teratoma: 
A Challenging Diagnosis
D’Souza, R.D; Salamera, J.S; Rajpal, S.R; Joshi, N.J; Trinitas 
Regional Medical Center, Seton Hall University
introduction: Anti-NMDAR encephalitis is a para-
neoplastic encephalitis associated with anti-NMDAR 
antibodies, first reported in 1997. It is most commonly 
seen in young women with ovarian teratoma, as well 
as in men and children. Some of the characteristic 
clinical features include bizarre dyskinesia, epileptic 
seizures, hypoventilation, neuropsychiatric manifes-
tations, and decreased level of consciousness.
cAse	 rePort: A 25-year old French woman with no 
medical or psychiatric history was brought in from 
Newark Liberty International Airport due to acute 
mental status changes. She was travelling with her 
boyfriend and younger sister from Belgium to United 
States for a leisure trip. The patient was noted to be 
acutely agitated on the plane, evidenced by incoher-
ence of speech, and attempting to open the cockpit 
door. On arrival, she exhibited bizarre behavior with 
uncoordinated movements. As per patient’s boyfriend, 
there was no history of alcohol or substance abuse. 
Urine drug screen, alcohol, and ammonia level were 
negative. Psychotropic medications did not improve 
her mental well-being. A CT scan as well as MRI of 
brain did not show any acute pathology. A diagnostic 
lumbar puncture has CSF lymphocytic pleiocytosis, 
with normal opening pressure, glucose, and protein. 
EEG revealed mild, diffuse slowing. Empiric acyclo-
vir was initiated pending CSF work-up.  Blood, urine, 
and CSF cultures were negative.  Fungal, viral, and 
acid fast bacilli culture were also negative.  Cytology 
has no malignant cells. Patient clinically deteriorated 
with acute urinary retention, and acute hypoxic respi-
ratory failure from aspiration pneumonia. A CT scan 
of the chest, abdomen, and pelvis disclosed multilo-
bar consolidation, and distended urinary bladder up 
to umbilicus. CSF studies including PCR for HSV 1/2, 
West Nile virus, Lyme, VDRL, 14-3-3 protein, myelin 
basic protein, oligoclonal bands, and cryptococcal an-
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tigen were negative. HIV antibody, interferon gamma 
release assay, and ANA were also negative. She was 
started on high dose steroids due to concern for au-
toimmune encephalitis, which was then tapered with 
modest improvement. A repeat CT of the abdomen 
and pelvis revealed a left ovarian mass suggestive 
of ovarian teratoma with positive serum anti-NM-
DAR antibodies on CSF. She underwent resection of 
ovarian teratoma, with concurrent intravenous im-
munoglobulin therapy. Currently, the patient has 
improved neurologically following a trial of ritux-
imab and cyclophosphamide.
discussion: Anti-NMDAR encephalitis and its as-
sociation with ovarian teratoma in young women is 
still a relatively unknown diagnosis. The diversity of 
symptoms frequently results in misdiagnosis as a psy-
chiatric, infectious or toxicological process. Internists 
must consider the diagnosis when a young female 
presents with acute mental status changes and dys-
kinesia, after ruling out toxicological and infectious 
causes. Resection of ovarian tumor and immunother-
apy has been associated with improved outcomes.
CV36
A Case of NSTEMI without Angiographically 
Significant Coronary Artery Disease: Cardiac 
Syndrome X
Dessalinies, N; Iyer, P; Ambreen, B; Siddqui, W; Wingfeld, E; 
Wallach, S; Saint Francis Medical Center, Trenton, NJ
introduction: Patient with cardiac syndrome X 
(CSX) usually presents with typical chest pain, EKG 
changes suggestive of ischemia and normal coronary 
arteries. The cardiac syndrome X is more prevalent in 
young female patients. Cardiac magnetic resonance 
(CMR) has been used primarily in research settings 
to diagnose CSX . The differential diagnoses include 
stress-induced cardiomyopathy, left ventricular hy-
pertrophy, right ventricular hypertrophy, systemic 
amyloidosis and diabetes mellitus. We report a case 
of NSTEMI without angiographically significant coro-
nary artery disease, likely cardiac syndrome X.
cAse	rePort: This is a 46 year-old Caucasian female 
with past medical history of Hypertension, obstruc-
tive sleep apnea and obesity who presented for 
evaluation of chest discomfort. She describes the pain 
at retrosternal chest pressure radiating to the back and 
her left arm. It was associated with shortness of breath, 
nausea and lightheadedness. She smoked half pack of 
cigarettes daily for 20 years but denied drinking alco-
hol or using illicit drugs. She takes no medications at 
home. Vitals showed blood pressure of 132/76 mmHg, 
heart rate of 73 beats/min; oxygen saturation 99% 
on room air and temperature of 97.1o F. The patient 
appeared to be in no acute distress. On physical ex-
amination, neck was supple without elevated jugular 
venous pressure. Cardiovascular exam revealed regu-
lar rate and rhythm without murmurs or gallops. The 
extremities had 2+ pulses throughout without edema. 
EKG showed sinus rhythm, first degree atrioventric-
ular block and T wave inversion in the inferolateral 
leads, suggestive of ischemia. Laboratory data showed 
an elevated troponin at 0.46ng/mL. The patient was 
admitted for NSTEMI and started on aspirin, statin. 
The cardiac catheterization conclusions were no 
angiographically significant coronary artery disease. 
The patient was discharged home with instructions to 
follow up with her cardiologist. However, one month 
later the patient experienced similar chest pain while 
working and was taken to the ER. At that time,acute 
coronary syndrome was ruled out. The patient was 
discharged with the instructions to follow up with 
her cardiologist.
discussion: We report a case of NSTEMI without 
angiographically significant coronary artery disease. 
It is most likely CSX because of her typical chest pain, 
acute coronary event and no angiographically sig-
nificant coronary artery disease. A cardiac magnetic 
resonance enhanced with gadolinium would have 
been helpful to localize the myocardial defect.
CV37
Central Neurogenic Hyperventilation in a 
Conscious Patient: Are Opiods the Only 
Resource as a Bridge Therapy?
Gavilanes, A.J.; D’Souza, R.; Remolina, C.; Schanzer, B.; 
Trinitas Regional Medical Center, Seton Hall School of Health 
and Medical Sciences
introduction: Central Neurogenic hyperventilation 
(CNH) is a rare respiratory syndrome first reported by 
Plum and Swanson in 1959. It is defined by respiratory 
alkalosis in the presence of normal or elevated arterial 
oxygen, decreased arterial carbon dioxide, elevated 
arterial pH. CNH has been strongly associated with 
CNS lymphomas, CLIPPERS (Chronic Lymphocytic 
Inflammation with Pontine Perivascular Enhancement 
Responsive to Steroids syndrome), anti-NMDA re-
ceptor Encephalitis, subcortical infarct specifically 
thalamic, brainstem astrocytomas, gliomas and a po-
tential consequence of hepatic encephalopathy.
cAse	rePort: A 74 year-old Cuban male presented to 
the ED with persistent nausea and vomiting accom-
panied by ataxia with a left-sided preference treated 
for CN VII palsy one-week prior. Initial MRI brain 
revealed a hyperintense lesion in cerebellar pedun-
cles. Symptoms were controlled under oral steroids 
but recurred once steroids were tapered. Patient was 
transferred to the ICU with resultant severe respi-
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ratory alkalosis with a respiratory rate of forties to 
fifties with inadequate metabolic compensation. 
ABG revealed pH of 7.63, PCO2 at 11, HCO3 at 20.9, 
PO2 at 149 and O2 saturation was 98.2% on room air. 
Ventimask (VM) with 330 cc of deadspace improved 
his work of breathing and respiratory rate despite a 
noted semi-stuporous state. Adjuvant pulse steroid 
dosing was initiated after reviewing worsened MRI 
findings including T2 flair hyperintensities in the me-
dial thalami, caudate heads, midbrain, pons, medulla 
and bilateral middle cerebellar peduncles, bilateral 
frontal, parietooccipital regions and both cerebellar 
hemispheres. Subsequently, CSF analysis revealed 
atypical lymphoid cells but flow cytometry diag-
nosed B-cell lymphoma with a normocellular bone 
marrow. CSF culture, AFB, HSV PCR, Cryptococcus, 
VDRL, JC virus PCR were negative. Patient was 
initiated on immunoglobulin therapy followed by 
chemotherapy with Rituximab. Patient later de-
veloped recurrent episodes of hyperventilation 
complicated with aspiration pneumonia and hypox-
emic respiratory failure. Patient also developed VRE 
bacteremia while receiving chemotherapy. Patient 
was intubated for septic shock, developed severe 
acute respiratory distress syndrome, and deteriorat-
ed further clinically. Patient eventually passed away 
on the 40th day.
discussion: Despite the longevity of CNH, no 
current guidelines exist likely due to its undefined 
pathophysiology. Prior approaches had included 
supportive and disease-specific treatments. The 
supportive component is crucial to improve quality 
of life affecting both comatose and alert patients. 
Opoid analgesics had reduced the respiratory burden 
historically.
CV38
Non-Secreting Non-Fibrotic Hepatocellular  
Carcinoma in an Average Risk Population
Gavilanes, A.J.; Asslo, F.; DelaTorre, A.; Baddoura, W.; St. 
Joseph’s Regional Medical Center, New York Medical College
introduction: Hepatocellular carcinoma (HCC) is 
the third leading cancer worldwide. Although the 
current HCC screening examinations in the high 
risk populations have led to increased detection and 
early interventions.  Screening and management of 
HCC in apparently average risk populations is still 
uncertain. Non-fibrotic HCC (NFHCC) is a fairly 
investigated entity potentially arising from non-al-
coholic fatty liver disease (NAFLD) with varying 
degrees of inflammation. Herein, a case of non-se-
creting NFHCC in a 63 year old obese male with no 
apparent risk factors.
cAse	 rePort: We present a 63 year old Caucasian 
obese male (BMI 35.2 Kg/m2) with no significant 
past medical history admitted to our hospital after 
sustaining injuries during motor vehicle accident. 
The patient complained of chest and abdominal pain. 
Subsequently, work up was significant for spinal frac-
ture and an incidental right hepatic lesion found on 
abdominal ultrasound.   On further questioning, the 
patient denied any alcohol abuse, intravenous drug 
abuse or family history for liver or GI tract malignancy. 
The patient also denied weight loss, jaundice or prior 
similar abdominal pain. The physical examination 
was unremarkable, except for right upper quadrant 
abdominal tenderness, mostly subcostal margin. 
Unremarkable liver function test, coagulation profile, 
hepatitis B serology, HBV DNA level, HCV antibody, 
anti-nuclear antibody, anti-smooth muscle antibody, 
iron profile and alfa Feto-protein serum level were 
obtained.  To further investigate the hepatic lesion, a 
MRI of the abdomen with IV contrast was done which 
revealed a 3.8 cm heterogenous lesion with dark cen-
tral and ring enhancement suspicious for malignancy 
and diffuse steatosis otherwise normal biliary tree 
and pancreatic duct appearance without lymphade-
nopathy. Malignancy was confirmed by liver biopsy. 
The patient underwent colonoscopy resulting benign. 
After a discussion with the patient and surgery de-
partment, the plan was to proceed with surgical 
resection of the isolated hepatic tumor. The patient 
successfully underwent a laparoscopic hand-assisted 
resection of the segment 6 and 7 of the liver. The final 
surgical pathology confirmed a moderately differenti-
ated HCC with hepatic steatosis.
discussion: NFHCC lesions were previously observed 
to be related to viral hepatitis especially HBV due to 
increased hepatocyte turnover. Nowadays, some 
NFHCC do not appear to have a clear cause or prema-
lignant environment. Molecular signaling pathways 
triggered by NAFLD may contribute. Fatty infiltration 
may become a sufficient insult in the future.
CV39
A Case of Superior Mesenteric Artery Dissection: 
The Important Facts in Order to Elucidate 
Treatment
Gavilanes, A.J.; Meyreles, G.; DePena-Fernandez, J.; Trinitas 
Regional Medical Center, Seton Hall School of Health and 
Medical Sciences”
introduction: The detection of superior mesen-
teric artery (SMA) dissection has increased by the 
advancement in diagnostic technology. The symp-
tomatic entity still remains a rare and potentially 
fatal disease if complicated. Cystic medial degenera-
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tion, atherosclerosis, fibromuscular dysplasia, elastic 
tissue disorders, rapid deceleration injuries are poten-
tial predisposing factors. No guidelines are available 
in the world bringing up controversy in particular 
instances. We report a case of superior mesenteric ar-
tery dissection of significant length caused by weight 
lifting in a non-smoker normotensive patient.
cAse	rePort: This is a 54 year old Hispanic male with 
no past medical history but remote history of alcohol 
abuse who presented to our hospital complaining of 
new onset epigastric pain triggered by attempting to 
mobilize a 500-pound load onto a carrier. Patient de-
scribed the pain as burning, non-radiating of great 
intensity, exacerbated by bending over, alleviated by 
hydromorphone and associated with self-limiting 
bilious non bloody emesis. The patient is overweight 
who was fully awake, hemodynamically stable. 
Absence of carotid bruits, cardiac murmurs, rubs 
or gallops. Mild epigastric tenderness to light and 
deep palpation of the abdomen. No voluntary or in-
voluntary guarding and normoactive bowel sounds 
present. Distal pulses present and brisk. Ancillary 
diagnostic tests were negative for hyperlactatemia, 
anemia, dyslipidemia or diabetes by hemoglobin 
A1C.  Initial CT abdomen and pelvis with IV contrast 
to evaluate abdominal pain out of proportion found 
a peripheral decreased density involving the SMA 
beginning 1.0 cm distal to the origin compatible 
with a dissection without aorta dissection. This was 
confirmed by follow up CT angiogram (CTA) which 
showed compromise of the entire length and the 
branches were arising from the true lumen.  Based 
on these results, high ranged heparin infusion was 
started to prevent further thromboembolism in the 
surrounding area of the intimal flap; and medical 
management continued in the intensive care unit. 
Presently, the patient is being treated with therapeu-
tic anticoagulation with a plan to continue with oral 
agents unless complications arise.
discussion: In patients with uncomplicated SMA 
dissection, a conservative approach with anti-
coagulation and follow-up imaging is strongly 
recommended as first line therapy. Length of in-
volvement could dictate a different approach such 
as endovascular stents or urgent laparotomy based 
on the emergence of clinical deterioration or radio-
graphic signs of bowel ischemia.
CV40
A Susceptible Bowel: The Natural Course after 
Disseminated Histoplasmosis
Gavilanes, A.J.; Salamera, J.; Pandya-Berry, S.; Trinitas 
Regional Medical Center, Seton Hall School of Health and 
Medical Sciences
introduction: Histoplasmosis is the most prevalent 
endemic mycosis in the United States, with gastro-
intestinal (GI) tract involvement reported in about 
70-80% of cases. Plenty has been said in regards to 
isolated episodes of progressive disseminated his-
toplasmosis (PDH) affecting the intestine, yet to be 
determined is the natural course of a disrupted bow-
el rendered susceptible to either a possible structural 
intestinal complication, or a superimposed infection.
cAse	rePort: A 49 year-old heterosexual male from 
Honduras with AIDS (CD4 count of 87 and viral load 
of >10 E6 copies/ml off HAART) presented with fever, 
abdominal pain, and bloody mucoid diarrhea. He 
appeared toxic, wasted, but hemodynamically stable. 
The is no rash, peripheral lymphadenopathy, with 
hyperactive bowel sounds, borborygmi, and peri-
umbilical tenderness radiating to left lower quadrant 
associated with guarding. He required multiple blood 
transfusions due to significant anemia. Colonoscopy 
revealed a mass-like ulcer in the ascending colon, 
initially identified as bowel wall thickening accom-
panied by fat stranding on CT abdomen. Biopsy was 
consistent with chronic granulomatous fungal coli-
tis. Cosyntropin stimulation test ruled out adrenal 
insufficiency. Induction Amphotericin B was started 
followed by oral itraconazole with significant clini-
cal improvement. Urinary antigen for Histoplasma 
was positive. Patient returned one week later with 
worsening abdominal distension and recurrence of 
diarrhea secondary to noncompliance to medica-
tions.  C. difficile colitis complicated the course but 
improved after oral metronidazole. Currently, pa-
tient is at his 4month of itraconazole with a plan to 
repeat colonoscopy to assess colonic mass.
discussion: Relapse from Histoplasmosis or com-
plications are significantly reduced by maintenance 
therapy after 12 to 24 months. Nevertheless, PDH 
sometimes takes an unexpected turn when co-in-
fections such as parasitic, viral or bacterial develop 
increasing Histoplasma pathogenicity. Should this 
occur, be alert to manage differently as it could af-
fect the long-term outcome.
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CV41
A Calcium Delema: A Case of Idiopathic Milk  
Alkali Syndrome
Goddard, K.K.; Ford, D.O.; Mcanally, J.F.; Trinitas Regional 
Medical Center, Seton Hall University
introduction: The presence of hypercalcemia is a 
relatively common problem. Most times it is encoun-
tered in the outpatient setting as an incidental finding 
on laboratory work up. The two most common causes 
by far, accounting for greater than 90% of cases, are 
primary hyperparathyroidism versus malignancy. In 
this case no cause could be identified.
cAse	 rePort: A 71-year-old white woman with a 
history of hypertension, dyslipidemia, and hypothy-
roidism, on lisinopril and levothyroxine presented to 
the emergency department with change in mental sta-
tus associated with weakness, fatigue, and 20 pound 
unintentional weight loss over six months. The initial 
serum calcium was 16.7 mg/dL. The serum creatinine 
was 1.7 mg/dL and the serum bicarbonate was 33 
mEq/L. Because of the magnitude of the hypercalce-
mia in the setting of the weight loss, the initial concern 
was that the hypercalcemia was related to an occult 
malignancy. Diagnostic studies revealed the follow-
ing: A decreased PTH level,a suppressed PTHrP level, 
a suppressed. 25-vitamin D level and a suppressed 
1,25-vitamin D level. A serum protein electrophoresis 
was normal. Since the patient had acute kidney injury 
and metabolic alkalosis in the setting of hypercalce-
mia, she met criteria for the diagnosis of milk-alkali 
syndrome. Despite extensive questioning this reliable 
patient denied ingestion of calcium-containing agents 
or food. Repeat values of PTH and calcium have been 
normal. We conclude that this patient had idiopath-
ic milk-alkali syndrome secondary to an unknown 
source of calcium and alkali.
discussion: A review of the literature did not reveal 
any documentation of ”idiopatic hypercalcemia”.
CV42
Neovascularity and Fistulous Communication  
on Coronary Angiography in a Patient with Left  
Atrial Thrombus and Severe Mitral Valve Stenosis
Habib, M.G; Shamoon, F.; Seton Hall University
introduction: Coronary neovascularity and fistula 
formation found on coronary angiogram have been 
described in the literature in association with left atri-
al neoplasm, thrombosis in patients with mitral valve 
disease, or congenital anomaly.
cAse	 rePort: 82 year old female with a past medi-
cal history significant for severe mitral stenosis and 
chronic atrial fibrillation (on anti-coagulation therapy 
with Coumadin) was admitted for blood-streaked 
sputum and shortness of breath. Transesophageal 
echocardiogram revealed normal ejection fraction 
of 55-60%, severe thickening and calcification of the 
anterior and posterior mitral valve leaflets, with re-
duced mobility, and a mean transmitral gradient of 
11 mmHg when averaged for 5 beats. The left atrium 
was severely dilated, with severe smoke (spontaneous 
contrast). The right atrium was also severely dilated. 
There was severe tricuspid regurgitation, with severe 
pulmonary hypertension (systolic pulmonary artery 
pressure of 72 mmHg). There was a large hetero-
geneous echodensity, extending from the left atrial 
appendage, and coursing along the lateral wall of the 
left atrium measuring 8.9 cm x 3.6 cm. Coronary an-
giogram revealed non-obstructive coronary artery 
disease; neovascularity and fistulous communication 
arising from the left circumflex artery, with staining 
of the myocardium. There was also some puddling of 
contrast within the left atrium from enlarged atrial 
branches, and pooled contrast outlining a large ir-
regular defect.
discussion: Although transesophageal echocar-
diography is most frequently used for non-invasive 
assessment of intracardiac structures, coronary angi-
ography can still provide a useful diagnostic tool in 
the diagnosis of left atrial thrombus in patients with 
mitral valve disease.
CV43
Spontaneous Isolated Infra-Renal Abdominal  
Aortic Dissection, A Rare Cause of Abdominal 
Pain
Habib, H; Thawabi, M; Shamoon, F; Saint Michael’s Medical 
Center
introduction: Acute aortic dissection occurs when 
blood enters to the medial aortic layer through an 
intimal tear, resulting in separation of the layers of 
the aortic wall. Thoracic aorta is usually involved 
with extension to the abdominal aorta in an antero-
grade fashion. Spontaneous isolated infra-renal 
abdominal aortic dissection is an extremely rare en-
tity that has been reported in few case reports in 
literature. However, its recognition and prompt 
management is crucial to prevent devastating com-
plications. Computerized tomography and Magnetic 
resonance images are the best modalities to identify 
this entity. Treatment strategies of IAAD are not well 
defined and relies on institutional preference and 
expertise. Therapeutic options include open surgical 
repair, endovascular repair, and observation.
cAse	rePort: A 54 year-old male patient, with a past 
medical history of hypertension, presented to the 
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emergency department with a history of one day left 
lower quadrant pain. The pain was associated with 
nausea. No vomiting, change in bowel habits, fever, 
chills, chest pain, or any focal neurological deficits 
were reported. No previous history of similar com-
plaints.  No previous history of trauma or previous 
surgeries or vascular interventions was reported. He 
had a history of 40 pack.year smoking and a history 
of intravenous drugs abuse. His vital signs were sig-
nificant for elevated blood pressure of 179/118. The 
physical examination didn’t reveal any significant 
abnormality. Basic blood workup didn’t reveal any 
significant abnormality. CT-scan of the abdomen and 
pelvis with intravenous contrast revealed acute iso-
lated abdominal aortic dissection extending from the 
distal aorta to the right common iliac artery. Blood 
pressure was promptly controlled with intravenous 
labetalol and vascular surgery was consulted. The pa-
tient symptoms improved with blood pressure control 
and a decision was made to observe the patient with-
out surgical intervention.
discussion: Spontaneous isolated infra-renal abdomi-
nal aortic dissection can present differently compared 
with the classic type B aortic dissection, and requires 
high index of suspicion. Accurate, timely diagnosis is 
crucial to prevent serious complications. Continued 
surveillance is an accepted modality in stable patients.
CV44
Grave’s Disease Unmasking Underlying Left  
Ventricular Non-Compaction
Habib, H.; Rampal, U.; Shamoon, F.; Saint Michael’s Medical 
Center, Newark NJ. Seton hall Univeristy
introduction: Isolated LV Non-compaction (LVNC) is 
a rare genetic cardiomyopathy characterized by modi-
fication of the LV wall into an outer compact layer and 
an inner non-compacted layer consisting of deep in-
tra-trabecular recesses and prominent trabeculations 
resulting in clinical manifestations of dilated cardio-
myopathy. Various congenital heart disorders and 
neuromuscular disorders have been associated with 
LVNC. We would like to report a case of LVNC, which 
was unmasked due to development of hyperthyroid 
state secondary to new onset Graves’s disease.
cAse	rePort: 26 y/o African American female with no 
significant medical history presented with chief com-
plains of worsening shortness of breath, orthopnea, 
PND for one month.  Patient also reported heat intoler-
ance, palpitation and multiple episodes of lose watery 
diarrhea over the proceeding few months. Physical 
exam revealed bilateral crackles and sinus tachycar-
dia on EKG. Laboratory values revealed and elevated 
BNP of 623 pg/ml, elevated T4 (4.49 ng/dl) with low 
TSH (<0.01 uIU/ml). Initial chest X-Ray revealed 
bilateral interstitial edema.  Echocardiogram with 
contrast demonstrated hyper-trabeculation Cardiac 
MRI confirmed diagnosis of LV Non-compaction 
with ratio of non-compacted to compacted myocar-
dium of 3.5 and ejections fraction of 30%. Elevated 
anti-thyroglobulin antibody (29IU/ml) and elevated 
thyroid stimulating antibody (261%) confirmed diag-
nosis of Graves disease fro which patient was started 
on methimazole.  Patient was treated for heart failure 
with diuretic, beta-blockers, ACE inhibtors and spi-
ronolactone and was discharged home on a wearable 
cardioverter-defibrillator.
discussion:	 LVNC is characterized by modification 
of the LV wall into a bi-layered outer compact and 
inner spongy layer. Hyperthyroidism can lead to a re-
markable increase in preload, heart rate resulting in 
precipitation of heart failure. To our knowledge this is 
the first reported case of LVNC unmasked by Grave’s 
disease.
CV45
A Case Report on Complications of Right-Sided 
Infective Endocarditis and Its Implications
Hao, F. Y. I.; Shittu, K.; Barahona, F.; Shamoon, F.; Slim, J.; 
St. Michael’s Medical Center
introduction: The right-sided infective endocar-
ditis (IE) has always been associated with a lesser 
degree of complications than the left-sided infective 
endocarditis.  Here we are reporting a case of com-
plicated, right-sided endocarditis with a large, friable 
and highly mobile tricuspid valve vegetation.  It has 
persistently produced embolic events (EE) despite an 
appropriate course of intravenous antibiotics.
cAse	rePort: A 36-year-old woman with a history of 
hepatitis C virus (HCV) infection and chronic poly-
substance dependence disorder presented to the acute 
medical unit with fever, dyspnea, pleuritic chest pain, 
and hemoptysis of one-week duration. The patient 
had been actively injecting cocaine and heroin into 
her right forearm causing a chronic open ulcer. Initial 
investigation involved a transthoracic echocardiog-
raphy, which revealed a large, friable highly mobile 
vegetation of >20 mm seen on the tricuspid valve.  Her 
presentation was further complicated by septic embo-
li shown on the CT of the chest.  The blood cultures 
were positive for Group G streptococcus and MRSA. 
In addition to administering bactericidal therapy for 
endocarditis, we considered the need for surgical in-
tervention, but this patient had no clear indications for 
valve surgery.  The patient received a total of 6 weeks 
of Vancomycin.  However, about 2 months after the 
completion of the intravenous antibiotics, the patient 
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returned to our acute care unit with a sudden onset 
of acute renal failure requiring emergency hemodi-
alysis.  Her chest x-ray showed worsening of septic 
emboli, which appeared to have become multiple cav-
itary lesions. The transthoracic echocardiography was 
repeated, which again showed the tricuspid valve 
vegetation measuring >20mm.  In light of nephrology 
recommendation, the kidney biopsy was done and 
resulted in a picture of crescentic necrotizing glomer-
ulonephritis, most likely due to persistent infective 
endocarditis.
discussion: The very large vegetations (>15mm) have 
been shown to be independently associated with a 
worse prognosis.  A recent prospective study showed 
that vegetation length on echocardiography has major 
prognostic implications by predicting EE under anti-
biotic therapy. Whether a more aggressive therapeutic 
strategy (ie, early surgery) is required warrants fur-
ther prospective studies.
CV46
A Case of Ascending Aortic Dissection with  
Concurrent Acute Myocardial Infarction, Stroke 
and Pericardial Tamponade
Hawatmeh, A.Y; Isbitan, A; Abu Arqoub, A.H; Jumean, K.H; 
Shamoon, F.; St. Michael’s Medical Center
introduction: Aortic dissection is a disease of 
immediate consequence, as mortality of a proximal 
dissection is in excess of 50% when left untreated. 
Early recognition of the dissection event can lead to 
faster definitive correction with surgical and/or novel 
percutaneous approaches. Widely varying signs 
and symptoms can, however, make this diagnosis a 
challenge. This is a case of aortic dissection that is 
presented as concomitant ST elevation myocardial 
infarction,stroke and pericardial tamponade.
cAse	rePort: 60 year old male with past medical histo-
ry of  hypertension which was adequately controlled, 
presented to emergency department with chest pain 
of 2 hours duration, the pain was described as tear-
ing, retrosternal, radiating to left neck and shoulder 
and associated with nausea, and sweating. Patient 
also reported having a new onset slurred speech and 
right upper extremity weakness.There was no history 
of coronary artery disease, diabetes mellitus, smok-
ing or family history of ischemic heart disease. Initial 
vital signs showed Blood pressure of 120/90 mmHg 
in right arm, and 100/70 mmHg in left arm, Heart 
rate of 90 beats.Physical exam showed jugular venous 
pressure 3 cm above the sternal angle with nega-
tive kussmaul’s sign. Cardiac exam showed muffled 
heart sounds, with early diastolic murmur, 3/6 in 
intensity,without radiation and with no S3 or S4 gal-
lop.Neurological and musculoskeletal exam showed 
expressive aphasia, intact cranial nerves, normal mus-
cle tone, power was 3/5 in the right upper extremity 
otherwise normal, had +2 deep tendon reflexes. Initial 
lab results showed a white blood cell count of 8.14 k 
/Î_L, hemoglobin of 12.2 g/dL, platelets of 177 k/Î_L, 
creatinine of 0.89 mg/dL,cardiac enzymes were nega-
tive.electrocardiogram (EKG) showed ST segment 
elevations in inferior and lateral leads. Given the pa-
tient chest pain and EKG findings, the patient’s chest 
pain was thought to be secondary to acute coronary 
syndrome, specifically ST elevation myocardial in-
farction (STEMI) and the patient was brought quickly 
to the cardiac catheterization lab for an emergent cor-
onary angiography. The coronary angiogram showed 
normal coronary arteries with ascending aortic 
dissection.After that  vascular surgery was  immedi-
ately consulted, and an aortic computed tomography 
(CT) scan was done, which showed dissection of the 
ascending aorta. Head CT scan was also done and 
showed acute left middle cerebral artery territory 
infarction.CT angiogram of the neck showed normal 
extracranial carotid, vertebral and subclavian arteries.
The decision for immediate surgical repair was made, 
the patient underwent emergency ascending aortic 
and hemiarch replacement under cardiopulmonary 
bypass with Hama shield (38 mm) platinum graft that 
was done successfully without complications. After 
that patient had an uncomplicated postoperative 
course and was discharged in a stable condition.
discussion: Acute aortic dissection (AD) an extremely 
severe condition having a high risk of mortality.The 
classic symptom may mimic other conditions such 
as myocardial ischemia,leading to misdiagnosis.
Coronary malperfusion associated with aortic AD is 
relatively rare but may have fatal results.The diagnosis 
of ACS may lead to the inappropriate administration 
of thrombolytic or anticoagulant treatment resulting 
in catastrophic consequences. Emergency imaging 
techniques help to guide the correct diagnosis.
CV47
Cannabinoids Hyperemesis Syndrome
Hawatmeh, A.Y; Abu Arqoub, A.H; Massarweh, F.M; Jumean, 
K.H; St. Michael’s Medical Center
introduction: Cannabinoid Hyperemesis Syndrome 
(CHS) was first described in 2004. CHS is character-
ized by cyclical nausea and vomiting, abdominal pain, 
and an unusual compulsion to take hot showers in the 
presence of chronic use of cannabinoids. The patho-
physiology of CHS is not well understood. However, 
it is known that chronic marijuana use stimulates 
cannabinoid receptor type 1 (CB1) in the brain result-
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ing in decreased peristalsis. Due to its novelty, CHS 
is often unrecognized by clinicians leading to expen-
sive workup of these patients with cyclical symptoms.
Testing should be geared towards excluding central 
nervous system, endocrine, metabolic, and gastroin-
testinal causes of nausea and vomiting after a careful 
history and physical examination.
cAse	rePort: 33 year old female with long-term histo-
ry of cannabinoid use and no significant past medical 
history, presented to emergency department com-
plaining of abdominal pain for 3 days, the pain was 
periumbilical, localized and cramping in nature, it 
was also associated with nausea and many episodes 
of vomiting of clear fluids, with no diarrhea, consti-
pation or urinary symptoms. The patient reported 
having recurrent similar episodes of pain, nausea 
and vomiting for the last 4 years, usually every 3-4 
months which used to last for 2-3 days and terminat-
ed without medical intervention and indicated that 
warm baths usually provides relief of her symptoms. 
She admitted to smoking marijuana daily, she smoked 
2-3 cigars per day for at least the past 12 years. An ex-
tensive gastrointestinal evaluations were done before, 
but failed to identify a clear cause. On physical exam 
her vital signs were normal, she was afebrile with 
temperature of 36.8°C, pulse of  88/min, a respiratory 
rate of 16/min, a blood pressure of 137/83 mmHg, and 
oxygen saturation of 98% while breathing ambient 
air. She was awake and alert, her mucus membranes 
were dry, her abdomen was soft, non tender with posi-
tive bowel sounds.  Laboratory data included a white 
blood cell count of 11,300 cells/mL with normal com-
plete blood count (CBC), basic metabolic profile (BMP) 
was normal except for potassium of 2.9 mmol/L, liver 
enzymes, amylase and lipase were normal. Urine 
drug screen was positive for cannabinoids. Based on 
proposed diagnostic criteria for CHS,  the diagnosis 
of Cannabinoid Hyperemesis Syndrome was made.
The patient was admitted for rehydration, antiemetics, 
the patient was advised to discontinue marijuana use. 
She had a symptom-free period with the cessation of 
marijuana use. 
discussion: Cannabinoid Hyperemesis Syndrome 
is characterized by cyclic vomiting, abdominal pain, 
and compulsive need to take hot showers. It is an epi-
sodic, recurrent disorder with symptom free periods 
in-between. The symptoms resolve in the hospital 
as cannabinoid blood levels wane. The associated 
abdominal pain is usually diffuse,mild, and poorly 
characterized. The pathophysiology of CHS is not 
well understood. However, it is known that chronic 
marijuana use stimulates cannabinoid receptor type 
1 in the brain.
CV48
Spontaneous Rupture of Hepatocellular 
Carcinoma
Hawatmeh, A.Y; Abu Arqoub, A.H; Jumean, K.H; Shaaban, H.; 
St. Michael’s Medical Center
introduction: Hepatocellular carcinoma (HCC) is 
the most common primary malignant tumor of the 
liver,and one of the leading causes of death in patients 
with cirrhosis.Spontaneous rupture is a fatal compli-
cation of HCC that occurs in 3-15 percent of cases, and 
is associated with worse short and long term progno-
sis. The exact mechanism of spontaneous rupture of 
HCC is not clearly known at the present time, but it 
is believed to be related to a tear in the tumor surface 
or rupture of a feeding artery.Risk factors that could 
be responsible for HCC rupture include subcapsu-
lar location,rapid growth of the tumor with necrosis 
and erosion of vessels and blunt abdominal trauma 
especially with superficial tumors. This case report 
exemplifies the importance of early diagnosis and 
treatment of ruptured HCC.
cAse	rePort: We are presenting a case of a 64 year-old 
female with past medical history of hypertension and 
hepatitis C which was diagnosed and treated in 2000, 
with interferon and ribavirin.She presented to our 
emergency department with a worsening right upper 
abdominal pain for the last few months, the symp-
toms continued to worsen until her presentation to 
the emergency department. Initial vital signs showed 
blood pressure of 140/76 mm Hg, pulse rate of 74 beat 
per minute, and respiratory rate was 18 breaths per 
min. Physical examination was significant for a right 
upper quadrant tenderness,soft abdomen with no 
guarding or rigidity and active bowel sounds, nor-
mal heart sounds with no murmurs or added sounds 
and normal breath sounds. Initial lab results showed 
a white blood cell count of 7.4 k /mL, hemoglobin of 
14.2 g/dL, platelets of 177 k/mL, creatinine of 0.89 mg/
dL, AST of 30 IU/L, ALT of 29 IU/L, ALP of 63, to-
tal bilirubin of 0.8, Prothrombin time of 13.6 seconds, 
Partial thromboplastin time of 25.7 seconds , INR of 
1.3, albumin of 3.9 g/dL, alpha feto protein of 1380 
ng/mL. An abdominal ultrasound was done which 
showed a 7 * 6 cm mass in the right hepatic lobe , then 
abdominal computed tomography (CT) scan with 
contrast and triple phase abdomen CT scan was done 
for better visualization of the mass which showed a 
7.2*5.8 cm heterogeneous enhancing mass in the sixth 
segment of the liver, with a pseudocapsule bulges on 
the liver capsule, which has an adjacent small 6*3 cm 
accumulation of complex fluid which likely repre-
sents a ruptured HCC, and less likely a benign liver 
tumor with regional hematoma, the liver was abnor-
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mal in appearance with nodular contour suggestive of 
underlying cirrhosis/fibrosis. The patient’s hemoglo-
bin level dropped to 12.2 g/dL and she became more 
tachycardic during the course of her admission, so the 
impression was that the patient has a ruptured HCC, 
and the decision was to do an IR guided bland em-
bolization of the tumor. The embolization was done 
using polyvinyl alcohol particles (PVA). After that, 
the patient remain hemodynamically stable, and later 
she underwent resection of the tumor and the sixth 
segment of the liver, during surgery there was no evi-
dence of spread of the tumor outside the liver. At this 
point the decision was made to follow up the patient 
closely with AFP,LFT and imaging studies every 3 
months for the first 2 years.
discussion: Spontaneous rupture is a major life 
threatening complication of HCC that occurs in 3-15% 
of cases with geographical differences. The incidence 
is decreasing due to early detection and screening 
for HCC. Short and long-term survival rate after rup-
tured HCC is worse compared to non-ruptured HCC 
patients. Spontaneous rupture is considered the third 
leading cause of HCC related death,after tumor pro-
gression and liver failure with an associated mortality 
that is higher than ruptured esophageal varices.
CV49
Percutaneous Endoscopic Gastrostomy Tube 
Migration Associated with Acute Pancreatitis
Hawatmeh, A.Y.; Al-Khateeb, A.J.; Jumean, K.H.; Abu Arqoub, 
A.H.; St. Michael’s Medical Center
introduction:	Percutaneous endoscopic gastrostomy 
(PEG) tube is a useful way of providing enteral nutri-
tion to patients with swallowing problems who need 
chronic nutritional support. Because of its ease and 
safety of placement, the number of patients with PEG 
tubes continues to rise. Most of the complications as-
sociated with PEG tube are minor, but several have 
the potential to cause significant morbidity if not 
recognized and treated correctly. This case report 
illustrates one of the problems related to PEG tube 
migration to the duodenum and the associated com-
plications, including disturbance of the biliary flow 
and acute pancreatitis. 
cAse	 rePort: A 76 year old female who is a nurs-
ing home resident, with a past medical history of 
Alzheimer dementia, diabetes mellitus, coronary 
artery disease, hypothyroidism, dyslipidemia and 
oropharyngeal dysphagia for which she had a PEG 
tube inserted one year prior to her admission ,her 
PEG tube was replaced at bedside in the nursing 
home with a balloon gastrostomy tube shortly before 
her presentation .The patient was sent from the nurs-
ing home for abdominal pain of one day duration,the 
pain was associated with non-bloody non-bilious 
vomiting, without any change in bowel habits, fever 
or chills. Her list of medications included Tylenol, 
Plavix, diltiazem, insulin lispro, levothyroxine, sim-
vastatin, esomeprazole, and magnesium hydroxide. 
Initial vital signs showed blood pressure of 145/70 
mmHg, pulse rate of 110 beat per minute, and respira-
tory rate was 18 breaths per min, oxygen saturation 
was 98 percent on room air. Physical examination was 
significant for tachycardia,normal heart sounds with 
no murmurs or added sounds, normal breath sounds 
and a soft abdomen with epigastric tenderness and ac-
tive bowel sounds, PEG tube was noted in place.Blood 
work showed Hemoglobin of 12.1 g/dL , WBC 8.9 k 
/Î_L , platelets 322 k /Î_L, creatinine 1.53 mg/dL, urea 
60 mg/dL, glucose 381 mg/dL, calcium 9.3 mg/dL, al-
bumin 3.3 g/dL, alkaline phosphatase 248 U/L, total 
bilirubin 0.5 mg/dL, AST 22 U/L, ALT 28 U/L, LDH 
204 U/L, lipase 918 U/L,serum triglyceride and se-
rum calcium were within normal limits. Abdominal 
ultrasound showed distended gallbladder with no 
gallstones, sludge or biliary dilatation. Computed 
Tomography (CT) scan of the abdomen revealed sub-
optimal position of the PEG tube,with the balloon 
and tip in the second/third portion of the duodenum 
,without evidence of pancreatic inflammation. 
discussion: PEG tubes use has increased significantly. 
It is estimated that 10 percent of nursing home residents 
and about 1.7 percent of Medicare patients over the age 
of 85 years undergo gastrostomy tube placement.The 
most common complications related to established 
PEG tubes are peristomal infection and leakage,buried 
bumper syndrome, peritonitis,necrotizing fasciitis 
and aspiration.Acute pancreatitis secondary to mi-
grated replacement gastrostomy tubes has been rarely 
reported in the literature.
CV50
Persistent Left Superior Vena Cava
Hawatmeh, A.Y.; Abu Arqoub, A.H.; Jumean, K.H.; St. Michael’s 
Medical Center
introduction: Persistent left superior vena cava 
(PLSVC) is rare, and yet the most commonly described 
thoracic venous anomaly. It is reported in 0.3% of the 
general population. This anomaly is frequently ob-
served in patients with congenital heart disease and 
has occasionally been reported in patients without 
evidence of other congenital abnormalities. 
cAse	 rePort: 75 year old male with past medical 
history of hypertension, Diabetes mellitus, seizure 
disorder, hemorrhagic stroke. Who was transferred 
from nursing home after he had a tonic-clonic seizure. 
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Upon arrival to emergency department he was found 
to be in postictal state, lethargic, febrile with temper-
ature of 101.6 F, hypotensive with BP of 86/45 mmHg, 
tachypnic and tachycardic. Head CT scan didn’t 
show any evidence any new intracranial hemorrhage, 
stroke or space occupying lesions. His labs showed 
white blood cells count of 14,000  K/uL, hemoglobin 
of 14g/dL,sodium level of 151, lactic acid of 3.6 and 
creatinine of 3.7mg/dl. After initial resuscitation , the 
patient was transferred to intensive care unit and a 
left side internal jugular central venous catheter was 
inserted under ultrasound guidance. Follow up chest 
x-ray after line placement showed a new left internal 
jugular vein central line with the tip projecting over 
the left side of the mediastinum instead of crossing 
midline to the right to enter the superior vena cava. 
Extravascular placement was excluded, and the blood 
sample drawn from the catheter looked like venous 
blood (dark blue rather than bright red) with PaO2 of 
45 mm Hg, while the ABG’s showed PaO2 of 85 mm 
Hg, which confirms that the catheter was intrave-
nous. A variation of venous anatomy was suggested, 
but confirmation of the anomaly was necessary. A 
computed tomography or venography with a contrast 
dye has been the conventional and precise method 
of investigation. But considering the patient’s status, 
exposure to contrast dye and radiation during the 
procedure was considered to be harmful. Finally, we 
performed a bed-side transthoracic echocardiogra-
phy for the diagnosis. Echocardiogram revealed a 
dilated coronary sinus with normal right sided filling 
pressures, raising the suspicion for the presence of a 
PLSVC. 
discussion: Persistent left SVC(PLSVC) is the result of 
a persistent patency of an embryological vessel that 
is present during the early developmental period. It 
usually drains into the right atrium through a dilated 
coronary sinus. However, in some cases, it may drain 
directly into the left atrium producing a right-to-left 
shunt, or directly into the right atrium.In most cases 
PLSVC is asymptomatic; however, in certain situa-
tions the observation of this abnormality may have 
important clinical implications.
CV51
A Case of Hepatitis C Virus Infection and Type 
I Membrano-Proliferative Glomerulonephritis 
without Cryogloburinemia
Imayama, I.; Dessalines, N.; Ejidike, M.; Mettupalli, N.; Aung, 
M.; Sheikh, S.; Smith, J. M.; Saint Francis Medical Center
introduction: HCV infection is associated with a 
4-fold increased risk of renal insufficiency. Renal 
manifestations seen among patients with chronic HCV 
infection include membrano-proliferative glomeru-
lonephritis (MPGN) resulting from essential mixed 
cryoglobulinemia. 
cAse	rePort: A 54-year-old African American prisoner 
with past medical history of hypertension, hepatitis 
B (post treatment), and chronic HCV infection pre-
sented with worsening epigastric pain of 5 weeks 
duration. On physical examination, the temperature 
was 36.7°C, the heart rate 87 bpm, the blood pressure 
181/122 mmHg, the respiratory rate 18/minutes and 
oxygen saturation 100% on room air. The positive per-
tinent findings were dry skin, elevated jugular venous 
pulse, and decreased breath sounds at the left lung 
base. The abdomen was distended but soft, with hypo-
active bowel sounds, tender and positive for fluid wave. 
There was pitting edema on bilateral lower extremities. 
There was no jaundice, rash, telangiectasia or caput 
medusae. Laboratory studies revealed increased blood 
uremia nitrogen level 67 mg/dl, creatinine 2.8 mg/dl, 
and aspartate aminotransferase 60 U/L; decreased total 
protein 5 g/dl and albumin 2.9 g/dl. Platelet, coagula-
tion panel, and alanine aminotransferase were within 
normal limits. Urinalysis showed red blood cell >100 
high power field, total protein >300 mg/dL with hya-
line casts, and elevated total protein-to-creatinine-ratio 
of 3.8. Complement levels (C3 and C4) were decreased 
to 88 and <3 mg/dL, respectively. IgM kappa and IgG 
lambda monoclonal bands were detected in immuno-
globulin assay. Antinuclear antibodies, anti-neutrophil 
cytoplasmic antibodies and cryoglobulin levels were 
negative. Hepatitis panel showed HCV genotype 1a 
with a viral load of 2.3x106 IU/mL. Computed tomog-
raphy of the abdomen without contrast revealed large 
volume intra-abdominal ascites and bilateral pleural ef-
fusions. No structural renal abnormality was observed. 
Paracentesis revealed spontaneous bacterial peritonitis 
without malignant cells. Renal biopsy revealed type 
I MPGN with focal crescents. The Patient was trans-
ferred to receive treatment for chronic HCV infection.
discussion: Few case reports exist on type I MPGN in 
patients who are HCV positive but cryogloburinemia 
negative. Reviews indicated multiple concerns on cryo-
globulin tests (e.g., sample handling and methodology) 
potentially leading to false-negative results. 
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CV52
A Case of Guide Wire Fracture with Minimal  
Manipulation: Case Report and Literature Review
Isbitan, A.A.; Abu Arqoub, A.; Hawatmeh, A.; jmeian, A.; 
Shamoon, F.; Saint Michael Medical Center, Seton Hall 
University
introduction: Dislodgment of wire is a rare com-
plication of endovascular interventions, often life 
threatening with a risk of distant embolization and 
acute coronary thrombosis though the outcome of 
those complications are unknown.
cAse	rePort: A 61-year-old  male with past medical 
history of diabetes mellitus, hypertension, dyslipid-
emia, admitted for staged PCI after history of recent 
STEMI with primary PCI of Left anterior descending 
artery. We initially cannulated the left circumflex ar-
tery, a KINETIX plus MOD support (0.014*185cm) wire 
was used, and drug eluting stent was placed across 
the mid left circumflex lesion and deployed at a maxi-
mum inflation pressure of 12 Atm, during an attempt 
to pull back the wire to cannulate OM-3 vessel a frac-
ture of the distal segment of KINETIX wire occurred 
though the operator did minimal manipulation of the 
wire. Because  an attempt of retrieval using a snare 
failed the decision to place a stent over the fracture 
wire was made.
discussion: Dislodgment or fracture of catheter com-
ponents is rare but more frequently encountered 
nowadays as the number of interventional procedures 
is increasing. Complications might be life threating 
and immediate intervention should be considered. 
Stenting over a fractured catheter component might 
be protective from future thrombotic events as in our 
case, consensus might be needed in this regard and 
further research is required.
CV53
Ruptured Left Ventricular Pseudoaneurysm:  
A Possible Complication of Power Injector  
Assisted Ventricular Angiography. A Case Report 
and Review of the Literature
Isbitan, A.A.; Hawatmeh, A.; Abu Arqoob, A.; Altheeb, Z.F.; 
Shamoon, F.; Saint Michael’s Medical Center, Seton Hall 
University
introduction: Left ventricular pseudoaneurysm, also 
referred to as contained left ventricular wall rupture, 
is a rare complication that is reported in about 0.2 to 
0.3 percent of all myocardial infarction patients.Since 
it has a high risk of fatal rupture, early surgical repair 
is recommended once pseudoaneurysm is diagnosed.
cAse	rePort: We are presenting a case of 66 year-old 
male with a past medical history of diabetes mellitus 
and hypertension, who presented to our emergency 
department complaining of chest pain for three 
days. Emergent  Coronary angiography was done 
for STEMI and showed a total occlusion of the pos-
terior descending artery. Left ventricular angiogram 
(LV Gram) showed an inferior wall pseudoaneurysm, 
During cardiac catheterization the patient received 
two powered injection LV Grams. Shortly after that 
the patient became hypotensive and hemodynamical-
ly unstable, which then developed in to cardiac arrest. 
At this point the assumption was that the pseudoa-
neurysm ruptured, causing hemopericardium and 
cardiac tamponade, so pericardiocentesis was im-
mediately performed and a bedside echocardiogram 
confirmed the diagnosis  of moderate to severe peri-
cardial effusion with diastolic collapse of the right 
atrium and ventricle. The patient’s blood pressure 
didn’t improve after the pericardiocentesis despite 
the removal of about 150 ml of bloody pericardial fuid. 
By that time the cardiothoracic surgeon was avail-
able and an emergent lower mini sternotomy surgery 
was performed ,during which the pericardium was 
resected, and bloody pericardial fluid with clots was 
seen confirming the diagnosis of cardiac rupture. 
Unfortunately the patient remained pulseless with 
no recordable blood pressure, despite all the efforts 
which were made to resuscitate him, and he was pro-
nounced dead.
discussion: Fatal rupture, hemopericardium, and 
tamponade are among the most important compli-
cations of pseudoaneurysm. Although no literature 
is available concerning the safety of left ventriculag-
raphy angiography in patients who presents acutely 
with left ventricular pseudoaneurysm, we suggest 
that care should be taken while performing left ven-
triculography to avoid fatal rupture.
CV54
A Interesting Case of Rhabdomyolysis Due to  
Ingestion of Energy Drink Volt
Iyer, P.; Miriyala, V.; Tatari, A.; Khan, M.; Aung, M.; Datla, A.R.; 
Smith, M.J.; Saint Francis Medical Center, Trenton, NJ
introduction: Rhabdomyolysis is defined as eleva-
tion of serum creatine kinase (CK) levels of at least 10 
times the upper limit of normal; followed by a rapid 
decrease of the CK level. Classical features include my-
algia, weakness and pigmenturia. Acute renal failure 
due to acute tubular necrosis is the most anticipated 
complication. Common causes include substance 
abuse, medication, trauma and epileptic seizures. We 
present a case of male who exercised for 2 hours after 
ingesting energy drink and subsequently developed 
rhabdomyolysis.
cAse	rePort: A 35 y/o male with no significant past 
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medical history presented to the Emergency depart-
ment for dark colored urine from past 3 days. Patient 
stated that he had not been to the gym for about a year 
and as part of a New Year resolution he wanted to 
start working out again. Patient took the supplement 
Neon Volt before starting the work out 3 days ago. 
He worked out for 2 hours that day and drank only 
juices. The next morning patient noticed inability to 
move his arms, chest pain and dark colored urine. His 
symptoms didn’t resolve so he came to the hospital. 
Patient denied dysuria, fever, and trauma. Patient has 
history of cigarette smoking half a pack a day from 
18 years. He admitted to taking marijuana daily but 
denied cocaine abuse. On Physical Examination, tem-
perature was 97.8, Respiratory rate 16, Pulse 77 and 
blood pressure 147/97, saturation was at 98% on room 
air. The positive pertinent findings are musculoskel-
etal examination were decreased range to movements 
at elbow with flexion and chest wall tenderness. Lab 
studies showed CK of 73739 and Basic metabolic panel 
showing sodium 140, potassium 4.0, chloride 104, bi-
carbonate 27, Blood Urea Nitrogen 14, creatinine 0.89.
The day after admission, patient’s CK level went up 
to 100,000. After continuing with the I.V fluids, CK 
levels decreased significantly and patient’s symptoms 
improved. All throughout hospital course, patient’s 
kidney function remained unremarkable.
discussion: The use of nutritional supplements in 
the United States has increased over the past 2 de-
cades. Review of literature revealed several reports 
of adverse events associated with the abuse of such 
products. Thus, we hypothesize that the supplements 
combined with normal physical training activities 
could result in serious muscle injury.
CV55
Kaposi’s Sarcoma Following Initiation of HAART
Jani, P.; Lanham, S.; Aurshiya, R.; Kibra, S.; Poonai, D.; Ibranya, 
G.; Saint Michael’s Medical Center
introduction: AIDS-related Kaposi’s sarcoma is a 
common indolent illness seen in our HIV population. 
These patients can have multiple episodes of Classic 
Kaposi’s before restarting HAART. There is another 
form of Kaposi’s sarcoma which is disseminated 
and rapidly progressive disease seen after initiation 
of HAART.  This is believed to be a form of Immune 
Reconstitution inflammatory syndrome (IRIS).
cAse	rePort: A 64 year old male with PMHx of HTN, 
HIV presented to the outpatient podiatry clinic for 
evaluation. In his initial visit the patient was noted 
to have multiple reddish-flesh colored nodules on 
the lower extremities and feet. He was recently diag-
nosed with HIV 4 months prior and was started on 
HAART 1 month ago. He stated he was compliant 
with his medications. Upon further questioning, the 
nodules had first appeared approximately 1 week 
ago and were rapidly progressing. He denied previ-
ous history of similar lesions or any other systemic 
complaints. Given the unusual presentation, a skin bi-
opsy was performed and pathology revealed Kaposi’s 
Sarcoma. The patient was referred to hematology/on-
cology clinic for further evaluation. A CT scan of the 
chest and abdomen was done which showed scattered, 
bilateral, irregular shaped, pulmonary nodules pre-
dominantly in a peribronchial vascular distribution, 
compatible with patients history of Kaposi’s Sarcoma 
and it also showed a 1.7 cm focal lesion within the 
right lobe of the liver. He continued to follow up in 
podiatry clinic and private infectious disease physi-
cian. He is now scheduled to receive chemotherapy 
with his hematologist/oncologist.
discussion: The onset of IRIS-associated Kaposi’s 
sarcoma is usually seen as early as 3 weeks after ini-
tiation of HAART. These cases can be either mild or 
severe (some even life threatening). In patients with 
rapidly progressing and symptomatic IRIS-associated 
Kaposi’s sarcoma, initiating systemic chemotherapy 
has been useful in suppressing further progression 
and HAART therapy should be continued.
CV56
A Case of Respiratory Failure with Dual 
Infectious Etiology
Jerome, M.; Slim, J.; Dazely, J.; St. Michael’s Medical Center, 
Seton Hall University
introduction: Combined, bacterial-bacterial infec-
tions in children and adults are less common and 
not commonly reported in the literature. Community 
acquired pneumonia can be severe even with mono-
infection of either bacteria or viral induced.  One-tenth 
of inpatients with severe CAP (SCAP) require treat-
ment in intensive care units (ICUs), typically requiring 
ventilatory support or septic shock treatment.
cAse	 rePort:	 49 yo African American female PMH 
significant for  SLE, DM2, HTN, latent tuberculosis 
detected 6 months prior to this episode, which has 
been treated with Isoniazid since then  presents to the 
ED @ SMMC, complaining of 1 day of labored breath-
ing.  The patient states she has a cough productive 
of green sputum and fevers. She checked her temp 
at home and it read 101.5 Fahrenheit. She became 
notably short of breath throughout the day with left 
sided chest pain on inspiration. Home medications in-
clude Isoniazid, Pyridoxine, Prednisone, azathioprine.
Exam reveals VS: T 101.5, BP  87/61, P: 120, RR 28 on 
96% 3LNC. On general appearance, she was lethargic; 
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speaking in short sentences, and was awake, alert and 
oriented. She had mild pallor.  She had no pharyngeal 
swelling, erythema or exudates.  Chest examination 
was remarkable for tachycardia and tenderness over 
the left lower chest wall. Lung examination was con-
sistent with rales in the left lower lung field. Subtle 
dullness on percussion was also noted on the left lung 
field.Lab data revealed Leukocytosis at 16.2, and pro-
calcitonin level of 163. CXR noted blunting of the left 
costophrenic angle due to suspected pneumonia. Pt. 
was in septic shock and respiratory failure. She was 
empirically given Vancomycin, PipTazobactam, and 
Levofloxacin.  Blood cultures drawn in ED, became 
positive for streptococcus pneumonia (2 bottles), de-
termining the organism responsible for the apparent 
pneumonia.  Atypical serologies which were also sent 
revealed Mycoplasma IgM antibody was positive (963).
discussion: Polymicrobial infections in CAP have 
been considered to cause more severe inflammation 
and clinical disease than single microbial infections. 
Our described case had a severe presentation, pos-
sibly due to a response to more than one etiologic 
organism. Failed clinical improvement in cases of 
appropriate therapy should prompt consideration for 
searching  additional infectious etiologies.
CV57
Left Ventricular Aneurysm and Ventricular 
Tachycardia as Initial Presentation of Cardiac 
Sarcoidosis
Jmeian, A.; Thawabi, M.; Goldfarb, I.; Shamoon, F.; Saint 
Michael’s Medical Center
introduction:	Cardiac sarcoidosis (CS) is a rare, po-
tentially fatal disease. It has a wide range of clinical 
presentations that range from asymptomatic elec-
trocardiogram changes to sudden cardiac death. 
Ventricular aneurysms and ventricular tachycardia 
are seen late in the disease, and are rarely the present-
ing manifestation of the disease. Diagnosis of CS is 
challenging and often missed or delayed.
cAse	 rePort: We report a 35-year-old patient who 
presented with sustained ventricular tachycardia and 
ST-elevation on electrocardiogram. Cardiac catheter-
ization showed normal coronaries and left ventricular 
aneurysm. Subsequent 2D-echocardiography showed 
an infiltrative disease pattern. Cardiac MRI was done 
that showed late gadolinium enhancement in the sep-
tum, apex and lateral wall. The patient was diagnosed 
with cardiac sarcoidosis and treated with immune 
suppression and antiarrhythmic agent. In addition 
underwent AICD implantation.
discussion: Our case highlights the importance of 
suspecting cardiac sarcoidosis in young patients pre-
senting with electrocardiogram changes, and present 
an atypical presentation of this disease.
CV58
Hafnia alvei as an Unusual Causative Agent for 
Skin and Soft Tissue Infection
Johnson, T.; St. Michael’s Medical Center and Seton Hall 
University
introduction: Hafnia, one of more than 40 genera 
of the Enterobacteriaceae family, H. alvei has for 
decades been considered a commensal of the human 
gastrointestinal tract. However, there is increasing 
awareness and recognition of H. alvei as a causative 
agent for disease especially in immunocompromised 
patients. The patient presented in the following case 
presented with cellulitis with abscess formation and 
subsequent acute osteomyelitis with Hafnia alvei 
isolated on culture.
cAse	 rePort: A 50-year-old gentleman with past 
medical history of intravenous drug abuse presented 
with complaint of right thumb swelling and pain 
associated with fever and chills for two days. He 
admitted to burning himself two weeks prior, and the 
swelling and erythema had progressively worsened. 
On exam diffuse swelling of the right thumb noted 
and fixed flexion with pain was elicited upon passive 
extension. X-ray revealed soft tissue swelling without 
any fracture or osseous abnormality. Infectious disease 
consultation was obtained, and patient’s antibiotic 
regimen changed from vancomycin and piperacillin 
plus azobactam  to ceftaroline plus metronidazole to 
cover for gram-positive organisms including MRSA 
and anaerobes.  The patient was evaluated by surgery 
and subsequently underwent incision and drainage 
of the right thumb flexor tendon sheath, drainage 
of the circumferential abscess, debridement of the 
necrotic nail bed, and resection of the distal phalanx 
after intraoperative exam revealed bone softening 
consistent with osteomyelitis. The purulent materials 
as well as necrotic tissue and bone samples were sent 
to microbiology and pathology respectively. Prior 
to the return of these results, however, the patient 
signed out against medical advice and received no 
further antimicrobial therapy. Cultures later revealed 
isolates of Hafnia alvei and Streptococcus viridans group, 
while the pathology results expressed fragments of 
hyperkeratotic skin and underlying subcutaneous 
tissue with acute inflammation consistent with 
abscess and fragments of bone with evidence of acute 
osteomyelitis. He was readmitted two weeks later 
with a complaint of increasing pain, erythema, and 
swelling of the right thumb associated with fever, 
chills, and generalized fatigue. Magnetic resonance 
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imaging (MRI) of the right hand, at that time, indicated 
the presence of soft tissue edema in the distal aspect 
of the thumb and possible osteomyelitis. Patient 
returned to the operating room for further excision 
of necrotic tissue and resection of osteomyelitic bone. 
He subsequently signed out against medical advice 
again before completing therapy. He was ordered 
to complete an extensive course of antibiotics with 
arrangements for outpatient follow up with surgery 
and infectious disease.
discussion:	 The most concerning issues pertaining 
to the Hafnia genus are its pathogenesis and subse-
quent disease spectrum in humans. Although there 
is prior isolation from nearly every body fluid and 
orifice, H. alvei infection rate is relatively rare; and its 
clinical significance is in those at the extremes of ages 
and immunocompromised states. Treatment is gener-
ally based on antimicrobial susceptibility testing with 
sensitivity generally to carbapenem, monobactam, 
quinolones, and aminoglycoside.
CV59
Peritoneal Tuberculosis Mimicking Advanced 
Ovarian Carcinoma
Jumean, K.H.; Abu Arqoub, A.H.; Hawatmeh, A.Y; Massarweh, 
F.; St. Michael’s Medical Center
introduction: Peritoneal tuberculosis is a form of 
abdominal tuberculosis that predominantly involves 
the omentum, intestinal tract, liver, spleen or the fe-
male genital tract in addition to the peritoneum. It 
results from reactivation of latent tuberculous foci in 
the peritoneum or from haematogenous spread from 
a primary disease in the lungs. Many women with 
peritoneal tuberculosis lack typical symptoms and 
laboratory data, therefore, peritoneal tuberculosis 
is usually difficult to diagnose in women and often 
mimics advanced-stage ovarian carcinoma or prima-
ry peritoneal carcinoma.
cAse	rePort: 39-year old female patient with no past 
medical history presented with a one week history of 
lower abdominal pain, unintentional weight loss, and 
generalized fatigue. Her first day of the last menstrual 
period was 30 days ago. She denied nausea, vomiting, 
or change in bowel habit. No fever or chills. No urinary 
symptoms.  She is from Peru, moved to the United 
States 8 years ago. She is G 5 P 2+3. Her vital signs 
were normal. Physical examination revealed mild 
lower abdominal tenderness. Gynecological examina-
tion results were normal. The rest of her examination 
was unremarkable. Laboratory studies were normal, 
except for CA125 level: 203 U/ml. Transvaginal ultra-
sound scan showed bilateral complex ovarian lesions. 
CT scan (abdomen/pelvis) showed bilateral complex 
multiseptated adnexal masses, small ascites with 
stranding of the suprapubic omental fat and perito-
neal nodules. Findings suggestive of bilateral ovarian 
malignancy with omental and peritoneal metasta-
sis. Diagnostic laparoscopy revealed the presence of 
multiple nodules diffusely covering the peritoneal 
surfaces, omentum and adnexa.  Frozen section, at the 
time of laparoscopy, revealed necrotizing granulomas 
most consistent with disseminated tuberculosis that 
was confirmed at the time of final pathologic review 
and culture. Laparoscopy confirmed the diagnosis 
of peritoneal tuberculosis and no malignancy, and 
thereby unnecessary extended surgery was avoided. 
Antituberculosis treatment was commenced, with full 
resolution of her symptoms and a decrease in CA-125 
level.
discussion: Peritoneal tuberculosis is an uncommon 
disease and many women are initially thought to have 
ovarian malignancy. Laparoscopy including biopsies 
is a sufficient method to provide the diagnosis. If no 
malignancy is detected and the diagnosis of perito-
neal tuberculosis is confirmed, unnecessary extended 
surgery is avoided and anti-tuberculosis treatment is 
started.
CV60
Warfarin-induced Leukocytoclastic Vasculitis
Jumean, K.H.; Hawatmeh, A.Y.; AlNabulsi, M.S.; Abu Arqoub, 
A.H.; St. Michael’s Medical Center
introduction: Oral anticoagulants are widely used in 
the prevention and treatment of venous and arterial 
thrombotic events. Bleeding is a major adverse effect, 
but other non-hemorrhagic adverse reactions are also 
considerable. Warfarin-induced skin changes are 
uncommon adverse effects of warfarin therapy. The 
cutaneous complications of warfarin therapy include 
ecchymosis, photosensitivity, purple toes syndrome, 
skin necrosis, and vasculitis. We report a 79-year old 
male with leukocytoclastic vasculitis secondary to 
warfarin. Skin biopsy confirmed leukocytoclastic vas-
culitis. Cutaneous lesions resolved after warfarin was 
discontinued.
cAse	rePort: 79-year old male presented with a 5-day 
history of progressive, well-demarcated non-pruritic 
cutaneous lesions on his lower extremities. He had 
a history of hypertension and dyslipidemia. He had 
prescriptions of Lisinopril, hydrochlorothiazide, and 
simvastatin. Moreover, he had taken warfarin 2.5 mg 
P.O daily for 4-weeks as a deep venous thrombosis 
prophylaxis after he had right total knee replacement 
surgery for sever osteoarthritis 4-weeks ago. The 
patient denied any history of drug or food allergy. 
No fever or chills. No insect bites. No joints pain or 
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headache. No nausea, vomiting, hematuria or urinary 
symptoms. His vital signs were normal. Physical ex-
amination revealed bilateral lower extremities (ankle 
- mid thigh) palpable non-planshale purpura. The rest 
of his examination was unremarkable. All blood tests 
including platelet count were normal, except for cre-
atinine: 1.47 mg/dL, proteinuria and complement 3 
level was mildly decreased. Histological examination 
of the involved skin demonstrated small blood vessels 
vasculitis with predominantly neutrophilic infiltrate 
admixed with few eosinophils consistent with leuko-
cytoclastic vasculitis. Warfarin was suspected as the 
cause of the vasculitis, and it was discontinued. Oral 
prednisone therapy was started at a dose of 40 mg/
day, as well as antihistamine. The skin lesions gradu-
ally improved after the discontinuation of warfarin 
and initiation of steroid therapy. Furthermore, his 
renal function recovered, as well as proteinuria. The 
patient was discharged, on tapered prednisone, in 
stable condition free of cutaneous lesions and with 
recovered renal function.
discussion: Warfarin-induced vasculitis is very 
rare. To our knowledge, this is the first case report 
of warfarin-induced normal-latency leukocytoclastic 
vasculitis who presented with proteinuria in addition 
to skin lesions. It is critical to be aware of this potential 
adverse effect of warfarin to enable prompt diagnosis 
and treatment in similar cases.
CV61
Mondor’s Disease of the Penis: A Forgotten Entity
Jumean, K.H.; Al Hadidi, M.; Hawatmeh, A.Y; Abu Arqoub, A.H.; 
Hanify, K.; St. Michael’s Medical Center
introduction: Mondor’s disease of the penis is a very 
rare and under-reported condition which is charac-
terized by thrombosis in the superficial dorsal penile 
vein (SDPV). This benign condition is self-limiting 
and usually completely resolves after 6-8 weeks of 
conservative management. Surgical options include 
thrombectomy and SDPV resection when the condi-
tion associated with chronic or severe pain. Although 
penile Mondor’s disease is rare, proper clinical diag-
nosis and consequent reassurance can help the patient 
to dissipate the anxiety and the following erectile 
dysfunction.
cAse	 rePort: 41-year old male with no past medi-
cal history presents with swelling and pain of penis 
for 3-weeks. Our patient noticed the appearance of 
a painful cord on the dorsal aspect of his penis, be-
ing more painful during erections. The pain was 
throbbing in nature. There was no associated itch-
ing, discharge, hematuria, or dysuria. He denied any 
history of trauma, vigorous sexual activity, or use of 
constriction devices. He admits to one sexual partner. 
He also denied any history of fever or lower urinary 
tract symptoms. Physical examination revealed a 
slightly-anxious but physically healthy man with a 
dorsal cord-like swelling, extending from the pubic-
symphysis to mid-shaft of his penis, mild tenderness 
during palpation. Genitourinary-examination was 
normal. There was no inguinal lymphadenopathy and 
the standard laboratory tests (blood and urine) were 
without pathologic findings. The patient underwent 
ultrasonography which revealed a non-compressible 
portion of superficial dorsal vein as well as the lack 
of venous flow signals in Doppler ultrasonography. 
Provisional diagnosis of thrombosis of the superficial 
dorsal vein of the penis was made, and conservative 
treatment was prescribed in the form of nonsteroidal 
anti-inflammatory drugs and 500 mg of ciprofloxacin 
twice daily for 5 days for prophylaxis. The patient was 
reassured of the benign nature of his condition and 
was instructed to abstain from sexual activity and 
was advised to review at three weeks. On his first 
follow-up visit at 3 weeks, his physical examination 
revealed a complete resolution of the swelling.
discussion: Mondor’s disease of the penis is a be-
nign and self-limited disease. Patients complain of 
cord-like-indurations on the dorsal-aspect of the 
penis. The etiology is unknown. The diagnosis is 
clinical. Treatment is conservative. Patients should be 
informed about the avoidance of sexual-intercourse. 
In most cases, symptoms resolve completely within 
6-8 weeks.
CV62
Bilateral Thalamic Stroke Due to Occlusion of 
the Artery of Percheron in a Patient with a  
Patent Foramen Ovale
Jumean, K.H.; Lanham, S.; Hawatmeh, A.Y.; Abu Arqoub, A.H.; 
Qaqa, F.Z.; Jani, P.; Weisbrot, F.; St. Michael’s Medical Center
introduction: The Artery of Percheron (AOP) is a 
rare vascular variant in which a single dominant thal-
amoperforating artery arises from the P1 segment 
and bifurcates to supply both paramedian thalami. 
Occlusion of this uncommon vessel results in a char-
acteristic pattern of bilateral paramedian thalamic 
infarcts with or without mesencephalic infarctions. 
We report a 37-year old man with acute bilateral 
thalamic infarcts. Further evaluation with an aim to 
define the etiology revealed a patent foramen ovale as 
the cause of embolism.
cAse	rePort: 37-year old man with no past medical 
history presented at the emergency department after 
being found unresponsive in bed. He was last seen 
normal approximately 6 hours before presentation. 
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There was no recent history of fever, headache, seizure, 
or trauma and no known toxic substance exposure. On 
arrival, his vital signs were normal. On neurological 
examination, he was comatose with a Glasgow coma 
scale of 6/15. The pupillary light reflex was absent in 
both eyes. The vertical oculocephalic reflex was absent. 
His limbs moved in response to painful stimuli. The 
rest of his examination was unremarkable. All blood 
tests including hypercoagulable state workup were 
normal. Patient was intubated for airway protection, 
improved after two days, and was extubated. Head 
Computed Tomography & Brain Magnetic Resonance 
Imaging demonstrated areas of abnormal signal with 
mildly restricted diffusion within the medial thala-
mi bilaterally suggestive of acute/subacute infarcts 
secondary to an acute ischemic stroke in the AOP 
territory. MR angiography demonstrated patent pos-
terior circulation including the tip of the basilar artery 
and both posterior cerebral arteries. Anticoagulant 
therapy was administered. Further evaluation with 
an aim of defining the etiology revealed a patent fo-
ramen ovale on transesophageal echocardiography 
with spontaneous passage of contrast bubbles from 
the right auricle to the left cavities. During his stay, 
he gradually regained consciousness during the hos-
pitalization days with Glasgow coma scale of 10/15. 
Upon discharge to acute care facility, his eye signs 
remained along with persistent memory impairment.
discussion: Occlusion of the Artery of Percheron 
(AOP) is a rare cause of coma in young patients. 
Diffusion-weighted-MRI is the imaging modality of 
choice for early diagnosis and should not be delayed 
for altered mentation which is a hallmark of this 
condition since early recognition may lead to more 
favorable outcomes.
CV63
Mucinous Neoplasm of the Appendix and  
Pseudomyxoma Peritonei
Jumean, K.H.; Abu Arqoub, A.H.; Hawatmeh, A.Y; Bataineh, 
A.B.; St. Michael’s Medical Center
introduction: Primary tumors of the appendix 
are unusual and most of them are carcinoids. 
Adenocarcinomas of the appendix are a category 
of rare tumors of the gastrointestinal tract, with a 
frequency of 0.2% -0.5% of all intestinal malignancies 
and 4%-6% over neoplastic lesions of the appendix. 
Mucin-producing cystedenocarcinomas or mucous 
adenocarcinomas, and non-mucin producing or 
colonic-type adenocarcinomas are included in this 
category. Their main presentation is that of an acute 
appendicitis or as a palpable mass, mainly in the 
right-lower quadrant.
cAse	 rePort: A 63-year old male patient presented 
with right lower quadrant abdominal pain, which 
started one day before, without other pathological 
findings in the clinical examination. Laboratory tests 
on admission showed: WBC: 6.600/mm3 (with normal 
type), Hb: 14.8 g/dl, Hct: 44.4% and normal coagulation 
values. The patient was hospitalized for further 
investigation and underwent medical treatment for 
2 days. Computed tomography (abdomen/pelvis) 
reported normal internal organs and the patient were 
discharged after the initial clinical symptoms were 
minimized. Two weeks later the patient presented 
again with the same abdominal pain. The diagnosis 
of acute appendicitis was set. CT scan showed and 
the patient underwent an open laparotomy on a 
MacBurney section. During the operation a dense 
and diffuse myxomatous collection was found 
around the appendix. Appendicectomy took place 
as well as thorough cleaning of the peritoneal cavity. 
Histological examination of the specimen revealed 
appendiceal mucinous neoplasm with high risk of 
recurrence arising in a mucinous cystadenoma with 
focal transmural mucin dissection with marked acute 
and chronic inflammation. The patient was then 
scheduled for peritoneal cavity infusion with heated 
chemotherapy in an attempt to eradicate residual 
disease.
discussion: Mucin producing adenocarcinomas of 
the appendix are a category of rare cancers of the 
gastrointestinal tract. Although at present they are 
a well-studied pathologic entity, the crucial issue of 
their preoperative diagnosis remains unsolved.
CV64
Fatal HSV-1 Pneumonia in Patient with Medically 
Controlled HIV Infection (High CD4, Low Viral 
Load)
Kadri, M.; Yim, H.; Patel, V.; Dabu, J.; Miller, R.; Saint Michael’s 
Medical Center
introduction: Herpes simplex viruses (HSV-1, HSV-2; 
Herpesvirus hominis) is a double stranded DNA vi-
rus which  produces a variety of infections involving 
mucocutaneous surfaces, the central nervous system 
and on occasion visceral organs. HSV pneumonitis 
is uncommon except in severely immunosuppressed 
patients and may result from extension of herpetic tra-
cheo-bronchitis into lung parenchyma. The mortality 
rate from untreated HSV pneumonia in immunosup-
pressed patients is high. Here we present a case with 
HSV-1 Pneumonia in patient with controlled HIV 
infection.
cAse	 rePort: 54 yo AAM with PMHx of HIV on 
HAART therapy (CD4-294/28%), COPD presents with 
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SOB * 1 week associated increased sputum produc-
tion greenish-yellow. Denied any fever, chills, nausea, 
vomiting or any muscle aches. Flu vaccine was up 
to date. Patient did say that in his household people 
were sick with cold like symptoms. No genital or oral 
lesions were appreciated on physical examination. 
Vitals in the ER showed RR 42, HR 112,  BP 122/86 and 
O2 Sat 88% on 42% Bipap. Labs showed WBC: 21, Pro-
calcitonin: 14.8. CXR showed multilobar PNA. Patient 
was intubated subsequently for Acute respiratory 
failure and started on Vancomycin, Azithromycin 
and Ceftriaxone. Influenza A and B was negative. 
LDH was 585. Patient was still spiking fever on an-
tibiotics with T max: 105 F. Patient went into septic 
shock secondary to PNA and needed pressor support. 
Despite treatment, patient’s oxygenation worsened. 
Bronchoscopy was done and BAL was sent which was 
Positive for Herpes Simplex Virus. HSV 1 IgG was 
high >62. HSV culture was sent.  Patient was started 
on Acyclovir and later changed to Valacyclovir which 
resulted in significant improvement of the overall con-
dition of the patient. Patient still needed respiratory 
support for which tracheostomy was done. Pt was dis-
charged to LTACH.
discussion: This patient with well controlled HIV had 
severe ARDS secondary to HSV - 1 Pneumonia which 
resulted in severe respiratory failure requiring trache-
ostomy. This case shows the severity by which HSV 
pneumonia can present and should always be kept 
in mind when treating HIV patients with pneumonia 
not responding to empiric antibiotic therapy.
CV65
Metoclopramide induced Parkinsonism in an  
Intensive Care Patient with Vomiting
Kaleel, A.; Mozaffarian, D.; Ibrahim, M.; New Jersey 
Neuroscience Institute, Edison, NJ; Seton Hall University, 
School of Health and Medical Sciences
introduction: Parkinsonism is a disorder character- 
ized by tremor, bradykinesia, and rigidity. While ap-
pearing as Parkinson’s disease clinically, Parkinsonism 
is comprised of all etiologies which may produce this 
particular constellation of symptoms, such as medi-
cations, heavy metals, or other toxins. We present a 
case of a patient who exhibited acute Parkinsonism 
features while on metoclopramide for post-operative 
nausea and vomiting.
cAse	rePort: The patient is a 55 year old male patient 
with Glioblastoma Multiforme who presented for 
elective craniotomy with resection of the lesion. The 
patient recovered well after treatment, but his course 
was complicated by nausea and vomiting which were 
felt to be post-operative in nature.  He was prescribed 
10mg of metoclopramide per required need every six 
hours which he took readily. On day 3 of his admission, 
the patient was noted to have rest tremor by the nurs-
ing staff. Further examination revealed bradykinetic 
movements and rigidity of the arms and legs bilateral-
ly, quite different from his baseline neurologic status 
the day prior. Metoclopramide was discontinued with 
eventual return of his symptoms to baseline.
discussion: Parkinsonism is a potential side ef-
fect of anti-dopaminergic medications such as 
Metoclopramide with its central and peripheral effects. 
This case illustrates the need for careful consideration 
and monitoring of patients on Metoclopramide.
CV66
Orolingual Angioedema in an Acute Stroke  
Patient After TPA Administration
Kaleel, A; Kaleel, H.R; Kirmani, J.F.; New Jersey Neuroscience 
Institute, Edison, NJ; Seton Hall University, School of Health 
and Medical Sciences
introduction: Orolingual angioedema is a life threat-
ening condition, most classically associated as a side 
effect of angiotensin converting enzyme inhibitors 
(ACE Inhibitors). In many cases, the complication is 
limited to the lips and tongue, but, occasionally, may 
extend to the oropharynx and lead to upper airway 
obstruction. We present the case of a 52 year old male 
patient who presented with an acute stroke and met 
criteria for thrombolytic therapy with secondary oro-
lingual angioedema after tPA administration.
cAse	 rePort: The patient is a 52 year old male pa-
tient with a past medical history of hypertension and 
diabetes who presented to the emergency room with 
acute onset of conjugate gaze palsy to the left, right 
hemibody weakness and sensory loss with neurolog-
ic symptoms localizing to the pons. His initial vitals 
were 154/66 BP, 99 HR, 23 RR, with a 98% oxygen satu-
ration. A non contrast CT of the head was obtained 
which revealed no acute intracranial hemorrhage. 
Due to lack of contraindications to thrombolysis, the 
patient was given tissue plasminogen activator (tPA). 
Shortly after administration, the patient began to 
complain of shortness of breath and “my tongue is 
swelling and I can’t talk well”. Physical examination 
revealed markedly swollen lips and tongue, limiting 
the oral cavity and complicating articulation. The pa-
tient was emergently treated with epinephrine and 
histamine blockers with some resolution of symptoms.
discussion:	Orolingual angioedema is a potentially 
life threatening complication of some medications. 
This illustrates another concerning case of orolingual 
angioedema secondary to tissue plasminogen activa-
tor (tPA) with marked swelling of the lips and tongue.
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CV67
Lymphangioma-Like Kaposi Sarcoma Present-
ing as Stasis Verruciformis-A Case Report
Khaladj, M.; Agunbiade, M.; Kotzias, G.; Trinitas Regional 
Medical Center
introduction: Lymphangioma-like Kaposi Sarcoma 
is a rare subtype manifestation of Kaposi Sarcoma. 
Kaposi Sarcoma is a tumor manifestation due to 
human herpesvirus 8  and typically presents in indi-
viduals who are HIV positive. Clinical presentations 
of lesions are unusual and non-specific to kaposi sar-
coma and can often result to a misdiagnosis. Early 
diagnosis of LLKS can lead to long term treatment 
options and significant reductions in symptoms. Such 
modalities include surgical debridements, HAART, 
and chemotherapy.
cAse	 rePort: A 68 year old male presented to the 
Wound Center for treatment of multiple slow grow-
ing granulating lesions that covered more than 60% 
of his left lower extremity.  Dermatological manifes-
tations had a wide variety of clinical presentations. 
A small portion of lesions were closed bulla type le-
sions that revealed fluctuantions  upon palpations. A 
good majority of the foot contained circumscribed 
verruca-like plaques with thickened, rough, and spiky 
appearance. The majority of the lesions appeared to 
be hypergranulated, pedunculated, denuded, weep-
ing wounds. Several excisional biopsies of lesions and 
wound cultures were obtained and came back with 
non-conclusive results. Initial biopsies results re-
vealed hypergranulation tissue with evidence of skin 
necrosis and bacterial colonization.
discussion: Discussed differential diagnosis included 
neurofibromas, filariasis, madura foot, and pyogenic 
granulomas. Histological identification remains the 
gold standard for identification despite clinic ap-
pearance with strong suspicion. Without a proper 
diagnosis and treatment of LLKS, it can lead to severe 
debilitating wounds leading to a loss of quality of life.
CV68
Split Thickness Skin Graft as a Successful Limb  
Salvage Option for Treatment of Diabetic Wounds  
Complicated with Subcutaneous Emphysema
Khaladj, M.; Mohiuddin, A.; Siddiqui, A.; Lalehparvar, S.; Safar, 
S.; Trinitas Regional Medical Center
introduction: Diabetic wounds complicated with 
subcutaneous emphysema can be life threatening 
infections and often result in aggressive surgical in-
tervention of the lower extremity especially in the 
diabetic population. These complications include 
major amputations and even death.  We present three 
diabetic patients who presented with complicated dia-
betic wound infections, underwent emergent surgical 
procedure, and later, successfully, underwent applica-
tion of split thickness skin graft to facilitate secondary 
closure of surgical sites.
cAse	 series: In our case series, we present three 
cases of gas gangrene that initially underwent emer-
gent I&D with antibiotic therapy, local wound care at 
post-op visits, and successful limb salvage with the 
application of autologous split thickness skin graft for 
secondary wound closure.
discussion: By applying split thickness skin graft to 
treat lower extremity wounds one can enhance sec-
ondary closure of wounds. Our three folded approach 
included initial I & D, aggressive local wound care, 
and finally STSG, to maximize healing process and 
achieve our limb salvage goals.
CV69
Adult Polycystic Kidney Disease: A Rare Cause 
of Uncontrolled Hypertension in a Young Man
Khan, M.Y.; Siddiqui, W.; Iyer, P.; Blanco, R.J.; Ursani, A.; 
Hussain, A.; Conaway, H.; Saint Francis Medical Center, 
Trenton, NJ
introduction: Autosomal dominant polycystic kid-
ney disease (ADPKD) occurs in approximately 1 in 
every 400 to 1000 live births. It is estimated that less 
than one-half of these cases will be diagnosed dur-
ing the patient’s lifetime, as it is often clinically silent. 
The diagnosis of (ADPKD) relies principally upon 
imaging of the kidney. Typical findings include large 
kidneys and extensive cysts scattered throughout 
both kidneys. Renal ultrasonography is customarily 
utilized for screening because it is safe, effective, and 
inexpensive.
cAse	 rePort: A 37 year old Hispanic male came to 
medical clinic for pre-operative evaluation for repair 
of his abdominal hernia. The patient’s blood pressure 
(BP) was elevated in clinic (210/136) and he was sent 
to the emergency room for further evaluation and 
management. He denied any complains of headache, 
visual changes, chest pain, dyspnea, palpitations, 
dizziness, abdominal pain, nausea or vomiting. 
The patient had known past medical history of 
hypertension and chronic kidney disease, which was 
diagnosed 3 years ago, but he had been non-compliant 
with respect to his antihypertensive medications. In 
the emergency department, patient’s vitals showed BP 
of 206/133 mmHg, heart rate of 72/min, respiratory rate 
of 16/min, temperature of 98.2˚F and O2 saturation of 
100% on room air. On physical exam, he had multiple 
cystic lesions of variable sizes on his scalp and back. 
Cardiovascular exam revealed normal first and 
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second heart sounds with no murmur, rub or gallop. 
Lung examination was clear to auscultation bilaterally. 
Neck exam did not demonstrate any jugular venous 
distension. Abdominal exam was significant for 3 
x 6 cm mass in the epigastrium. Lab work showed 
elevated blood urea nitrogen and creatinine of 30 and 
3.71 respectively. CT abdomen revealed bilateral renal 
and hepatic cysts.  Patient was admitted to coronary 
care unit for BP control with intravenous nicardipine 
and nitroglycerin. He developed a headache for which 
CT of the head was done which ruled out a cerebral 
bleed. Patient was counseled regarding adherence to 
medication and regular follow up with nephrology 
and was discharged on oral medications.
discussion: ADPKD is common genetic disorder 
leading to end stage renal disease in the United States. 
Almost 50% of patients require dialysis by age of 60. 
If left undiagnosed, fatal complications like subarach-
noid hemorrhage may occur. Early screening in young 
patients; with family history of ADPKD is recom-
mended to avoid significant morbidity or mortality.
CV70
Acute Iron Poisoning in an Adult
Kollu, V.; Butler, J.; Seton Hall University School of Health 
and Medical Sciences at Trinitas Regional Medical Center, 
Elizabeth, NJ
introduction: Iron is an element essential for myriad 
cell functions, but in excess quantities is highly cyto-
toxic, and can even be lethal. The majority of acute iron 
toxicity cases occur in children less than 5 years of age 
who present with accidental ingestion of iron supple-
ments.  Intentional iron tablets overdose in adults is 
uncommon. Clinical outcome is variable and depends 
upon the quantity of iron ingested, other drugs con-
sumed concurrently and the time until treatment.
cAse	 rePort: We report a case of a 25-year-old fe-
male with no past medical history who presented 
after a suicide attempt via multi-drug overdose. 
She felt depressed for the past 2 months after un-
dergoing an elective termination of pregnancy at 
approximately 24 weeks. The patient ingested an in-
definite number of prenatal vitamins, iron pills and 
diphenhydramine along with unknown medications 
from her step-father’s prescriptions. She took 2 hand-
fuls of medications at 10 AM, and within 15 minutes 
developed symptoms of nausea and non-bilious, non-
projectile red colored vomiting. Three hours after 
ingestion she developed intermittent epigastric pain 
and presented to the Emergency Department at 7pm. 
She was noted to have lassitude, flat affect and severe 
abdominal pain; she could not lay supine, and felt 
better curled up and lying still. Her tenderness was 
associated with feelings of warmth and sweating and 
decreased urinary output. She did not develop con-
stipation, cough, diarrhea, dyspnea, headaches, fever, 
loss of consciousness or seizure activity.   Diagnostic 
tests were notable for WBC 12.9, hemoglobin 14, anion 
gap 12, elevated iron level 322, salicylates < 4, acet-
aminophen 2.4, elevated osmolality 298. Of note, Iron 
level was 322. Normal liver fuction. Urine drug screen 
was positive for opiates and tricyclic antidepressants. 
Abdominal x-ray revealed hyper opaque densities in 
the antral area of her moderately distended stomach. 
Her bowel was irrigated via nasogastric tube and 
she received chelation therapy with desferrioxamine 
along with supportive care. During the patient’s hos-
pital stay, her iron level continued to decrease and 
her physical symptoms completely resolved although 
psychiatry was involved for her depression.
discussion: Treatment of acute iron poisoning in-
cludes early decontamination of the gut, chelation 
with parenteral desferrioxamine, intensive supportive 
therapy and, occasionally, dialysis.  Administration of 
desferrioxamine may color the urine a pinkish red, a 
phenomenon termed “vin rose urine.”
CV71
Oncologic Brainstem Herniation
Krathen, J.A.; Zia, S.; Iyer, P.S.; Wang, S.S.; Seelagy, M.M.; 
Seton Hall;  St. Francis Medical Center
introduction: Basal cell carcinoma is commonly re-
ferred to as an “epithelioma” because of its typical low 
propensity for metastasis.  Metastatic basal cell carci-
noma is estimated to occur in less than 0.5% of cases, 
making widespread malignant disease an incredibly 
rare occurrence.  Primary basal cell carcinoma in the 
head and neck is the culprit lesion in an estimated 
85% of metastatic disease.  This case demonstrates a 
primary head and neck basal cell carcinoma with me-
tastases to the brain, with devastating results.
cAse	rePort: This is a 62 year old African American 
male with extensive oncologic history of basal cell 
carcinoma.  Notably, the patient had no medical care 
previous to being incarcerated.  The patient had been 
previously diagnosed with basal cell carcinoma with 
pulmonary metastases, as well as an occipital mass 
lesion thought to represent brain metastases.  The 
primary basal cell tumor was estimated to be greater 
than 10 cm, as evidenced by a large scar from resection. 
He underwent multiple surgeries as well as radiation 
therapy, with limited success.. There was extensive 
tumor invasion into the oropharynx, necessitating 
a PEG insertion. His overall prognosis was labeled 
as guarded. Immediately prior to presentation, the 
patient had been developing worsening ataxia. The 
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patient was evaluated in the emergency department. 
The patient was found to be significantly altered with 
a GCS score of 8. He was febrile with a temperature 
of 101.4 degrees Fahreinheit. A head CT with 
contrast showed a concerning increase in the size 
of the previously mentioned occipital brain lesion. 
Additionally, there was concern for mass effect, 
vasogenic edema, and threatening early brainstem 
herniation. The patient was intubated and transferred 
to a tertiary facility for stat neurosurgical intervention.
discussion: This case demonstrates an unusual con-
sequence related to basal cell carcinoma. While head 
and neck basal cell carcinoma is the most likely bas-
al cell to metastasize, there are few reports of brain 
metastases in the literature. Had this patient sought 
even basic medical care, his outcome might have been 
different.
CV72
Prader Willi Syndrome and Medication 
Sensitivity
Kwok, E; Trinitas Regional Medical Center; Seton Hall University 
School of Health and Medical Sciences
introduction: Prader Willi Syndrome is a genetic dis-
order characterized by neonatal hypotonia, feeding 
problems, global developmental delay, small stature, 
hypogonadism and small hands and feet. Hyperphagia 
results in obesity and medical conditions such as dia-
betes, hypertension and hyperlipidemia. Patients with 
Prader Willi Syndrome are more vulnerable to psychi-
atric disorders such as psychosis and mood disorders. 
Behavioral issues often impacts the individual and 
families the most.  Patient’s can become overmedi-
cated due to agitation or disruptive behavior. Careful 
monitoring and awareness of medication sensitivity is 
essential in this population.
cAse	rePort: Patient is a 27-year-old, obese, Caucasian 
male with history of Prader Willi syndrome, 
intellectual disability, mood disorder NOS and 
intermittent explosive disorder. He was a transfer from 
another facility where he was admitted for increased 
agitation, screaming and flight of ideas.  He was having 
paranoid delusions that gang members were trying to 
kidnap him.  He had recent medication changes by his 
outpatient psychiatrist.  Upon admission, he appeared 
sedated, diaphoretic, illogical and disorganized. 
Prior to admission, he was given multiple p.r.n. 
medications including Intramuscular Haloperidol, 
Lorazepam and Diphenhydramine.  It appeared the 
patient had drug toxicity and he had a rash in the 
buttock region.  All medications were held and he 
was transferred to the medical unit for intravenous 
hydration and observation. His labs and electrolytes 
improved. His rash was a result of contact dermatitis. 
He returned to the psychiatric unit AAOX3 and less 
disorganized. However, he would have outbursts of 
agitation and begin crying unprovoked. Medications 
were slowly introduced and he was titrated up to 
50mg PO TID of Chlorpromazine. He tolerated the 
medication well. He was also noted to be isolative 
with poor sleep and anxiety at bedtime. He was given 
Mirtazapine 30mg PO QHS and Clonazepam 0.5mg 
PO QHS. With this medication regimen, family and 
staff noted improved behavior. He was less agitated, 
paranoid, sedated and denied auditory hallucinations. 
Along with medication management, he was given 
a strict behavioral plan to address his food seeking 
tendencies and provide a strict routine to minimize 
agitation.
discussion: Management of Prader Willi Syndrome 
is a collaborative effort between the medical and 
psychiatric teams. Co-morbid conditions associated 
with Prader Willi Syndrome require close observation 
for drug-drug interactions and medication sensitivi-
ties. Behavioral issues, such as agitation, aggression, 
skin-picking or head banging are best addressed with 
behavioral interventions and cautious medication 
administration.
CV73
Sickle Cell Disease and Recurrent Psychosis
Kwok, E.; Trinitas Regional Medical Center; Seton Hall 
University School of Health and Medical Sciences
introduction: Sickle cell disease is an autosomal 
recessive disorder that can clinically manifest in 
multi-organ dysfunction. Patients can suffer from 
anemia, vaso-occlusion, hypoxia, micro-infarction, 
acute chest syndrome and stroke. Neuropsychiatric 
symptoms such as depression and anxiety may de-
velop. In rare cases, patients will develop delusions 
or hallucinations.  Reported cases of psychosis and 
sickle cell disease did not report a family history of 
psychotic disorders.  This case presents a sickle cell 
patient who develops psychosis and the treatment of 
those symptoms.
cAse	rePort: 30 year old Haitian female with history 
of sickle cell disease - hemoglobin SC, seizures, TIA, 
acute chest, DVT and psychosis NOS presents with 
peri-rectal abscess and paranoid, disorganized 
behavior. Her first psychotic episode began 10 
months ago during a sickle cell crisis. Since that time, 
she was hospitalized twice psychiatrically.  Both 
admissions resulted in transfer to the medical floors 
for sickle cell crisis. She was prescribed Risperidone 
with good effect. However, she was non-compliant 
with psychiatric treatment and follow up.  She was 
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compliant with her hematology appointments. On 
this admission, she was admitted for incision and 
drainage of peri-rectal abscess in the left gluteus. CBC 
showed mild anemia and electrolytes were within 
normal limits. Urine toxicology was positive for 
opiates and CT and MRI of the head without contrast 
done from previous admissions were unremarkable. 
Psychiatric examination showed the patient dressed 
in a hospital gown with a scarf over her head. She 
was fairly groomed, AAOX3, paranoid, agitated, 
disorganized, rocking back and forth, and mumbling 
to herself. She believed that people were hacking into 
her computer. She was preoccupied with “spirits” 
disturbing her. She also described poor sleep, poor 
appetite, poor concentration and low energy. She was 
prescribed Risperidone 1mg PO BID for psychosis 
and Duloxetine 30mg PO Daily for depressive 
symptoms. She was medically cleared and transferred 
to inpatient psychiatry unit for further treatment. She 
became less paranoid and bizarre on the medications 
and her mood symptoms improved.
discussion: Sickle cell patients developing psy-
chosis have been reported with possible etiologies 
such as hypoxia, silent infarctions, substance use, 
depression or idiopathic cause.  Resolution of psy-
chotic symptoms occurred with anti-psychotics. In 
this case, Risperidone was beneficial for the patient. 
Collaborative psychiatric and medical follow up are 
essential to manage these patients.
CV74
Recurrent Pneumonia in an Adult Secondary to 
Aspiration of a Molar Tooth
Latif, N.; Ahmed, S.; Abdeen, Y.; Miller, R.; St. Michael’s Medical 
Center, Seton Hall University
introduction: Unlike children, clinical presentation 
of foreign body aspiration in adults is often subtle, and 
diagnosis requires careful clinical assessment and use 
of bronchoscopy. Patients with recurrent pneumonia 
or wheezing limited to a particular region (eg. right 
middle lobe) have a local anatomic abnormality sug-
gesting the presence of a benign of malignant disease. 
We present a case of an adult with two years of atypi-
cal asthma, chronic cough and recurrent pneumonia 
secondary to unintentional aspiration of her molar 
tooth.
cAse	rePort: Patient is a 41 y/o Hispanic female with 
history of asthma (2 years), recurrent pneumonia (>2 
episodes in 1 year), chronic cough (2 years), diabetes 
who presented with progressive cough with produc-
tive whitish sputum, fevers, worsening shortness of 
breath for 4 days. The cough occurs throughout the 
day intermittently and does not worsen at night or 
day. Her last episode of pneumonia was 4 months. 
Patient also admits to losing her job at a cafeteria 
due to her chronic cough. She denies any allergies. 
Socially drinks alcohol and denies tobacco and drugs. 
Family history is negative for lung cancer or asthma. 
Vitals revealed Temp: 102.1F BP: 133/77 HR: 115 RR: 
18 Oxygen: 94% room air.  Pertinent physical exam 
findings revealed poor dentition, crackles at the Right 
lung base with dullness to percussion. No wheezes 
were heard bilaterally. Left lung: clear to auscultation. 
Pertinent lab findings revealed leukocytosis of 16.6. 
Normal renal function and hemoglobin. HIV test was 
negative. Chest X-ray showed persistent right middle 
and lower lobe lung opacity since last admission. CT 
scan revealed a possible broncholith in the right bron-
chus with signs of pneumonia and atelectasis distally. 
Bronchoscopy was performed which revealed a par-
tially obstructing right main bronchus due to a molar 
tooth. Patient recovered after removal of foreign body 
without complications. She was discharged on oral 
antibiotics and her pneumonia, chronic cough and 
atypical asthma resolved within a few weeks.
discussion: Adults presenting with signs of asthma 
later in life with recurrent pneumonias isolated to 
one lobe should be evaluated cautiously. Aspirations 
in adults are variable depending on age and culture. 
With regards to treatment, flexible bronchoscopy is 
used for diagnosis with rigid bronchoscope being the 
standard of care in removal.
CV75
Terminal Complement Blockade By Eculizumab 
(Ecu) For Vero-Toxin E.coli (VTEC) Associated 
Hemolytic-Uremic Syndrome (HUS)
Lieberman, K.V.; Ettinger, L.; Picareli, C.; Hackensack University 
Medical Center
introduction: Cell injury in VTEC HUS is, in part, 
complement mediated. Ecu, a humanized monoclonal 
antibody, is directed at C5 and prevents the formation 
of the C5-9 membrane attack complex (MAC). Here we 
explore the use of Ecu in Ecoli O157 HUS.
cAse	series: Children with typical diarrheal prodrome 
HUS received Ecu at clinical presentation. Doses 
were administered as per a previously established 
weight cohort dosing regimen at time 0, +1 wk, then 
every 2 wks until all disease manifestations resolved, 
but at least for 3 doses. Two patients presented with 
1-2 wks of bloody diarrhea followed by progressive 
weakness, palor and oliguria. Microangiopathic 
hemolytic anemia was demonstrated along with 
significant renal dysfunction. Patient 1 became 
anuric with hyperkalemia and received hemodialysis. 
Both patients received Ecu approx 18 hrs after 
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hospitalization. Ecoli O157 was demonstrated in the 
stool of both patients.
discussion: The rapid resolution of disease 
manifestations in both patients, with normalizing 
of the hematologic parameters within 24 hours and 
dramatic improvement in renal function within 48 
hours of the first dose, establishes Ecu as potentially 
the first effective treatment for VTEC HUS. The 
absence of any early adverse reactions is reassuring. 
The complete normalization of the urinalyses of both 
patients (including the patient who required dialysis) 
within a few weeks is encouraging given the well 
known propensity for late renal complications in 
patients s/p HUS episodes. More experience with 
this agent in the treatment of VTEC HUS is urgently 
needed to fully establish its role.
CV76
A case of Type A Aortic Dissection Diagnosed by 
Percutaneous Coronary Intervention
Lindner, M.A.; Seton Hall University: Saint Michael’s Medical 
Center and Trinitas Regional Medical Center
introduction: This is the case of a patient present-
ing with acute onset of chest pain and ST-segment 
elevation myocardial infarction on electrocardiogram 
(EKG) who was subsequently diagnosed with Type 
A aortic dissection and cardiac tamponade during 
cardiac catheterization. Following diagnosis by per-
cutaneous coronary intervention (PCI) the patient was 
immediately transferred to an affiliated hospital for 
emergent cardiothoracic surgical repair.
cAse	rePort: The patient is a 60 year-old male with 
a history of hypertension who presented to a tertiary 
care facility complaining of constant, sharp retroster-
nal chest pain, severity 10 out of 10, radiating to the 
neck and left shoulder associated with diaphoresis 
and dyspnea. Pain began acutely 12 hours prior to 
presentation, without aggravating or alleviating fac-
tors; the patient denied fever, chills, or abdominal 
pain. During initial assessment he was found to be 
hypertensive at 164/118 with significant EKG findings 
of ST-segment elevations in Leads II, III, and aVF rep-
resenting acute inferior wall infarct. The remaining 
vital signs were within normal limits. A Code STEMI 
was called and the patient was rapidly transported to 
the cardiac catheterization lab. During percutaneous 
transluminal coronary intervention the guidewire 
was advanced and contrast dye injected. Contrast 
injection revealed a false lumen, with turbulent flow 
of contrast and a dye hold in the proximal ascending 
aorta. Following PCI the patient was continued on ven-
tilatory support under sedation and was transported 
to an affiliated tertiary care hospital for cardiotho-
racic surgery evaluation and emergent surgical repair. 
Pre-operative CT scan confirmed ascending aortic an-
eurysm with dissection and hemopericardium with 
tamponade. The patient underwent open surgical 
repair of the ascending aorta with hemiarch replace-
ment. The patient was managed post-operatively in 
the cardiac recovery unit, where the patient was con-
tinued on ventilatory support. He received platelet 
and red blood cell transfusions for thrombocytopenia 
and acute blood loss anemia. He was prescribed anti-
hypertensive medications to maintain a systolic blood 
pressure of 130-140 mmHg. He was successfully ex-
tubated on post-operative day 3 and began physical 
therapy. On post-operative day 7 the patient devel-
oped waxing and waning confusion and neurology 
was consulted. Head CT showed no acute intracranial 
abnormality, carotid Doppler was negative for steno-
sis and dissection, and a daily baby aspirin regimen 
was recommended. The patient was discharged to 
home on carvedilol, amlodipine, amiodarone, atorv-
astatin, aspirin, pantoprazole, and cephalexin.
discussion: This case demonstrates an incident in 
which acute Type A aortic dissection was diagnosed 
as an incidental finding during PCI for ST-segment el-
evation myocardial infarction. It should be noted that 
PCI may worsen aortic dissection because contrast 
injection has been reported to be a risk factor for the 
extension of dissected aorta. It remains unclear if car-
diac catheterization contributed to a worsening in the 
extent of this patient’s aortic dissection.
CV77
Mantle Cell Lymphoma Presenting With Ascitis
Lotfalla, M.; Al Nabulsi, M.; Cholankeril, M.; Basnet, A.; Osman, 
N.; Trinitas Regional Medical Center, Seton Hall University”
introduction: Mantle cell lymphoma (MCL) is a B-cell 
lymphoma that represents 2-6% of non-Hodgkin lym-
phoma (NHL). It affects males more than females, 
usually over the age of 50. Its’ course varies from 
being indolent to aggressive with overall median 
survival 3-5 years and is incurable. Malignant cells 
are positive for CD19, 20, 22, 5, Cyclin-D1, surface 
IgM/D and negative for CD23. Translocation (11:14) 
is the main underlying pathogenic genetic aberration, 
which over-expresses Cyclin-D1 that promotes cell 
cycle progression.
cAse	 rePort: A forty-six year old male with a past 
medical history of rheumatoid arthritis and type 
2 diabetes mellitus, who was on adalimumab and 
metformin, presented to the hospital with worsen-
ing respiratory tract infection. He also complained 
of increasing abdominal distension over a period of 
three months and unintentional weight loss. On ex-
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amination, he was febrile with generalized wasting 
and non-tender palpable lymphadenopathy, ascites, 
and hepatosplenomegaly. Labs showed elevated WBC 
count of 71,000 and absolute lymphocyte count of 
61,000 elevated uric acid and LDH. Peripheral smear 
showed more than 50% atypical lymphocytes with 
no blasts seen. The bone marrow biopsy flow cytom-
etry and cytogenetics showed t(11:14), positive cyclin 
D1 and CD5 and negative CD10 and CD23. The diag-
nosis of MCL was established. Once the patient was 
stabilized, an abdominal paracentesis was performed 
and showed cytological analysis consistent with MCL. 
Staging work up revealed findings consistent with 
Ann Arbor stage IV disease. Two cycles of chemother-
apy were given, however minimal was seen on repeat 
imaging. The patient was discharged but readmitted 
subsequently several times for symptomatic ascites 
and progression of disease. Palliative chemotherapy 
was administered, however. he continued to deterio-
rate and expired within five months from diagnosis.
discussion: Most patients with MCL usually pres-
ent with generalized adenopathy, splenomegaly and 
bone marrow infiltration. The gastrointestinal tract 
and Waldeyer’s ring are the most common sites of 
extra-nodal involvement. Our patient has a rare pre-
sentation of ascites as the initial site of involvement.
CV78
A Case of Staphylococcus Intermedius Vertebral 
Osteomyelitis
Lu, A.H.; Kollu, V.; Farrer, W.; Trinitas Regional Medical Center, 
Seton Hall University
introduction: Staphylococcus intermedius (S. 
Intermedius) is a zoonotic pathogen that is part of the 
normal skin and oral flora of dogs and other animals. 
Case reports of human infections are rare, but the 
true incidence is unknown because the pathogen is 
frequently misidentified as Staphylococcus aureus. Most 
reported cases in humans have been related to dog 
exposure. To our knowledge, ours is the only known 
case of vertebral osteomyelitis with S. intermedius due 
to Staphylococcus intermedius without significant 
canine exposure.
cAse	 rePort: A 49-year-old Hispanic male patient 
with a past medical history of anxiety and alcoholic 
liver disease presented with progressive low back 
pain, worsening acutely over the preceding week. The 
pain was severe, and radiated bilaterally to the legs, 
with the right predominantly affected. He had fallen 
six months prior, reporting a compression fracture of 
L1 and a clavicular fracture that were both managed 
conservatively. The patient denied having any pet ex-
posure in the home, however had reported a single 
remote exposure to a dog while at a social gathering. 
He denied any fever, chills, rigors, chest pain, dyspnea, 
cough, urinary frequency or urgency, dysuria, uri-
nary or fecal incontinence, anesthesia, leg weakness 
or paresthesia, or abdominal pain. On examination 
there were no neurological deficits, nor saddle an-
esthesia. Straight leg raise testing was negative, and 
strength was intact in both lower extremities. Focal 
tenderness was elicited over the midline in the lum-
bar region. MRI with contrast showed heterogeneous 
marrow, intra-discal and end plate enhancement 
from L1-L3 compatible with discitis and osteomyelitis. 
CT-guided biopsy of the L3-L4 interspace confirmed 
osteomyelitis and biopsy culture initially reported as 
coagulase negative staphylococcus grew S. intermedi-
us. Auxiliary infectious workup including blood and 
urine cultures, Hepatitis B and C viral panels, HIV, 
and TB Quantiferon were all negative. He completed 
a course of intravenous Vancomycin for 42 days as an 
inpatient, followed by a course of oral Trimethoprim/
Sulfamethoxazole. Follow-up MRI showed improve-
ment in the discitis and osteomyelitis.
discussion: S. intermedius represents an interesting 
and novel pathogen that’s relevance is apparent given 
the growing pet-owner population. As well, in terms 
of basic microbiological techniques, current literature 
shows it can be falsely identified as MRSA, notably 
due to its intermediate Coagulase reactivity, which 
can be sluggishly or rapidly reactive. Case
CV79
Streptococcus Pyogenes Pneumonia with 
Pleuritis
Mathew, J.J.; Sekhon, R.; Ghazarian, Z.; Khan, M.A.; 
St. Joseph’s Regional Medical Center / Seton Hall University
introduction: Streptococcus pyogenes pneumonia, a 
group A strep (GAS) species, is a relatively uncom-
mon cause for pneumonia in an immunocompetent 
adult.  Complications, specifically pleuritis, can rap-
idly occur and require prompt recognition and 
appropriate treatment.  We present one of four recent 
cases of Streptococcus pyogenes pneumonia with pa-
tients who presented with classic symptoms, and then 
rapidly developed significant pleuritis.
cAse	rePort: We present a 57 y/o hispanic male with 
past medical history of asthma who presented with 
shortness of breath, wheezing, and cough productive 
of yellowish sputum.  Vital signs on admission were 
blood pressure of 121/77, heart rate of 128, respiratory 
rate of 18, temperature of 101.1, and oxygen saturation 
of 100% on room air.  X-ray on admission demonstrated 
a right-sided patchy infiltrate and so the patient was 
diagnosed with community acquired pneumonia and 
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started on vancomycin and azithromycin.  Within 48 
hours, a small to moderate sized right-sided pleural 
effusion was noted.  A CT scan confirmed a large 
loculated pleural effusion, but also evidenced a 3.4cm 
x 4.1cm abscess in the right lower lobe.  CT guided 
drainage was performed removing 590cc of yellowish 
pleural fluid, and 40cc of pus from the abscess.  A 
repeat CT guided drainage was performed removing 
an additional 350cc of serosanguinous fluid.  Cultures 
evidenced Streptococcus Pyogenes Sero Group A in 
both the sputum/tracheal aspirate and in the blood. 
The patient continued to show improvement and was 
subsequently discharged on Augmentin for 2 weeks.
discussion: GAS pneumonia is characterized by 
the rapid onset of fever, chills, dyspnea, productive 
cough, and pleuritic pain, with numerous potential 
complications, most notably rapidly progressing 
pleuritis.  Prompt recognition and early intervention 
are key to positive outcomes. Treatment consists of 
antibiotics and surgical drainage, but may require 
surgical intervention (i.e. thoracoscopy).
CV80
Hepatocellular Carcinoma in the setting of  
Acute Intermittent Porphyria:A Case Report
Mathews, M.; Paish, L.; Kumar, A.; Khan, N.; Maroules, M.; 
St. Joseph’s Regional Medical Center, Paterson. New York 
Medical College
introduction: Acute intermittent porphyria (AIP) is 
a genetic disorder involving an insufficiency of the 
enzyme porphobilinogen deaminase of the heme 
biosynthesis pathway. Clinically, this manifests as 
acute attacks of abdominal pain and neuropsychiat-
ric dysfunction, these attacks can be life threatening. 
Although rare condition, AIP is reported to be the 
most common form of acute hepatic porphyrias in the 
United States and genetic carriers of this condition are 
found to be at an increased risk of hepatocellular car-
cinoma (HCC).
cAse	 rePort: We report a case of 55 year old 
Slovakian female with a past medical history of 
acute intermittent porphyria since 25 years. She 
presented to the emergency room complaining of 
persistent, sharp,right upper quadrant pain with 
intractable nausea and vomiting. On physical 
exam, she appeared dehydrated with tachycardia 
and right upper quadrant tenderness but murphy’s 
sign was absent.  Laboratory studies revealed: 
hemoglobin-14.6 g/dL, hematocrit-43.8%, white blood 
cell count -13.8 K/mm3, platelets-147 K/mm3. An 
underlying contraction related  metabolic alkalosis 
was present with bicarbonate level -28 meq/L.Renal 
functions revealed BUN/ creatinine- 27/0.8 mg/
dL, likely secondary to dehydration. Liver function 
tests indicated AST-33 U/L, ALT-23 U/L, alkaline 
phosphatase-78 IU/L, bilirubin(total)-0.4 mg/dL and 
albumin-4.4 G/dL. Urine porphobilinogen levels were 
found to be significantly elevated at 43.3mg/L. A 
Triple Phase Computed Tomography scan(CAT Scan)
of the abdomen Figure-1A, revealed HCC with arterial 
enhancement of  a fungating mass measuring 7.3 cm 
x 8.7 cm x 6.3cm in segments 4a and 8 of the liver. In 
addition the  serum alpha fetal protein level was found 
to be only 3 ng/mL, and she tested negative for HIV 
,Hepatitis A,B, and C serologies. In the acute setting, 
patient was aggressively treated with glucose loading 
and intravenous fluids and antihypertensive therapy. 
She showed  remarkable clinical improvement, with 
the need for us to begin hemin therapy.
discussion: In recent years the incidence of HCC has 
tripled in the United States, although surveillance is 
recommend for high risk groups such as in HCV, HBV 
carriers. American Physicians also need to be aware of 
the established risk of HCC in genetic carriers of  AIP , 
and implement recommended screening options.
CV81
Hypercalcemia in Advanced Prostatic Carcinoma: 
A Rare Event
Mathews, M.; Kumar, A.; Awkar, N.; Dhaliwal, D.; Maroules, M.; 
St. Joseph’s Regional Medical Center, Paterson. New York 
Medical College
introduction: Advanced prostate cancer is most fre-
quently associated with predominantly osteoblastic 
metastasis and hypocalcemia, the occurrence of hy-
percalcemia in this setting is an exceptionally rare 
event. Despite its propensity for skeletal metastases 
during the advanced stages, prostate cancer is most 
frequently associated with hypocalcemia, this is 
contrary to malignancies of the breast, lung and mul-
tiple myeloma. Many factors work against the onset 
of hypercalcemia in prostate cancer, beginning from 
the osteoblastic nature of lesions favouring a positive 
calcium balance, suggesting a different physiology of 
mineral metabolism in these patients.
cAse	 rePort: We present the case of a  63 year old 
Mexican man with history of advanced prostatic ad-
enocarcinoma and trans-urethral resection of prostate 
presented to ER with nausea, vomiting, polydipsia 
and altered mental status. The patient had previously 
received multiple lines of therapies including leupro-
lide, pelvic radiation therapy, docetaxel, cabazitaxel 
and abiraterone. He was medically castrated second-
ary to leuprolide therapy, with a testosterone level 
level 1.20 ng/dL. Clinically, he appeared dehydrat-
ed and pale, with no other remarkable findings. 
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Laboratory findings indicated severe hypercalcemia 
with calcium-16.1 mg/dL, serum alkaline phospha-
tase -251 IU/L, PSA-149 ng/mL, hemoglobin-7.6 g/
dL and platelets-61,000, BUN-30 mg/dL and creati-
nine-2.44 mg/dL, intact Parathyroid hormone (PTH) 
of 10.5 PG/mL and PTH related peptide (PTHrp) of 
0.74 pmol/L (normal<2.0 pmol/L). He underwent a 
PET scan (Figure 1A) and bone scan (Figure 1B) re-
vealing extensive metastatic osteoblastic lesions. His 
bone marrow biopsy was indicative of metastatic car-
cinoma of prostatic origin,resulting in severe anemia 
and thrombocytopenia. The patient was treated with 
aggressive hydration, calcitonin and pamidronic acid. 
The patient’s clinical status improved with resolving 
hypercalcemia and acute kidney injury, he was dis-
charged on enzalutamide, leuprolide and zometa. Our 
patient had followed up two weeks after discharge, 
his improvement in clinical status was maintained 
and there was complete resolution of the hypercalce-
mia with calcium of 9.5 mg/dL.
discussion: Prostate cancer is typically associated 
with metastatic osteoblastic lesions, hypocalcemia 
and hypophosphatemia. We believe that independent 
and synergistic roles between direct stimulation of 
osteoclastic activity (via neoplastic cells) and growth 
factors (like EGF, TGF) and underlying tumor mo-
saicism should be considered in patients presenting 
with unexplained hypercalcemia in prostatic carcino-
ma, it is not merely an extension of skeletal metastases.
CV82
A Case of Posterior Circulation Stroke Mimicking 
Transient Global Amnesia
Mechineni, A.; Khan, N.; Khan, A.; Department Of Internal 
Medicine, St. Joseph’s Regional Medical Center
introduction: Ability to deduct the anatomical cor-
relation of posterior ischemic infarcts is challenging 
because majority of the time the clinical presentation 
in these cases is a symptom salad with a syndrome 
like picture rather than clear cut clinical deficits. One 
of the rarest forms of presentation is by transient am-
nesia. This controversial presentation led us to explore 
the etiological debate of transient global amnesia 
(TGA), which is a short term, transient, limited neu-
rological disorder.
cAse	 rePort: An 88 year old Hispanic female was 
brought to the hospital due to confusion of unknown 
duration. She was last seen normal 2 days ago. Past 
medical history is significant for hypertension, hyper-
lipidemia, chronic systolic heart failure, bioprosthetic 
mitral valve replacement, atrial fibrillation currently 
on anti-coagulation. Patient was living independently 
prior coming to the hospital. On physical exami-
nation, patient was found to have profound global 
amnesia with predominant retrograde memory loss. 
Neuropsychological testing revealed normal execu-
tive functioning, intelligence, attention, language, and 
mood.  Her short term working memory was also in-
tact. Her confusion was attributed solely because of 
her memory loss to the extent that she was unable to 
identify her family. She had no other complaints. No 
gross motor, sensory deficits were noted. Gait exami-
nation revealed ataxia. Initial lab tests revealed patient 
was sub therapeutic despite being on Coumadin for 
anti-coagulation. Computed tomography of brain 
without contrast was unremarkable. Magnetic reso-
nance imaging of brain revealed multiple tiny infarcts 
in bilateral occipital lobes, right cerebellum and poste-
rior pons. The multiplicity of infarcts, regionalization 
of vascular supply, prominent cardiac risk factors, 
state of sub therapeutic anti-coagulation point to-
wards etiology of thromboembolism to distribution of 
posterior circulation. Patient was treated for Ischemic 
stroke and given higher doses of Coumadin to achieve 
therapeutic range of INR. At 6 weeks of follow-up pa-
tient completely regained her memory and currently 
has no neurological deficits.
discussion: The usual clinical presentation of ver-
tebra-basilar cerebrovascular ischemic events is 
dizziness, limb weakness, dysarthria, headache, nau-
sea, vomiting with amnesia being one of the rare 
forms.We hope to highlight this varied presentation 
of posterior circulation stroke at the same time rais-
ing a question regarding pathophysiology of transient 
global amnesia.
CV83
Acute Aortic Dissection With Rupture Into The 
Right Ventricular Outflow Tract
Mechineni, A.; Bajaj, S.; Yamini, S.; Manda, J.; Shah, P.; Bikkina, 
M.; Shamoon, F.; Department of Cardiology, St. Joseph’s 
Regional Medical Center
introduction:	Acute aortic dissection is a dreaded di-
agnosis. One of the rarer complications is the rupture 
of dissection into one of the cardiac chambers, also 
known as aorto-cameral fistula. It is similar to acute 
aortic syndromes in clinical presentation and mortal-
ity, emphasizing the need for prompt diagnosis and 
management. We present a case of 76-year-old female 
who presented with chest pain and was found to have 
acute aortic dissection with rupture into right ventric-
ular outflow tract (RVOT).
cAse	 rePort: A 76-year-old female with a history 
of hypertension, diabetes, chronic kidney disease 
and coronary artery disease s/p bypass grafting (18 
years ago) presented with sudden onset chest pain. 
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Examination revealed a continuous murmur loudest 
at the left upper sternal border, unremarkable elec-
trocardiogram and minimally elevated troponins. A 
bedside transthoracic echocardiogram showed an 
abnormal continuous flow originating in the RVOT 
and traveling into the right atrium. Subsequently, a 
transesophageal echocardiogram revealed a localized 
dissection flap in the ascending aorta just above the 
sinotubular junction with intact sinuses of valsalva. 
Right and left heart catheterization localized the site 
of aorto-RVOT fistula and confirmed the step-up in 
the RVOT oxygen saturation. The patient however de-
cided against surgery and opted for supportive care. 
She died a week later after an eventful hospital course.
Prior history of cardiac surgery seems to be the most 
predominant risk factor in majority of these cases. 
Adhesions due to surgery can explain the pathologi-
cal process that leads to the formation of fistula with 
rupture into a cardiac chamber, bypassing pericar-
dial sac. Clinically patients may present acutely with 
severe chest pain or chronically with heart failure 
symptoms. A good auscultatory exam and a prompt 
bedside echocardiogram might suffice in establishing 
this less known diagnosis.
discussion: It is extremely rare for an acute aortic 
dissection to rupture externally into the RVOT while 
sparing the aortic root.The anatomy of mediastinum 
dictates the extension of ascending aortic dissection 
into its contiguous structures. It is paramount to ex-
clude this entity due to its significant impact on the 
hemodynamic status of the patient.
CV84
Diabetes Ketoacidosis in Thin Young Type 2  
Diabetes Mellitus Patient
Meloro, R.T.; Wallach, S.; St. Francis Medical Center, Seton Hall 
University School of Health and Medical Sciences
introduction: Diabetic ketoacidosis (DKA) is a poten-
tially life threatening complication in patients with 
diabetes mellitus (DM). Predominantly occurring in 
Type 1 DM (T1DM) patients, it can occur in Type 2 
DM (T2DM) patients.  Several investigators reported 
> 50% of African-American persons with newly diag-
nosed DKA have clinical, metabolic and immunologic 
features of T2DM including obesity and significant 
family history of DM. Here we present a young thin 
male patient in DKA who states he has T1DM yet has 
features suggesting T2DM.
cAse	rePort: 18 year old African-American male with 
past medical history of DM presents to hospital com-
plaining of epigastric pain for two days.  Associated 
symptoms included intermittent blurred vision, poly-
uria, polyphagia and polydipsia for two weeks.  Per 
patient, this presentation was similar to one year 
earlier when first diagnosed with T1DM. Home medi-
cations included 34 units subcutaneous (SC) long 
acting basal insulin nightly and four daily SC prandial 
rapid acting insulin based on a sliding scale regimen. 
Patient explained he lost his means to procure insulin 
five weeks earlier, used what he had and was without 
insulin for the past three weeks.  Initially labs: blood 
glucose level of 611 mg/dL, an anion gap of 21 and a 
positive serum acetone.
discussion: Describing DM as 3 distinct types (T1DM, 
T2DM, gestational) appears too simplistic with 
the recognition of variants. Pending immunologic 
studies, this case illustrates either the potential for 
misdiagnosing T2DM (e.g. “Flatbush diabetes”) or a 
T1DM variant with T2DM features.
CV85
Intravenous Bisphosphonate Induced 
Hypocalcemia
Meloro, R.T.; Mohan, V.; St. Francis Medical Center, Seton Hall 
University, School of Health and Medical Sciences
introduction: Bisphosphonates are often used in pa-
tients with advanced osteolytic metastatic cancer to 
relieve bone pain. 1,2  Bisphosphonates are generally 
well tolerated.  Hypocalcemia can result from intra-
venous (IV) bisphosphonate use in patients with low 
to normal levels of calcium or vitamin D.  Metastatic 
prostate cancer typically presents with osteoblastic le-
sions which can also increase risks for hypocalcemia. 
Here we present an example of hypocalcemia second-
ary to IV bisphosphonate use in a patient with bony 
metastatic prostate cancer.
cAse	 rePort: 72 year old male with past medical 
history of coronary disease status post recent coro-
nary bypass graft surgery, prostate cancer with bony 
metastases, diabetes mellitus, hypertension, and pe-
ripheral artery disease status post femoropopliteal 
bypass was admitted to hospital for CHF exacerbation 
and a right hip fracture.  Initial lab results demonstrat-
ed low-normal levels of calcium (8.5 mg/dL), albumin 
(3.9 g/dL), elevated PTH (193 pg/mL) and insufficient 
vitamin D (23 ng/mL). Alkaline phosphatase was also 
elevated, consistent with bony metastases.  After hip 
repair surgery, the patient received a single dose of IV 
bisphosphonate treatment for skeletal muscle stabili-
zation.  After two days calcium levels began to decline. 
Calcium and vitamin D were repleted with oral cal-
citrol, ergocalciferol, calcium gluconate and calcium 
carbonate.   Calcium levels continued to decline reach-
ing a nadir of 5.3 mg/dL.  The patient was immediately 
placed on calcium infusion drip and telemetry with 
aggressively monitoring of serum calcium.  Within 24 
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hours, calcium levels rose to the lower end of normal 
limits (5.3 mg/dL to 7.3 mg/dL [8.2 mg/dL corrected]). 
Calcium infusion was subsequently replaced with 
oral calcium and calcitrol was tapered down.  All 
electrolytes, including calcium, normalized over the 
next 48 hours.  The patient remained asymptomatic 
and had no electrocardiogram changes.  Subsequently, 
the patient underwent physical therapy and was later 
discharged in stable condition.
discussion: IV bisphosphonate use in cancer patients 
for bone stabilization is becoming more common but 
can particularly worsen hypocalcemia in bony meta-
static prostate cancer patients. Vitamin D and calcium 
levels must be adequate prior to IV bisphosphonate 
use and calcium values must be monitored closely 
to prevent significant morbidity/mortality from 
hypocalcemia.
CV86
Baclofen Induced Brain Death
Meloro, R.T.; Ursani, M.A.; Sasinowska, S.; Imayama, I.; 
Kososky, C.; Seelagy, M.M.; St. Francis Medical Center, Seton 
Hall University, School of Health and Medical Sciences
introduction: Brain death implies permanent absence 
of cerebral and brainstem functions.  Pre-requisites 
must be cleared before the clinical exam for brain 
death shall be done including: core temperature > 
36 C, SBP >100, eucapnia, euvolemia, no hypoxia, no 
drug use, poisoning or medical conditions which may 
confound the exam.  In adult patients, trauma and 
subarachnoid hemorrhage are the most common eti-
ologies.  Baclofen, a widely used central acting muscle 
relaxant, can mimic brain death in overdose.
cAse	 rePort: 30yo Hispanic male with past medi-
cal history of paraplegia status post traumatic injury 
fracture of the T7 vertebrae one year earlier, presented 
to the Emergency Department after a friend found 
him unconscious and nonreactive to verbal or pain-
ful stimuli.  He was last witnessed carrying out his 
normal activities of daily living the prior night. The 
patient was intubated in the field.
discussion: Baclofen overdose can mimic brain death. 
Here we describe our patient who overdosed on 
Baclofen, met brain death criteria, who subsequent-
ly was discharged fully functional.  Any patient on 
Baclofen meeting brain death criteria should be re-
evaluated frequently to rule out reversible metabolic 
cause secondary to drug overdose.
CV87
A Case of Graves Disease requiring Total 
Thyroidectomy
Miriyala, V.; Zijoo, R.; Amodu, A.; Bukhari, S.; Moncayo, J.L.; 
Mohan, V.; St. Francis Medical Center, Trenton, NJ
introduction: Graves disease is an autoimmune 
disorder that results in hyperthyroidism. Treatment 
includes anti-thyroid drugs, radioactive iodine abla-
tion or thyroidectomy. The decision is made on a case 
by case basis. Medical therapy is a low cost, convenient 
option which may not be lead to permanent remission. 
Radioactive ablation also a low cost option which 
results in permanent resolution of hyperthyroidism. 
Surgery, a high cost option,  leads to immediate and 
permanent cure of hyperthyroidism. However, it is 
associated with complications such as recurrent la-
ryngeal nerve palsy and hypoparathyroidism.
cAse	rePort: A 30 year old Hispanic Female presented 
to our hospital with increasing neck swelling for 
2 months. The neck swelling was associated with 
increasing dysphagia and cough.  On further history 
she reported diarrhea, unintentional weight loss, 
tremors, palpitations and irregular menses for many 
months. She had been diagnosed with Grave’s Disease 
ten years ago and was treated with methimazole and 
propranolol as an outpatient but was non-compliant 
with therapy. Her history was also remarkable for 
allergy to iodine in the past, resulting in generalized 
edema and shortness of breath. Her initial vital signs 
were remarkable for heart rate was 114/min, BP 114/60, 
respiratory rate 16 of  and afebrile. Her physical 
exam was remarkable for bilateral exophthalmos 
and a diffusely enlarged thyroid gland with positive 
bruit. Cardiopulmonary exam was significant 
for tachycardia and lungs clear on auscultation. 
Neurological exam noted mild bilateral upper 
extremities tremors and generalized proximal muscle 
weakness.  Her skin was warm and moist to touch. 
Labs were remarkable for TSH <0.01 uIU/ml (Normal 
0.27-4.2) , free T4 >7.77 ng/dl (Normal 0.93-1.7) and free 
T3 >20 pg/ml (2.3-4.2). Non-contrast CT of the neck 
revealed diffuse thyromegaly with mild transverse 
narrowing of the subglottic trachea.  The patient’s 
symptoms were stabilized in hospital and permanent 
treatment options were entertained. However, given 
her non-compliance with medications as an outpatient, 
enlarged thyroid gland with compressive signs and 
symptoms, and significant iodine allergy the only 
viable treatment option was total thyroidectomy. She 
underwent successful total thyroidectomy and is 
currently doing well on levothyroxine therapy.
discussion: The goal of treatment for patients with 
Graves disease is to induce euthyroid state. If a patient 
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is unable to achieve remission in a reasonable time by 
using medical management, the next option usually 
considered is iodine ablation. The incidence of true 
iodine allergy is rare. However, this patient described 
symptoms very suggestive of a true allergic reaction. 
Total thyroidectomy is the least common form of ther-
apy because of risks. However, it was the only choice 
available for this patient.
CV88
Meningiomas; Not as Harmless as they Seem
Miriyala, V.; Imayama, I.; Ramanujam, S.; Kososky, C.; 
St. Francis Medical Center
introduction: A meningioma is a type of tumor that 
develops from the meninges. Most meningioma (90%) 
are categorized as simply benign tumors, with re-
maining 10% being atypical or malignant. However, 
the term simply benign can be misleading as growth 
of these tumors can constrict the brain; leading to di-
sastrous complications. We report a case of Hispanic 
man plagued with uncontrollable headaches, seizures 
and diplopia due to large cavernous sinus meningio-
ma that entangled the left internal carotid artery and 
was refractory to conventional therapy.
cAse	rePort:	A 38 year-old Hispanic man presented 
with severe migratory right hemicranial headaches 
for 2 weeks. The headache was accompanied with 
vertigo and nausea. His only past medical history 
was migraines. Computed tomography scan of head 
done one year prior did not show any intracranial 
pathology. Initial physical exam was unremarkable 
with regards to cardiopulmonary, gastrointestinal, 
and genital-urinary.  His neurological examination 
revealed a sustained lateral gaze nystagmus and a 
minimal end-point dysmetria bilaterally.  All other 
components of the neurological examination were un-
remarkable. Magnetic resonance image (MRI) of brain 
with and without contrast revealed a left cavernous 
sinus mass, 2.4 x 1.7 x 5.0 cm, causing a narrowing of 
the intracavenous portion of left internal carotid ar-
tery. The mass displaced pituitary gland. The dural 
enhancement overlying cavernous sinus suggested 
meningioma. MR angiography showed high-grade 
left internal carotid artery stenosis of at least 80%, 
secondary to the mass. Transcranial Doppler showed 
vasospasm of the right anterior cerebral and middle 
cerebral arteries without evidence of right to left 
anastomotic redirection of flow in the anterior com-
municating artery.
discussion: Meningiomas account for about 34% of 
primary brain tumors. They are typically classified 
as benign due to slow growth.  Usually large menin-
giomas are amendable to surgical intervention. But 
surgical options are limited based on location and 
involvement of surrounding structures. In such cas-
es, these simply benign lesions lead to incapacitating 
complications.
CV89
Acute Aphemia in a Young Adult Male with  
Congestive Heart Failure
Mozaffarian, D.; Kaleel, A.; Seton Hall University, JFK Medical 
Center, New Jersey Neuroscience Institute
introduction: Aphemia has been described as an 
“isolated disorder of articulation” and may be best, or 
most simply, understood as severe apraxia of speech, 
though this designation has been met with some con-
troversy. It possibly lies on the spectrum of aphasia 
with preservation of comprehension and ability to 
communicate by writing with loss of articulation. 
Lesions causing isolated aphemia have been localized 
to the left precentral gyrus. We present the case of a 32 
year old male patient who presented with acute onset 
of aphemia.
cAse	rePort: This is a 32 year old male patient with 
viral non-ischemic cardiomyopathy s/p biventricu-
lar assist device (BiVAD) who was completely at his 
neurological baseline whereupon he developed acute 
onset of loss of the ability to speak. A stroke code was 
activated with a subsequent full neurological assess-
ment which revealed an awake, alert individual who 
appropriately nodded “yes” or “no” to questions of 
orientation, followed all simple and complex com-
mands well indicating intact comprehension, and 
was able to fully communicate by writing, but was 
unable to form any words. The remainder of the ex-
amination was normal, including intact cranial nerves, 
intact and symmetric motor strength of the face and 
appendicular musculature, intact and symmetric 
sensory exam, and an intact cerebellar function and 
normal gait. Within 20 minutes, the patient’s symp-
toms improved to the point that he was able to speak 
with evidence of severe dysarthria with eventual full 
resolution of symptoms within 30 minutes. During 
the period of resolving symptoms, the patient was 
reassessed for language functions several times and 
these were found to be intact. An MRI was not per-
formed as the patient’s ventricular assist device was 
not MRI-compatible, and a CT of the head was per-
formed which was unremarkable. This was felt to be 
consistent with the nature of the patient’s transient 
event. The mechanism for this event was felt to be 
secondary to his reduced ejection fraction, ultimate-
ly resulting in an embolic process or hypoperfusion 
resulting in decreased perfusion to the brain tissue 
acutely, though this is less likely.
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discussion: Aphemia is rare and, very often, presents 
a diagnostic conundrum for the inexperienced physi-
cian. Knowledge of the features of aphasia will prove 
beneficial in correctly identifying this condition. Most 
notably, this disorder is characterized by the patient’s 
intact comprehension and intact ability to communi-
cate by writing.
CV90
Enterobacter Cloacae-Induced Right Heart Valve 
Infective Endocarditis in a Woman Without  
Valvular Disease
Nemani, K. C.; Salamera, J.; Butler, J.; Trinitas Regional Medical 
Center and Seton Hall University
introduction: Infective Endocarditis is observed in 
patients with predisposing factors such as Intravenous 
Drug Use (IVDU) and underlying Valvular dis-
ease (including rheumatic fever). The organisms 
are predominantly gram positive bacteria. Infective 
Endocarditis (IE) due to Gram Negative Bacteria (GNB) 
is uncommon as the causal organisms; within those, 
the majority are due to Haemophilus, Actinobacillus, 
Cardiobacterium, Eikenella, and Kingella (HACEK) 
species. Non-HACEK GNB IE is rarer still in patients 
without valvular heart disease which predisposes to 
septic vegetations. This case describes such a patient 
with Enterobacter cloacae IE in the absence of classical 
risk factors.
cAse	rePort: A 63-year old Haitian female with long 
standing history of type 2 diabetes mellitus, hyperten-
sion, and end stage renal disease on Renal Replacement 
Therapy presented with an alteration in mental status. 
Initial evaluation ruled out intracranial sources, medi-
cation side effects and uremia. A few days prior, she 
had a brief hospital stay for vaginal bleeding at which 
time blood cultures showed Enterobacter cloacae.  She 
received dialysis via a right-sub-clavian PermaCath 
and received one-dose of levofloxacin during dialy-
sis on the day of admission. Her catheterized urine 
sample was cloudy with positive leukocyte esterase 
and nitrites, but, unfortunately, no urine culture was 
submitted. Both her PermaCath line and peripheral 
cultures confirmed line sepsis with superimposed 
urinary tract infection. Her PermaCath was removed, 
the tip also grew Enterobacter cloacae and sensitivi-
ty-adjusted antibiotics were continued. Her mental 
status did not improve, and she had recurrent fevers 
despite removal of the seeding source. A transesopha-
geal echocardiogram (TEE) revealed vegetations on 
the Tricuspid Valve (TV) with small perforation on 
the anterior leaflet. After the bacteremia had cleared, 
she received six weeks of carbapenem monotherapy, 
with follow-up cultures and TEE to confirm successful 
treatment of IE.
discussion: The recent International Collaboration of 
IE Prospective Cohort Study analyzed 2,761 cases of 
IE where <2% were GNB of the non-HACEK variety; 
only 2 cases were attributed to Enterobacter species. 
Despite the rarity, clinicians must be aware of the 
increased risk in our growing population with ubiq-
uitous intravascular devices e.g., cardiac pacemakers, 
ICDs, PICCs, PermaCaths etc. Even in the absence of 
valvular disease, as in our patient, one must suspect 
Gram-Negative Infective Endocarditis.
CV91
Dual Left Anterior Descending Artery System: 
One Native, One Aberrant
Nemani, K.C.; Patel, H.R.; Millman, A.E.; Shamoon, F.E.; 
Joshi, M.B.; Trinitas Regional Medical Center and Seton Hall 
University
introduction: A dual left anterior descending artery 
(LAD) System is a rare coronary anomaly defined as the 
presence of two LADs in the Anterior Interventricular 
Sulcus (AIVS). In this report, we present a rare form 
of the Dual LAD system in which one vessel arises 
natively and the second aberrantly from a separate 
ostium.
cAse	rePort: Our patient is a 60 year old male with a 
PMH of hypertensive heart disease, dyslipidemia, and 
non IDDM who presented for evaluation of chest pain 
with abnormal stress test showing a reversible defect 
in the territory of the LAD. Patient was scheduled for 
an elective cardiac catheterization. The left coronary 
sinus revealed separate LAD and left circumflex artery 
origins; the LCx had mild 30-40% diffuse disease. The 
Native LAD had 80% eccentric narrowing proximally; 
it then gave rise to a large septal perforator and 
moderate Diagonal vessel, both at jeopardy from the 
proximal lesion. Just distal to the first Septal Perforator, 
the LAD shows chronic total occlusion. Right coronary 
sinus angiography showed a Right Coronary Artery 
as well as, via contrast reflux, and aberrant vessel 
travelling to the Anterior LV region arising from a 
separate ostium. Selective engagement of this vessel 
revealed a large artery with excellent flow running 
from its origin in the right coronary cusp, anteriorly 
across the pulmonary arterial trunk, and entering 
the anterior Interventricular (IV) Sulcus immediately 
distal to the stump of the Native LAD. We believe this 
vessel is an aberrant dual LAD because it gave septal 
perforators and wrapped around the apex.
discussion: In cases with a high total occlusion of the 
Native LAD, cardiologists must keep in mind that, 
though rare, collateralization can mitigate the lesion, 
even to such as extent as to preserve LV Ejection 
Fraction. In our case, the anomalous vessel was a 
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second LAD arising from the right coronary cusp, 
which is exceedingly rare. If suspicion of collaterals 
were not raised, unnecessary angioplasty may have 
resulted.
CV92
Diabetic Predisposition to Klebsiella pneumoni-
ae Pyogenic Liver Abscesses
Nemani, K. C.; Syed, J. A.; Isaac, L.; Brescia, M.; Trinitas 
Regional Medical Center with Seton Hall University
introduction: Klebsiella pneumoniae is a known cause 
of nosocomial URI in the United States. In recent 
years, however, the K1 serotype has emerged from 
Southeast Asia as a causal pathogen for Community-
Acquired Pyogenic Liver Abscesses (CA-PLA), with 
a small scattering of cases reported in America. 
Diabetes Mellitus type-2 has recently been proposed 
as a predisposing factor for Klebsiella pneumoniae K1 
infection and its subsequent CNS sequelae.
cAse	rePort:	A 54-year-old male cargo-ship worker 
with previously diagnosed but untreated DM-II 
presented with a three-day history of constipation 
and anuria with suprapubic distention. Foley 
catheterization yielded 1L of urine. Laboratory 
studies revealed diabetic ketoacidosis superimposed 
on sepsis, addressed with an insulin drip / IVF and 
Vancomycin with Zosyn, respectively. At the time, 
patient was admitted to the ICU. Initial CT scan of the 
abdomen to identify cause of obstructive uropathy 
revealed a severely enlarged prostate and right 
peri-/para-renal stranding indicative of severe UTI. 
Multiple ill-defined hepatic lesions were also noted. 
Over the first twelve hours, the patient progressed 
into septic shock necessitating vasopressor support 
for persistent hypotension despite adequate 
fluid replacement. Antibiotics were switched to 
meropenem. The patient developed ARDS requiring 
ventilator support. He also developed sepsis-induced 
ITP with thrombocytopenia to 18,000; Solumedrol 
therapy was initiated.  After two days of ventilator 
support, antibiotics, and steroid therapy, patient 
improved and was extubated. Leukocytosis 
resolved and vasopressor support was weaned 
and discontinued. Antibiotics were switched from 
meropenem to Ceftriaxone. At this time, the patient 
was stable enough for a liver biopsy to assess the 
ill-defined lesions noted on initial CT scan, which 
turned out to be pyogenic abscesses. The patient 
was subsequently transferred to the medical 
ward. The patient continued to improve but noted 
continued abdominal pain. Repeat CT-scan indicated 
prostatitis and persistent nephritis with areas of 
liquefaction. TURP and laparoscopic-nephrectomy 
were performed with good clinical response. Patient 
was maintained on ceftriaxone therapy and showed 
excellent clinical improvement. He was finally able to 
return home to the Philippines on oral ciprofloxacin.
discussion:	 K. pneumoniae has, in the last decade, 
become an emerging global pathogen with highest 
incidence in Southeast Asia. A firm link is established 
between the K1 serotype and CA-PLA, often result-
ing in CNS damage. In our patient, early, aggressive 
therapy including ventilator and vasopressor support 
then surgical removal of necrotic areas allowed for 
recovery without CNS sequelae. This case reminds 
clinicians to be mindful of the possibility of CA-PLA 
in Diabetics, especially from Southeast Asia.
CV93
Primary Tuberculosis Presenting as Pleural  
Effusion in a Young HIV-Seronegative Patient
Pandya, S.; Kollu, V.; Salamera, J.; Trinitas Regional Medical 
Center
introduction: Tuberculosis (TB) is an important cause 
of morbidity and mortality which can be prevent-
able if an appropriate diagnosis is made, and prompt 
treatment is provided in a timely manner. Pleural ef-
fusion is seen in 5% of extra-pulmonary disease due to 
Mycobacterium tuberculosis. It can occur with prima-
ry tuberculosis, or more frequently as a reactivation 
disease. Here we present a case of an HIV-seronegative 
young patient who presented acutely with extensive 
pleural disease and responded well to multi-drug 
therapy after prompt diagnostic evaluation.
cAse	 rePort: A 28-year old female, originally from 
Mexico with no past medical history, manifested 
with a 3-day history of left sided pleurity and resting 
tachycardia. A CT angiography of her chest ruled out 
pulmonary embolism, but it showed small left pleural 
effusion and pleural based 3mm nodular opacity. A 
tuberculin skin test (TST) had > 15mm induration, and 
HIV screening was non-reactive.  Patient previously 
had a negative TST 3 years before admission, which 
was performed during her pregnancy. Urinary anti-
gens for legionella and pneumococcus as well as ANA 
were negative. Multiple sputa for acid-fast bacilli were 
negative. After cardiothoracic surgical evaluation, 
a left exploratory thoracotomy with pleural biopsy, 
wedge resection, and pleural fluid analysis were per-
formed. Pleural fluid was grossly cloudy, with wbc 
of 1700, predominantly lymphocytes at 90%, and glu-
cose of 79 mg/dL. Intraoperatively, multiple whitish 
nodules on visceral pleura as well as large granuloma 
on diaphragmatic surface were identified. Pathology 
was consistent with granulomatous pleuritis, but AFB 
stain was negative without evidence of malignant 
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cells. A lung biopsy showed multiple non-caseating 
and caseating granulomas. After 44 days of incuba-
tion, a tissue culture from her diaphragm and left 
lower lobe was positive for AFB. Anti-Koch’s regi-
men was initiated consisting of isoniazid, rifampin, 
ethambutol, and pyrazinamide. Patient continued to 
improve post-operatively and was advised to follow-
up at the TB clinic.
discussion: This case highlights importance of keep-
ing TB as one of differential diagnosis in a patient 
presenting with unilateral pleural effusion. Definitive 
diagnosis depends on finding M. tuberculosis in pleu-
ral fluid, sputum, or pleural biopsy. Natural history of 
untreated TB pleural effusion is usually spontaneous 
resolution in 4-6 weeks with development of active 
pulmonary TB or extrapulmonary TB in 40-60% of 
cases several years later.
CV94
Disseminated Histoplasmosis Mimicking Colon 
Malignancy
Pandya, S; Salamera, J; Ahmed, M; Trinitas Regional Medical 
Center
introduction: Histoplasma capsulatum, a thermally 
dimorphic fungus, is an important opportunistic in-
fection in patients with advanced HIV disease and 
is associated with significant morbidity and mortal-
ity. Progressive Disseminated Histoplasmosis (PDH) 
occurs in 1 in 2,000 patients with acute infection. 
Diagnosis of PDH requires a high index of suspicion 
with identification of symptoms and signs, along with 
appropriate diagnostic tests. Here we present a case of 
a young, HIV infected patient with a CD4 count of 15 
who was found to have disseminated histoplasmosis 
but eventually recovered with appropriate treatment.
cAse	 rePort: A 48-year old male, originally from 
Honduras with HIV for the past 10 years (viral load 
>1 million, CD4 count of 15) and has not been on any 
treatment, presented with intermittent fevers for a few 
months, 20-lbweight loss, anorexia, abdominal pain, 
melena, and profound anemia requiring blood trans-
fusion. A colonoscopy revealed an ulcerated mass in 
his ascending colon, and pathology was consistent 
with narrow based budding yeast without malignant 
cells. Carcinoembryonic antigen was normal, but the 
urinary antigen for Histoplasma came back as posi-
tive. Quantiferon TB gold assay, serum cryptococcal 
antigen, and AFB blood cultures were non-diagnostic. 
Liposomal Amphotericin B was initiated for 2 weeks 
and followed by oral itraconazole as consolidation 
treatment. HAART was eventually started, along with 
prophylactic trim-sulfa and azithromycin. This led to 
excellent virologic and decent immunologic response. 
Repeated complete blood counts and CT of patient’s 
abdomen revealed improving  cytopenias and resolu-
tion of sigmoid colitis.
discussion: Histoplasmosis is found in USA but also 
in the Central America. It usually manifests as pro-
gressive disseminated histoplasmosis in HIV patients. 
Most of cases of histoplasmosis have GI involvement 
and colonoscopy can show ulcerated or polypoid 
masses involving the colon or ileum, mimicking a 
malignant process. Histoplasma antigen, from urine, 
CSF, serum, and BAL fluid, is diagnostic test for dis-
seminated disease. Duration of treatment is at least 1 
year for PDH.
CV95
Septic Emboli Causing Acute ST-Elevation  
Myocardial Infarction
Patel, K.M.; Cholankeril, M.; Bikkina, M.; Shamoon, F.; Saint 
Michael’s Medical Center, Seton Hall University School of 
Health and Medical Sciences
introduction: Systemic embolism is a well-known 
complication of infective endocarditis. The most fre-
quent sites include the central nervous system, spleen, 
kidney, liver, and iliac or mesenteric arteries. In rare 
cases, these vegetations may embolize to the coronary 
arteries and cause potentially fatal acute myocardial 
infarction. In patients having signs of acute myocardial 
infarction and also appear to be septic, the possibility 
embolic myocardial infarction should always be in 
the working differential diagnosis. We present a case 
of a 43 year old male who presented to the Emergency 
Department with complaints of fevers, chills, and 
pressure-like feeling in his chest who was found to 
have an acute ST-elevation myocardial infarction as a 
result of septic emboli from aortic valve endocarditis.
cAse	rePort: Our patient is a 43 year old male with 
multiple medical problems including Hypertension, 
End-stage Renal Disease on Hemodialysis, Hepatitis 
B and C, HIV, and history of intravenous drug use 
who presented to the Emergency department with 
complaints a pressure like feeling in his chest for a 
few hours. He admitted that during the prior 3 days 
he was also having progressive fevers, chills, lethar-
gy, and fatigue. Electrocardiogram revealed Normal 
sinus rhythm with 1st degree AV block, 1mm ST seg-
ment elevations in leads II, III, and AVF, and 1mm ST 
segment depressions in leads V1, V2 consistent with 
acute infero-posterior ST-elevation myocardial infarc-
tion. The patient was emergently taken to the cardiac 
catheterization lab for coronary angiography and pos-
sible revascularization. The procedure revealed a 
distal filling defect with 99% stenosis of a type III 
(“wrap-around”) left anterior descending (LAD) 
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coronary artery. All other coronary arteries were an-
giographically normal. Contrast ventriculogram of 
the left ventricle showed an ejection fraction of 50-55% 
with no wall motion abnormalities. The decision was 
made to treat the patient with medical therapy rather 
than intervention given that the patient was hemo-
dynamically stable, his comorbidities and history of 
noncompliance put him at high risk of stent related 
complications, and his ejection fraction was normal. 
Serial cardiac markers later revealed troponin levels 
reached a maximum of 19 on day 2 of hospitalization 
before returning towards baseline. Transesophageal 
echocardiogram was also done which showed a large, 
highly mobile echodensity attached to the aortic valve 
as well as severe aortic regurgitation. Despite intra-
venous antibiotics, the patient had persistent fever, 
elevated white blood cell count, and multiple blood 
cultures positive for Rothia Mucilaginosa; a gram-
positive cocco-bacilli normally found in the human 
upper respiratory tract and known to cause infections 
in immunocompromised individuals. Ultimately, the 
patient required surgical aortic valve replacement 
during the hospitalization. Intraoperatively, the large 
vegetation and the aortic valve were removed and 
successfully replaced with a bioprosthetic valve. The 
patients postoperative course was uncomplicated and 
he was discharged to a subacute facility after recovery.
discussion: Early transesophageal echocardiogram 
and cardiac catheterization play an important role 
in diagnosis and management of this condition. 
Treatment options include percutaneous coronary in-
tervention, surgery, or embolectomy.  PCI should be 
noted to carry the risk of creating mycotic aneurysms 
at the site of coronary embolism. Surgical embolec-
tomy is very high risk, and typically only done if the 
patient is unstable.
CV96
Infective Endocarditis Associated C3 Glomerulo-
nephritis: A Case Report
Patel, A.S.; Hawatmeh, A.; Ahmed, S.; Massarweh, F.; Abu-
Taleb, A; Saint Michael’s Medical Center
introduction: Cases of infective endocarditis are as-
sociated with various renal complications including 
acute tubular necrosis, acute interstitial nephritis, and 
variants of  membranoproliferative glomerulonephri-
tis. Most cases of infective endocarditis associated 
renal disease resemble post-infectious glomerulone-
phritis, in which there is glomerular deposition of 
immune complexes on the renal biopsy. Treatment 
with immunosuppressants and antibiotics is followed 
by renal recovery. Complement C3 glomerulonephri-
tis is associated with congential or acquired activation 
of the alternative complement pathway, leading to ex-
cess deposition of complement C3. We will present a 
case of acute infective endocarditis associated c3 glo-
merulonephritis which persisted to renal replacement 
therapy.
cAse	rePort: Our patient is a 36 yo hispanic female 
with past medical history of  untreated Hepatitis 
C, polysubstance abuse, intravenous drug abuse 
presented with 2 week history of exertional dys-
pnea, palpitations and non-productive cough. 
Approximately four months prior to presentation, the 
patient was hospitalized for staphylococcus aureus 
infective endocarditis; at which point, the kidney func-
tion was normal. Upon current presentation, patient 
was hypotensive at 101/57, with a pulse of 97 and nor-
mal temperature, respirations and oxygenation. Chest 
radiograph showed multiple predominantly cavitary 
bilateral pulmonary nodules compatible with septic 
emboli. Further diagnostics revealed a tricuspid valve 
vegetation, while blood cultures revealed a methicil-
lin sensitive staphylococcus aureus and enterobacter. 
Initial laboratory data revealed acute kidney failure, 
with creatinine of approximately 10; urine analysis 
was initially bland and fractional excretion of sodi-
um at 0.65%.  She was treated as prerenal azotemia, 
hydrated appropriately and received antibiotics for 
MSSA. The creatinine improved to 4.59, however did 
not resolve. Further studies revealed 3+ proteinuria, 
hematuria, and clinical oliguria despite hydration. 
Clinically, patient required hemodialysis as there 
was no improvement in renal status. After begin-
ning inpatient dialysis, renal biopsy was performed 
revealed membranoproliferative glomerulonephritis. 
The biopsy described 13 of 20 glomeruli with cres-
centic glomerulonephritis with dominant C3 staining 
and acute interstitial nephritis, severe and aggres-
sive necrotizing and crescentic glomerulonephritis, 
with endocapillary proliferation. Upon immunofluo-
rescence, there was C3 staining in mesangium and 
capillary walls; however glomeruli were negative 
for IgA, IgG, IgM, C1q, albumin, kappa, lambda light 
chains or immune deposits.Throughout the hospital 
course, patient’s serum complement measurement 
revealed a persistently low complement C3; however 
she had a normal complement C4. Autoimmune and 
monoclonal gammopathy diagnostics were nega-
tive. Patient was started on high dose corticosteroids 
for renal recovery, however 24 hour urine collection 
revealed three gram proteinuria. Despite improving 
clinical status, she continued dialysis upon discharge 
from the hospital. Outpatient evaluation of renal func-
tion will prompt further continuation of hemodialysis.
discussion: Clinically, our case appeared to be an 
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endocarditis associated postinfectious glomeru-
lonephritis; such cases included immune complex 
mediated glomerulonephritis. In contrast, our patient 
had only C3 mesangial staining, decreased serum 
complement C3 levels, persistent proteinuria and 
hematuria and rapidly progressive crescentic  glomer-
ulonephritis. The biopsy and laboratory evaluation 
are characteristic of activation of the alternative com-
plement pathway and of C3 glomerulonephritis.
CV97
Arrythmogenic Right Ventricular Dysplasia/Cardio- 
myopathy (ARVD/C) and Cathecholaminergic 
Polymorphic Ventricular Tachycardia (CPVT):  
A Phenotypic Spectrum Seen in Same Patient
Patel, H.; Shah, P.; Patel, K.; Rampal, U.; Costeas, C.; 
Shamoon, F.; Tiyyagura, S.; Saint Joseph Regional Medical 
Center-Paterson
introduction: ARVD/C and CPVT are rare inherit-
able sudden cardiac death syndromes predominantly 
expressed in young. ARVD/C is characterized by pro-
gressive fibrofatty replacement of the myocardium 
that predisposes to ventricular tachycardia while 
CPVT is characterized by exercise-induced bidirec-
tional / polymorphic ventricular tachycardia (VT) 
and structurally normal heart. A mutation in dif-
ferent genes causes these syndromes but recently, 
mutation in a common gene RYR2 has been associat-
ed with both disorder and it has been suggested that 
CPVT and ARVD/C represent a phenotypic spectrum. 
We present a case unique in expressing both these 
phenotypes.
cAse	 rePort:	 30-year-old Caucasian female, who is 
a teacher; with no PMHx was admitted for evalua-
tion of aborted sudden cardiac arrest while walking 
to her work. No prior history of syncope, palpita-
tions, or any family history of unexplained early or 
sudden death. Physical examination was benign and 
toxicology screen was negative. Initial EKG showed 
ventricular bigeminy and subsequent EKG’s showed 
non-specific TWI in antero-lateral leads with normal 
QTc interval. 2D echocardiography showed transient-
ly reduced LV systolic function sec. to stunning with 
no obvious structural abnormality. Cardiac catheter-
ization showed normal coronaries. Electrophysiologic 
study showed no evidence of overt preexcitation 
and no inducible ventricular tachycardia. Patient got 
single chamber ICD placed for possible inherited sud-
den cardiac death syndrome. Subsequent cardiac CT 
scan showed classic right ventricle (RV) dysplasia 
with thinned RV and reduced RV ejection fraction 
of 20%. We diagnosed our patient with ARVD/C 
but to our surprise, outpatient exercise stress test-
ing showed classic bi-directional and polymorphic 
ventricular tachycardia with graded exercise sug-
gestive of CPVT, though genetic testing for ARVD/C 
and CPVT Panel was negative. (Note: 40% of patients 
with both, ARVD/C and CPVT, do not have disease 
specific mutations) Phenotypic mimicry of bidirec-
tional VT can also be seen in patients with Anderson 
Tawil Syndrome (a form of long QT syndrome) but our 
patient tested negative for KCNJ2 mutation. We man-
aged our patient as CPVT because it’s highly lethal 
with mortality rates of 30-50% by age 35yrs. Also, our 
patient is at high risk for adverse outcome as she pre-
sented with cardiac arrest before the diagnosis. She 
was counseled about the lifestyle changes and beta 
blocker dose was up titrated (Class I recommendation 
in CPVT).
discussion: Our patient is unique in expressing both 
the phenotypes of ARVD/C and CPVT in absence 
of RYR2 gene mutation; maybe our patient has dis-
ease causing mutation that has yet been unidentified. 
Hence, due to overlapping clinical features &/ evolu-
tion of clinical phenotype, it’s important to actively 
monitor the phenotype in patients with inheritable 
sudden cardiac death syndromes as it has an implica-
tion on their management and also in screening their 
relatives.
CV98
Takotsubo Cardiomyopathy Presenting as Acute 
Stroke: Case Report and Literature Review
Patel, H.; Shah, P.; Patel, K.; Rampal, U.; Habib, M.; Hamdan, 
A.; Shamoon, F; Saint Michael’s Medical Center
introduction: Takotsubo cardiomyopathy (CMP), also 
known as stress-induced cardiomyopathy or transient 
left ventricular apical ballooning syndrome or bro-
ken heart syndrome, is a clinical entity mimicking 
an acute coronary syndrome (ACS) and is character-
ized by reversible left ventricular dysfunction that 
is frequently precipitated by a stressful event either 
emotional or physical stress.  LV thrombus is a known 
complication of stress-induced cardiomyopathy but 
its clinical significance and management remains un-
clear. We report a case of 59-year-old woman who had 
embolic cerebral infarction following LV thrombus 
with stress-induced cardiomyopathy and its literature 
review.
cAse	rePort: 59 year old female with PMHx of HTN 
and NIDDM came in with complaint of left arm 
weakness since 1day. Family noticed left side facial 
droop that started 2-3 days ago. Patient also reported 
intermittent, left sided chest pain, radiating to arm, as-
sociated with diaphoresis and vomiting for last 3 days 
but didn’t seek any medical attention. Notably she 
recently lost her husband and was binge drinking in 
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last few weeks. Admission vitals were normal with left 
facial droop but normal motor function in left arm and 
leg. EKG showed normal sinus rhythm and T-wave in-
versions in V2-V6, I and II. Troponin-I was elevated at 
6.5ng/ml. Initial transthoracic echocardiography (TTE) 
showed apical and anteroapical hypokinesis with left 
ventricular ejection fraction (LVEF) of 40% and no LV 
thrombus. Patient was treated for NSTEMI. MRI of 
brain showed multiple infarcts with largest in right 
parietal lobe and left thalamus. Transesophageal echo-
cardiography also showed apical hypokinesis with 
LVEF 40% but no left atrial appendage or patent fora-
men ovale. Cardiac catheterization done after 5days 
showed non obstructive CAD and LV gram showed 
basal hyperkinesis and akinteic apex with LV apical 
thrombus. Contrast echocardiography confirmed mul-
tiple LV thrombi in LV apex which was still akinetic. 
Patient was discharged on Coumadin and a follow up 
TTE after 6 weeks showed near normal LVEF (55%) and 
complete resolution of LV thrombus.
discussion: Takotsubo CMP can present with LV 
thrombus (8%) and risk of accompanying embolic 
events is about 33%. LV thrombus can occur at the 
initial presentation or any time during the disease. 
Although no specific data exist regarding the role of 
anticoagulation in stress induced cardiomyopathy, 
short term anticoagulation therapy should be con-
sidered in all patients with or without LV thrombus 
especially if LVEF is <30% and until akinesia or dys-
kinesia has resolved.
CV99
Small Bowel Obstruction Mimicking Acute  
ST-Elevation Myocardial Infarction
Patel, K.M.; Chang, N.L.; Shulik, O.; DePasquale, J.; Shamoon, 
F.; Saint Michael’s Medical Center, Seton Hall University School 
of Health and Medical Sciences
introduction: Acute ST-elevation myocardial in-
farction is a medical emergency and is typically 
associated with high cardiac mortality if brisk inter-
vention is not undertaken. It is important however to 
understand that there are several conditions that may 
mimic acute ST-elevation myocardial infarction and 
they should be considered as a differential diagnosis 
especially in the correct clinical scenario. This case 
highlights the importance of understanding the dif-
ferent pathologies, namely gastrointestinal, that can 
potentially present very similar to patients with acute 
myocardial infarction.
cAse	 rePort: A 42 year old female with history of 
endometriosis, status post hysterectomy a number of 
years prior presented to our institution complaining 
of 3 day history of nausea and vomiting. Computed 
tomography of the abdomen showed bowel obstruc-
tion of the distal ileum. The patient was taken for 
emergent exploratory laparotomy for adhesiolysis 
and decompression. Postoperatively during her re-
covery, the patient started having watery diarrhea 
and was being monitored on telemetry for persistent 
sinus tachycardia. Despite intravenous fluids and 
electrolyte repletion her condition deteriorated. On 
day thirteen, ST-elevation MI code was called after an 
electrocardiogram (Figure 1) suggested the possibility 
of acute inferolateral myocardial infarction. The pa-
tient described epigastric discomfort and shortness of 
breath but denied chest pain. An immediate bedside 
Transthoracic Echocardiogram showed predominant-
ly normal left ventricular systolic function however 
inferior wall hypokinesis was noted. Subsequent car-
diac catheterization showed normal coronary arteries 
(Figure 2, Figure 3) and normal left ventricular con-
tractility by ventriculogram. Serial cardiac enzymes 
were normal. Alternate causes for the ECG changes 
were entertained at this point. Thereafter, the patient 
had a repeat CT scan of the abdomen, which showed 
severe distention of the stomach and proximal small 
bowel and recurrent obstruction at the level of distal 
ileum (Figure 4, Figure 5). The patient was again taken 
for emergent exploratory laparotomy and decompres-
sion, and this time, with resection and anastomosis. 
A total of 2800cc of fecal material was drained from 
the small bowel at the time of decompression. Repeat 
postoperative electrocardiogram (Figure 6) showed 
normalization of ST segments.
discussion: Few cases of intra-abdominal pathol-
ogy causing ST-elevation on ECG have been reported. 
These conditions have been related to pancreatic, gall-
bladder, and esophageal disease, splenic rupture, and 
hiatal hernia. Our case may be the first reported case 
of small bowel obstruction as a cause for significant 
ST-elevation on ECG mimicking acute MI. It is be-
lieved that the intra-abdominal distension resulted in 
the compression of the diaphragmatic surface of the 
heart and the led to the ECG changes.
CV100
DTAP-Vaccine induced Myopericarditis  
Mimicking ST-Elevation Myocardial Infarction  
in an Adult
Patel, K.M.; Peralta, P.; Correia, J.J.; Shamoon, F.; Saint 
Michael’s Medical Center, Seton Hall University School 
of Health and Medical Sciences Cardiovascular Disease 
Fellowship
introduction: Myocarditis can be produced by a 
variety of different etiologies, namely viral being 
the most common presumed cause. Vaccine related 
myocarditis is one of the rarer causes. Smallpox vac-
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cination-induced myocarditis has been well-reported 
in literature however a thorough review of literature 
shows that only two cases of myocarditis related to 
DTaP vaccination have been reported. Both of these 
cases were documented in the pediatric population. 
We present the first case of a DTaP-vaccine induced 
myopericarditis in an adult.
cAse	rePort: Our patient is a 37 year old Portuguese 
male with past medical history only significant for 
drug abuse in the past that came to the emergency 
room with complaints of pressure like chest pains, 
pleuritic in nature associated with fevers  and chills 
for five days. The patient had a DTAP vaccine placed 
five days prior to the admission after which his symp-
toms began. Upon arrival to the emergency room an 
electrocardiogram was performed which showed ST 
elevations in leads II, III , AVF , v4 and v5. An emer-
gency echocardiogram done at bedside showed an 
ejection fraction 40% with moderate global hypoki-
nesis but no evidence of pericardial fluid. Immediate 
cardiac catheterization revealed normal coronary ar-
teries. First Troponin I level was elevated at 30. The 
patient was transferred to CCU with a presumed 
differential diagnosis of Myocarditis vs Coronary 
Vasospasm. Rheumatologic screening and serum 
viral antibody titers for suspected acute infectious 
causes were all negative. This included Coxsackie vi-
rus group B, Human immunodeficiency virus (HIV), 
Cytomegalovirus, Ebstein-Barr virus, Hepatitis virus 
family, and Influenza viruses. In addition, urine and 
hair samples were sent for drug screen; they were neg-
ative for recent cocaine or amphetamine use. Cardiac 
MRI with and without gadolinium was performed for 
definitive diagnosis and showed delayed myocardial 
enhancement involving the myocardium of the mid-
inferior and mid-inferolateral wall of the left ventricle. 
These findings were consistent with edema, inflam-
mation, and myocarditis. Troponin I values were 
trended to monitor extent of myocardial damage and 
serial values reached 30, 46.4, 17.8, 0.19, respectively. 
The patient was treated with Colchicine and NSAIDs 
and his symptoms improved significantly over the fol-
lowing 3 days.
discussion: Myocarditis has multiple etiologies 
however vaccine related causes are rare. Small pox 
vaccination induced myocarditis has been reported 
on multiple occasions. In a thorough review of litera-
ture, we found only two cases of myocarditis induced 
by tetanus vaccine. Both were reported in the juvenile 
population: one in a 3 month old after a DTAP vac-
cine  and the other in a 13 year old male after tetanus 
vaccination. Our case may well be the first one seen 
in an adult.
CV101
Renal Artery Stenosis in Young Female without 
Fibromuscular Dysplasia
Peralta, P.; Cholankeril, M.; Koneru, J.; Shamoon, F.; St. 
Michael’s Medical Center, Seton Hall University School of 
Health and Medical Sciences
introduction: Renal artery stenosis (RAS) is rare in a 
young patient without fibromuscular dysplasia (FMD). 
RAS is characterized by a heterogeneous group of 
entities being atherosclerotic RAS (ARAS) and fibro-
muscular dysplasia (FMD), 90% and 10% respectively, 
the most common. We report a case of a 25-year-old 
female who developed uncontrolled hypertension 
due to renal artery stenosis and no evidence of fibro-
muscular dysplasia or underlying renal dysfunction 
that underwent successful angioplasty and stenting.
cAse	 rePort: We present a 25 year old African 
American female, smoker with history of uncontrolled 
hypertension that presented with abdominal pain 
intermittently for three years. The patient had no sig-
nificant past medical history except for hypertension 
and depression, and no family history of premature 
coronary artery disease. The patient smokes 3 ciga-
rettes a day for the past 4 years and social alcohol use. 
The patient was on Norvasc 10 mg daily. Patient was 
sent from primary medical doctor office after Renal 
US showed a hemodynamically significant left renal 
artery stenosis in the mid aspect of the renal artery 
with a left resistive index of 0.3, left renal/aortic ratio 
3.91 and left mid renal artery velocity Sys/Dias 313/213. 
Patient’s vital signs on admission showed a blood 
pressure 166/105, heart rate 75, respiratory rate 16, and 
body temperature 98.7. Physical exam was within nor-
mal limits and no abdominal bruits were appreciated. 
She had a 2D Echocardiography showing mildly in-
creased left ventricular wall thickness with an EF of 
65%. The electrocardiogram (EKG) showed a normal 
sinus rhythm with sinus arrhythmia. Thereafter, the 
patient underwent cardiac catheterization the sub-
sequent day (Figure 1A). Based on catheterization, a 
severe 99% mid left renal stenosis with significant 
post stenotic dilation was appreciated after which 
,the interventionist decided to perform a balloon an-
gioplasty initially however as the patient was noted 
to have a >24mmHg gradient post angioplasty a stent 
was then successfully placed. Following intervention 
there was an excellent angiographic appearance with 
a 0% residual stenosis.   This shows a case of second-
ary hypertension secondary to renal artery stenosis 
not caused by fibromuscular dysplasia as expected 
in this age group. This case is unique as it describes 
a case of a young female with resistant hypertension 
without any evidence of fibromuscular dysplasia on 
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angiography that completely resolved after balloon 
angioplasty with stent placement.
discussion:	 Atherosclerotic renal artery stenosis is 
not common in young females. It is a medical condi-
tion with complex pathophysiology that involves early 
recognition and effective medical therapy to prevent 
future cardiovascular events.
CV102
Leuconostoc Induced Endocarditis in a Patient 
with No Risk Factors: A Case Presentation
Peralta, P.J.; Osman, N.; Jaffry, S.; Sabato, L.; Trinitas Regional 
Medical Center, Seton Hall University
introduction: Infective endocarditis is an infection 
of the endocardial surface of the heart, which may 
include heart valves, mural endocardium, or a sep-
tal defect. Its complications include severe valvular 
insufficiency, intractable congestive heart failure and 
myocardial abscesses. Leuconostoc species are mem-
bers of the Streptococcaceae family, thought to be 
non-pathogenic but only recently were recognized as 
potential pathogens after few cases in the literature 
reported as a cause of endocarditis. We are presenting 
a case of a 65 year old male with no risk factors that 
developed Leuconostoc endocarditis with severe aor-
tic valve insufficiency.
cAse	 rePort: This is a 65 year old male with past 
medical history of chronic obstructive pulmonary 
disease and atherosclerotic peripheral vascular dis-
ease, who was admitted to the hospital for evaluation 
after a syncopal episode at home with prodrome of 
abdominal pain, gas sensation and intermittent fevers 
for 2 months prior to admission. Upon evaluation in 
the emergency room, electrocardiography showed 
ST segment depressions in lateral leads and T wave 
inversions with initial troponins of 0.5.Transthoracic 
echocardiography revealed a calcified mobile echo 
density attached to the ventricular surface of the 
aortic valve consistent with vegetations which was 
corroborated with a trans esophageal echocardiogra-
phy that revealed two vegetations on the right and left 
leaflet respectively with severe aortic insufficiency. 
Three different blood cultures grew Leuconostoc SP 
resistant to vancomycin for which the treatment was 
switched from the empiric ceftriaxone and vancomy-
cin to intravenous ampicillin. Para nasal computed 
tomography (CT) failed to show any evidence of den-
tal infection, abscess or other abnormality. His course 
was complicated with ventilator dependent respirato-
ry failure secondary to acute congestive heart failure 
with further extubation within 36 hours and clinically 
improvement of patients’ condition after which was 
transferred to a rehabilitation center for completion 
of antibiotics. Cardiac spect scan showed a reversible 
defect in distal anterior wall and cardiac catheter-
ization was planned. After completion of antibiotics, 
he was transferred to another hospital for coronary 
artery bypass graft (CABG) and valve replacement. 
Unfortunately, the patient died with post-surgical 
complications.
discussion: Leuconostoc species had always been 
thought to not clearly play a role in human infections 
but associated with gastrointestinal symptomatology. 
To our knowledge this is the first case of endocarditis 
reported in a patient with no previous valve disease 
and no risk factors for endocarditis. This will be an 
important entity to consider as new cases arise, es-
pecially because of its detrimental effects, inherent 
vancomycin resistance and consideration of different 
antibiotic coverage.
CV103
Transient ST Elevation with Persantine Nuclear 
Stress Test: A Good Indicator for Emergent  
Cardiac Laboratory Activation
Rampal, U.; Pullatt, R.; Shamoon, F.; Trinitas Regional Medical 
Center, Seton Hall University
introduction: Pharmacological nuclear stress testing 
is performed routinely during the early phase of the 
acute coronary syndrome spectrum to further risk 
stratify patient for the development of adverse cardio-
vascular events. Persantine is considered to have good 
safety profile with a mortality rate of 0.05% in all pa-
tients with suspected acute coronary syndrome and 
0.001 % in patients with unstable angina. However 
rarely adverse events such as ST-elevation myocardial 
infarction are can occur which require prompt identi-
fication and treatment.
cAse	rePort: A 70 year old Hispanic male presented 
to the Emergency department with chief complain 
of multiple episodes of new onset pressure like, 
retrosternal chest pain, 7/10 in intensity, occurring 
at rest, relived by nitroglycerin administration since 
last two days associated with new onset shortness of 
breath with exertion. Initial EKG did not reveal any 
ischemic changes, three sets of cardiac biomarkers 
were negative and Echocardiogram revealed normal 
ejection fraction with no wall motion abnormalities. 
Patient remained chest pain free for 48 hours and un-
derwent risk stratification for coronary artery disease 
with Persantine nuclear stress testing. During the 
pharmacological stress test the patient developed 3 
mm of ST elevation after 7 min of Persantine infusion 
associated with typical chest pain.  Prompt reversal of 
Persantine with administration of aminophylline and 
nitroglycerin resulted in resolution of patient’s chest 
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pain and ST segment elevation. Patients stress nuclear 
images done immediately afterwards sh”
discussion:	 Transient ST elevation is a rare compli-
cation of vasodiltory pharmacological stress testing 
resulting from the “coronary steal phenomena”. This 
finding signifies a large area of trans-mural ischemia 
on SPECT nuclear imaging and high-grade obstruc-
tive coronary lesion, which requires prompt activation 
of cardiac catherisation laboratory and angioplasty of 
the culprit lesion.
CV104
Iatrogenic Inferior Vena Cava Syndrome Second-
ary to Delayed Partial Embolization of an Atrial 
Septal Defect Occluder Device: Challenging 
Clinical Scenario
Saad, M.; Suleiman, A.; Shamoon, F.; Trinitas Regional Medical 
Center, Seton Hall University School of Health and Medical 
Sciences
introduction: Inferior vena cava (IVC) syndrome is 
caused by either partial or complete occlusion of the 
IVC. Iatrogenic IVC syndrome is a rare entity that can 
complicate percutaneous closure of an atrial septal de-
fect (ASD) with catheter-implanted occluder devices.
cAse	rePort: A 9-year-old child was evaluated for pro-
gressive abdominal discomfort that started 3 months 
prior to her presentation. According to her parents, 
she also had easy fatigability gradually worsening 
over the last year. She has a past history of a hemody-
namically significant ASD, which was closed 2 years 
ago using a percutaneous occluder device with subse-
quent improvement in her symptomatology. Physical 
examination was significant for heart rate of 112 bpm, 
few distended abdominal wall veins, trace edema 
of the legs and mild tenderness of the right upper 
quadrant with unremarkable heart and lung exami-
nation. Electrocardiogram showed sinus tachycardia. 
Transthoracic echocardiography revealed emboliza-
tion of the ASD occluder device between the interatrial 
septum (IAS) and IVC, causing partial obstruction of 
the IVC but with no affection of the pulmonary artery. 
Minimal residual shunting across the IAS as well as 
dilated proximal IVC was noted. Given her presenta-
tion, physical signs and echocardiography findings, 
the decision to retrieve this occluder device to relief 
the IVC obstruction was made. Our patient had an 
uneventful cardiac surgery with retrieval of partially 
endothelialized occluder device and surgical closure 
of the defect. Three months later, the patient had com-
plete resolution of her symptoms with disappearance 
of the dilated abdominal wall veins and leg edema.
discussion: IVC syndrome is a rare complication of 
ASD occluder devices and can have a subtle clinical 
course. High index of suspicion, delicate physical 
examination and proper evaluation with echocar-
diography are important to establish the diagnosis. 
Surgical retrieval of the occluder device two years 
after its deployment was feasible and led to complete 
resolution of the IVC syndrome complicating this 
ASD closure.
CV105
Anterior Wall Transmural Myocardial Infarction 
Complicating CREST Syndrome: A Case Report
Saad, M; Cholankeril, M; Koneru, J; Shamoon, F; Trinitas 
Regional Medical Center, Seton Hall University School of 
Health and Medical Sciences
introduction: Systemic sclerosis also known as 
Scleroderma is a systemic inflammatory disease char-
acterized by extensive deposition of fibrous tissue in 
the skin and internal organs. Vasculopathy secondary 
to endothelial dysfunction and microvascular oblit-
eration is a main feature of the disease. Recently, some 
studies showed an increase risk of atherosclerosis in 
patients with scleroderma.
cAse	 rePort: A 45-year-old Caucasian female was 
evaluated at our emergency department for sub-
sternal compressing chest pain, shortness of breath 
associated with nausea and vomiting that started 2 
hours prior to her presentation. Her past medical his-
tory is significant for CREST syndrome, asthma and 
migraine headaches. She denied smoking, alcohol 
or illicit drug use. No family history of premature 
coronary artery disease and her only medication is 
Topamax 50mg bid.  Vital signs showed blood pres-
sure of 180/95 mmHg, heart rate of 105 beats per min, 
respiratory rate of 20 breaths per min, and tempera-
ture of 98.5Â°F. Physical examination was significant 
for thickened tight skin changes on the fingers bilater-
ally with mild bluish discoloration at the tips. Besides 
tachycardia, heart and lung examination was nor-
mal. Electrocardiogram (EKG) showed ST-segment 
elevation in lead V3 e.g., 6, I and aVL. Laboratory 
investigations were only significant for elevated tro-
ponin-I (Tn-I). Chest radiography (CXR) was normal. 
Primary coronary angiogram showed mid segment 
total occlusion of the left anterior descending coronary 
(LAD) as well as total occlusion of the second diagonal 
branch (D2). Successful percutaneous transluminal 
coronary angioplasty (PTCA) and drug eluting stent 
placement in the LAD was done, whereas PTCA alone 
was enough to restore thrombolysis in myocardial 
infarction (TIMI) III flow in D2. The post-primary 
PCI course of the patient was uneventful and was 
discharged on full anti-ischemic medical therapy in-
cluding dual antiplatelet therapy, statin, Beta-blocker 
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and angiotensin-converting enzyme inhibitor. Follow 
up echocardiography after 3 months showed ejection 
fraction of 45-50% with hypokinesis of the mid ante-
rior, mid anteroseptal and apical anterior walls.
discussion: Systemic sclerosis, also known as 
Scleroderma, is an immune-mediated disorder char-
acterized by deposition of fibrous tissue in the skin 
and internal organs as well as vasculopathy. In lit-
erature, many cases of myocardial infarction with 
patent coronary arteries were reported in scleroder-
ma patients, and were attributed to coronary spasm 
and impaired microcirculation; however, cases of ST-
segment elevation myocardial infarction secondary to 
scleroderma are scarce in literature.
CV106
Significant Improvement of the Timed 25 
Foot Walk (T25FW) after Administration of 
Dalfampridine in Secondary Progressive 
Multiple Sclerosis
Salehi, M.; Kaleel, A.S.; New Jersey Neuroscience Institute, 
Edison, NJ; Seton Hall University, School of Health and Medical 
Sciences
introduction: Patients with Multiple Sclerosis (MS) 
commonly suffer disabling symptoms during the 
course of their illness, preventing their ability to 
walk and otherwise limiting their mobility. Disease 
modifying agents, rehabilitation, and other forms of 
symptom control has proven beneficial at improv-
ing the quality of life and delaying progression of 
symptoms. Dalfampridine is a recent FDA-approved 
organic compound that works by blocking the potas-
sium channels, thereby prolonging action potentials. 
It has shown promise in improving the walking 
speed of patients afflicted with Multiple Sclerosis. We 
hereby present the case of an MS patient who showed 
significant improvement in walking speed after ad-
ministration of dalfampridine.
cAse	rePort: The patient is a 62 year old female with 
a past medical history of secondary progressive 
Multiple sclerosis who suffered multiple relapses 
during the course of her 10 year affliction. On a 
previous visit, the patient had begun to express diffi-
culties with her gait. A Timed 25 Foot Walk (T25FW) 
was performed, which revealed a walking time of 
35 seconds. On examination, the patient was awake, 
alert, and oriented to person, place and time. Her 
appendicular examination revealed moderate spas-
ticity of bilateral upper and lower extremities with 
hyperreflexia noted in all four limbs. Her sensation 
was intact. On that visit, Dalfampridine was initiated 
and T25FW was measured on separate follow-up oc-
casions, with improving times of 31, 25, 22, and 19 
seconds noted.
discussion: Multiple Sclerosis is a disabling 
autoimmune condition which can significantly 
affect a patient’s quality of life. Medications like 
Dalfampridine can help to delay progression and 
enhance a patient’s motor skills, improving their 
functional status.
CV107
A Bedside Test to Distinguish a Myasthenic from 
a Vascular Cause of Bilateral Ino
Samaan, M.M.; Rosenberg, M.; JFK Medical Center, Seton Hall 
University
introduction: Bilateral slowness of adducting sac-
cades is typically thought to be diagnostic of a bilateral 
medial longitudinal fasciculus (MLF) lesions. This 
clinical presentation is however not pathognomonic 
and perhaps is more commonly seen from myasthe-
nia. We present a little known clinical test that can 
distinguish these conditions at the bedside.  Vertical 
vestibule-ocular reflex projections from the anterior 
canals are via the brachium conjunctivum while the 
projects from the posterior canals are transmitted vis 
the medial longitudinal fascicule. Thus patients with 
bilateral MLF lesions consistently have an abnormal 
VOR to backward head thrusts whereas VOR for for-
ward head thrusts remain normal.
cAse	 rePort: 81 year-old woman presented with 
acute onset of binocular horizontal diplopia and 
lightheadedness. The lightheadedness feeling re-
mained throughout the day but the diplopia resolved 
spontaneously in about 10-15 minutes. The next day, 
the diplopia returned and it has not changed since 
then. She has been on a baby ASA since a TIA 10-15 
years ago manifested as the acute onset of garbled 
speech lasting about 10-15 minutes. A full work-up 
was unremarkable. Her exam was normal with the 
exception of total loss of adduction of the right eye 
and a mild loss of adduction of the left eye. Saccades 
were of normal accuracy and velocity for vertical 
saccades. The VOR gain by rapid head thrust testing 
was normal in the horizontal.
discussion: Vertical vestibule-ocular reflex project 
from the anterior canals via the brachium conjuncti-
vum while the projections from the posterior canals 
are transmitted via the MLF. Thus patients with bilat-
eral MLF lesions consistently have an abnormal VOR 
to backward head thrusts whereas VOR for forward 
head thrusts remain normal allowing for a rapid ac-
curate clinical diagnosis.
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CV108
Adult Onset Langerhans Cell Histiocytosis  
Misdiagnosed as Toxoplasmosis
Sartawi, T.; Kollu, V.; Basnet, A.; Seneviratne, C.; Ahmad, 
R.; Capo, G.; Trinitas Regional Medical Center, Seton Hall 
University School of Health and Medical Sciences
introduction: Langerhans cell histiocytosis (LCH) is 
a rare disorder that comprises a spectrum of diseases 
ranging from a localized indolent to an aggressive 
systemic form. It is described mostly among children 
and has rare occurrence in adults. Involvement of the 
skin may represent the earliest sign while lymphade-
nopathy is seen only in approximately 20 percent of 
patients.  Systemic lesions may involve bones, lungs, 
liver and spleen. Due to the rarity of the disease, no 
consensus in treatment exists yet.
cAse	rePort: We present a 58 year old Hispanic male 
from Dominican Republic, without significant past 
medical history, who presented with complaints 
of pruritis and a diffuse rash, worsening over four 
months duration. Due to constant pruritis, excoria-
tions progressed to fluid filled blisters and chronic leg 
ulcers over time. He also reported a 20 pound weight 
loss, night sweats and increased fatigue. He denied 
fever, diarrhea, cough, bone pain, and use of im-
munosuppressive medications. He was diagnosed 
and treated for cutaneous toxoplasmosis after test-
ing positive for IgG titer in the Dominican Republic. 
Despite treatment, his skin lesions progressively 
worsened. On examination, diffuse but modest cer-
vical, axillary, and inguinal lymphadenopathy was 
palpated. His skin was remarkably thick, leathery, 
and scaly. Laboratory studies  revealed leukocytosis 
with predominant eosinophilia and elevated alka-
line phosphatase. HIV, hepatitis B, C, toxoplasmosis, 
syphilis, histoplasmosis antigen, cryptococcus an-
tigen, HTLV 1/2, ANA, and complement levels were 
negative. CT of neck, chest, abdomen and pelvis 
confirmed diffuse lymphadenopathy without lymph 
node station measuring greater than two centimeters. 
Excisional biopsies of the right groin lymph node and 
skin were performed. Histology revealed effacement 
of lymph node architecture by nodular histiocytic 
cell proliferation. Immunohistochemical stains of the 
lymph node were positive for CD1a, S100+, with pre-
dominant CD3+ lymphocytes and also presence of 
CD4, CD8 and CD7 T cells. The diagnosis of systemic 
LCH was made. Treatment will be initiated with vin-
blastine and prednisone for systemic LCH.
discussion: Though histiocytes in LCH resemble 
the langerhans cells of skin, they are myeloid den-
dritic cells that express the same antigens as the skin 
langerhans cell. Isolated skin lesions may resolve 
spontaneously or may respond to topical steroids. 
Disseminated disease may respond to chemothera-
peutic agents.
CV109
Telescoping Technique to Engage Left Main in 
a Massively Dilated Aortic Root and Ascending 
Aorta
Shah, P.; Bikkina, M.; Virk, H.; St. Joseph’s Regional Medical 
Center
introduction: It can be difficult to engage the coro-
nary arteries when aortic root and ascending aorta 
are dilated. In case where they are massively dilated 
(>10 cm), it is not possible to engage the coronaries 
using regular catheters. We present a case where tele-
scoping technique was used to engage left main in a 
patient with ascending aortic aneurysm of 10.2 cm.
cAse	 rePort: 78 y/o male with past history of hy-
pertension, dyslipidemia, prosthetic aortic valve 
replacement (10 years ago in Ecuador) presented to ED 
with complaints of exertional shortness of breath for 
few days.Chest x ray showed widened mediastinum. 
Subsequently, CT angiogram of the chest showed 
massively dilated ascending aorta with maximum di-
ameter of 10.2 cm. The patient was then transferred to 
our hospital for surgical management. Transthoracic 
echocardiogram revealed normal ejection frac-
tion with mild aortic insufficiency, well functioning 
prosthetic aortic valve and no aortic stenosis. His 
creatinine was 1.4 mg/dl and he had received 100 
ml of contrast for CT angiogram. It was necessary 
to evaluate hiscoronary arteries prior to surgery for 
ascending aortic aneurysm. There were two options 
in his case:coronary CT angiography or conventional 
coronary angiography. Coronary CT angiography 
would require about 100 ml of contrast. A diagnos-
tic coronary angiogram can be done using < 50 ml 
of contrast. Given his renal insufficiency, we decided 
to do conventional coronary angiography.  Since the 
ascending aorta and the root were extremely dilated, 
we knew it would not have been possible to engage 
the coronaries using regular catheters and standard 
technique. Hence telescopic technique was used. AL3 
(Amplatz Left) 7F (French) guide catheter (100 cm) was 
initially used and non-selective injection of contrast 
was done to see the coronary ositum. After that a 5F 
MP (multipurpose) catheter (110 cm) was telescoped 
through 7F AL3 guide catheter to engage the ostium 
of the left main coronary artery. Using this technique, 
images of coronaries were obtained and it showed 
minimal luminal irregularities in all three major epi-
cardial coronary arteries. Total of 50 ml contrast was 
used. Patient underwent successful surgery with aor-
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tic valve replacement and excision of aneurysm with 
graft placement.
discussion: In cases where aortic root and/or ascend-
ing aorta are massively dilated, coronary angiography 
can be performed relatively easily with the use of tele-
scopic technique.
CV110
Thrombus Formation in Left Atrium on  
Dabigatran Therapy
Shah, P.; Soyombo, A.; Virk, H.; Bikkina, M.; St. Joseph’s 
Regional Medical Center
introduction: Dabigatran is a direct thrombin inhibi-
tor binding to thrombin in competitive and reversible 
manner. Binding of dabigatran to thrombin prevents 
catalytic conversion of fibrinogen to fibrin by throm-
bin. It also inhibits thrombin-mediated activation of 
platelets and amplification of coagulation cascade. 
Dabigatran was approved in the United States in 2010 
for non-valvular atrial fibrillation based on the results 
of the RE-LY trial. We report one such rare case of left 
atrial thrombus formation in a patient with chronic 
atrial fibrillation on dabigatran therapy.
cAse	 rePort:	A 60 year old male with past medical 
history of hypertension, coronary artery disease, 
chronic atrialfibrillation, and stroke (in 2011) present-
ed to the hospital with complaints of slurred speech, 
dizziness and gait imbalance in October 2014. He 
denied any other complaints. His blood pressure on 
admission was 180/102 mm Hg and heart rate was 
77/minute. Physical examination was significant 
for left facial droop and irregularly irregular heart 
sounds. Rest of the physical examination was normal.
Electrocardiogram showed atrial fibrillation with ven-
tricular rate of 80 beats per minute. A non-contrastCT 
scan of the brain showed new lacunar infarct in 
right corona radiata and old right frontal lobe infarct. 
Subsequent MRI of the brain showed acute infarcts 
in right insular cortex, subinsular region, and right 
corona radiata along with an old right frontal lobe 
infarct. His laboratory tests were within normal lim-
its. The patient was continued on dabigatran 150 mg 
twice daily, which he was taking at home. His other 
home medications included aspirin 81 mg, metopro-
lol succinate 100 mg, diltiazem sustained release 120 
mg, and atorvastatin 40 mg daily. The patient had 
a regular follow up with his cardiologist and was 
compliant with all his medications. He had a trans-
esophageal echocardiogram done in August 2011, 
which did not reveal any smoke or clot in left atrium 
or left atrial appendage. He subsequently underwent 
electrical cardioversion for atrial fibrillation at that 
time but reverted back to atrial fibrillation shortly 
thereafter. He has been on dabigatran since then. A 
transesophageal echocardgiogram was done on this 
admission to evaluate a likely embolic source of acute 
stroke. Surprisingly, it revealed significant smoke and 
a mobile thrombus in the left atrium measuring about 
0.6cm x 0.3 cm (Figure 1). The left atrial appendage 
was free of thrombus. The patient was switched to 
warfarin anticoagulation for presumed dabigatran 
failure. Rest of his hospital course wasunremarkable 
and he was discharged to acute rehabilitation after 3 
days on warfarin anticoagulation along with low mo-
lecular weight heparin bridging.
discussion:	 Some of the proposed mechanisms for 
thrombus formation on dabigatran are as follows. 
First, single level downstream inhibition of thrombin 
can lead to compensatory increase in upstream clot-
ting factors. Second, all the available thrombin might 
not beinhibited. The best strategy of anticoagulation 
in patients who develop thrombus on dabigatran ther-
apy is also not known. However, a tried and tested 
therapy with warfarin should beused in such patients.
CV111
ST Elevation Myocardial Infarction with Acute 
Limb Ischemia
Shah, P.; Bajaj, S.; Shamoon, F.; St. Joseph’s Regional Medical 
Center, Trinitas Regional Medical Center
introduction:	Large anterior wall myocardial infarc-
tion (MI) can lead to thrombus formation, which can 
embolize to systemic circulation. This complication 
usually leads to stroke however it can rarely cause 
acute limb ischemia. If recognized in timely fashion, 
thrombolysis can salvage the limb.
cAse	rePort: A 42 year-old female with past medical 
history of uncontrolled diabetes and hypertension 
presented with pressure like chest pain for 1 week. 
Pain was initially intermittent, but then continu-
ous for past 2 days. She denied any other symptoms. 
Vitals were stable. Heart and lung exam was within 
normal limits. However, the left lower extremity 5 cm 
below the knee joint was cold to touch. Dorsalis pe-
dis, anterior tibial and posterior tibial pulses were not 
palpable on the left side. Power and sensations in the 
left lower extremity below the knee joint were signifi-
cantly diminished. Upon further questioning, patient 
complained of numbness in the left foot for one day. 
Electrocardiogram showed sinus rhythmwith ST el-
evation in anterior leads. A presumed diagnosis of 
ST elevation MI (STEMI) with distal embolization 
from left ventricular (LV) thrombus was made. The 
patient was taken immediately to catheterization lab 
and vascular surgeon was consulted. Left heart cath-
eterization showed 100% occlusion of mid left anterior 
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descending (LAD) artery. After aspiration thrombec-
tomy, LAD lesion was dilated with Maverick balloon 
and drug-eluting stent was deployed. We decided to 
defer left ventriculography and proceed with angio-
gram of lower extremities. It showed thrombus at left 
tibioperoneal trunk. Femoral sheath was left in place, 
via which EkoSonic catheter was inserted such that 
the distal tip was at the tibioperoneal trunk. Local 
thrombolysis using tissue plasminogen activator bo-
lus 5 mg followed by infusion 1 mg/h for 12 hours 
was performed. Patient improved dramatically with 
resolution of weakeness and numbness in left leg 
next day. Echocardiogram showed ejection fraction of 
30% with thrombus in LV. She is doing well 5 months 
later on anticoagulation. Repeat echocardiography 
showed imporved systolic function and resolution of 
thrombus.
discussion:	 This case demonstrates importance of 
high index of suspicion for complications of STEMI 
and prompt intervention.
CV112
Unusual Case of Idiopathic Pulmonary Arterial  
Hypertension in a Young Male: A Report of a Case
Sharaan, A.S.; Shashpal, F.S.; Salamera, J.S.; Trinitas Regional 
Medical Center, Seton Hall University School of Health and 
Medical Sciences
introduction: Pulmonary arterial hypertension 
(PAH) is characterized by elevated pulmonary arterial 
pressure, which is confirmed when mean pulmonary 
artery pressure is >25 mmHg at rest.  PAH can be id-
iopathic. Idiopathic PAH has an annual incidence of 
1-2 cases per million in US and Europe. It is 2-4 times 
more common in women than in men.  Mean age of 
diagnosis of which is around 45 years. The presenting 
symptoms of pulmonary hypertension, being non-
specific, often results in delayed diagnosis.
cAse	 rePort: We present a 24 year old Guatemalan 
male who was admitted for worsening shortness of 
breath of two weeks duration.  He mentioned decrease 
in exercise capacity for one year, and denies use of an-
orexigens.  Physical examination revealed palpable, 
accentuated second heart sound (S2) with splitting of 
S2 at the apex. Screening serology for HIV, antinuclear 
antibody, anti-Scleroderma 70, and rheumatoid factor 
was negative; liver function tests and thyroid stimulat-
ing hormone were non-diagnostic. Electrocardiogram 
showed features consistent with right atrial enlarge-
ment, right axis deviation, incomplete right bundle 
branch block, and right ventricular hypertrophy. A 
chest radiograph revealed large main pulmonary ar-
tery, confirmed by computed tomographic angiogram 
without signs of pulmonary embolism and definite 
parenchymal abnormalities. Transesophageal echo-
cardiogram disclosed right ventricular volume and 
pressure overload with moderately enlarged right 
ventricle, patent foramen ovale, and mild right to left 
shunt. Cardiac catheterization did not show response 
up to 500mcg\kg\min of adenosine.  Sildenafil, along 
with anticoagulation using warfarin, was initiated 
with overall clinical improvement.
discussion: Pulmonary arterial hypertension (PAH) 
is a vasculopathy, characterized by vasoconstriction, 
cell proliferation, fibrosis, and thrombosis. PAH is 
diagnosed by right heart catheterization, with pul-
monary vasoreactivity. Mortality was most closely 
associated with male gender, right ventricular 
hemodynamic function, and exercise limitation in 
idiopathic PAH. What makes our case unusual is idio-
pathic pulmonary hypertension typically presents in 
women with mean age of diagnosis of 45 years of age.
CV113
Neurosyphilis Mimicking Symptoms of  
Recurrent TIA
Shashpal, F.; Ahmad, R.; Ahmed, S.; Pandya, S.; Schanzer, B.; 
Seton Hall University, Trinitas Regional Medical Center
introduction: Neurosyphilis an infection of brain 
or spinal cord by Treponema pallidum. It occurs in 
chronic untreated syphilis. The most common forms of 
neurosyphilis involve the CSF, meninges, and vascu-
lature. Late in disease it involves the brain and spinal 
cord parenchyma (general paresis and tabes dorsalis). 
Syphilitic meningitis can result in infectious arteritis 
and can cause thrombosis, ischemia, and stroke in-
volving the brain or spinal cord making it difficult to 
diagnose. We wish to report a case of Neurosyphilis 
who presented with TIA and Abnormal brain MRI.
cAse	 rePort: A 55 y/o portuguese male with past 
medical history of dyslipidemia, coronary artery dis-
ease s/p CABG (2005) presented with 2 week history 
of recurrent episodes of slurring of speech lasting 
few hours and resolving spontaneously. The family 
had noticed cognitive dysfunction, change in person-
ality, gaps in memory, confabulation and unsteady 
gait for 2 months. He denied history of fevers, head-
aches, seizures, head trauma, loss of consciousness, 
or other focal deficits. He was an ex smoker and ex 
alcoholic (quit 1 year ago) but denied drug abuse. He 
had multiple sexual partners in the past but monoga-
mous for past 6 years. Physical exam was positive 
for bilateral intentional hand tremors, left sided hy-
perreflexia, positive romberg’s sign and difficulty 
performing complex task. Our initial differential 
diagnoses included TIA, neurosyphilis, Wernicke’s 
encephalopathy, B12 deficiency and HIV encepahlo-
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pathy. CT head and B12 levels were normal. HIV 
status was negative. ANA, ESR and CRP were normal. 
RPR was positive at 1:64 titers with positive FTA-ABS. 
MRI brain showed increased signal intensity in bilat-
eral temporal and frontal lobes suggestive of herpes 
or limbic encephalitis. Cerebrospinal fluid analysis 
showed elevated protein, lymphocyte predominant 
cell count, VDRL positive, negative for Cyptococcus 
and HSV. A diagnosis of neurosyphilis was made 
and patient started on Crystalline penicillin 4 mil-
lion units IV every 4 hrs for the next 10 days. Patient 
was discharged with improvement in his neurological 
symptoms and on follow up was noted to have a RPR 
titer of 1:32.
discussion: Syphilis testing should always be con-
sidered a part of the dignostic workup of TIA and 
stroke. Patients with TIA and stroke with positive 
syphilis serology, it is appropriate to further pursue 
diagnosis and treatment. In patients unable to under-
go LP, empiric treatment for neurosyphilis should be 
considered.
CV114
A Case of Spontaneous Coronary Artery  
Dissection in Young Healthy Women
Siddiqui, W.; Iyer, P.; Dessalinies, N.; Amba, S.; Tatari, A.; 
Wingfeld, E.; Wallach, S.; Saint Francis Medical Center
introduction: Spontaneous coronary artery dissec-
tion (SCAD) is a rare cause of myocardial infarction 
seen in young women with no coronary artery disease. 
It is also seen during third trimester of pregnancy 
and postpartum period. Hormonal changes and he-
modynamic stress are implicated in its pathology. The 
spectrum of clinical presentation ranges from mild 
symptoms to cardiac arrest. We present a case of 
young healthy female with SCAD of proximal to mid 
left anterior descending artery, who had to undergo 
emergent bypass surgery.
cAse	 rePort: A 49 year old female with no signifi-
cant cardiac history presented to emergency room 
with complaints of chest pain which was substernal 
heaviness with no radiation. Patient stated that she 
developed chest pain during pre-marathon train-
ing. There was no associated dyspnea, palpitations or 
diaphoresis. She denied any prior episodes of similar 
chest pain or any family history of coronary artery 
disease and Myocardial Infarction (MI). She also de-
nied history of smoking, alcohol or illicit drug abuse. 
On exam, patient appeared to be in no acute distress. 
Vitals showed Blood Pressure 137/88, Heart Rate 64/
min, Respiratory Rate 20/min, Temperature 97.2oF 
and saturation 99% on 2L of Oxygen. Cardiovascular 
exam Â¬revealed regular rate and rhythm with 
no murmur, rubs or gallop. First and second heart 
sounds were heard. Point of maximal impulse was not 
displaced. Neck exam showed no jugular venous dis-
tension. Lungs were clear to auscultation bilaterally. 
Peripheral pulses were intact bilaterally. On further 
workup, electrocardiogram (EKG) showed non-spe-
cific ST-T segment changes in the inferior leads. Her 
first Troponin was normal but the subsequent was 
elevated at 1.08. CKMB was also elevated at 36.5. CT 
angiogram ruled out aortic dissection. Patient was 
admitted for non-ST segment elevation MI. Patient un-
derwent cardiac catheterization which revealed large 
spontaneous spiral dissection of proximal to mid left 
anterior descending artery extending into first major 
diagonal branch. Patient was emergently taken for by-
pass surgery. Post-operative course was uneventful. 
She was discharged home 4 days later.
discussion: The overall mortality of SCAD is in excess 
of 60%. Thus, possibility of dissection should be con-
sidered in any young women who presents with chest 
pain. Currently, there are no established guidelines re-
garding management strategy for such patients. This 
case illustrates the importance of medical therapy vs 
early surgical management.
CV115
Ventricular Septal Rupture: A Rare Complication  
of Right Ventricular Myocardial Infarction:  
A Case Report
Siddiqui, W.; Iyer, P.; Amba, S.; Aung, M.; Khan, M.; Ejidike, M.; 
Muddassir, S.; Saint Francis Medical Center
introduction: Right ventricular (RV) infarction 
is seen in 50% of acute inferior wall myocardial in-
farctions. Ventricular septal rupture (VSR) is a rare 
complication of right ventricular infarction. It is as-
sociated with significant mortality (91%) secondary to 
cardiogenic shock. With surgical repair, in-hospital 
mortality is substantially reduced from 90% to 33-45%. 
We present a case of right ventricular Infarct compli-
cated by VSR and cardiogenic shock. Diagnosis was 
confirmed by transesopahgeal echocardiogram (TEE). 
Patient was treated with percutaneous insertion of 
VSD occluder device.
cAse	 rePort: A 69 year old Caucasian female with 
past medical history of hypertension, hyperlipidemia 
and obesity presented to the hospital with chest pain 
and shortness of breath. Chest pain lasted for about 5 
days but then subsided on its own. 24 hours prior to 
presentation patient again had continuous chest tight-
ness. Patient denied any h/o of smoking cigarettes or 
using illicit drugs. On arrival to the ED; patient was 
tachycardic, tachypneic and normotensive. Within 
the next few minutes, patient became significantly hy-
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potensive. Vitals at that time were BP 78/52, HR 109/
min, RR 22/min and O2 saturation of 96% on 3L of 
oxygen via nasal cannula. On physical exam, patient 
appeared to be dyspneic and in acute distress. Rest of 
physical exam revealed audible S1 S2 with no added 
murmur or gallop, bilateral pitting lower extremity 
edema, bilateral rhonchi and increased respiratory ef-
fort. EKG showed ST Segment elevations in leads III 
and aVF. First set of troponin levels were found to be 
elevated at 1.60 and CK was 118. Patient was started on 
vasopressors and emergently transferred to our facil-
ity to undergo cardiac catheterization. It showed 99% 
stenosis at mid right coronary artery for which angio-
plasty was performed. Two days later, patient again 
became hypotensive. Urgent 2D echocardiogram was 
done which showed a ventricular septal defect (VSD). 
Patient was urgently transferred to tertiary facility; 
where a percutaneous amplatzer occluder device was 
placed. Ultimately, patient died secondary to septic 
shock and ischemic colitis.
discussion: VSR is a potentially life threatening com-
plication of AMI. It usually occurs within the first 10 
to 14 days after MI. In patients with cardiogenic shock, 
death is inevitable in the absence of urgent surgical 
intervention. Delayed elective surgical repair is feasi-
ble option only in patients with heart failure without 
shock.
CV116
Rare Case of Gastric Antral Vascular Ectasia in a 
Cirrhotic Patient
Sonia, F.; Chiavetta, C.; Trinitas Regional Medical Centre, Seton 
Hall University
introduction: GAVE syndrome is a rare cause of non-
variceal upper GI bleeding not typically associated 
with cirrhosis. However, it increases mortality sig-
nificantly when accompanying underlying cirrhosis, 
because often it is confused with Portal Hypertensive 
Gastropathy. Differentiating between the two is im-
perative as the treatments are different. Here, we 
present a rare case of a middle-aged female who un-
derwent surgical intervention for vascular ectasias 
and was found to have advanced liver cirrhosis of un-
clear etiology.
cAse	 rePort: 58 Year old Hispanic female, with a 
history significant for multiple AVM’s of the stomach, 
IDDM, HTN, Collagen Vascular Disease, Chronic 
Pancytopenia, and a variant of SLE versus RA,  who 
presented with complaints of lightheadedness and 
palpitations, and was noted to have a hemoglobin of 
7.6. Patient has had multiple admissions in the past 
for anemia secondary to bleeding from the AVM’s, 
with multiple endoscopies in past. In 2012 Endoscopy 
showed multiple AVM’s, fresh bleeding, underwent 
cauterization. Notably on endoscopy in the antrum, 
were linear-shaped thickened folds with red spots, 
consistent with “Watermelon Gastropathy”. Patient 
was most recently scoped for argon-laser ablation, 
but the procedure needed to be aborted secondary to 
bleeding.At the time of presentation to the hospital, 
patient acknowledged some weakness and shortness 
of breath. Initially patient was treated conservatively 
with blood transfusion to stabilize hemoglobin, and 
then decision was made to do surgery on patient in 
the view that she had failed multiple therapies in 
past. Subsequently patient was to undergo Subtotal 
Gastrectomy, but intraoperatively was found to 
have advanced cirrhosis. Post operatively patient 
had a complicated course .She went into hepatic 
encephalopathy and was intubated for airway 
protection, LFTS and ammonia were trending up. She 
also had Anterior wall MI, became septic and went 
into Multiorgan Dysfunction Syndrome. Her MELD 
score was calculated to be 17 and Child PUGH B-C 
which imposes a high risk of mortality. Eventually 
patient went into Ventricular fibrillation and family 
made the decision to make her DNR.
discussion: GAVE Syndrome presents 4% of UGI non-
variceal bleeding and is not typically associated with 
cirrhosis. Diagnosis is based on endoscopic appear-
ance of “watermelon stomach” and histopathology. 
Presentation can range from being asymptomatic, to 
acute or chronic hemorrhages with iron deficiency 
anemia. Mainstay of therapy is endoscopic ablation. 
Surgery with Bilroth-1 Anastomosis is curative and 
efficacious, but is associated with high mortality in 
cirrhosis.
CV117
The Significant Role of Consultation Psychiatrist 
in Preventing, Identifying and Treating Wernicke’s 
Encephalopathy
Spariosu, M.; Coira, D.; Hackensack UMC, Rutgers NJMS; St. 
George’s University Medical School
introduction: Wernicke’s encephalopathy is an acute 
neuropsychiatric disorder which occurs as a direct re-
sult of a thiamine deficiency. Prevalence of Wernicke’s 
encephalopathy is 1.4-2.2 % in the general popula-
tion with an increased rate in known alcoholics of 
12.5 %, and 35% in alcoholics with cerebellar damage. 
Wernicke’s encephalopathy is missed on clinical ex-
amination in up to 75-80% of cases and only verified 
on autopsy. Thiamine deficiency can occur due to ei-
ther alcoholic or nonalcoholic causes.
cAse	rePort: Early and adequate intervention may pre-
vent the development of Wernicke’s encephalopathy.
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discussion: The role of psychiatry in preventing, 
identifying, treating Wernicke’s encephalopathy and 
educating the primary team had significant impact on 
improving patient’s care and prognosis.
CV118
Acute Thrombus Formation within a Coronary 
Artery Aneurysmal Segment During Coronary 
Angiogram
Suleiman, A.; Saad, M.; Shamoon, F.; Saint Michael’s Medical 
Center
introduction: Coronary aneurysms represent anom-
alies identified in 0.15-4.9% of patients undergoing 
coronary angiography. According to current defini-
tions, the term ”aneurysm” refers to both diffuse over 
150% dilation of the largest diameter of a coronary ar-
tery, and limited spherical or saccular dilation”
cAse	rePort: in this case we present a 59 years old man 
with history of chest pain and abnormal nuclear stress 
test who was referred for cardiac catheterization. The 
initial angiographic images revealed an aneurysmal 
mid circumflex artery which was seen to be patent, 
but later on during the procedure a well visualized 
thrombus was seen within this segment, without 
causing luminal obstruction. Afterward the throm-
bus disappeared without any interventional.
discussion: Aneurysms are observed most commonly 
in the right coronary artery, and least frequently in 
the left main coronary artery.Â There is consensus 
that the majority (50%-52%) of coronary artery an-
eurysms are arteriosclerotic in origin. Several case 
reports have described the presence of a thrombus 
inside the aneurysm.
CV119
Unusual Presentation of a Femoral Artery Pseu-
doaneurysm After Left Cardiac Catheterization
Suleiman, A.; Saad, M.; Shamoon, F.; Saint Michael’s Medical 
Center/Cardiology
introduction: Femoral pseudoaneurysm (FPA) is one 
of the most common complications of percutaneous 
cardiac catheterization performed through the femo-
ral artery. It develops from a defect in the arterial wall 
post puncture with an extravasation of blood into sur-
rounding tissue forming a pulsatile hematoma
cAse	rePort: This case illustrate a 62 years old female 
who underwent emergency cardiac catheterization 
for acute inferior wall MI. her post cath. 2 days after 
that she was noted to have a diffuse swelling and ten-
derness of the whole right leg(Rt. Femoral artery was 
accessed during cath.) down to the ankle. Subsequent 
arterial and venous Doppler studies confirmed the di-
agnosis of common femoral artery pseudoaneurysm 
without any evidence of venous thrombosis.
discussion: The incidence of PSA after diagnostic 
catheterization ranges from 0.05% to 2%. The presence 
of pain or swelling in the groin after catheterization 
is the most common presentation of a PSA. Swelling 
from a large PSA or hematoma may also lead to 
compression of nerves and vessels with associated 
neuropathy, venous thrombosis, claudication, or, rare-
ly, critical limb ischemia.
CV120
Elevated Cardiac Enzymes with Normal 
Coronary Angiography After IVIG Infusion
Suleiman, A.; Saad, M.; Shamoon, F.; Saint Michael’s medical 
Center/Cardiology
introduction: Intravenous immunoglobulins (IVIgs) 
are used for several indications, including autoim-
mune and neurological conditions. IVIg treatment is 
associated with several possible adverse reactions in-
cluding induction of a hypercoagulable state.
cAse	rePort: We report a 68-year-old woman treated 
with IVIg for Chronic Inflammatory Demyelinating 
polyneuropathy, which developed shortness of breath 
and weakness following IVIg infusion session. The 
symptoms were associated with elevated troponin 
levels in the absence of ischemic ECG changes. The 
patient was diagnosed with non-ST elevation myocar-
dial infarction (NSTEMI) and received the guideline 
directed medical therapy. The patient had undergone 
cardiac catheterization which revealed non obstruc-
tive CAD.
discussion: This case is compatible with IVIg-induced 
hypercoagulability resulting in NSTEMI likely on the 
microvascular level. Cardiac evaluation should there-
fore be considered prior to initiation of IVIg treatment 
especially in patients with multiple cardiovascular 
risks.
CV121
Kikuchi-Fujimoto Disease a.k.a Histiocytic  
Necrotizing Lymphadenitis in an African-
American Male
Szabela, M.E.Y.; Rana, S.B.; Boghossian, J.; Saint Michael’s 
Medical Center, Seton Hall University, 
introduction: Kikuchi-Fujimoto disease, also known 
as histiocytic necrotizing lymphadenitis, is an ill-
ness characterized by self-limited inflammation of 
the lymph nodes. It was first described in 1972 as a 
lymphadenitis with focal proliferation of reticular 
cells surrounded by histiocytes and nuclear debris. 
This is a case of an African American male who pre-
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sented with fever, chills, back pain and found to have 
abdominal and retroperitoneal lymphadenopathy. 
Biopsy revealed histiocytes, and lymphocytes with a 
predominance of CD8+ T cells, suggestive of Kikuchi-
Fujimoto disease.
cAse	 rePort: The patient is a 49 year old African 
American male smoker with no significant past medi-
cal history, who presented with fever, chills, and 
intermittent back pain for several weeks. Initially, 
he visited the emergency room and sent home on 
Levaquin and Tamiflu. He subsequently returned 
with no improvement in his symptoms. He denied 
any respiratory symptoms, chest pain, abdominal 
pain, joint pain, diarrhea, and urinary symptoms. His 
sick contacts included a mother-in-law with tubercu-
losis. Upon presentation to the hospital, the patient 
was found to have fever of 101.7Â°F and tachycardia, 
with poor dentition. The remainder of the physical 
exam was within normal limits. Laboratory results 
revealed a mild leukopenia with a differential within 
normal range and the patient was started on antibiot-
ics for presumptive community acquired pneumonia. 
He then underwent an abdominal/pelvic CT which 
showed multiple enlarged lymph nodes greater than 1 
cm, anterior to the pancreas with mesenteric stranding. 
A biopsy of a left groin lymph node revealed exten-
sive fibrosis and smooth muscle metaplasia with no 
evidence of lymphoma. Omental lymph node biopsy 
was also performed which showed dense infiltration 
by histiocytes, lymphocytes, large areas of necrosis, 
expression of CD68, with B immunoblasts positive 
for CD30, with no evidence of lymphoma, consistent 
with histiocytic necrotizing lymphadenitis. Over the 
course of hospitalization, the patient was given sup-
portive care and symptoms improved.
discussion: Kikuchi-Fujimoto disease usually affects 
persons of Japanese and Asian origin under the age of 
40. It is a self-limited disease of the lymph nodes that 
must be differentiated from lymphoma and improves 
with symptomatic therapy. In this case, we have 
an unusual presentation with a person of African 
American ethnicity.
CV122
Late Presentation of Infantile Laryngeal 
Agenesis
Szczech, E.; Parikh, S.P.; Burjonrappa, S.; St. Joseph’s 
Regional Medical Center
introduction: We present a case of a six-month-old 
female with delayed diagnosis laryngomalacia and 
laryngeal agenesis.  She was hospitalized for failure 
to thrive and was found to have intermittent stridor. 
At the time, she did not meet the weight threshold to 
be evaluated by bronchoscopy. After failed intubation 
attempts, an urgent tracheostomy was performed to 
allow the surgical treatment for failure to thrive and 
gastroesophageal reflux. After sufficient weight gain, 
bronchoscopy revealed laryngomalacia and agenesis 
of the larynx, which is an entity seldom encountered.
cAse	rePort: A six-month-old female presented with 
a history of severe failure to thrive, stridor, and gas-
troesophageal reflux disease (GERD). At birth she was 
34 weeks gestation and diagnosed with apnea, stridor, 
failure to thrive, GERD, chromosomal duplication 
7q11.23 and hyperglycemia secondary to hyperinsu-
linism. Ear, nose, throat (ENT) specialist evaluation 
for her intermittent stridor indicated that her weight 
was insufficient for bronchoscopy exam. To alleviate 
the GERD which was causing worsening respiratory 
symptoms and to facilitate weight gain, the surgical 
service was consulted for Nissen fundoplication and 
feeding gastrostomy tube placement. At the time of 
surgery, multiple intubation attempts by specialized 
pediatric anesthesiologists were not successful and an 
urgent tracheostomy was placed prior to the planned 
procedures.  After subsequent stabilization, laryn-
goscopy and bronchoscopy were performed which 
demonstrated pinhole airway through the arytenoids, 
lack of true vocal cords, agenesis of larynx, large an-
terior epiglottic web and severe subglottic stenosis 
preventing intubation.
discussion: Infants with congenital laryngeal mal-
formations may have a delayed diagnosis depending 
on their severity of airway obstruction. In order to 
successfully manage these patients with a definitive 
airway, surgical tracheostomy must be considered 
early in their care. Once stabilized and medically 
optimized, multi- or single-stage laryngotracheal re-
construction with cartilage grafting is indicated for 
definitive management of severe laryngomalacia or 
agenesis.
CV123
Duodenal Atresia with a Normal Abdominal 
Radiograph
Szczech, E; Parikh, S; Bhattacharyya, N; St. Joseph’s Regional 
Medical Center
introduction: Abdominal radiographs associated 
with duodenal atresia typically demonstrate paucity 
of distal intraluminal intestinal gas. We present a case 
of duodenal atresia with air throughout the intestine. 
This unexpected imaging presentation complicated 
the diagnosis and eventual treatment.
cAse	rePort: We present the case of a 2 day old infant 
with duodenal atresia and concomitant pancreatic 
ductal anomalies.  On day 1 of life this 35 week gesta-
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tion male infant was noted to have feeding intolerance. 
On neonatal echo an atrial-ventricular canal was 
noted, and at birth he was noted to have facial fea-
tures associated with Downs’ Syndrome.  Given the 
feeding intolerance, gastrointestinal abnormalities 
were suspected.  Abdominal radiograph demonstrat-
ed proximal dilated duodenum and stomach with 
an orogastric tube in place.  Of note, the radiograph 
demonstrated air throughout the bowel to the rectum. 
Due to this gas pattern, malrotation of the foregut was 
suspected.  Upper GI Series contrast radiographs were 
obtained which showed duodenal atresia.  Given this 
diagnosis, operative intervention was undertaken.  A 
retrospective review of the initial radiograph lead to 
the understanding that air was entering the pancreas 
and given the presence of pancreatic ductal anoma-
lies, such as pancreatic divisum, was entering the 
distal duodenum and passing through the length of 
the bowel to the rectum.  This phenomenon created 
imaging inconsistent with the diagnosis of complete 
duodenal atresia.
discussion: Our case of duodenal atresia and anom-
alous pancreatic ducts is of important consideration 
in the neonatal population as it may have an atypical 
clinical and radiographic presentation. In this pa-
tient’s future, pain may occur as a result of pancreatic 
divisum. This could easily be misdiagnosed due to 
the prior duodenoduodenostomy. Understanding the 
rare abnormalities associated with duodenal atresia 
allows the clinician the best possible treatment op-
tions, whether they may be medical or surgical.
CV124
Goodpasture’s Syndrome
Tahir, M.H.; Bukhari, S.; Bulos, S.; Siddiqui, W.; Ramanujam, S.; 
Datla, A.; Seelagy, M.; Seton Hall Univeristy: St Francis Medical 
Center
introduction: Diffuse alveolar hemorrhage cou-
pled with acute glomeruli nephritis due to anti 
Glomerular Basement Membrane antibody (anti 
GBM Ab) is a rare disease. It occurs in less than one 
case per million population and is one of the unique 
Pulmonary-Renal Syndromes. (1) Hemoptysis is 
usually the presenting symptom. Early diagnosis 
with initiation of treatment determines the prog-
nosis. This autoimmune disease is diagnosed by 
identifying anti-GBM Ab and presence of crescentic 
glomerulonephritis with linear immunofluoresent 
staining of IgG on basement membrane. More rare is 
the presentation of both antineutrophil cytoplasmic 
antibodies (ANCA) positive and anti GBM antibody 
positive.  We present a case of a 74 yr old male with 
such a presentation.
cAse	 rePort: A 74-year-old Caucasian male present-
ed with one month history of productive cough with 
whitish-yellow sputum. It was associated with short-
ness of breath, 30 pounds weight loss in two months, 
fever and night sweats. He received antibiotics and 
prednisone as part of his outpatient therapy with-
out any improvement. His symptoms continued to 
progress, and prior to his admission, he developed he-
moptysis with one episode of hematemesis. His past 
medical history was significant for hypothyroidism, 
hypertension, hyperlipidemia, and bladder cancer 
status post treatment. In addition, he had a significant 
history of smoking, alcohol abuse and drug abuse in-
cluding cocaine, heroin and marijuana.
discussion:	 Anti-GBM antibody disease requires 
early diagnosis with prompt initiation of treatment. 
These patients may have an atypical presentation, 
which may delay diagnosis and treatment. Treatment 
of choice in such patients is plasmapheresis in com-
bination with prednisone and cyclophosphamide. 
Pulmonary complication may require mechanical 
ventilation. Early diagnosis is critical for achieving 
the best response to therapy.
CV125
Cryptococcal Antigenemia in an Asymptomatic 
HIV Positive Patient
Tahir, M.H.; Iyer, P.; Amba, S.; Krathen, J.; Siddiqui, W.;  Amodu, 
A.; Smith, M.J.; Seton Hall; St. Francis Medical Center
introduction: Previous studies have shown that 
serum cryptococcal antigenemia may precede the 
development of cryptococcal meningitis. It is associ-
ated with at least 10% attributable burden of death in 
patients with advanced HIV. However, a stratified ap-
proach starting with cryptococcal antigen testing for 
patients with CD4 count below 100 cells/mL may be 
more cost-effective than universal prophylaxis for pa-
tients with low CD4 cell counts. We present a case of 40 
year old male with HIV infection who presented with 
asymptomatic cryptococcal antigenemia.
cAse	rePort: 40 year old African-American male with 
past medical history of HIV was sent to our facility for 
having positive cryptococcal antigen in blood serum. 
The patient was totally asymptomatic. He denied any 
chest pain, shortness of breath, headaches, weak-
ness, fatigue, next stiffness, abdominal pain, loss of 
consciousness and lymphedema. Patient had a good 
appetite and denied any vision loss. He denies any tin-
gling or numbness in the extremities. He underwent 
routine blood work on which he was found to have a 
positive cryptococcal antigen. Patient was diagnosed 
with HIV six months back and had undetectable vi-
ral load with a CD-4 count of 24. In the emergency 
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department patient’s vitals were: Temperature 36.8 F, 
respiratory rate 18/min, Pulse 89/min, blood pressure 
117/78, and saturation 97% on room air. On physi-
cal examination, the patient was lying in bed in no 
acute distress. Neurological exam showed intact with 
no acute deficit. Rest of the physical exam was non-
contributory. Lab work showed low hemoglobin and 
hematocrit of 13 and 39.9, white blood cell count of 
2100. Chest X-ray and computerized tomography scan 
of head revealed no acute abnormality. Lumbar punc-
ture was negative for any infection. The patient was 
admitted for systemic cryptococcal infection and was 
started on amphotericin B along with tele-monitoring 
as induction therapy for cryptococcal meningoen-
cephalitis as per Infectious Disease. This treatment 
was continued for 14 days after which the patient 
was discharged on fluconazole for 12 weeks. His HIV 
medications were to be continued.
discussion: Targeted approach of screening for cryp-
tococcal antigen in patients with low CD4 cell count 
is necessary to reduce the high mortality in such pa-
tients. This step followed by diagnostic testing like 
lumbar puncture and pre-emptive antifungal treat-
ment for those who are positive; may help in reducing 
early mortality.
CV126
Brachial Artery Septic Emboli Causing Complete 
Occlusion
Tatari, A.; Bukhari, S.; Awan, M.; Siddiqui, W.; Muddassir, S.; 
Wallach, S.; St. Francis Medical Centerl
introduction: Septic embolization from endocarditis 
(IE) occurs in 22-50% of patients;  most frequently af-
fecting the brain. The lungs, coronary arteries, spleen, 
liver, bowel and peripheral vasculature can be affected 
too. Highest rates of embolic complications are seen 
with left-sided IE. Staphylococcus aureus, Candida, 
HACEK and Abiotrophia are usually implicated. In this 
case report, a rare presentation of Pseudomonas caus-
ing complete occlusion of brachial artery is described. 
Literature search hasn’t revealed a case of embolic oc-
clusion of Brachial Artery due to Pseudomonas.
cAse	 rePort: 52 year old African American female 
with a past medial history of IV Drug Abuse, Hepatitis 
C and spinal stenosis along with recently diagnosed 
Mitral Valve infection (Pseudomonas A) endocarditis, 
was transferred from another facility with complaints 
of high grade fevers, fatigue & generalized weakness 
for 3 weeks. She also presented with worsening left 
arm weakness and numbness for the past few days. 
Upon presentation, the patient was afebrile with re-
spiratory rate 16, pulse 105, blood pressure 105/72, and 
pulse oximetry 97% on room air.  Physical Examination 
revealed tachycardia along with a grade-3 holosystolic 
murmur loudest at the apex. Extremity exam revealed 
4/5 strength in the left upper extremity. The left ex-
tremity was cold to touch distally from the wrist and 
there was a feeble radial pulse. Laboratory data showed 
WBCs-17, Hb-10.2 with MCV of 81.6 and platelet count 
of 550. Patient was continued on antibiotics and was 
evaluated for the new LUE findings. A CT angiogram 
demonstrated complete occlusion of the left brachial ar-
tery at the level of the elbow with reconstitution of the 
left radial artery distally with occlusion of the left radial 
artery at the wrist along with mid left ulnar occlusion. 
Cardiothoracic surgery was consulted, was started on 
heparin, and continued on antibiotics.  The patient’s 
symptoms improved with non-invasive treatment and 
subsequently underwent successful mitral valve re-
placement. With physical therapy; the patient was able 
to recover complete sensation and some strength in her 
dominant (left) hand.
discussion: Embolization from endocarditis can affect 
many different areas of the body. This is a case that 
highlights a septic emboli causing hand numbness and 
weakness due to complete brachial artery occlusion 
along with occlusion distal to the wrist. The patient 
improved with conservative treatment and underwent 
successful valve replacement.
CV127
A Purple Foot, a Unique Presentation of 
Microembolism
Tatari, A.; Bhatti, H.; Khan, M. Y.; Pantelick, J.; Wallach, S.; 
St. Francis Medical Center; Seton Hall
introduction: Vascular disease typically presents 
with localized pain, discoloration and loss of flow 
in the arteries and or veins of peripheral extremi-
ties. Typically it manifests as either chronic or acute 
limb ischemia. We present a case of a 57 year old 
patient who presents with a purple colored foot, su-
pratherapeutic INR with palpable pulses and negative 
imagines studies upon admission.
cAse	 rePort: A 57 year old Hispanic female with a 
past medial history of Coronary artery disease, chron-
ic obstructive pulmonary disease, Hypertension, 
diabetes mellitus type 2, history of pulmonary em-
bolism due to hyperhomocysteinemia on warfarin 
therapy presented with a new onset left purple pain-
ful foot of unknown duration and altered mental 
status. On examination the patient had a well demar-
cated purple discoloration 2 cm above the left medial 
malleolus extending up to the distal phalanges. There 
was no palpable purura, livedo reticularis, evidence 
of necrosis or crepitus. Pulses were 1+ in the left lower 
extremity and 2+ in all other extremities. Initial labo-
ratory results showed BUN 18, Creatinine 1.01, INR 
>7.4, PT >64.0, PTT>66.2, D-Dimer >20, WBC 16.4, 
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Hemoglobin 9.3. The patient was found to have aspira-
tion pneumonia and was started on IV antibiotics and 
her mental status improved with treatment. A CTA of 
bilateral lower extremities demonstrated, no evidence 
of stenosis or occlusions. Other diagnoses were en-
tertained including warfarin skin necrosis, vasculitis 
and hypercoagulable states for which all workup was 
negative. The discoloration distribution remained un-
changed except for bullae formation three days later. 
After her supratherapeutic INR was corrected on ad-
mission she developed DVT’s in all 4 extremities one 
week afterwards and was started on heparin drip. The 
patient was reevaluated and it was deemed her foot 
was non-salvageable with the presence of palpable 
pulses. The foot was amputated and biopsy revealed 
thrombi in large and small vessels.
discussion: A purple discoloration of peripheral 
extremities typically occurs from an acute arterial 
thrombus. Alternative diagnoses such as vasculitis, 
hypercoagulable states, purple foot syndrome, warfa-
rin skin necrosis are a few that need to be considered. 
If a definitive diagnosis can’t be made, biopsy may be 
necessary.
CV128
B-Cell Lymphoma of the Thoracic Spine  
Presenting with Spinal Cord Pressure Syndrome
Thomas, T.; Fouerte, E.; St. Michael’s Medical Center
introduction: Diffuse large B cell lymphoma 
(DLBCL) is the most common histological subtype of 
non-Hodgkin lymphoma (NHL) accounting for ap-
proximately 25 percent of NHL cases.  Non-Hodgkin’s 
lymphomas arising in the spinal cord are extremely 
rare. DLBCL arises from a mature B cell, and is usu-
ally comprised of cells resembling centroblasts or 
immunoblasts, two distinct types of activated B cells. 
The molecular pathogenesis of DLBCL is complex and 
includes both genetic lesions that are relatively spe-
cific for this disease and molecular alterations that are 
shared with other NHL variants.
cAse	 rePort: 64-year-old Hispanic Female with a 
past medical history of hypertension, presents with 
parasthesia and lower extremity weakness progres-
sively worsening over one month. Patient was unable 
to bear weight on her legs. Patient denied any back 
pain or trauma, weakness or numbness in the upper 
extremities.  The patient denied chest pain, short-
ness of breath, fever, chills, urinary symptoms, and 
gastrointestinal symptoms. On neurological exam 
patient has 3/5 muscle strength in the lower extremi-
ties and 5/5 in the upper extremities. Sensation was 
intact in all extremities and reflexes were normal 
bilaterally. Patient underwent thoracic MRI which 
detected osseous metastatic disease status from T2 
to T4 levels along with a dorsal epidural tumor, mild/
moderate cord compression at the level of the great-
est thickness at the T3 and T4 levels. The patient was 
transferred to UMDNJ Hospital where she underwent 
T2-T5 laminectomy and decompression of the thoracic 
spine as well as excision of tumor from epidural space. 
Microscopic examination revealed Diffuse Large 
B-cell Lymphoma involving dense fibrous connective 
tissue and adipose tissue, with partial replacement 
of bone marrow elements. Immunohistochemistry 
revealed lymphoma cells positive for B-cell markers 
CD20, CD10, bcl-2 with more than 25 percent of the 
cells positive for bcl-6, with lymphoma cell nuclei pos-
itive for PAX-5. The lymphoma cells are negative for 
CD30, CD23, and MUM1, while the nuclei are nega-
tive for cyclin D1. Antibodies to CD3 and CD5 stain 
some T lymphocytes that are admixed with the lym-
phoma cells. The patient had a Port-a-cath placed in 
anticipation of chemotherapy treatment.
discussion: Epidural lymphoma accounts for 4% of all 
cases of lymphoma. It is almost invariably of the B-cell 
type. Presentation includes bone involvement with 
back pain and epidural spread with cord compression 
with motor and sensory deficits and bowel and blad-
der incontinence. Patients will undergo laminectomy, 
decompression, and biopsy followed by field radiation 
therapy and CHOP chemotherapy. Functional inde-
pendence with disease remission is not uncommon in 
these patients.
CV129
A Rare Case of Moyamoya Disease in a 40 Year 
Old Caucasian Female
Tseng, G.; Medel, R.; Iyer, P.; Tatari, A.; Sasinowska, S.; 
Kososky, C.; Wallach, S.; Department of Internal Medicine, 
Seton Hall University School of Health and Medical Sciences
introduction: Moyamoya disease is a unique 
cerebrovascular disease characterized by bilateral 
occlusion of the arteries around the circle of Willis with 
prominent arterial collateral circulation. “Moyamoya” 
is a Japanese word meaning puffy, obscure, or hazy 
like a puff of smoke in the air. Patient’s usually present 
with multiple episodes of stroke at young age. The 
prevalence is 3-10 per ten thousand, but the majority 
of patients are of Asian descent. We present a rare case 
of a Caucasian female who was newly diagnosed with 
moyamoya disease.
cAse	 rePort: A 40 year-old Caucasian female with 
a past medical history of IV drug abuse, hyperten-
sion and hyperlipidemia presented with complaints 
of nausea, vomiting, and diarrhea for the past three 
days.  She was admitted to the medicine floor for 
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heroin withdrawal.  The next morning; she was found 
to have right facial palsy, dysarthria and slurred 
speech.  The patient was found within 10 minutes of 
onset of symptoms. Her NIH stroke score was 4 at 
the time. An urgent computerized tomography scan 
of head showed no hemorrhage or acute intracranial 
process. The scan did show an old right frontal lobe 
infarct but the patient denied any knowledge of stroke 
symptoms in the past. After evaluation by a neurolo-
gist, the patient was treated with tissue plasminogen 
activator. Four hours later, the patient’s neurological 
symptoms improved. A subsequent MRI of the brain 
showed bilateral frontal infarcts. MRA of the head 
and neck showed evidence of a right cervical internal 
carotid artery (ICA) occlusion suspicious for vas-
culitis v/s Moyamoya disease. The transesophageal 
echocardiogram showed no patent foramen ovale or 
valvular vegetation. Patient also had a TSH and ANA 
levels done which were normal. The patient was trans-
ferred to a tertiary facility for further evaluation. The 
patient underwent a four vessel cerebral angiography 
that showed bilateral occlusion at the ophthalmic 
segment of the Internal Carotid Arteries. These find-
ings were consistent with a diagnosis of Moyamoya 
disease. She was subsequently taken to the operating 
room to have superficial temporal artery to middle 
cerebral artery bypass (encephaloduroarteriosynangi-
osis). Postoperatively, the patient was stable and later 
discharged from the hospital with regular follow-up 
instructions.
discussion:	As per our literature search, moyamoya 
disease is a rare occurrence in the Caucasian popula-
tion. Only ten cases have been reported in the United 
States. Moyamoya is associated with lupus, hyper-
thyroidism and neurofibromatosis but the presence 
of moyamoya disease in a patient with no such risk 
factors is unheard of.
CV130
Adult Patent Ductus Arteriosis in Two Siblings: 
Case Report and Investigation
Tseng, G.; Awan, M.; Hussain, A.; Zia, S.; Krathan, J.; 
Cheboratev, O.; Pantelick, J.; Seton Hall University School of 
Health and Medical Sciences, St. Francis Medical Center
introduction: The ductus arteriosus (DA) is a fetal 
vascular connection between the main pulmonary ar-
tery and the aorta which usually obliterates upon the 
birth of the fetus. A patent ductus arteriosus (PDA) 
occurs when the DA fails to completely close within 
one week after birth. PDA is common in neonates, 
but is a rare finding in the adult population. In addi-
tion, having a genetic association adds an even more 
unique angle to this pathology.
cAse	rePort: A 44 year old female with no medical 
history was referred to the cardiology clinic with pal-
pitations and exertional dyspnea. She stated that she 
has been dsypneic since child-hood with poor exer-
cise tolerance. Her symptoms have worsened in the 
past 6 months. Her initial electrocardiogram shows 
normal sinus rhythm with right axis deviation and an 
ischemic pattern in the anterior leads. A TTE showed 
increased right ventricular volume and diastolic pres-
sure. A TEE confirmed pulmonary hypertension with 
a communication between the right and left pulmo-
nary artery and descending aorta consistent with a 
patent ductus arteriosus.
discussion: There has been an increase in the in-
cidence of PDA secondary to the survival rate of 
preterm infants. The un-repaired PDA in the adult is 
rare in developed countries. This case also displays 
a genetic component. Prior case reports have shown 
familial PDA associated with mutations in chromo-
some six.
CV131
Takotsubo Cardiomyopathy in a Patient Admitted  
with Acute Myasthenic Crisis
Tseng, G.; Dessalines, N.; Awan, M.U; Muddassir, S.; Tabowada, 
J.; Rosvold, D.; Seton Hall University at St. Francis Medical 
Center
introduction: Takotsubo cardiomyopathy mim-
ics acute coronary syndrome and is accompanied by 
reversible left ventricular apical ballooning in the ab-
sence of angiographically significant coronary artery 
stenosis. This type of cardiomyopathy usually relates 
to an event of physical or emotional stress. Patients 
usually present clinical signs and symptoms of myo-
cardial infarction. The cardiomyopathy recovers 
spontaneously in a short period of time. We present 
a rare case of a patient who presented with acute my-
asthenia crisis simultaneously developed Takotsubo 
Cardiomyopathy.
cAse	rePort: A 50 year-old male with history of my-
asthenia gravis, asthma, glucose intolerance and 
hypertension presented with one week history of pro-
gressive worsening shortness of breath along with 
double vision and dysphagia. On Evaluation he was 
found to have acute myasthenic crisis and was admit-
ted to ICU. His EKG showed lateral wall ischemia, with 
T wave inversion in V4 and V5. He was found to have 
positive troponin 0.9 initially and later on increased 
to 2.2. A diagnosis of acute coronary syndrome was 
made and an emergent cardiac catheterization was per-
formed. However, coronary angiography did not find 
any significant coronary stenosis. The result also reveals 
severe hypokinesia and akinesia in several segment of 
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his left ventricle. Echocardiography showed left ven-
tricular ejection fraction of 15%. He was subsequently 
treated with IVIG and plasmapharesis for myathenia 
crisis. With the plasmaphersis patient showed marked 
improvement in his symptoms.  Echocardiography 
was repeated after resolution of symptoms, revealed 
normal systolic ejection fraction of 55-60%. Repeat 
Troponin was within normal range without cardiac 
intervention.  Repeat EKG also revealed resolution of 
T wave inversion. From cardiology stand point, the pa-
tient spontaneously recovered within one week. The 
patient did not have any signs of myocarditis or pheo-
chromocytoma.  This patient met the three out of the 
four criteria of diagnosis of takotsubo cardiomopathy.
discussion: Our case represents a rare presentation 
of takotsubo cardiomyopathy with acute myasthe-
nia crisis. There is hypothesis that the physical stress 
induced Myasthenia Crisis triggers the pathological 
change in myocardium. Further research is needed to 
evaluate the association of myasthenia crisis with ta-
kotsubo cardiomyopathy
CV132
Vagus Nerve Stimulator: A Hidden Culprit for 
Sleep-Disorder Breathing
Upadhyay, H.; Ming, S.; Bhat, S.; Gupta, D.; Chokroverty, S.; 
JFK Hospital Medical Center
introduction: VNS is an effective adjuvant therapy 
for intractable seizures, but is known to precipitate 
sleep-disordered breathing (SDB).  Often, Obstructive 
Sleep Apnea (OSA) and VNS-induced SDB may oc-
cur in the same patient. We report a patient in whom 
OSA improved after tonsillectomy, but coexistent 
VNS-induced SDB persisted and improved with VNS 
setting adjustments.
cAse	rePort: A 14 year-old female presented in 8/2013 
with a 6-month history of snoring/choking and wit-
nessed sleep apneas.  She had history of perinatal 
stroke, intractable seizures since infancy, and VNS im-
plantation at the age of 8 years. On exam, she had BMI 
of 37 kg/m2, right hemiparesis and bilateral grade 3+ 
tonsils. Her initial diagnostic polysomnogram (PSG) 
in 7/2013 showed moderate OSA (apnea+hypopnea 
index or AHI of 19/hr, O2 saturation nadir 90%) with 
predominantly clustered, obstructive-type apnea/
hypopnea. In addition, there were airflow-limitation 
events correlating with VNS stimulations. She subse-
quently underwent tonsillectomy/adenoidectomy and 
also lost 20 lbs weight. Repeat diagnostic PSG was 
done in 7/2014 due to residual symptoms. It showed 
interval improvement of OSA to mild range (AHI 12/
hr). However, now the obstructive respiratory events 
occurred in a periodic pattern synchronized with 
VNS stimulations, suggestive of VNS-induced SDB. 
VNS settings were: amplitude 2.25 mAmps, frequency 
30 Hz, pulse width 250 microsec, on-time 30 seconds, 
off-time 3 minutes.  Patient underwent another PSG 
in 10/2014 during which we serially decreased VNS 
amplitudes, only, (from baseline to 1.75 mAmp and 
then to 1.25 mAmp). The frequency of flow limitation 
events improved with each reduction in amplitude. 
Eventually VNS was switched off and all respiratory 
events resolved. The patient’s VNS was then restarted 
at reduced amplitude of 1.75 mAmp at discharge.
discussion: The mechanism of VNS-induced SDB is 
uncertain. Vagal nerve activation can lead to constric-
tion of both upper and lower airways musculature 
which could in term increase airway resistance lead-
ing to compromise ventilaton. The management of 
VNS-induced SDB is yet to be standardized. The im-
provement in the breathing during sleep in this case 
is with VNS adjustment which is reported in the 
literature.
CV133
Obstructive Sleep Apnea (OSA): Is Tracheostomy 
a Limiting Factor for Diagnosis and Treatment?
Upadhyay, H.; Polos, P.; Gupta, D.; Bhat, S.; Ahmad, M.; 
Rubinstein, M.; JFK Hospital Medical Center, Seton Hall 
University
introduction: Positive airway pressure (PAP) is - first 
line treatment for - obstructive sleep apnea (OSA). 
Before PAP therapy, tracheostomy was the only 
treatment option available.  However recurrence of 
apnea (mainly central) was often noted. We present - a 
68 year-old male with OSA - with daytime sleepiness 
post-tracheostomy. His symptoms were attributed 
to ongoing sleep apnea post-tracheostomy. This was 
corrected with average volume assured pressure 
support (AVAP), a novel mode of bi-level pressure 
ventilation.
cAse	rePort: 68 year-old male - (BMI 32 kg/m2) pre-
sented with daytime sleepiness.  He was diagnosed 
with OSA in 2004 and had been on CPAP therapy. 
In December 2013 he had respiratory failure from 
allergic reaction requiring emergent tracheostomy. 
Despite stable weight he had relapse of daytime sleep-
iness with Epworth sleepiness scale (ESS) of 12/24. He 
underwent a PSG for these symptoms in 2014. During 
the PSG, a transducer (p-flow) was connected to tra-
cheostomy. The study revealed moderate-severe OSA 
AHI 19.3/hr in general and 44.8/hr in REM sleep with 
SPO2< 90% for 14% total sleep time. He underwent 
AVAP titration with the following settings: IPAP max 
22 cm H2O, IPAP min 15 cm H2O, EPAP 5 cm of H2O 
and target tidal volume (Vt) 450 ml. On treatment PSG 
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-AHI improved to 2.7/hr in general. After 2 months of 
treatment, daytime sleepiness improved significantly 
(ESS of 4/24).
discussion: OSA is primarily treated with PAP. 
However, a subgroup of these patients, treated with 
tracheostomy, have continued residual symptoms 
of sleep apneas perhaps due to mechanical obstruc-
tion or concomitant respiratory control dysfunction. 
Hypoxemia may - be present.
CV134
Langerhans Cell Histiocytosis and Grave’s Dis-
ease: A Case Report of An Unusual Association
Viswanathan, L.; Eckman, A.; Trinitas Regional Medical Center 
- Seton Hall University
introduction: Langerhans Cell Histiocytosis (LCH) is 
a rare histiocytic disorder involving clonal prolifera-
tion of langerhans cells. It is commonly characterized 
by osteolytic bone lesions demonstrating infiltration 
with histiocytes on biopsy. They can also manifest 
with or without extraskeletal lesions. This involves the 
skin, lymph nodes, lungs, thymus, liver, spleen, bone 
marrow, or central nervous system. Approximately 
1,200 new cases per year are reported in the United 
States with a male-to-female ratio of 2:1 although it ap-
pears to be more common in children 0-15 years of age. 
It does not commonly involve the thyroid gland and 
very few cases have been reported as Grave’s disease.
cAse	rePort: We are presenting the case of a 23 year 
old female who was diagnosed with LCH at the age 
of 4 months by lymph node biopsy, currently in re-
mission after chemotherapy. She presented with 
complaints of excessive nausea and vomiting of 4 
weeks duration associated with left sided chest pain 
which was moderate in intensity and palpitations. 
She noticed excessive diaphoresis especially at night 
time and bilateral hand tremors. She denied weight 
loss, alteration in bowel or bladder habits, dysphagia, 
dyspnea or hair loss. She denied any family history of 
thyroid disease.
discussion: Endocrinopathies associated with LCH 
include diabetes insipidus, hypogonadism, growth 
failure, abnormalities of glucose metabolism and an 
enlarged thyroid gland. LCH of the thyroid gland is 
misdiagnosed as benign goiters, undifferentiated car-
cinoma, lymphoma or lymphocytic thyroiditis. There 
have been many references to the occurrence of LCH 
and hypothyroidism but the association of LCH and 
Grave’s disease is extremely rare with only two other 
cases reported in literature.
CV135
“Special K”: A Rare Case of Cardio-Pulmonary 
Toxicity Masquerading as Pneumonia and Heart 
Failure
Yamini, S.; Manda, J.; St Joseph`s Regional Medical Center
introduction: Ketamine is a popular club drug espe-
cially in the Asian population. It is abused primarily 
because of its dissociative effect, preferred for its rapid 
onset and short duration of action. Neuropsychiatric, 
neurologic, urinary, renal and hepatic are the usual 
reported toxicities. We present an interesting case of 
ketamine induced flash pulmonary edema.
cAse	rePort: A 41 year old Filipino male with history 
of bipolar disorder on Lamotrigine and possible drug 
abuse was found unresponsive at home with cyanotic 
extremities and chest compressions were initiated by 
wife. EMS found good pulses and cardiac arrest was 
ruled out. He initially responded to Naloxone given 
by EMS. In the ED he was initially agitated however 
quickly became unresponsive and hemodynamically 
unstable, got intubated, was started on pressors and 
antibiotics. There was a history of fever and nonpro-
ductive cough for 2 weeks. Patient was admitted to 
Intensive Care for septic shock and acute respiratory 
failure. Bilateral infiltrates on chest radiograph and 
severe hypoxia raised suspicion for Acute Respiratory 
Distress Syndrome. CT of the chest however showed 
bilateral consolidation. Toxicology screen was 
negative. Interestingly, within 24 hours chest x-ray im-
proves and patient self extubates the next day. Septic 
work up returns negative and he becomes hemody-
namically stable. However latest chest radiograph 
shows pulmonary edema and previously normal BNP 
is now elevated. EKG shows sinus tachycardia and 
troponins are as high as 1.985 but this trended down 
eventually. Patient responds to Lasix but cardiac work 
up, in the form of 2D ECHO, TEE and Nuclear Stress 
Test, is negative. Patient, a pharmacist, later reveals 
he baked Ketamine pills in a microwave oven and 
inhaled the powder. At the time of discharge he was 
symptom-free and chest radiograph was completely 
normal.
discussion: We believe this is the first reported case of 
cardiopulmonary toxicity from ketamine. The sudden 
onset of respiratory symptoms shortly after inhaling 
Ketamine, rapid clearing of consolidation, negative 
septic work-up and then appearance of pulmonary 
edema responsive to diuretic despite a negative car-
diac workup is suggestive of Ketamine toxicity.
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CV136
Adult Hemophagocytic Lymphohistiocytosis: A 
Single Center Experience with a Rare Disease
Yamini, S.; Awkar, N.; Maroules, M.; Ismail, M.; St. Joseph’s 
Regional Medical Center
introduction: Hemophagocytic Lymphohistiocytosis 
(HLH) is a syndrome of immune hyperactivity in 
which the cytokine excess often causes multi-organ 
failure. Generally a disease of the pediatric popula-
tion, this disease has been reported in adults both 
as primary as well as secondary disorder. Infections, 
malignancies, immune disorders and rheumatologic 
diseases are common triggers both for primary and 
secondary HLH. Diagnosis is paramount since mor-
tality is high. Here we discuss 6 cases of adult HLH 
diagnosed at our hospital from 2008 to 2014.
cAse	 rePort: Out of a total of 6 patients, 4 were 
males and 2 females. The mean age was 32.67 . Four 
were Hispanic, 1 was African-American and 1 was 
Caucasian.  4 of them had fever, 2 patients had a rash, 
2 had jaundice and one had splenomegaly. The mean 
ANC was 1,883.33, mean hemoglobin was 6.58, mean 
Platelet count was 47,000 and fibrinogen was low in 
3 patients ranging from 90-143. Mean Triglyceride 
was 653. Ferritin ranged from a mean of 2995.5 to 
>43,207.5 Soluble IL-2 receptor ranged from 7,049 to 
19,487. All were treated with steroids and chemother-
apy.  Associations with HLH were Still`s disease in 2 
patients, ALL in one, disseminated EBV in one, West 
Nile Encephalitis in one and rheumatologic disease 
of unknown etiology in one. 3 patients died during 
hospitalization and 3 were alive at the end of obser-
vation period. The patients who died were as follows: 
28 year old Hispanic Male admitted for multi-lobar 
Pneumonia, found to have disseminated EBV with 
titres as high as 1,800,000, died at day 55 ; a 32 year 
old African-American Female with Still`s disease 
came in for septic shock from Hidradenitis suppu-
rativa, developed dry gangrene of extremities, died 
at day 21; and a 33 year old male, just returned from 
Dominican Republic was admitted for sepsis from 
possible Dengue Hemorrhagic Fever, went into fulmi-
nant hepatic failure, finally found to have West Nile 
Encephalitis, developed MODS and died on 9th day.
discussion: Adult HLH is a rare disease with high 
mortality. Fever and multi-organ involvement are the 
presenting features. Labs show pancytopenia, high 
ferritin, high Triglyceride, low Fibrinogen and elevat-
ed inflammatory pathway proteins on flow cytometry. 
Hemophagocytosis is not required for diagnosis. Treat 
with steroids and chemotherapy. HSCT is for refrac-
tory cases.
CV137
A Rare New Onset Junctional Bradycardia with 
Retrograde Conduction and Ataxia Resulting 
from Oral Phenytoin Toxicity: The Eclectic Side 
Effect Profile for Which Clinicians Should Look
Yamini, S.; Patel, D.; Manda, J.; Saint Joseph’s Regional 
Medical Center
introduction: Phenytoin has a very narrow therapeu-
tic index and a hepatic metabolism implies numerous 
drug-drug interactions. It` s side effects involve almost 
all the organ systems making it a diagnostic dilemma. 
We present a rare case of an elderly patient who had 
neurologic and cardiac symptomatology resulting 
from oral Phenytoin toxicity.
cAse	 rePort: 85 y/o Caucasian female with hy-
pertension, hypothyroidism, seizure disorder, left 
frontal meningioma post resection, previously inde-
pendent, was brought from home with complaints 
of progressive bilateral lower extremity weakness, 
multiple falls and decline in mentation for 6 weeks. 
Prior to presentation, a friend noted her to be star-
ing into space for several seconds. At baseline she 
remained aphasic after meningioma resection. Home 
medications included Phenytoin 100 mg twice daily, 
Levothyroxine150 mcg and Irbesartan150 mg. On 
physical examination reflexes were diminished to 
absent with a narrow based gait, however she was 
alert and oriented. Also blood pressure was elevated 
at 200/99 mm of Hg but she was bradycardic in 40s. 
Patient was admitted to telemetry with suspected 
complex partial seizures versus neuro-cardiogenic 
cause of her falls given the bradycardia. She was start-
ed on Hydralazine and Irbesartan which brought the 
BP down to normal range but asymptomatic bradycar-
dia persisted in 40s. Neurology and Electrophysiology 
services were consulted. MRI of brain, CT of head and 
thyroid function tests were all within normal lim-
its. EEG showed possible partial focal seizures. EKG 
showed junctional bradycardia with retrograde con-
duction at 42bpm. Troponins were negative and 2D 
Echo showed no wall motion abnormality. Free and 
total Phenytoin levels were elevated at 3.45 and 27.2 
respectively, so it was switched to Lacosamide. With 
free levels finally down to <0.3, patient` s ataxia and 
bradycardia resolved completely as verified by repeat 
EKG. All the consultants concurred with our diagno-
sis of dilantin toxicity and patient was discharged to 
subacute rehab in stable condition.
discussion: Multiple studies have shown the involve-
ment of almost all organ systems in IV Phenytoin 
toxicity but only three case reports have been pub-
lished with bradycardia as the cardiac side effects of 
oral Phenytoin. Recognizing its harmful side effects 
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involving multiple organ systems, prompt discontinu-
ation and substitution with other anti-epileptic drug 
if needed is critical as rarely death has been known to 
occur and there is no antidote.
CV138
A Case Of Granulomatosis With Polyangitis
Zia, S.; Iyer, P.; Awan, M.U.; Mettupalli, N.; Hussain, M.; 
Sasinowska, S.; Pantelick, J.; St. Francis Medical Center
introduction: Antineutrophil cytoplasmic antibody 
(ANCA) associated vasculitides are rare diseases, 
with 30 new cases per million per year. Their main 
characteristic is systemic involvement with necrosis 
of media and inflammation of adventitia and intima. 
Granulomatosis with polyangitis is a heterogeneous 
disease with respect to severity and clinical mani-
festation. It could be a rapidly progressive disease 
with a fatal ending or it could be limited to one organ. 
Diagnosis is supported by ANCA positivity and the 
presence of  typical histological findings.
cAse	rePort: We report a case of 55 year old African 
American female with past medical history of dia-
betes, hypertension and hyperlipidemia, who was 
admitted with complaints of malaise, paresthesias 
and hemoptysis for the past one month. Two weeks 
prior to admission she was treated with oral antibiot-
ics for sinusitis without improvement. On evaluation 
she was found to have severe anemia with a hemo-
globin level of 5 g/dL and acute renal failure with 
a creatinine of 5.5 mg/dL. A chest x-ray showed 
bilateral infiltrates. Blood transfusions and intrave-
nous fluids were given but kidney function did not 
improve. The patient was started on dialysis with 
a presumptive diagnosis of pulmonary-renal syn-
drome. Rheumatologic  work up revealed an elevated 
erythrocyte sedimentation rate, but normal  anti-
nuclear antibody, (ANA), antidoublestranded DNA 
(Anti DsDNA), anti-glomerular basement membrane 
(Anti-GBM) antibody and antimyeloperoxidase (anti 
MPO). Anti-proteinase 3 antibody, however, was 
positive. Our patient was started on high dose cor-
ticosteroids. A kidney biopsy showed pauci-immune 
necrotizing glomerulonephritis with crescent forma-
tion thus a diagnosis of granulomatous polyangitis 
(Wegener’s granulomatosis) was made. Treatment 
included seven sessions of plasmapheresis, 1 dose 
of cyclophosphamide and a continuation of high 
dose steroids. Patient showed marked improvement. 
Because of the patient’s compromised immune sta-
tus, she was started on Bactrim as prophylaxis for 
Pneumocystis jirovecii pneumonia (PJP). She was 
transferred to rehabilitation with the plan of dialysis 
and Cytoxan administration every two weeks.
discussion: Initial immunosuppressive therapy in 
granulomatosis with polyangiitis (GPA) typically 
consists of glucocorticoids combined with cyclophos-
phamide. Plasma exchange has no overall mortality 
benefit except in severe active and rapidly progres-
sive renal disease, concurrent anti-GBM antibody 
disease and severe pulmonary hemorrhage. In these 
conditions plasma exchange is the initial treatment of 
choice.
CV139
A Case of Stage IV Non Small Cell Lung  
Carcinoma with Siadh and Superior Vena Cava 
Syndrome
Zia, S.; Iyer, P.; Amba, S.; Siddiqui, W.J; Rosvold, E.; Smith, 
J.M.; St. Francis Medical Center
introduction: Non-small cell lung cancer (NSCLC) is 
a rare cause of Syndrome of inappropriate secretion 
of ADH (SIADH), with three published cases over 
past two decades. SIADH is characterized by hypo-
natremia caused by retention of free water secondary 
to dysregulated release of anti-diuretic hormone. 
Superior vena cava syndrome (SVCS) is caused by 
extracaval compression of the SVC by a bronchogenic 
tumor. Long-term survival for malignancy-related 
SVCS is very low. We present a case of NSCLC pre-
senting with SIADH and SVC syndrome.
cAse	rePort: This is a 70 year old Caucasian male with 
past medical history of hypertension, BPH and anxi-
ety. He was admitted for c/o dizziness, palpitation, 
anorexia and weight loss. He has a smoking history 
of 40 pack years and no family history of malignancy. 
On admission; he had orthostatic hypotension that 
was treated with IV fluids. Workup showed right 
middle lobe lung mass, pleural effusion and hypona-
tremia. His dizziness did not resolve after adequate 
hydration so MRI brain was done which showed 
multiple supra and infra tentorial metastatic lesions. 
Patient was started on IV decadron and palliative 
whole brain radiation after which he displayed some 
symptomatic improvement. Patient subsequently de-
veloped bilateral arm swelling, facial swelling and 
plethora. There was a high clinical suspicion of supe-
rior vena cava syndrome that was confirmed by CT 
chest which showed a central lung mass encasing SVC 
with bilateral pleural effusion. Bronchoscopy guided 
lung biopsy showed poorly differentiated, necrotic 
non-small cell cancer (NSCLC). As prognosis for stage 
IV NSCLC is very poor, patient was offered palliative 
radiation to lungs for symptomatic relief as he was 
not a candidate for chemotherapy secondary to his 
advanced cancer. Workup for hyponatremia revealed 
urine sodium of 126, urine osmolality of 626, and plas-
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ma osmolality of 268 with normal TSH and morning 
cortisol levels. Diagnosis of SIADH was made and pa-
tient responded to salt tabs and fluid restriction. He 
was transferred to nursing home with instructions to 
follow up for radiation.
discussion: This case report portrays a male smoker 
who presented with metastatic NSCLC with poor 
long term prognosis.  Due to worse outcomes in SVC 
syndrome associated with end stage NSCLC, new 
treatment modalities like palliative stent placement 
might be of value in imparting long-standing im-
provement in functionality and quality of life.
CV140
Isolated Cryptococcal Pneumonia in Idiopathic 
CD4+ Lymphocytopenia
Zia, S.; Moncayo, J.L.; Bhatti, H.; Meloro, R.; Ambreen, B.; 
Krathen, J.; Wallach, S.; St. Francis Medical Center
introduction: Idiopathic CD4+ T cell Lympho-
cytopenia (ICL), is an heterogeneous syndrome which 
is defined by a CD4+ cell count <300 cells/microL ,or 
less than 20 % of total lymphocytes on two or more 
occasions separated by two to three months . There 
must be no evidence of Human Immunodeficiency 
Syndrome or any other explanation for the lympho-
cytopenia. Typically, ICL presents as an opportunistic 
infection or triggers an autoimmune disorder. Hereby, 
we present a case of ICL with Cryptococcal Pneumonia.
cAse	rePort: A 65 year old Caucasian female with his-
tory of Hypertension, Hyperlipidemia, severe Mitral 
and Tricuspid Regurgitation, Tonsillar MALT lym-
phoma s/p radiotherapy, presented to another hospital 
facility with dyspnea on exertion. She was transferred 
to our hospital for mitral valve replacement and tri-
cuspid annuloplasty. On the 6th post- operative day 
the patient developed fever with respiratory distress. 
Our clinical suspicion was a Health Care Associated 
Pneumonia as the work up showed a neutrophil 
predominant leukocytosis and a right lower lobe con-
solidation/infiltrate. However, the bacterial sputum 
culture, Legionella, Pneumococcal antigen and blood 
cultures were all negative.  Subsequent fungal sputum 
gram stain, culture and cytology were all positive for 
Cryptococcus neoformans. The Serum Cryptococcal 
antigen was 1:256 and the CSF was negative for cryp-
tococcal antigen. HIV 1 and 2 by ELISA were negative. 
The absolute CD4 count was 64 and the CD4 count 
was 18% of total lymphocytes. A CT of the neck, chest, 
abdomen and pelvis was negative for malignancy. A 
tagged white blood cell scan ruled out any other site 
of infection or malignancy. Interestingly without 
any obvious clinical findings, autoimmune workup 
revealed positive ANA, negative dsDNA and posi-
tive anti-SSA/SSB; our final diagnosis was Idiopathic 
Lymphocytopenia with cryptococcal pneumonia 
and Sjogren’s syndrome. Based on her worsening 
renal function she was treated with fluconazole in-
stead of amphotericin B. Atovaquone was started for 
Pneumocystis jirovecii pneumonia prophylaxis. The 
patient was transferred to a long term acute care fa-
cility on fluconazole. Two months later at a follow-up 
appointment, she had subjective improvement, with a 
new CD4 count of 181.
discussion: Multiple cases of ICL have been described 
during the last twenty years. Isolated cryptococcal 
pneumonia with ICL is rare. Though there were some 
case reports of ICL and Sjogren’s syndrome however, 
the etiology and pathophysiology of having both 
Cryptococcal pneumonia and Sjogren’s Syndrome 
with ICL is unclear warranting further research. ICL 
should be included in the differential diagnosis of 
lymphopenia.
CV141
Plasmapharesis for Treatment of Transverse  
Myelitis Secondary to Multiple Sclerosis
Zijoo, R.; Amba, S.; Bukhari, S.; Amodu, A.; Nadeem, S.; Moser, 
R.; Smith, J.M.; St. Francis Medical Center
introduction:	Multiple sclerosis (MS) is a demyelin-
ating autoimmune disease of unclear etiology and 
pathogenesis, leading to destruction of myelin and 
axons to a variable degree. Transverse myelitis is an 
inflammatory disorder of a segment of the spinal cord 
leading to neurological deficits with an evident senso-
ry level. Transverse myelitis may be the first symptom 
of MS. Steroid therapy leads to recovery however re-
sponse may decrease over time. Therapeutic plasma 
exchange (TPE) and immunoadsorption (IA) has 
shown benefit in those patients.
cAse	rePort: A 55 year old African American female 
came into the hospital for worsening Right leg weak-
ness for 2 weeks. Patient also mentions decreased 
sensation in the right leg. She denied any urinary 
disturbances, weakness or numbness in the left leg or 
upper extremities. She denied headache, blurring of 
vision, trouble speaking or swallowing. She states that 
she has had such episodes every 3 months. On physi-
cal examination the vital signs were temperature 
36.5 C, Pulse 83, Blood pressure 115/79, respiratory 
rate 18. The patient was alert, awake, oriented to time 
place and person. Cardiac and pulmonary examina-
tion was noncontributory. Neurological examination 
demonstrated lower extremity motor weakness on the 
right side 3/5, with 5/5 strength in all other extremi-
ties. Deep tendon reflexes intact 1+ in all extremities 
with down going planter reflexes bilaterally. A senso-
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ry level of T6, impaired vibration and proprioception 
sense in the right lower extremity, normal on the left. 
Impaired pin prick sensation on left lower extremity, 
which was intact on the right. The patient obtained 
MRI Brain and Spine, demonstrating an ill defined in-
creased signal in the thoracic spinal cord at about the 
T7-T9 segment. There appears to be slight thinning of 
the cord in this region suggesting chronicity. The pa-
tient was previously treated with plasmapharesis and 
responded well but was only on steroids currently. In 
this admission she was newly classified as a variant of 
MS. She was started on long term plasmapharesis and 
showed immense improvement.
discussion:	TPE and IA have shown benefit in treat-
ment of MS. TPE benefits by removing autoantibodies. 
TPE can be used in treatment of acute MS exacerba-
tion, when unresponsive to high dose steroids. It is 
also recommended for therapy of chronic progressive 
MS.
CV142
Immune Thrombocytopenic Purpura Secondary 
to Antibiotics
Zijoo, R.; Tatari, A.; Pantelick, J.; Wallach, S.; St. Francis 
Medical Center
introduction: Thrombocytopenia leads to defects in 
primary hemostasis. Inherited hemostatic disorders 
are rare, however acquired disorders are common. The 
most common acquired disorder is Immune throm-
bocytopenic purpura (ITP). Presenting signs and 
symptoms include petechiae, purpura, ecchymosis, 
epistaxis and gum bleeding. Hemoptysis, hematemesis, 
hematuria, hematochezia, and melena are rarely the 
initial manifestations. ITP may be acute; a self-limited 
form is more common in children, or chronic which 
is more common in adults. Diagnosis is established by 
exclusion of other causes of thrombocythemia.
cAse	rePort: A 79 year old Caucasian male, from a 
rehabilitation center was transferred to our hospital 
for an abnormal lab value of five thousand platelets. 
The patient had a past medical history of deep venous 
thrombosis of the left lower extremity after hip sur-
gery which he was receiving warfarin. The patient 
was previously admitted two weeks earlier for left 
lower extremity cellulitis which was treated with van-
comycin and cefepime. He was discharged to a rehab 
facility where he received oral cephalexin for 3 days. 
The patient complained of easy bruising of the skin 
due to a high INR. He denied any blood in the stool or 
urine, bleeding gums, nose bleeds or joint pains. The 
patient had a temperature of 36.4 C, respiratory rate 
of 16, blood pressure 135/62, pulse 98 and pulse ox-
imetry of 97% on room air. Physical examination was 
remarkable for S1, S2 and 3/6 systolic murmurs in the 
aortic and mitral region, bilateral left lower extremity 
2+ pitting edema with a macular erythematous rash 
on the left lower extremity located in the mid tibia. 
No hepatosplenomegaly, petechiae or purpura were 
noted. Laboratory tests demonstrated a WBC 9900/
ml, Hematocrit 39.8%, Hemoglobin 13.1 g/dl, Platelets 
7000/ml, PT 31 seconds, INR 3.0 and PTT 31.3 seconds. 
It was believed that the patient developed ITP second-
ary to cephalexin, which was held during the hospital 
stay. Patient received four doses of intravenous im-
munoglobulin with no complications which led to 
significant increase in platelets up to 138,000/ml.
discussion:	Many drugs have been known to cause 
ITP, due to the development of drug induced antibod-
ies which destroy platelets. Cephalexin is a commonly 
prescribed antibiotic, which has an uncommon side 
effect of thrombocytopenia. More caution needs to be 
taken when prescribing the antibiotic, especially in 
predisposed individuals.
CV143
A Male Patient with Breast Cancer, Prostate 
Cancer and Lymphoma
Zijoo, R.; Iyer, P.; Mughal, A.; Conaway, H.; St. Francis Medical 
Center
introduction: Breast cancer is rare in men and com-
monly presents as a retroareolar painless mass. 
Mammography is utilized in differentiating cancer 
from other benign conditions; however a biopsy is 
necessary to confirm diagnosis. Treatment modali-
ties depend on stage. BRCA1 and BRCA2 testing is 
recommended in all male breast cancer patients. Male 
BRCA1 and BRCA2 mutation carriers have increased 
risk of breast cancer and prostate cancer. Men and 
women with Hereditary Breast and Ovarian Cancer 
Syndrome have increased risks for other cancers.
cAse	rePort:	A 61 year old African American male pa-
tient presenting with left sided breast mass which has 
been increasing in size over the past 1.5 years.  Patient 
complained of itching on the mass but denied any 
pain, discharge or change in color of overlying skin. 
In addition to the above findings, the patient had an 
enlarged prostate on physical exam with an elevated 
prostate specific antigen of 143.6 ng/ml (normal<4ng/
ml). Labs demonstrated a WBC of 442,000/ml, hemo-
globin 12.1 g/dl, hematocrit 36.8% with normocytosis, 
platelets 184,000/ml, neutrophil 7.4% and lymphocyte 
89.9%. A multidisciplinary team was involved in the 
care of the patient, including Urology, Hematology/
Oncology and General Surgery. The patient initially 
underwent an inconclusive fine needle aspiration 
biopsy. Subsequently, a percutaneous core biopsy 
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of the mass was performed which revealed carcino-
ma.  Diagnosis and alternate treatment options were 
presented to the patient.  A left modified radical mas-
tectomy with left axillary dissection was performed. 
Pathologic examination of the breast mass revealed 
invasive ductal carcinoma Grade 2; Estrogen recep-
tor positive, Progesterone receptor positive and HER2 
receptor positive. Lymph node biopsy showed small 
lymphocytic lymphoma, confirmed by immunohisto-
chemical stains. Prior to discharge patient underwent 
transrectal ultrasound guided biopsy of the prostate 
demonstrating prostatic adenocarcinoma. Inadequate 
insurance prevented the patient from receiving rec-
ommended BRCA1 and BRCA2 testing and genetic 
counselling.
discussion: All men with breast cancer need BRCA 
testing, positive test increases likelihood of other can-
cers. Awareness is needed on importance of genetic 
counseling. Significant research in being conducted 
in the field of tumor markers, but more is needed to 
make these commercially available and affordable.
CV144
Occult Primary Breast Carcinoma
Zijoo, R.; Rosvold, E.; Kish, K.; Mechanic, L.; Pantelick, J.; 
St. Francis Medical Center
introduction: Breast cancer, the leading cause of can-
cer death in women, has many presentations. Occult 
primary breast carcinoma is an uncommon form of 
cancer, and is defined as the presence of carcinoma in 
the axillary lymph nodes without evidence of a prima-
ry breast lesion. In the absence of distant metastasis, it 
is classified as Stage IIa; with distant metastasis, it is 
classified as Stage IV. Both are associated with a poor 
prognosis, but potentially curable when treated ac-
cording to established guidelines.
cAse	rePort:	A 60 year old female patient was evalu-
ated for a progressively enlarging right axillary mass. 
The mass, as measured by ultrasound in February 
2014, was found to be 4.7 cm in size. An ultrasound 
performed on the patient two years prior showed only 
large, typical appearing lymph nodes measuring 8mm, 
35mm, and 6mm.  Our examination of the patient for 
a primary lesion included mammography, repeat 
breast ultrasound and bilateral breast MRI. A Cat 
scan of the chest, abdomen, and pelvis proved nega-
tive for a primary source, as did an upper endoscopy. 
A percutaneous core biopsy of the right axillary mass 
confirmed our suspicion of invasive carcinoma of the 
breast. The patient declined chemotherapy, however 
accepted treatment with Anastrazole. After discus-
sions with the oncologist and the surgeon, the patient 
also agreed to a surgical intervention. Right axillary 
dissection was performed and the axillary mass and 
lymph nodes were removed. The patient tolerated the 
surgery well. Immunohistochemical staining on the 
mass demonstrated weak estrogen receptor positiv-
ity and intermediate progesterone receptor positivity. 
Stains of mammary origin such as GCPDF-15 and 
mammoglobin were negative. Negative results, how-
ever, do not exclude primary mammary carcinoma. 
The patient continued her therapy with anastrazole 
and follows up with her oncologist.
discussion: In spite of increased breast cancer aware-
ness, rarer presentations of breast cancer are not well 
recognized. We believe patients need increase aware-
ness and education. Additionally, continued research 
is necessary to produce commercially accessible tests 
enabling accurate immunohistochemical determina-
tion of tumor origin.
CV145
Kikuchi-Fujimoto Disease, a.k.a. Histiocytic  
Necrotizing Lymphadenitis in an African- 
American Male 
Szabela, M.E.Y.; Rana, S.B.: Boghossian J.;  Saint Michael’s 
Medical Center and Seton Hall University
introduction: Kikuchi-Fujimoto disease, also known 
as histiocytic necrotizing lymphadenitis, is an ill-
ness characterized by self-limited inflammation of 
the lymph nodes. It was first described in 1972 as a 
lymphadenitis with focal proliferation of reticular cells 
surrounded by histiocytes and nuclear debris. This is a 
case of an African American male who presented with 
fever, chills, back pain and found to have abdominal 
and retroperitoneal lymphadenopathy. Biopsy revealed 
histiocytes, and lymphocytes with a predominance of 
CD8+ T cells, suggestive of Kikuchi-Fujimoto disease.
cAse	 rePort: The patient is a 49 year old African 
American male smoker with no significant past medical 
history, who presented with fever, chills, and intermit-
tent back pain for several weeks. Initially, he visited 
the emergency room and sent home on Levaquin and 
Tamiflu. He subsequently returned with no improve-
ment in his symptoms. He denied any respiratory 
symptoms, chest pain, abdominal pain, joint pain, di-
arrhea, and urinary symptoms. His sick contacts 
included a mother-in-law with tuberculosis. Upon pre-
sentation to the hospital, the patient was found to have 
fever of 101.7Â°F and tachycardia, with poor dentition. 
The remainder of the physical exam was within normal 
limits. Laboratory results revealed a mild leukopenia 
with a differential within normal range and the patient 
was started on antibiotics for presumptive community 
acquired pneumonia. He then underwent an abdomi-
nal/pelvic CT which showed multiple enlarged lymph 
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nodes greater than 1 cm, anterior to the pancreas with 
mesenteric stranding. A biopsy of a left groin lymph 
node revealed extensive fibrosis and smooth muscle 
metaplasia with no evidence of lymphoma. Omental 
lymph node biopsy was also performed which showed 
dense infiltration by histiocytes, lymphocytes, large 
areas of necrosis, expression of CD68, with B immuno-
blasts positive for CD30, with no evidence of lymphoma, 
consistent with histiocytic necrotizing lymphadenitis. 
Over the course of hospitalization, the patient was giv-
en supportive care and symptoms improved.
discussion: Kikuchi-Fujimoto disease usually affects 
persons of Japanese and Asian origin under the age of 
40. It is a self-limited disease of the lymph nodes that 
must be differentiated from lymphoma and improves 
with symptomatic therapy. In this case, we have 
an unusual presentation with a person of African 
American ethnicity.
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HSR01
Balance Across the Menstrual Cycle
Baker, J.; Smith, C.; Odubayo., Y.; Maher, C.; Hill-Lombardi, V.; 
Seton Hall University School of Health and Medical Sciences
introduction:	Previous studies have demonstrated a 
prevalence of balance deficits in women as well as bal-
ance related injuries.  The purpose of this study was 
to identify the three phases of the menstrual cycle and 
their influence on postural sway, balance and limits 
of stability responses during static and dynamic 
activities.
metHods: Repeated measures design conducted 
in the Human Performance Lab. 3 subjects, mean 
age=41.33(Â±2.30),mean BMI=25.5(Â±1.6), mean cycle 
length=27.8 days(Â±5.2). IV was menstrual cycle, three 
levels:1) follicular, 2) ovulatory and 3) luteal phase, de-
termined via saliva and urine ovulation testing. The 
DVs included Sensory Organization Test (SOT), Limits 
of Stability Test (LOS), Functional Limitation Tests 
(WA, SUO, TW, SQT, FL) using Balance MasterÂ® . 
Repeated measures ANOVAs determined significant 
differences between phases, with post-hoc paired t-
tests. All analyses used p<0.05, SPSS V.22.
results: Significant differences Limits of 
Stability (LOS): MVL4 F=7.055 (p=0.049) MVL6 
F=10.966(p=0.024), EPE1 F=9.689(p=0.029). Walk Across 
(WA): SP F=528.197(p=0.0). In LOS MVL4 and MVL6, 
Ovulatory was greater than Luteal t=12.095(p=0.007), 
t=6.351(p=.024) respectively. Luteal error percentage 
was greater than follicular in Tr1, (t=-7.201, p=.019). In 
WA, Luteal step speed was greater than both follicu-
lar and ovulatory (t=-23.476, p=.002) (t=-85.183, p<.001) 
respectively. Ovulatory step speed was greater than 
follicular (t=-4.990, p=.038).
conclusion: There was a significant increase during 
ovulatory phase in movement velocity while lean-
ing backwards both to the left and right. The luteal 
phase had the fastest step speed in all phases, with 
ovulatory phase significantly higher than follicular 
phase. Potentially, these differences could be attribut-
ed to the hormone surges associated with the phases. 
Overall, these findings conflict with existing research 
that suggests that the phase of menstrual cycle has no 
significant effect on balance.
HSR02
The Effect of Saddle Positioning on Joint  
Kinematics and Muscle Recruitment for 
Triathlon Cycling in the Aero Position.
Boergers, R.J.; London, L.H.; McDonald, B.M.; Teller, M.E.; 
Seton Hall University
introduction: Assessment of muscle recruitment and 
joint kinematics on a triathlon bike can facilitate rec-
ognition of mechanical efficiencies in triathlon cycling. 
The purpose of this study was to determine the effects 
of fore/aft saddle positioning on muscle recruitment 
and joint kinematics while cycling in the aero position.
metHods: In a repeated measures within-subject 
design, five subjects rode triathlon bikes with their 
saddles in 3 positions: their typical neutral, 2cm aft, 
and 2 cm fore. Subjects performed a 5min warm up 
followed by a maximal effort while maintaining a 
cadence of 90 RPM.  Next, subjects rode at their func-
tional threshold power at a cadence of 90 RPM for 
5-10min in all 3 positions. Data was sampled for 5 sec-
onds during each trial.
results: There were no significant main effects of seat 
position on any of the outcome variables.  Trends in 
the data showed that there was increased knee flexion 
angle in the forward position compared to the aft posi-
tion in all positions through the pedal stroke.  Trends 
in the EMG data showed improved muscle activity of 
the vastus lateralis and rectus femoris in the forward 
position compared to the aft position in all positions 
of the pedal stroke, while muscle activity of the biceps 
femoris and semimembranosus seemed to increase in 
the aft position compared to the forward position.
conclusion: Placing the seat in the forward position 
increases knee flexion and seems to increase muscle 
activity, which may not be beneficial for a triathlete 
who will be running upon completion of the bike 
segment.
HSR03
Ergonomic Risk of Development of Upper Quad-
rant Work Related Musculoskeletal Disorders in 
Forklift Operators and its Relationship to Posture, 
Operator Stance / Cab Design, and Task
Brush, L.M.; Cruz, A.B.; Schopperth, C.L.; Duff, J.M.; Seton 
Hall University School of Health & Medical Sciences
introduction: Work related musculoskeletal disor-
ders (WMSDs) account for 34% of reported injuries 
and illness, averaging 12 lost work days per injury. 
In forklift operators the most prevalent causes of lost 
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work days due to WMSDs are injuries to the trunk and 
upper extremity (US Bureau of Labor Statistics, 2012). 
The purpose of this study was to determine ergonom-
ic risk for development of upper quadrant WMSDS in 
forklift operators and to investigate the relationship 
between risk, operator stance/cab design and task.
metHods: Video/photographic images of 39 forklift 
operators performing customary work tasks were 
retrospectively analyzed by a certified associate er-
gonomist (CAE) expert using both the Rapid Entire 
Body Assessment (REBA) and the Rapid Upper Body 
Assessment (RULA). Descriptive statistics were used 
to analyze the risk score data and the Fisher’s Exact 
Probability Test ( p = .05) was used to determine 
whether category of risk differed significantly in rela-
tion to 1) operator stance / cab design, and 2) task type.
results: The sample mean risk scores obtained were 
REBA 5.82 Â± 1.604 and RULA 5.95 Â± 0.724 which 
categorized the sample as medium risk - further inves-
tigation and change recommended soon. Stratification 
by category of risk was Low risk; REBA 10.26%, RULA 
2.56%, Medium risk; REBA 74.35%, RULA 76.93% and 
High risk; REBA 15.40%, RULA 20.1%.  Analysis of 
the relationship between risk category and operator 
stance /cab design, produced statistically significant 
Fisher scores for the REBA (pa: 0.0063, pb: 0.0063) but 
not for the RULA  (pa: 0.4812, pb: 0.4812).  The analy-
sis of the relationship between risk category and task 
type showed no significant difference for the REBA 
(pa: 0.4316, pb: 0.4113) or the RULA ( pa: 0.1846, pb: 
0.1643).
conclusion: Results showed that forklift operators 
are at moderate risk of developing WMSDs and re-
quire timely investigation and intervention. Data 
trends suggest an association between increased ergo-
nomic risk and task type but these findings were not 
statistically significant. Increased risk, however, was 
significantly associated with the use of dock stance 
versus universal stance. The relationship between 
ergonomic risk, task, operator stance and other po-
tential risk factors needs further investigation before 
effective interventions can be developed.
HSR04
Autism Spectrum Disorder (ASD) and  
Immunizations: College Students’ Beliefs
Desmarais, B.M.; Viereck, A.M.; Berfet, S.K.; Newby, D.S.; 
Jurgensen, L.M.; Goonetilleke, J.A.; Seton Hall University
introduction: In 1998 Wakefield proclaimed there to 
be a link between vaccinations and autism; while the 
results have since been disproven, some still hold that 
belief. The purpose of this study is to evaluate college 
students’ beliefs regarding whether there is an associ-
ation between immunizations and Autism Spectrum 
Disorder (ASD).
metHods:	This study is a non-experimental, quantita-
tive analysis using volunteer college age students. A 
13 question survey on beliefs of immunizations and 
ASD that was validated by practicing professionals 
was handed out in the college student center. Analysis 
was done using SPSS to calculate frequency counts 
and descriptive statistics.
results: Two hundred thirty-four college students 
completed the survey and the average age was 19. 77 
(32.9%) believed there to be a link between vaccina-
tions and ASD. Of the students surveyed, 38 students 
(16.2%) reported that they would not vaccinate any 
of their own future children. 28.6% of the students 
cited hearing of a link from media sources such as 
television and radio, with only 4.7% of students ever 
discussing the topic with a health care provider.
conclusion: While the majority of college students 
do not believe in a link between vaccinations and 
ASD, a concerning percentage do. Most students plan 
on vaccinating their future children; however, 16.2% 
unvaccinated children can lead to a loss of herd immu-
nity. It is important to confront these misconceptions 
so that the current vaccination rate improves instead 
of declines. There is a need for healthcare providers 
to assess their patients’ knowledge on vaccinations 
and provide proper education so that individuals can 
make informed decisions without media bias.
HSR05
Considerations for Writing Instruction in  
Children with High Functioning Autism
Gauntlett, D.N.; Koutsoftas, A.D.; School of Health and Medical 
Sciences
introduction: Language is cataloged as one of the 
hallmark deficits of children with Autism, with writ-
ten language being affected in addition to other modes 
of language. This meta-analysis reviews research for 
treatment considerations in written language skills 
of children with High Functioning Autism (HFA). 
The Hayes and Flower (1980) writing process model 
is used as a framework to report on writing skills in 
terms of planning, translating, and revising.
metHods: Researchers used a set of search terms 
across appropriate data-bases to obtain studies with-
in the last 20 years on the assessment or treatment of 
writing in children with HFA. Studies had to include 
either direct intervention of writing in children with 
HFA. Studies were organized into planning, translat-
ing, revising and cross-referenced by genre. Studies 
that accounted for meta-cognitive approaches includ-
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ing theory of mind were also included in the review.
results: 17 studies met our inclusionary criteria. 
Data is reported as an aggregate across all studies and 
then as aggregates of the specific writing component 
discussed.
conclusion: Findings from this review help iden-
tify high-need areas for future intervention research. 
There is a paucity of research on writing interventions 
for children with HFA which does not bode well for 
improving this skill. This is especially detrimental 
for two reasons. First, children with HFA are more 
frequently placed in general education environments 
without writing support and second, academic de-
mands are increasing their emphasis in terms of 
writing requirements.
HSR06
Participation Instruments: A Systematic Review
George, K.W.; Monteleone, S.A.; Shevardnadze, A.; Seton Hall 
University
introduction: Participation as defined by the 
International Classification of Functioning (ICF) 
is “involvement within a life situation in relation 
to health conditions, body functions and structure, 
activities and contextual factors.” Tools exist that mea-
sure participation in various settings and in varied 
populations. It was not known if a tool exists to mea-
sure participation that is considered meaningful and 
useful for students enrolled in college. This system-
atic review was undertaken to find a tool to measure 
participation factors of students with and without dis-
abilities who are enrolled in college.
metHods: Four databases, including Ebscohost 
and its associated databases; ProQuest Health and 
Medical Complete; Seton Hall Library Search includ-
ing ScienceDirect, Cinhal, and Medline; and Pubmed 
were reviewed; articles generated in the searches 
were inserted into Refworks. Articles were organized 
and eliminated based on title using pre-determined 
criteria, including “participation” defined by the ICF. 
The remaining references were reviewed based on 
abstract using agreed upon inclusion and exclusion 
criteria. A second abstract review, with more specific 
criteria, was completed to funnel more meaningful 
search results. Some abstracts lacked adequate in-
formation regarding existing outcome measures; 
therefore, they were analyzed for their intended pur-
pose and population.
results: One-thousand and one different articles met 
the initial title search criteria. A total of twenty-eight 
articles contained existing outcome measures; no ar-
ticles met all criteria of the search.
conclusion: The American Physical Therapy 
Association (APTA) reports that major benefits of 
receiving physical therapy services include improv-
ing the quality of life, the ability to earn a living and 
enjoy leisure pursuits. Physical therapists are now us-
ing outcome measures to assure that these benefits 
have been garnered through treatment interventions. 
Unfortunately, objective measures of participation in 
life activities are few. After an initial review of 1,001 
article titles and the reading of 28 articles containing 
existing outcome measures, this systematic review 
concluded that no tools met the criteria of this exten-
sive search. Our next step is to evaluate and extract 
aspects from existing participation assessment tools 
in order to create a measure intended for college-aged 
individuals.
HSR07
The Most Cited Articles regarding Anterior  
Cruciate Ligament Injuries in the Past 20 Years
Goljan, P.; Pierce, C.M.; Scillia, A.J.; Festa, A.; Patel, D.V.; 
McInerney, V.K.; Feagin, J.A.; St. Joseph’s Regional Medical 
Center/Seton Hall University
introduction: Anterior cruciate ligament (ACL) in-
juries continue to be a major focus within sports 
medicine research.  With so many changes to our 
understanding of ACL anatomy and rapid advances 
in reconstruction techniques and rehabilitation proto-
cols within the past 20 years, it is important to identify 
the landmark articles that make up the foundation of 
current ACL treatments.  This study set out to identify 
and create a reading list of the most commonly cited 
articles related to ACL injuries within the last 20 years.
metHods: A Web of Science Citation Index Search was 
performed using terms related to ACL research topics 
within the area subset of orthopedic and surgery.  The 
search was limited to January 1994 to present day.  The 
generated list was sorted from highest to lowest cita-
tion number. Clinical studies were subcategorized as 
therapeutic, prognostic, diagnostic, or economic/deci-
sion analysis and assigned a level of evidence.  Basic 
science articles were designated as anatomic, animal, 
biomechanical or clinical.  The number of citations per 
year (citation density) was calculated.
results: The search yielded 6,345 articles.  The total 
number of citations among the top 30 ranged from 
188 to 611.  Citation density ranged from 10.1 to 66.2. 
Nineteen articles were clinical, 8 were basic science, 
and 3 were video analyses.  Clinical articles were most 
commonly therapeutic (18 of 19; 95%).  Basic science 
articles were most commonly biomechanical (7 of 8; 
88%).  The most common level of evidence was Level 
II (10 of 19; 53%).  More than half (16 of 30; 53%) of the 
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articles in the top 30 were published in The American 
Journal of Sports Medicine.
conclusion: Many of the articles in the present list have 
played a large role in shaping current clinical practice 
regarding ACL injuries. We hope that by compiling 
this list we can both identify potential deficiencies in 
recent ACL research, as well as create a reading list of 
high impact studies for easy reference by residents, fel-
lows and practicing sports medicine surgeons.
HSR08
The Effect of Dynamic Warm-Up on Strength
Henze, M.; Rock, P.; Carroll, R.; Cunningham, M.; Phillips, H.J.; 
Hill-Lombardi, V.; School of Health and Medical Sciences
introduction:	For optimal performance, rotator cuff 
musculature should be prepared for activity via a 
warm-up routine in overhead athletes. However, con-
troversy exists over which exercises are most effective. 
Traditional plyometrics have been widely accepted. 
However, the creation of the Bodyblade has initi-
ated an argument that oscillatory warm-up is most 
effective. Our purpose is to determine whether a ply-
ometric or oscillatory warm-up exercise routine will 
produce greater strength during internal rotation (IR) 
and external rotation (ER).
metHods: Using a within-subjects, repeated measures 
design, 13 university students (6 females, 7 males); 
mean age=23.69 (Â±1.1094), mean BMI=25.32 (Â± 2.57) 
were tested. The IV was dynamic warm-up with three 
levels: a) plyometric, b) oscillatory, c) no warm-up. 
Pre- and post-strength measurements including peak 
torque (PT) (ft/lb), angle of peak torque (APT) (deg), 
mean of peak torque (MPT) (ft/lb), time to peak torque 
(TPT) (msec) during IR and ER. Repeated measures 
ANOVA were used to determine significant differ-
ences in change scores, paired t-tests to determine 
pre-to-posttest differences. All analyses were con-
ducted using SPSS V22.0 (p < 0.05).
results: Significant results: MPT ER with BD F = 3.5 
(p = .046), MPT ER with BD (t = -2.618, p = 0.022), PT IR 
with BB (t = -2.773, p = 0.018), PT ER with BD (t = -2.360, 
p = 0.038), MPT ER with BD (t = -2.618, p = 0.022).
conclusion: MPT ER and PT ER increased followed 
plyometric exercise, which is necessary for the pre-
stretch mechanism critical to plyometric exercises. 
This pre-stretch mechanism combined with elastic tis-
sue recoil energy increases the motor unit stimulation 
and strength of contraction, which will help increase 
the strength of the preceding IR contraction. Therefore, 
the athlete will have more thoroughly activated rota-
tor cuff musculature prior to overhead sports using a 
plyometric warm-up.
HSR09
The Impact of Cycling Exercise on Physiological, 
Functional and Psychosocial Outcomes in 
Persons with Multiple Sclerosis: A Systematic 
Review
Inirio, D.; Taylor, J.M.; Seton Hall University
introduction: Multiple Sclerosis (MS) is an autoim-
mune disease which presents with a wide range of 
symptoms commonly including fatigue, sensitiv-
ity to heat, weakness, impaired balance, depression, 
spasticity, and reduced mobility.  However, the 
health benefits of light to moderate exercise in this 
population have been well documented.  Cycling 
is an intervention that can be utilized to decrease 
symptoms and maintain health and mobility in per-
sons with MS while minimizing potential adverse 
effects. In other neurological populations such as 
spinal cord injury populations, cycling has shown 
to improve functional mobility.  The purpose of this 
paper is to systematically review the studies exam-
ining the effects of cycling exercise on physiological, 
functional and psychosocial outcomes in individuals 
with MS.
metHods: PubMed, PEDro, CINAHL, and Google 
Scholar were searched from 1994-2015.  The search 
terms used were “Cycling multiple sclerosis”, 
“Bicycling multiple sclerosis”, “Cycle exercise multiple 
sclerosis”, “Bicycle multiple sclerosis”, and “Ergometer 
multiple sclerosis.” 237 titles were identified through 
PubMed (105), PEDro (12), CINAHL (4), and Google 
Scholar (116).  146 titles were rejected because they 
did not contain the appropriate intervention.  65 titles 
were further excluded because they were duplicates. 
26 articles were chosen for inclusion in the study.
results: Cycling exercises were executed using sever-
al different types of cycling interventions such as arm 
cycling, leg cycling, loaded cycling and/or unloaded 
cycling across the studies which resulted in varying 
outcomes. Most studies reported that cycling had 
significant beneficial effects on functional outcomes 
such as walking speed, distance, dynamic balance 
and psychosocial outcomes such as quality of life 
and depression ratings. The results for physiological 
outcomes were mixed; only half of the studies noted 
significant improvements in spasticity, pain and aero-
bic capacity. Several studies evaluated arm cycling 
versus leg cycling and reported that although both 
had significant beneficial effects, leg cycling was more 
effective.  Most studies reviewed used unloaded leg 
cycling and reported significant improvements in aer-
obic capacity and reduction in fatigue. The few studies 
examining the effect of loaded leg cycling, reported 
significant improvements in functional mobility.
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conclusion: This review selected articles with varying 
styles of cycling interventions (arm/leg cycling, loaded/
unloaded cycling) and study designs (cross-sectional 
and longitudinal). However the majority of the studies 
concluded that cycling has a positive impact on the 
physiological, functional and psychosocial outcomes 
in individuals with varying stages of multiple sclerosis.
HSR10
Factors and Attitudes that Impact the  
Completion of Advance Directives
Isaacson, A.S.; Appleman, J.M.; Armenia, S.J.; Poland, M.D.; 
Samsky, E.N.; Sedrak, M.M.; Seton Hall University
introduction: The decision to complete an advance 
directive is influenced by a multitude of factors in-
cluding race, cultural differences, family-centered 
decision-making, and level of trust in healthcare pro-
viders. While more than 60% of individuals in the 
general population aged 18 and older expect their end-
of-life plans to dictate their care, less than one-third of 
this population has completed an advance directive. 
The purpose of this study is to identify factors that 
influence the completion or lack of completion of ad-
vance directive forms.
metHods: This study is a non-experimental, quantita-
tive analyses of the factors and attitudes that impact 
the completion of advance directives. The conve-
nience sample was comprised of 55 faculty, staff and 
administrators at Seton Hall University. The survey 
instrument, the Advance Directive Attitude Survey 
(ADAS), has previously proven reliability and con-
tent validity, and was obtained and modified with 
permission by the original authors. The survey was 
administered via email using the Academic Survey 
System and Evaluation Tool (ASSET). Analysis of the 
data was performed using SPSS 19.0 and inferential 
statistics were applied using Chi Square, frequency of 
means and crosstab analysis with a p value of 0.05.
results: Eighty percent of participants were females 
and 83% were males. Participants varied in age, with 
10.9% of participants aged 18-30, 23.6% aged 31-40, 
20% aged 41-50, 32.7% aged 51-60 and 12.7% aged 
60 and older. Participants also varied in religious 
affiliation, with 47.3% identifying as Catholic, 12.7% 
identifying as Christian, 3.6% identifying as Jewish, 
20% identifying as other and 16.4% identifying as non-
religious. The Pearson Chi-Square test demonstrated 
no significant association between presence of religion 
and individuals agreeing or strongly agreeing that 
family members would support the completion of 
an advance directive. However, this value trended 
towards significance X2 (4, N = 53) = 9.06, p =.06. No 
significant association was found between age and 
agreeing or disagreeing that having an AD would 
prevent costly medical expenses for family members 
X2 (12, N=53)=11.95, p=.45. No significant association 
was found between age and individuals agreeing 
or strongly agreeing that they are not sick enough to 
complete advance directive forms X2 (12, N=55)=13.23, 
p=.35.
conclusion: No significant association was found 
between religion and perceived familial support 
of advance directive completion. Furthermore, no 
significant associations were found between age and 
perceived costly medical expenses for family members, 
nor between age and individuals perceiving that they 
are not sick enough to complete an advance directive. 
Low completion rates despite generally favorable 
attitudes towards ADs suggest additional factors 
influencing the decision not to complete advance 
directive forms. A replicate study with a higher n 
may demonstrate a significant association between 
presence of religion and likelihood of individuals 
agreeing or strongly agreeing that family would 
support the completion of an advance directive.
HSR11
Use of Arterial Pulse Wave Analysis Following 
Concussion: A Perspective on Post-Injury  
Cardiovascular Autonomic Function
LaFountaine, M.L.; Megherian, K.M.; Ambrogio, A.A.; Hurley, 
J.H.; Hill-Lombardi, V.L.; Seton Hall University
introduction: The arterial pulse wave has a distinct 
morphology whose contour reflects dynamics in car-
diac function and peripheral vascular tone as a result 
of sympathetic nervous system control. With a transi-
tion from rest to one of increased metabolic demand, 
the expected augmentation of SNS outflow will not 
only affect arterial blood pressure and heart rate, it 
will also induce changes to the contours of the APW. 
Following a sports concussion, previous evidence has 
suggested that a state of transient cardiovascular au-
tonomic dysfunction is present.  How this state affects 
the APW, has yet to be described. To evaluate changes 
in APW characteristics at rest and during an isometric 
handgrip test (IHGT) in recently concussed athletes 
and non-injured controls.
metHods: Prospective, parallel-group, observational 
study design in University sports medicine labora-
tory. Eleven intercollegiate athletes with concussion 
and 7 non-injured athletes who served as controls 
completed the study procedures. Cardiovascular 
autonomic assessment was performed in the seated 
upright position at rest and during a 3 minute IHGT 
(30% maximum voluntary contraction) within 48 
hours of concussion. Heart rate, systolic, diastolic and 
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pulse pressure were determined and APW contour 
analyses were performed on the beat-to-beat blood 
pressure signal to calculate the slope of the systolic 
and diastolic upstroke. To evaluate differences in the 
transition from rest to “work”, group mean data were 
calculated for rest and the F60 seconds of the IHGT.
results: Separate univariate analyses of variance 
were performed and there were no group differences 
for HR, SBP, DBP or PP at rest or F60.  Because the 
SysS is inherently related to SBP and DiaS to DBP, 
separate analyses of covariance were performed (with 
the respective BP serving as the covariate) to identify 
the presence of conditional group differences.  The 
concussion group has a significantly reduced SysS 
compared to controls at rest [estimated marginal 
means (EMM): 403 vs. 448 mmHg/sec, respectively] 
and during F60 (EMM: 358 vs. 495 mmHg, respectively). 
DiaS was not conditionally different by group.
conclusion:	Use of APW contour analysis revealed 
that concussed athletes have a reduced SysS at rest, 
and a paradoxical transition to a state of increased 
metabolic demand within 48 hours of injury.  Further 
work is needed to determine how and when this 
change resolves, and whether or not it may contribute 
to exercise intolerance seen during the progressive 
return-to-play.
HSR12
Antipsychotic Quality Reporting: Effects on Anti-
psychotic and Psychoactive Medication Use
Lucas, J.A.; Bowblis, J.R.; Brunt, C.S.; Seton Hall University; 
Miami University; Georgia Southern University
introduction: With evidence of negative health 
outcomes for use of antipsychotic medications in 
nursing home residents with dementia, public policy 
initiatives have attempted to reduce the unnecessary 
use of these medications. However, unintended 
effects such as substitution of other medications with 
similar sedating properties, may occur. This study 
examines how nursing homes changed their use of 
antipsychotic and other psychoactive medications in 
response to Nursing Home Compare’s initiation of 
publicly reporting a quality measure of antipsychotic 
use for long stay residents in July 2012.
metHods: The study includes all state recertification 
surveys (n=40,415) for facilities six quarters prior 
and post the initiation of public reporting.  Using a 
difference-in-difference framework, the change in 
use of antipsychotics and other psychoactive medica-
tions (hypnotics, anxiolytics, antidepressants, or any 
psychoactive medication) is compared for facilities 
subject to public reporting and facilities not subject to 
reporting.
results: The percentage of long stay residents us-
ing antipsychotics, hypnotics, or any psychoactive 
medication is found to decline after public reporting. 
Facilities subject to reporting experienced an addition-
al decline in antipsychotic use (-1.94 v. -1.40 percentage 
points) but did not decline as much for hypnotics (-0.60 
v. -1.21 percentage points).  Any psychoactive medica-
tion use did not vary with reporting status, and the 
use of antidepressants and anxiolytics did not change 
over the study period.   Reporting facilities saw de-
clines about 40% larger than non-reporting in the 
short run. This is clinically meaningful, representing 
over 6,800 fewer residents receiving antipsychotics on 
a given day. By six quarters out, the non-reporting fa-
cilities saw similar declines in antipsychotics.
conclusion: Quality reporting seems to be having the 
intended effect. Public reporting of an antipsychotic 
quality measure can be an effective policy tool for re-
ducing the use of antipsychotic medications - though 
the effect many only exist in the short run.
HSR13
Barriers to CPR Training Among College Aged 
Students
Manappuram, B.; Grajales, K.; Pathickal, S.; Franco, J.; Seton 
Hall University School of Health and Medical Sciences
introduction: According to the American Heart 
Association, about 70% of Americans feel helpless 
during a cardiac emergency situation since they do 
not know how to adequately administer CPR. CPR 
performed immediately after cardiac arrest can dou-
ble, or even triple an individual’s chance of survival. 
However, only 32% of these cases receive CPR by a 
bystander. The amount of people with heart disease 
is increasing, which is likely to increase the incidence 
of myocardial infarctions. It is important to have 
someone present who has knowledge about what to 
do in an emergency situation. Research mostly shows 
the reasons why the elderly population may not be 
interested in CPR training. The younger student pop-
ulation may have different reasons, such as cost, that 
could be helpful for the future of CPR classes.
metHods: Students over 18 years old and currently 
not enrolled in a Medical/Allied Health profession 
program (Physical Therapy, Occupational Therapy, 
Athletic Training, Physician Assistant, Speech 
Pathology, Nursing) were asked to voluntarily com-
plete a computer-based survey through Asset. The 
survey was developed by the authors and consisted 
of 15 questions that gathered demographic and train-
ing status information, reasons why they did not take 
training classes as well as willingness/confidence to 
perform CPR. Descriptive statistics and frequency 
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counts were used to analyze the demographic data. 
Chi Square and Phi coefficient were used for informa-
tion regarding CPR training. The Statistical Package 
for the Social Sciences (SPSS) software was used for 
computations with a p value set a 0.05.
results: Of the 135 surveys collected, a majority of 
participants were non-Hispanic white (44.4%), females 
(58.5%) between the ages of 18-20 (80.1%), freshmen 
and sophomores (69.6%). The majority of respon-
dents who did not take CPR classes were freshmen 
and sophomores (42.5%). The most common reasons 
found for not taking CPR classes were that students 
were unaware of courses (19.3%) and time (10.4%). 
Students stated they would take CPR classes if there 
were more advertisement of classes (50.8%) or if cost 
was decreased (21.3%). The most common reason for 
not being trained among unemployed students was 
because students were unaware of courses (37.9%) 
while the least concerning reason was cost (0.03%). A 
Chi-Square correlation performed showed a positive 
correlation between age and level of confidence in 
performing CPR in those who were CPR certified (p 
< 0.05). It demonstrated that younger students (ages 
18 and 19) were more confident in administering CPR 
than older students (ages 20+). Exercising and smok-
ing habits did not affect CPR training status. There 
were no other statistically significant relationships 
found with the data.
conclusion: Lack of public advertisement is the lead-
ing cause of why college aged students are not CPR 
trained, even among unemployed students. Such re-
sults indicate that more public advertisement may 
increase the number of CPR trained students. The 
study also suggests that the younger aged students 
had more confidence in performing CPR than the older 
students. Although the results of our study cannot be 
generalized to the entire college population as a whole, 
the results demonstrate a need for further research to 
be conducted. Further research can be done on college 
students worldwide to find other relationships be-
tween CPR training status and the student population 
as well as evaluate why younger students are more 
confident in CPR performance than older students.
HSR14
Development of a Chemical, Radiological,  
Environmental Threat Warning System for a 
Disaster Response Mobile Hospital
Morchel, H.; Bonin, C.; Ogedegbe, C.; DelMoro, G.; Feldman, 
J.; Goncalves, T.; Cerbone, J.; Hackensack University Medical 
Center, CACI Technologies INC
introduction: Hackensack UMC hosts a fleet of disas-
ter response mobile hospitals. The mobile hospitals 
have provided emergency medical care at multiple 
events including storms and the 2014 Super Bowl.  A 
warning system for chemical,radiological, environ-
mental threats was developed”
metHods: HUMC teamed with CACI Technologies, 
Inc. and secured funding through the New Jersey 
Technology Solutions Center to develop a Concept of 
Operations and Proof of Concept System to provide 
the deployed MACH assets with sensors and an au-
tomated decision support capability to detect and 
respond to Chemical, Biological, Radiological and 
Weather (CBRW) threats in the area of the deployed 
assets.  This CBRW monitoring and mitigation capa-
bility will be incorporated into MACH deployment 
scenarios to secure the safety of responders and 
facilities.
results: As a result of the grant from the NJ 
Technology Solutions Council (NJTSC), Phase I has 
been completed.  This phase included the comple-
tion of Requirements Analysis, Threat Analysis, 
Concept of Operations Document and the Design 
and Development of a prototype system for Proof 
of Concept.  The prototype system, named “CACI 
Thunderstorm”, includes an array of networked 
sensors, communications and a network-enabled 
Decision Support System (DSS) Dashboard.
conclusion: The results of this effort have provided 
a technical, operational and programmatic frame-
work suitable for the engineering and deployment of 
CBRNEW/FP capabilities for the MACH and similar 
systems deployed across the nation and abroad in 
support of homeland defense/homeland security 
operation in the US and OCONUS expeditionary 
operations.
HSR15
Attitudes Regarding the Utilization of Ultraviolet 
Radiation in Healthcare Facilities for Infection 
Control
Morris, E.A.; McKeever, K.M.; Schilder, V.G.; Turner, J.A.; 
Seton Hall University
introduction: UV-C radiation technology can be ap-
plied in a range of healthcare settings such as patient 
rooms, operating rooms, emergency rooms, intensive 
care units, shared staff areas, and public areas. The 
purpose of this study is to evaluate attitudes and 
opinions of coordinators of infection control or equiv-
alents on the use of UV-C radiation for disinfection 
in their health care facilities in order to gain a better 
understanding of how UV-C radiation can be more ef-
fectively utilized in the future.
metHods: This is a non-experimental, qualitative 
study that utilizes an interview-based type of ques-
tioning of persons holding the title of “Coordinator 
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of Infection Control” or equivalent job description 
in health care facilities in the Northeast region of the 
United States. They were asked a series of open-ended 
questions on their attitudes and opinions of the uti-
lization of UV-C radiation for disinfection in their 
facilities. The interviews were transcribed and then 
analyzed using analytic induction in order to identify 
trends and formulate a working hypothesis. The iden-
tified patterns were assigned labels for coding, which 
were then placed into potential thematic categories. 
Finally, the data were summarized in order to gain a 
generalized understanding of all of the responses.
results: The individuals who participated in this 
study stated that UV-C radiation is to be used in 
addition to manual cleaning. They have observed 
reductions in infectious disease in their facilities, as 
well as peace of mind amongst their patients and staff. 
Depending on the number of machines they own or 
lease, they prioritize the rooms that they consider to 
be most important, namely isolation rooms and oper-
ating rooms. They support the use of this method in 
other health care facilities as well. However, all of the 
subjects identified cost and time as the primary deter-
rents to the use of this method of cleaning.
conclusion: The common themes presented by the 
subjects of this study suggest that UV-C radiation 
technology is a useful supplement to manual clean-
ing in health care facilities that can be effectively used 
in order to reduce the rates of hospital-acquired in-
fections. Although costly and time consuming, the 
responses also imply that UV-C radiation should be 
used as a standard cleaning technique in more hospi-
tals nationwide.
HSR16
It’s The Way You Said It!  Evaluation of Emotional 
Tone in Aprosodia
Odejar, M.; Patel, S.M.; Seton Hall University
introduction: Everyday interactions involves the 
exchange of emotional information.  Vocal communi-
cation of one’s emotions is particularly important for 
interpersonal interactions. In a variety of neurologi-
cal diseases this ability is impaired or nearly absent. 
Methods to evaluate and rehabilitate individuals with 
emotion communication deficits are lacking.  Hence, 
the purpose of this study was to learn about how peo-
ple judge and evaluate deficits in emotional speech 
expressions. 
metHods: Ten individuals (18-26 years) participated 
in this study. Subjects judged 238 samples taken from 
a database of five patients with aprosodia. These 
samples were obtained using the Florida Emotional 
Expressive Battery (FEEB), in which the patients were 
asked to express sentences with one of five emotional 
tones (happy, sad, angry, fearful, neutral) while being 
recorded.  These speech samples were played to sub-
jects over headphones, one at a time, on a computer 
using Matlab software. Subjects were asked to judge 
whether the speaker correctly produced any of the 
five emotional tones based on ONLY the tone-of-voice. 
After selecting the emotion category, they were asked 
to rate the magnitude of the emotion from 1 (little 
emotion) to 7 (lot of emotion).  Responses were saved 
into an Excel file.
results: Matlab software was used to aggregate 
responses from all subjects.  Results show that na-
ive raters tend to judge emotional expressions from 
patients with aprosodia as being less expressive com-
pared to 1) the clinician’s ratings at the time the test 
was administered “online”, 2) the clinician’s ratings 
performed on the recordings after meeting the patient 
(“offline”) and similar to a group of expert listeners 
in the field of speech language pathology who never 
met the patient. Although individual listeners varied 
in their accuracy of judgments, the highest overall 
percentage correct was 65%, indicating that these pa-
tients do in fact have a difficult time expressing their 
emotions effectively enough for listeners to recognize. 
Differences between patients were also seen.  For ex-
ample, the emotions of Patient 5 were more difficult 
to identify than others (measured as percent correct), 
while the emotions of Patient 1 were the easiest to 
identify.  Differences were observed in patients’ abil-
ity to produce certain emotions over others and also 
in patients’ ability to produce an emotional tone for a 
tone that matched the sentence content as opposed to 
mismatched or neutral content.
cAse	rePort: We conclude that patients with aproso-
dia vary in their degree of disabilityâ€”some have 
more difficulty expressing their emotions while oth-
ers’ intended emotion could be identified albeit with a 
low degree of expressivity. We conclude that using the 
FEEB in a clinical setting to assess emotion communi-
cation ability does not match how everyday listeners 
perceive the emotions of the speaker. 
HSR17
Solo Flipped Learning Environment: Merging 
Ideas to Foster Critical Thinking
Pinto Zipp, G.; Maher, G.; School of Health and Medical Science
introduction: Today’s learning environments have 
transitioned from teacher-focused to student-focused 
environments. With this transition the introduction of 
various teaching strategies including webinars, videos, 
cases, and mind/concept mapping to mention a few 
134
have been introduced into the classroom to support 
a student’s knowledge acquisition and critical think-
ing skills. Recently, the notion of creating a “Flipped 
Classroom” has emerged as a means to address the 
needs of today’s learning environments and students.
metHods:	 In the flipped classroom model the place-
ment of lectures on line is only one part of the learning 
environment. As Carpenter (2012) wrote, “If students 
are to become more than just multi choice test experts 
then teachers must help them to do more intellectual 
work in the classroom.” In order for learning environ-
ments to truly engage students in developing as active 
critical thinkers, flipped classroom experiences must 
maximize active learning.
results: The authors are proposing a “flipped learn-
ing environment” based upon the SOLO (Structure 
of Observed Learning Outcomes) model of learning 
proposed by Biggs and Collis (1982) as a mechanism to 
develop student critical thinking skills. In the SOLO 
based Flipped learning environment lectures are 
placed on line and provided to students prior to class 
sessions.  Students are expected to complete assigned 
readings and engage in the lectures prior to the onsite 
learning session.  During the onsite learning session 
the professor acts as a mentor or coach and sets the 
stage for students active learning experiences by 
developing rich engaging thought provoking experi-
ences which focus on applying what has been lectured 
on and read. The faculty can use diverse teaching and 
learning strategies to engage students in practicing 
and applying their skills under the mentorship and 
guidance of a faculty member.
conclusion: Regardless of the strategy employed the 
authors suggest that the goal of this flipped learning 
environment is to increase complexity in a student’s 
understanding of the subject matter by fostering the 
transition along five stages of development presented 
in the SOLO model, pre-structural, unistructural, mut-
listructural, relational, and extended abstract level. 
Ultimately, this environment supports student-teach-
er interactions that foster feedback, engage students, 
and create opportunities for rich self-paced learning.
HSR18
Caffeine Consumption and its Side Effects:  
A Comparative Study of Healthcare Students in 
the Didactic versus Clinical Phase of Study
Pry, K.N.; Costa, C.; Sweeney, M.A.; Pellechio, S.; Walden, 
C.E.; Hanifin, C.; Seton Hall University
introduction: Caffeine is the most widely used psy-
choactive stimulant with more than half of American 
adults drinking an average of three cups of coffee a 
day. While a positive correlation between caffeine 
intake and stress levels in students has been demon-
strated in a previous study, the impacts of caffeine on 
physical and mental well-being were not specifically 
interrogated. The purpose of this study is to compare 
the use of caffeine in didactic versus clinical phase of 
study as well as analyze the negative side effects of 
caffeine consumption that could lead to poor focus 
and medical errors in the clinical field.
metHods: The study employed a non-experimental, 
quantitative survey design utilizing a convenience 
sample of health science graduate students from a 
small university. The survey instrument used in 
this research study was created by the authors and 
validated. It consisted of 12 multiple choice questions 
addressing program affiliation, phase of schooling, 
average caffeine use, reasons for consumption and 
perceived effects of caffeine and stress levels. The 
survey was distributed via a blast email by each 
program’s department chair or other delegated per-
son. Descriptive statistics were used to analyze the 
responses pertaining to amount of caffeine consump-
tion between clinical and didactic phase of schooling 
using SPSS software version 15.0.  A p value of <0.05 
was considered statistically significant.
results: A total of 60 students completed the survey, 
of which 26 students were in the didactic phase of 
schooling and 34 students were in their clinical 
phase. Of those in their clinical phase who drink 
caffeine, 48.4% answered that they drink less caffeine 
than in didactic phase while 48.4% of students stated 
that they drink the same amount of caffeine. 3.2% 
of students stated they drink more caffeine in their 
clinical phase vs. didactic. There is no statistical 
significance in caffeine consumption between 
clinical and didactic phases. We also investigated 
perceived negative side effects from caffeine and 
caffeine withdrawal, which was also found to be not 
statistically significant with p values of 0.602 and 
0.854 respectively.
conclusion: When comparing the use of caffeine in 
the didactic versus clinical phase of study, the data 
demonstrated equal or lesser amounts of caffeine 
consumption in the clinical phase of study. However, 
there was no statistically significant difference with 
nearly half of all responses, indicating no change in 
caffeine consumption. Also, there was no statistically 
significant data found when looking at the perceived 
negative side effects from caffeine and caffeine 
withdrawal.  For our study to be statistically relevant 
and significant, we would need a larger sample 
size and preferably a longitudinal study design in 
order to control for individual variation and to be in 
conjunction with studies in the literature review.
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HSR19
HPV Knowledge Among College-Aged Students
Roessler, L.; Logue, M.; Cangialosi, M.L.; Peluso, H.J.; Rizzolo, 
D.; Seton Hall University
introduction: Human Papillomavirus is currently 
one of the most common sexually transmitted infec-
tions.  Research demonstrates that there still remains 
a general lack of knowledge regarding HPV.  Research 
also demonstrates that knowledge regarding HPV 
increases when populations are educated about HPV. 
Questionnaires given to participants months after re-
ceiving brief education regarding HPV demonstrated 
an increased level of knowledge.  There are many 
modes of transmission of information regarding HPV 
including health care professionals, the Internet, mag-
azines, television, etc.  The purpose of this study is 
to determine where college students primarily obtain 
their information regarding HPV from as well as to 
determine their knowledge of HPV and its association 
with the development of oral cancer.
metHods: The study employed a qualitative survey 
design.  The survey instrument used in this research 
study was borrowed from a study done by Ricardo 
Lopez titled “College-aged Men’s (18-24) Knowledge 
and Perceptions of Human Papillomavirus and 
Cervical Cancer”.  The survey consisted of 14 knowl-
edge questions and 1 question regarding education 
methods. Undergraduate and graduate students be-
longing to a private college were asked to voluntarily 
complete the survey.  The survey were distributed 
in the student center.  Analysis of the data was per-
formed using SPSS, inferential statistics were applied 
using descriptive statistics.
results: A total of 138 students completed our survey. 
In regards to the students’ knowledge of HPV and 
oral cancer, 46% answered correctly and indicated 
that there was a link, while 53% indicated that there 
was not a link between HPV and oral cancer.  The 
most common resource students obtained HPV infor-
mation from was their Healthcare Provider at 29.7%. 
The least common source was the students’ partners 
at 0.8%.  Of the 138 students who took our survey, 7.8% 
indicated that they have never heard of HPV.
conclusion: The results of this study suggest that 
while students do possess some knowledge about 
HPV and the manifestations, most do not have full 
knowledge of the disease and possible complica-
tions, specifically oral cancer. Many students reported 
receiving their information regarding HPV from a 
source other than a health care professional. Such re-
sults indicate that this population would benefit from 
educational interventions designed to increase aware-
ness about HPV as well as more thorough discussions 
from primary care providers regarding HPV. Through 
open discussion between clinicians and patients pro-
viding factual information, the public can become 
more knowledgeable of HPV and the associated risks 
and complications.
HSR20
The Role of Shape Cues in Preschoolers’ Word 
Learning
Saks, J.; Capone Singleton, N.; Seton Hall University
introduction: Shape and function cues have been ef-
fective in eliciting the names of taught words (Capone 
& McGregor, 2005; Capone Singleton, 2012). However, 
shape cues provide the additional benefit of extend-
ing those names to untaught exemplars. Here, we 
compare shape and indicator cues (a new control), but 
test children repeatedly over time and task, to discern 
the effect of shape cues. We use error analysis, naming 
performance and word extension tasks. In particular, 
error analysis and word extension to ever-before-
seen-exemplars help disambiguate what aspects 
of the semantic-, lexical- and linking of the two are 
strengthened by shape cues.
metHods: Twenty preschoolers learned object words 
in a Shape condition (words paired with a gesture 
highlighting the shape of the object) and in a Control 
condition (indicating gestures paired with words). 
Naming was tested on days 1, 2, and 3 via iPAD. Word 
teaching occurred after the Naming test on days 1 and 
2. On day 3 children named untaught exemplars us-
ing objects they had never seen (i.e., Extension).  Word 
forms were controlled for syllable shape, phonotactic 
probability and neighborhood density.
results: Errors were subject to 2(condition)x2(day) 
repeated measures-ANOVA. Error results were that 
children’s over-extension errors and semantically-
related errors declined and increased, respectively, 
from day 2 to 3, but did not differ between conditions. 
There was a trend toward fewer indeterminate errors 
(i.e., missing representations) in the Shape condition 
by day 3. Children produced no phonological errors. 
On day 3, children named marginally more taught 
objects as a whole in the Shape condition (p = .06), but 
mapped more phonemes in their Shape condition re-
sponses (i.e., Phonological Make-up; p = .02). Children 
extended taught names to shape-similar and -dissimi-
lar exemplars more often in the Shape condition (p = 
.01), and to shape-similar exemplars regardless of con-
dition (p = .01).
conclusion: This study examined the role of shape 
cues in word learning. A surprising absence of pho-
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nological errors indicated weak/missing links to 
lexical representations of the word representations 
themselves. Only with shape cues did access to word 
forms emerge (i.e., Naming, Phonological make-up, 
Extension Naming). There was a trend toward fewer 
indeterminate errors on day 3 in the Shape condition, 
indicating fewer missing representations. Results 
suggest that shape cues move children toward map-
ping the word form sooner but also toward building a 
durable link between meaning and word form.
HSR21
The Association of a Long-Term Shoulder and 
Neck Strengthening Program and Injuries of 
the Head, Neck, and Shoulder: A Retrospective 
Study
Sivo, A.; DeCuffa, J.; Amicucci, J.; McCartney, J.; Hill-Lombardi, 
V.; Seton Hall University School of Health and Medical Sciences
introduction: Neck and shoulder strength have been 
identified as potential factors in reducing the risk 
of head and neck injury in contact sports, with the 
potential of a strong neck/upper quadrant absorb-
ing and redistributing concussive forces. The results 
of previous studies are inconclusive, therefore the 
purpose is to determine if there is a relationship be-
tween participation in an isotonic neck and shoulder 
strength training protocol and the occurrence of head, 
neck, and shoulder injuries over a five-year span. The 
neck strengthening protocol was implemented for the 
latter four of the five years.
metHods: Data collected from 91 HS FB players from 
2009 -2013 football seasons. Neck exercises: shrugs, 
chin tucks, flexion, extension, lateral bending; upper 
extremity exercises: bench press, chest press, seated 
row, shoulder press exercises. A “workout” was de-
fined by completing 75% of the assigned exercise. The 
protocol began in the 2010-11 school year but data 
collection on workout frequency began in the 2012-
13 school year.  Frequency of football related injuries 
of the head, neck, and shoulder prior to and follow-
ing implementation of the strength training protocol 
was documented in school years 2009-14.  In addition, 
frequency of workouts was assessed and correlation 
was used to determine if that significantly impacted 
the number of injuries seen. All analyses were run in 
SPSS v22, p<0.05.
results: In 2012-13 athletes performed an average of 
8.2 neck workouts, 5.4 shoulder workouts. In 2013-14 
athletes performed an average of 13.7 neck workouts, 
7.9 shoulder workouts. In 2010-2011, regimen changed 
and neck strengthening was first incorporated. During 
that year there were a total of 10 concussions. In 2011-
12, when the main focal point of the intervention was 
neck strengthening, there were 4 concussions. In 2012-
13 there were 2 concussions and in 2013-14 there were 
3 concussions.  No significant correlation was found 
between the number of workouts and the number of 
injuries.
conclusion: Following the implementation of the 
workout protocol there was a decrease of injuries 
that occurred to individuals who were compliant 
in performing the neck and shoulder strengthening 
protocol.  While there was a decrease in the number 
of injuries, further research needs to be done on this 
topic to determine if there is a significant impact of 
neck strengthening in reducing the risk of injury.
HSR22
Lacrosse Helmet Removal Versus Helmet 
Facemask Removal: A Comparison of Time and 
Head and Neck Movement
Smith, G.A.; Olini, K.J.; Bird, A.; Boergers, R.J.; Seton Hall 
University
introduction: Cervical spine injuries are potentially 
life threatening events that may occur in collision 
sports, including lacrosse. Following a catastrophic 
injury, standard procedures to access the airway in a 
timely manner are essential to facilitate patient and 
spine stabilization.  There are no established stan-
dards for accessing an airway during pre-hospital 
management of an acute cervical spine injury for a 
lacrosse athlete.
metHods: Subjects were randomly assigned to 1 hel-
met and performed 3 trials each of FM removal and 
helmet removal. During HR, subjects placed their 
hands just outside the earholes of the helmet while a 
second rescuer assisted with head/neck stabilization. 
During FMR, subjects used an electric screwdriver 
to remove the screws that held the facemask in place 
while the second rescuer assisted with head/neck 
stabilization.
results: We found significant interactive effects 
for removal method and helmet type (P=0.004) as 
well as significant main effects for removal method 
(P<0.001, FMR=36.68sÂ±12.76s, HR=24.99sÂ±5.00s) 
and helmet type (P=0.004, Warrior=26.20sÂ±6.32s, 
Cascade=34.82sÂ±13.11s) on removal times.  We 
also found significant main effect for removal 
method on movement in the sagittal plane (P<.001, 
FMR=4.03Â°Â±1.99Â°, HR=9.74Â°Â±3.72Â°).  Lastly, we 
found a significant helmet effect for movement in the 
transverse plane (P=0.012, Warrior=4.63Â°Â±1.96Â°, 
Cascade=5.93Â°Â±0.93Â°).
conclusion: HR was faster than FMR however created 
more movement in the sagittal plane.  In order to limit 
motion at the cervical spine, FMR should be consid-
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ered during pre-hospital management of catastrophic 
injuries.  The Cascade R helmet took longer to remove 
via FMR and produced greater motion because of the 
complex helmet design.  It is important to take func-
tionality into consideration when designing a helmet, 
rather than adding features for aesthetics since it can 
cause complications in a medical emergency.
HSR23
Five Types of Knowledge for Spelling:  
A Developmental Study
Wilson, O.; Koutsoftas, A.; Seton Hall University
introduction: Current research supports that spelling 
acquisition is a linguistically governed skill, which 
develops from growth in knowledge of phonology, 
morphology, and orthography. However, English or-
thography is full of irregularities and variations that 
require knowledge extending beyond Triple Word 
Theory (Bahr et al., 2012). This study investigates the 
presence of additional types of knowledge required 
for spelling development, specifically Semantic and 
Mental Orthographic Representations, also required 
for successful spelling. Additionally, the study exam-
ined spelling in the context of a naturalistic writing 
task.
metHods: Eighty children from fourth and sixth 
grade participated in the study. Spelling errors were 
catalogued from rough drafts and finals copies as part 
of an extended writing process task. Errors were cod-
ed under five categories: phonological, orthographic, 
morphological, semantic, and mental orthographic 
representations. Proportions of spelling errors by cat-
egory in relation to the total number of errors were the 
measures of interest.
results: Data analysis is ongoing. Initial coding of the 
samples revealed that errors have been noted across 
all five categories, including semantic and Mental 
Orthographic Representations. Early trends suggest 
that participants decreased the total number of mis-
spellings from rough draft to final copy.
conclusion: Findings indicate that school age stu-
dents are detecting spelling errors when given time to 
revise their writing, with older students demonstrat-
ing higher rates of spelling correction. Differences in 
spelling ability by grade and type of errors produced 
provide insight into tangible assessment and inter-
vention targets.
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IP01
The Relationship Between Menstrual Cycle 
Changes, Postural Control and Balance:  
A Systematic Review
Barthel, C.L.; Crowley, D.C.; Greenfield, A.C.; Maher, C.M.; 
Seton Hall University
introduction: It has been observed that female ath-
letes suffer more injuries than their male counterparts. 
Investigators have reported the different potential 
explanations for this observation: anatomical, bio-
mechanical and neuromuscular differences and 
influence of hormones. It has been hypothesized that 
force generation, balance and postural control may be 
compromised during different phases of the menstru-
al cycle as a function of circulating hormones.
IP02
Biting and Chewing Development in Young  
Children: A Pilot Study
Capone-Singleton, N.C; Goodrich, E.A; Walter, E.J; Patel, N.V; 
Seton Hall University
introduction: Speech-Language Pathologists (SLPs) 
evaluate feeding disorders in young children. SLPs 
use the Pre-Feeding Skills Checklist (Morris & Klein, 
2000) as a gold-standard in the evaluation of feeding 
development. This checklist is based on longitudinal 
study of 6 children but has not gone through peer-
review or publication in scientific journal. This pilot 
will provide the foundation for a larger data-base be-
ing collected toward that end. Our aim is to provide a 
peer-reviewed published data-base of age-milestones 
for SLPs to reference.
IP03
Cell Phone Use Changes Walking Strategies
Fina, M.J.; Perniola, R.P.; Wilson, D.O.; Stiskal, D.M.; Seton Hall 
University- Physical Therapy Department
introduction: Technology continues to rapidly 
increase and we become dependent on it. The 
smartphone is a key device during activities of daily 
living (ADLs). Because of the numerous capabilities 
that can be performed with a smartphone, humans 
devote varying amounts of visual, physical, and 
cognitive attention to the applications rather than 
focusing on primary tasks, such as ambulation. 
There is limited research on safety risks that occur 
while walking and using a smartphone. Previous 
research suggests that gait changes do occur in adults 
while they simultaneously walk and participate in 
smartphone tasks. To date, no published studies have 
quantified the temporal-spatial parameters of gait 
during different walking conditions.
IP04
Correlation between Speech and Language  
Fluency in Normal Adult Speakers
Gardner, M.E; Dayalu, V.N; Koutsoftas, A.D.; Department of 
Speech-Language Pathology, School of Health and Medical 
Sciences
introduction: Normal adult speakers manifest errors 
in speech fluency. The overall percentage of speech er-
rors is less than 3% of the total output but it varies 
across speaking tasks and context. Further, individ-
ual variability in the percentage of fluency errors and 
type of errors have been recorded. Considering the in-
tricate relationship between speech and language, it is 
likely that variations in fluency across context and the 
overall percentage and type of errors are correlated to 
measures of language fluency.
IP05
Concurrent Validity of the Shaw Gait Assessment 
Tool in Individuals with Incomplete Spinal Cord 
Injury
Haggan, J.H.; Esemplare, N.E.; Liesch, J.L.; Sutor, T.S.; Nair, 
P.N.; Seton Hall University
introduction: Background: There is a need for assess-
ing walking outcomes after a therapeutic intervention 
in people with incomplete spinal cord injury (ISCI). 
The Shaw Gait Assessment Tool (SGAT), a cost-effec-
tive and easily available tool would be of great value 
to the treating clinician. It is therefore important to 
establish the validity of the tool for the assessment of 
walking in people with spinal cord injury.
IP06
Insulin Resistance and Microvascular Function 
in Persons with SCI
LaFountaine, M.; Blankenship, S.; VanderGroef, K.; Najafi, J.
introduction: Cutaneous microvascular blood 
flow is regulated by multiple mechanisms, includ-
ing that by insulin and by the sympathetic nervous 
system (SNS). Insulin is the principal hormone re-
sponsible for the disposal and storage of glucose in 
skeletal muscle, in part by the re-direction of blood 
flow through the rhythmic dilatation or contraction 
of arterioles. In insulin-sensitive individuals, this 
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“vasomotion” is thought to involve the activation of 
the vascular smooth muscle, with vasodilatation oc-
curring through nitric oxide. In persons with spinal 
cord injury (SCI), a disproportionately high preva-
lence of insulin resistance and diabetes mellitus has 
been reported. We postulate that insulin resistance, 
in combination with the added consequence of SNS 
impairment below the neurological level of injury, 
contribute to hemodynamic dysregulation and a vari-
ety of medical complications, including pressure ulcer 
formation and decreased wound healing.
PurPose: To determine the relationship between the 
homeostatic model assessment-derived measurement 
of insulin sensitivity and the magnitude of change in 
blood perfusion during insulin iontophoresis above 
and below the level of lesion in persons with SCI.
Protocol: Persons with SCI and able-bodied controls 
will complete the study. Fasting blood samples will 
be obtained to determine insulin and glucose concen-
trations; HOMA calculation of insulin sensitivity will 
be determined for later comparison. All participants 
will undergo iontophoresis treatment with insulin 
and placebo that will deliver the respective agent 
trans-dermally.  Iontophoresis requires that two elec-
trodes be placed at the specified locations on the right 
arm and right leg. The cathode electrode will contain 
0.2 ml of liquid insulin or 0.2 ml of placebo (normal 
saline) in separate procedures; the anode electrode 
will be adhered to the other location. Laser Doppler 
flowmetry (LDF) measurements to obtain cutaneous 
blood perfusion unit (BPU) responses will be taken at 
baseline for 3 minutes, after which the iontophoresis 
will begin and last for 14 minutes. After the area has 
been treated by iontophoresis, LDF measurements 
will be performed to obtain the peak blood perfusion 
unit (BPU) response; the percent change of BPU from 
baseline will be calculated for comparison to HOMA 
scores.  The net difference in BPU between the Insulin 
and Placebo responses to treatment will be calculated 
and compared to HOMA scores.
IP07
The Application of Hyperspectral Imaging to 
Evaluate the Extent of Burn Injury 
Morchel, H.; Sheby, D.; Hazelood, V.; Carlisle, A.; Kaul, S.; 
DeVinck, D.; Hasser, C.; Hackensack University Medical Center
introduction: To determine whether Hyperspectral 
Imaging (HSI) can identify spectral parameters use-
ful for classifying burn wounds in order to aid in the 
diagnosis of burn severity, especially differentiating 
between partial thickness and full thickness burns, 
which would help to guide treatment.
metHods: Data was obtained from six porcine subjects 
with a total of two wounds each. Partial Thickness 
thermal wounds were created on the back of each 
subject using a 3cm x 5cm brass template.   The brass 
template was heated in a 70C water bath, wiped dry, 
and placed on the skin with no pressure other than 
gravity for 15 seconds to create the thermal wound. 
An image was captured with a hyperspectral camera 
at each time point in addition to a 6mm punch biopsy 
at the edge of the wound as well as control biopsy 
from the center of the wound.
results: It is expected that the histology data will 
show a positive correlation with the parameters 
identified with the hyperspectral images.  These 
correlations can possibly result in the quantitative 
measurement of burns to differentiate between par-
tial thickness and full thickness burns.
conclusion: The ability to quantitatively measure 
burn severity with a hyperspectral camera image has 
the potential to compliment the physician’s qualita-
tive assessment of patients with thermal injuries.
IP08
Writing Analysis in Children with Hearing  
Impairments: An Exploratory Study
Odiase, J.E; Koutsoftas, A.; Seton Hall University
introduction: Language develops across the four 
modalities of language: speaking, listening, writing 
and reading. If there is an impairment in one modal-
ity, then it will negatively impact one or more of the 
other modalities. Children who are hearing impaired 
have obvious difficulties with the listening modality; 
however, it is unclear how this might affect other mo-
dalities, in particular writing. The aim of this study is 
to better understand the written modality in children 
with hearing impairments.
IP09
Inter-Rater Reliability of Novice Learners Using 
the Behaviorally-Anchored Lift Task Evaluation 
(BALTE)
Phillips, H.J.; Papaccio, M.; Kratch, A.; Antonios, M.; Seton Hall 
University
introduction: Lift task evaluations are used in physi-
cal therapy to determine a person’s ability to perform 
specific tasks related to their occupation and assess 
their readiness for return to work. The Behaviorally-
Anchored Lift Task Evaluation (BALTE) can be used to 
determine safe lifting abilities and safe levels of exer-
tion for patients who are trying to return to work. The 
BALTE has been proven to be reliable when used by 
experienced physical therapist evaluators, but has not 
been used by novice learners.
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IP10
Gender Differences in Surface Electromyography 
and Postural Stability in Healthy Seton Hall 
University 3rd Year Doctor of Physical Therapy 
Students During a Step Down Task
Quevedo, D.; Tababa, B.; Tonon, A.; Seton Hall University
introduction: Healthy males and females between 
18-45 perform functional tasks, such as walking and 
stepping down from a curb or staircase, as part of 
everyday normal activities. There are known differ-
ences in basic walking patterns, center of mass (CoM), 
and muscle activity between genders during normal 
walking. During gait, males activate hip muscles 
more, display decreased hip flexion and greater knee 
extension, while females activate calf muscles more 
prior to heel contact. Considering these known dif-
ferences, there is likely a gender difference in surface 
electromyography (sEMG) and ground reaction forces 
(GRF) during other functional tasks. However, litera-
ture related to differences between genders during a 
step down task is lacking. Thus, this project serves to 
investigate this gap in knowledge.
IP11
“It’s All in Your Head” – The Psychiatrist’s Role in 
the Diagnosis and Management of Conversion 
Disorder in Medical Settings: Case Series and 
Literature Review
Spariosu, M.; Coira, D.; Hackensack UMC, Rutgers NJMS, 
St George’s University Medical School
introduction: Conversion disorder is a diagnosis that 
can cause a lot of stigma in patients and their families 
as well as feelings of helplessness in medical care pro-
fessionals. Patients with conversion disorder usually 
present to a hospital in despair, with acute motor or 
sensory deficits, with symptoms closely mimicking 
a cerebrovascular accident, seizures, or other fright-
ening diagnosis. After a thorough noncontributory 
medical and neurological work up, when patients hear 
that “nothing is wrong with them and it’s all in their 
head” they may further develop decompensation or 
lack of symptom resolution. More education needs to 
be provided to the primary medical team regarding a 
therapeutic approach towards a patient with suspect-
ed functional disorders. Rapid involvement of a well 
trained psychiatrist in working with patients with 
conversion disorder is crucial.
IP12
Writing Macrostructure in Children with and 
without Language-Learning Disabilities
Tinagero, K.L.; Koutsoftas, A.; Seton Hall University
introduction: This paper reports on writing macro-
structure in children with language learning disorders 
(LLD). Writing is an important academic skills and 
within the scope of practice for the speech-language 
pathologist. This study compares macrostructure 
analysis of narrative writing samples in children with 
LLD to children with typical development (TD) and 
will help us better understand how to account for writ-
ing macrostructure in children with and without LLD.
IP13
The Effect of Dual Tasking on Spatiotemporal 
Gait Parameters in Older Adults During Incline 
Walking Under Various Task Conditions:  
A Review of the Literature
Zipp, G.; Maher, C.; Sholander, P.; Lee, A.; Seton Hall University- 
Physical Therapy Department
introduction: In daily life, older adults are often re-
quired to do more than one thing at a time, which has 
been defined as “dual tasking”. Understanding the im-
pact of dual tasking on spatiotemporal characteristics 
of gait across age groups is foundational to designing 
effective treatment interventions that address activity 
limitations and foster one’s participation within their 
community.
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